
<html lang="en"     class="pb-page"  data-request-id="a7a36d4b-2f4b-4ace-b7bd-bc27ce603c77"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b00532;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-10;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC)" /></meta><meta name="dc.Creator" content="Wentian  Wang" /></meta><meta name="dc.Creator" content="Lu  Zhang" /></meta><meta name="dc.Creator" content="Lorraine  Morlock" /></meta><meta name="dc.Creator" content="Noelle S.  Williams" /></meta><meta name="dc.Creator" content="Jerry W.  Shay" /></meta><meta name="dc.Creator" content="Jef K.  De Brabander" /></meta><meta name="dc.Description" content="Despite advances in targeted anticancer therapies, there are still no small-molecule-based therapies available that specifically target colorectal cancer (CRC) development and progression, the seco..." /></meta><meta name="Description" content="Despite advances in targeted anticancer therapies, there are still no small-molecule-based therapies available that specifically target colorectal cancer (CRC) development and progression, the seco..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 9, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00532" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00532" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00532" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00532" /></link>
        
    
    

<title>Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00532" /></meta><meta property="og:title" content="Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0013.jpeg" /></meta><meta property="og:description" content="Despite advances in targeted anticancer therapies, there are still no small-molecule-based therapies available that specifically target colorectal cancer (CRC) development and progression, the second leading cause of cancer deaths. We previously disclosed the discovery of truncating adenomatous polyposis coli (APC)-selective inhibitor 1 (TASIN-1), a small molecule that specifically targets colorectal cancer cells lines with truncating mutations in the adenomatous polyposis coli (APC) tumor suppressor gene through inhibition of cholesterol biosynthesis. Here, we report a medicinal chemistry evaluation of a collection of TASIN analogues and activity against colon cancer cell lines and an isogenic cell line pair reporting on the status of APC-dependent selectivity. A number of potent and selective analogues were identified, including compounds with good metabolic stability and pharmacokinetic properties. The compounds reported herein represent a first-in-class genotype-selective series that specifically target apc mutations present in the majority of CRC patients and serve as a translational platform toward a targeted therapy for colon cancer." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00532"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00532">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00532&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00532&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00532&amp;href=/doi/10.1021/acs.jmedchem.9b00532" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5217-5241</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00497" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01912" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Wentian Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wentian Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wentian++Wang">Wentian Wang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Lu Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lu Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cell Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lu++Zhang">Lu Zhang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Lorraine Morlock</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lorraine Morlock</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lorraine++Morlock">Lorraine Morlock</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Noelle S. Williams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Noelle S. Williams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Noelle+S.++Williams">Noelle S. Williams</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jerry W. Shay</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jerry W. Shay</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cell Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jerry+W.++Shay">Jerry W. Shay</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Jef K. De Brabander</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jef K. De Brabander</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#561c3330781233142437343738323324160302053923223e2133252233243878333223"><span class="__cf_email__" data-cfemail="f4be9192dab091b6869596959a909186b4a1a0a79b81809c8391878091869ada919081">[emailÂ protected]</span></a>. Tel: (214) 648-7808. Fax: (214) 648-0320.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jef+K.++De+Brabander">Jef K. De Brabander</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8816-5798" title="Orcid link">http://orcid.org/0000-0001-8816-5798</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00532&amp;href=/doi/10.1021%2Facs.jmedchem.9b00532" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5217â5241</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 9, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 March 2019</li><li><span class="item_label"><b>Published</b> online</span>9 May 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00532" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00532</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5217%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWentian%2BWang%252C%2BLu%2BZhang%252C%2BLorraine%2BMorlock%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D10%26contentID%3Dacs.jmedchem.9b00532%26title%3DDesign%2Band%2BSynthesis%2Bof%2BTASIN%2BAnalogues%2BSpecifically%2BTargeting%2BColorectal%2BCancer%2BCell%2BLines%2Bwith%2BMutant%2BAdenomatous%2BPolyposis%2BColi%2B%2528APC%2529%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5241%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00532"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1339</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00532" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wentian&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Lu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Lorraine&quot;,&quot;last_name&quot;:&quot;Morlock&quot;},{&quot;first_name&quot;:&quot;Noelle&quot;,&quot;last_name&quot;:&quot;S. Williams&quot;},{&quot;first_name&quot;:&quot;Jerry&quot;,&quot;last_name&quot;:&quot;W. Shay&quot;},{&quot;first_name&quot;:&quot;Jef&quot;,&quot;last_name&quot;:&quot;K. De Brabander&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5217-5241&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00532&quot;},&quot;abstract&quot;:&quot;Despite advances in targeted anticancer therapies, there are still no small-molecule-based therapies available that specifically target colorectal cancer (CRC) development and progression, the second leading cause of cancer deaths. We previously disclosed the discovery of truncating adenomatous polyposis coli (APC)-selective inhibitor 1 (TASIN-1), a small molecule that specifically targets colorectal cancer cells lines with truncating mutations in the adenomatous polyposis coli (APC) tumor suppressor gene through inhibition of cholesterol biosynthesis. Here, we report a medicinal chemistry evaluation of a collection of TASIN analogues and activity against colon cancer cell lines and an isogenic cell line pair reporting on the status of APC-dependent selectivity. A number of potent and selective analogues were identified, including compounds with good metabolic stability and pharmacokinetic properties. The compounds reported herein represent a first-in-class genotype-selective series that specifically target a&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00532&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00532" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00532&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00532" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00532&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00532" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00532&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00532&amp;href=/doi/10.1021/acs.jmedchem.9b00532" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00532" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00532" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00532%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DWang%26date%3D2019%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BTASIN%2BAnalogues%2BSpecifically%2BTargeting%2BColorectal%2BCancer%2BCell%2BLines%2Bwith%2BMutant%2BAdenomatous%2BPolyposis%2BColi%2B%2528APC%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D10%26spage%3D5217%26epage%3D5241%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/jmcmar.2019.62.issue-10/20190523/jmcmar.2019.62.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Despite advances in targeted anticancer therapies, there are still no small-molecule-based therapies available that specifically target colorectal cancer (CRC) development and progression, the second leading cause of cancer deaths. We previously disclosed the discovery of truncating adenomatous polyposis coli (APC)-selective inhibitor 1 (TASIN-1), a small molecule that specifically targets colorectal cancer cells lines with truncating mutations in the adenomatous polyposis coli (APC) tumor suppressor gene through inhibition of cholesterol biosynthesis. Here, we report a medicinal chemistry evaluation of a collection of TASIN analogues and activity against colon cancer cell lines and an isogenic cell line pair reporting on the status of APC-dependent selectivity. A number of potent and selective analogues were identified, including compounds with good metabolic stability and pharmacokinetic properties. The compounds reported herein represent a first-in-class genotype-selective series that specifically target <i>apc</i> mutations present in the majority of CRC patients and serve as a translational platform toward a targeted therapy for colon cancer.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57358" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57358" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Colorectal cancer (CRC) is the second leading cause of cancer deaths resulting in â¼600â000 deaths worldwide every year (49â700 in the United States and 152â000 in the European Union).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Despite the fact that the disease etiology for the majority of CRCs is fairly well understood, there are still no therapies available that specifically target oncogenotypes that drive CRC development and progression.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2â4)</a> In addition to early detection (colonoscopy and genetic testing) and surgical removal of precancerous adenomatous polyps (adenomas), current treatment options for advanced CRC include surgery, radiation therapy, and chemotherapy.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2â4)</a> A large body of studies have shown that the primary initiating event in both familial adenomatous polyposis (FAP) and sporadic CRC is a loss of function of the adenomatous polyposis coli (APC) tumor suppressor gene leading to aberrant crypts and early adenomas.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5â7)</a> According to the model of Fearon and Vogelstein, these early events in the adenoma to adenocarcinoma sequence cause genomic instability leading to the acquisition of additional mutations in various oncogenes such as KRAS or BRAF, SMAD4, TGF-Î², and frequently in the tumor suppressor TP53.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Although the full spectrum of biological pathways regulated by the large multifunctional <i>apc</i> protein remains a topic of debate,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> it is now commonly accepted that wild-type APC (APC<sup>wt</sup>) is essential for intestinal cell differentiation and crypt homeostasis at least in part via regulation of the Wnt signaling pathway.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> It is estimated that mutations in the APC gene occur in >80% of patients diagnosed with CRC with >90% of those mutations targeting the mutation cluster region leading to defined truncated APC (APC<sup>TR</sup>) gene products.<a onclick="showRef(event, 'ref13 ref14 ref15 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref5 ref6">(13â15,5,6)</a> While loss of tumor-suppressive function of APC mutations is believed to be important for CRC tumorigenesis,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> increasing evidence suggests that the truncated form of the mutant APC<sup>TR</sup> protein also endows these tumors with gain-of-function properties.<a onclick="showRef(event, 'ref10 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref10 ref16 ref17 ref18 ref19">(10,16â19)</a> For instance, a recent paper co-authored by some of us documented that <i>apc</i>-truncations relieve the autoinhibition of C-terminal activation of Asef (APC-selective guanine exchange factor) leading to downstream Golgi fragmentation via activation of an Asef-ROCK-MLC2 signaling pathway.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p last">In light of the above, we reasoned that small-molecule cytotoxins that specifically target colon cancer cell lines with APC<sup>TR</sup> while sparing normal cells with APC<sup>WT</sup> would provide for a potential highly selective therapy for the vast majority of CRC patients. This approach is further supported by a recent study demonstrating that introduction of APC<sup>WT</sup> in colon cancer models reestablishes normal intestinal crypt homeostasis and function, even in the presence of potent oncogenic drivers such as Kras and p53.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> We have recently described a potent small molecule that selectively kills CRC cells with truncated <i>apc</i> protein termed truncated APC-selective inhibitor 1 (TASIN-1) using a 200â000 compound high-throughput screen (HTS) to identify small molecules with selective cytotoxic activity against an experimentally developed human colonic epithelial cell (HCEC) line with introduced oncogenes (KRAS, CDK4, TERT), coupled with loss of tumor suppressor function (p53) and expressing a mutant <i>apc</i> protein truncated at amino acid residue AA1309 (1CTRPA A1309).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> TASIN-1 was not toxic against the isogenic HCEC cell line that expressed the wild-type <i>apc</i> protein (1CTRPA), and selectivity for <i>apc</i>-truncating mutations was retained in every human cell line (normal and cancer) that we tested. Based on serum and sterol rescue experiments, we postulated that TASIN-1 exerts its cytotoxic effects through inhibition of cholesterol biosynthesis at the level of emopamil-binding protein (EBP), the enzyme that isomerizes a Î8,9 to a Î7,8 double bond.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Furthermore, TASIN-1 inhibited the growth of human tumor xenografts in mice implanted with tumors derived from DLD-1 or HT29 (APC<sup>TR</sup>), but not HCT116 (APC<sup>WT</sup>) CRC cell lines.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Also, TASIN-1 treatment significantly reduced the number of polyps and tumor size in the colons of a genetically engineered mouse <i>apc</i> inactivation model of colonic adenoma-carcinoma progression (<i>CPC</i>;<i>APC</i> mice).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In addition, TASIN-treated mice (90 day treatment) gained weight and did not show any signs of overt toxicity (histopathology, liver function, kidney function, and blood cell counts all looked normal).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Given these promising initial results with TASIN-1, we further characterized the TASIN chemotype and present herein our results related to an extensive medicinal chemistry program that delineates the structureâactivity relationships (SAR) within this scaffold. A number of very potent and selective analogues were identified, including compounds with good metabolic stability against murine microsomal fractions (S9) and pharmacokinetic (PK) properties. The small molecules reported herein thus represent a first-in-class genotype-selective series that specifically target <i>apc</i> mutations present in the vast majority of CRC patients and therefore serve as a translational platform toward a potential targeted therapy for colon cancer. Finally, although we speculate that TASINs target the cholesterol biosynthesis enzyme EBP, we have no direct evidence for this interaction. Therefore, the current SAR studies are also essential for the development of photoactivatable probe reagents for pull-down studies in an unbiased search for the molecular target of TASINs, efforts that are currently being pursued in our laboratory.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> SAR Design and Primary Assays</h3><div class="NLM_p">The starting point for the described SAR studies is the HTS hit-compound TASIN-1.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> TASIN-1 (<b>6</b>) is typified by an arylsulfonamide attached to a 1,4â²-bipiperidine (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The objectives for the enclosed SAR studies encompassed optimization for potency, selectivity, and the absorption, distribution, metabolism, and excretion properties via exploration of the following structural characteristics: (i) functionalization and substitution patterns in the sulfonylated aromatic ring, or replacement with biaryl or heteroaryl groups; (ii) substitution patterns in the terminal piperidine ring; (iii) replacement of the terminal piperidine ring with other heterocycles, aromatic rings, or acyclic substituents; (iv) replacement of the central sulfonylated piperidine ring with other ring systems or an acyclic tether; and (v) replacement of the sulfonamide with an amide, a carbamate, an urea, a sulfone, or a sulfamamide. All new compounds were initially evaluated in a cell proliferation assay (CellTiter-Glo, Promega) using two human colorectal cancer cell lines, one with a truncating mutation in the APC gene (DLD-1) and one with wild-type APC status (HCT116). The assay was performed under low-serum conditions (HCEC medium supplemented with 0.2% fetal bovine serum) as described before.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A select set of compounds were additionally evaluated against another human CRC cell line with truncating mutations in the APC gene (HT29) and a pair of diploid isogenic HCEC-derived cell lines (CTRPA, APC<sup>WT</sup>; CTRPA A1309, APC<sup>TR</sup>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Finally, the select compounds were evaluated for in vitro metabolic stability using mouse liver S9 fractions and in vivo PK properties.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure, properties, and analogue design of TASIN-1 (<b>6</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis</h3><div class="NLM_p">The synthesis of analogues <b>5</b>â<b>91</b>, <b>101</b>, <b>103</b>, <b>104</b>, <b>113</b>, <b>115</b>, <b>116</b>, <b>124</b>, and <b>126</b>â<b>129</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Standard sulfonylation of substituted 1,4â²-bipiperidines <b>1a</b>â<b>c</b>, 4-(pyrrolidin-1-yl)piperidine (<b>1d</b>), or 1-(piperidin-4-yl)azepane (<b>1e</b>) with a variety of commercially available aryl- or heteroaryl-sulfonyl chlorides at room temperature (rt) provided analogues <b>5</b>â<b>9</b>, <b>11</b>â<b>24</b>, <b>26</b>â<b>51</b>, <b>57</b>â<b>60</b>, <b>71</b>â<b>91</b>, <b>101</b>, <b>103</b>, and <b>104</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> A subsequent hydrogenolysis of nitro-substituted analogues <b>7</b> and <b>24</b> over Pd/C at room temperature yielded aniline analogues <b>10</b> and <b>25</b>. The 2-, 3-, and 4-bromophenylsulfonamide analogues <b>17</b>, <b>29</b>, and <b>30</b>, respectively, offered viable starting materials for further diversification toward biaryl-substituted congeners <b>52</b>â<b>56</b> and <b>61</b>â<b>70</b> via Suzuki cross-coupling with commercially available arylboronic acids.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Variants in the bipiperidinyl moiety were prepared via reaction of the corresponding heterocyclic amines <b>1f</b>â<b>l</b> with 2,4,6-trimethylphenylsulfonyl chloride under the same standard sulfonylation conditions.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Aromatic and Heteroaromatic Sulfonamide Analogues via Sulfonylation/Cross-Coupling<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) amine <b>1a</b>â<b>d</b>, <b>1f</b>â<b>j</b>, RSO<sub>2</sub>Cl, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) amine <b>1e</b>, <b>1k</b>â<b>m</b>, RSO<sub>2</sub>Cl, K<sub>2</sub>CO<sub>3</sub>, CHCl<sub>3</sub>/H<sub>2</sub>O (1/1), rt; (c) Pd/C, H<sub>2</sub>, MeOH, rt; and (d) ArB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> (10 mol %), aqueous (aq) Na<sub>2</sub>CO<sub>3</sub> (2 M)/tetrahydrofuran (THF) (1/10), reflux. Mes, mesitylene, 2,4,6-Me<sub>3</sub>Ph.</p></p></figure><div class="NLM_p">Additional sulfonamide analogues not directly available from direct sulfonylation of commercially available amines were synthesized via procedures outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. First, reaction of piperidine-4-one (<b>2a</b>) or 4-aminocyclohexan-1-one (<b>2b</b>) with phenyl-, 4-bromophenyl-, or 2,4,6-trimethylphenylsulfonyl chloride provided intermediate sulfonamides <b>3a</b>â<b>c</b> and 2,4,6-trimethyl-<i>N</i>-(4-oxocyclohexyl)benzenesulfonamide (not shown, derived from <b>2b</b>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Subsequent reductive amination (NaBH(OAc)<sub>3</sub> or NaCNBH<sub>3</sub>) of these materials with a variety of amines yielded analogues <b>97</b>â<b>100</b>, <b>102</b>, <b>106</b>â<b>111</b>, <b>114</b>, and <b>123</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Analogue <b>105</b> was obtained after an additional condensation of the intermediate 4-((1-(mesitylsulfonyl)piperidin-4-yl)amino)butan-2-ol with paraformaldehyde. Analogue <b>117</b> was derived from acylation of intermediate <i>N</i>-benzyl-1-(mesitylsulfonyl)piperidin-4-amine, which upon subsequent hydrogenolysis yielded analogue <b>118</b>. Analogue <b>96</b> was made from hydroxyethyl-substituted analogue <b>100</b> (R = â4-(CH<sub>2</sub>)<sub>2</sub>OH) via a sequence of reactions including Swern oxidation, addition of (4-(trimethylsilyl)but-3-yn-1-yl)magnesium bromide, silyl-deprotection, and oxidation to the ketone with DessâMartin periodinane. Analogues <b>92</b>â<b>94</b> are derived after reductive amination of arylsulfonylpiperidinone <b>3a</b> or <b>3b</b> with 2- or 4-(hydroxyethyl)piperidine, followed by alkylation with propargyl bromide (â<b>94</b>, <b>95</b>). Alternatively, the same reductive amination products were oxidized to the aldehyde, followed by the GilbertâSeyferth (â<b>92</b>) or the CoreyâFuchs alkynylation (â<b>93</b>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Sulfonamide Analogues via Sulfonylation/Reductive Amination</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 1,3-dioxanyl-containg analogue <b>112</b> (1.56:1 mixture of cis/trans isomers) was synthesized from 4-hydroxymethyl-piperidine <b>2c</b> via sulfonylation (â<b>4</b>), followed by the Swern oxidation and condensation with 2-methyl-1,3-propanediol (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The synthesis of analogue <b>125</b> relied on a copper-catalyzed Buchwald amination of 1-iodo-4-(2,4,6-trimethylphenylsulfonyl)benzene with 4-methylpiperidine.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> We also explored analogues wherein the sulfonamide linker is replaced with various other functionality. As shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, condensation of 4-methyl-1,4â²-bipiperidine with 4-trifluoromethoxybenzoic acid provided amide analogue <b>119</b>, whereas reaction with 4-methoxyphenyl carbonochloridate or 4-methoxyphenylisocyanate yielded carbamate analogue <b>120</b> and urea analogue <b>121</b>, respectively. Finally, reaction of piperidinone <b>2b</b> with (4-methoxyphenyl)sulfamoyl chloride, followed by reductive amination with 4-methylpiperidine furnished analogue <b>122</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogues <b>112</b>, <b>125</b>, and <b>119</b>â<b>122</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) amine <b>2c</b>, RSO<sub>2</sub>Cl, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) (COCl)<sub>2</sub>, dimethyl sulfoxide (DMSO), CH<sub>2</sub>Cl<sub>2</sub>; then â78 Â°C, Et<sub>3</sub>N, â78 Â°C â rt; (c) MeC(CH<sub>2</sub>OH)<sub>2</sub>, cat. PPTS, MgSO<sub>4</sub>, PhMe, reflux; (d) AlCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) 4-Me-piperidine, CuI, proline, K<sub>2</sub>CO<sub>3</sub>, DMSO, 90 Â°C; (f) <b>1a</b>, 4-CF<sub>3</sub>OPhCO<sub>2</sub>H, EDCÂ·HCl, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt; (g) <b>1a</b>, 4-MeOPhOC(O)Cl, K<sub>2</sub>CO<sub>3</sub>, Et<sub>2</sub>O, 0 Â°C â rt; (h) <b>1a</b>, 4-MeOPhNCO, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C â rt; (i) <b>2a</b>, 4-MeOPhNHSO<sub>2</sub>Cl, Et<sub>3</sub>N, Na<sub>2</sub>SO<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (j) 4-Me-piperidine, NaBH(OAc)<sub>3</sub>, AcOH, DCE, rt. DCE, 1,2-dichloroethane; DMAP, <i>N</i>,<i>N</i>-dimetylaminopyridine; EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide; Mes, 2,4,6-Me<sub>3</sub>Ph; PPTS, pyridinium <i>para</i>-toluenesulfonic acid.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> SAR of Monocyclic Functionalized Arylsulfonamides</h3><div class="NLM_p">Our SAR studies initiated with an evaluation of the arylsulfonamide moiety. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, compared to the parent 4-methoxyphenyl-substituted comparator TASIN-1 (<b>6</b>), replacement with an unsubstituted phenyl ring (â<b>5</b>) led to about a 5-fold reduction in antiproliferative activity. A survey of various para-substituents indicated that strongly electron-withdrawing (âNO<sub>2</sub>, <b>7</b>; âCO<sub>2</sub>Me, <b>8</b>; or âCN, <b>9</b>) or polar hydrophilic substituents (âNH<sub>2</sub>, <b>10</b>) were not tolerated. Increasing the size of the 4-alkoxy substituent from methoxy (<b>6</b>) to a propoxy (<b>18</b>), butoxy (<b>19</b>), or benzyloxy (<b>20</b>) also led to a significant drop in activity. That steric hindrance in the para-position might be the culprit was in agreement with the observation that the 4-methyl-substituted analogue <b>11</b> yielded single-digit nanomolar activity (IC<sub>50</sub> = 9.1 nM), whereas increasing the size of the 4-alkyl substituent (ethyl, <b>12</b>; isopropyl, <b>13</b>; or <i>t</i>-butyl, <b>14</b>) abrogated activity in the DLD-1 cell line. Replacement of the 4-methoxy group with fluorinated congeners (âOCF<sub>3</sub>, <b>21</b>; âOCHF<sub>2</sub>, <b>22</b>) or halides (âCl, <b>16</b>; âBr, <b>17</b>) improved potency 4- to 28-fold, in agreement with smaller hydrophobic van der Waals-interacting substituents being preferred at this position. An exception was noted for the 4-trifluoromethylphenyl analogue <b>15</b>, which was 20-fold less active than the corresponding 4-methylphenyl analogue <b>11</b>. Although less extensively explored, single meta-substituents that improved activity versus the unsubstituted parent <b>5</b> were restricted to methyl (<b>26</b>, IC<sub>50</sub> = 25 nM) and bromine (<b>29</b>, IC<sub>50</sub> = 3.2 nM), whereas 3-methoxy, 3-nitro, 3-amino, 3-trifluoromethyl, and 3-chloro substitution (<b>23</b>â<b>25</b>, <b>27</b>, <b>28</b>) led to a virtual complete loss of antiproliferative activity. <i>Ortho</i>-bromo substitution (<b>30</b>) also provided high potency (IC<sub>50</sub> = 3 nM). Trends for a series of disubstituted arylsulfonamides were less clear. Addition of a 2-methoxy substituent to the 4-methylphenyl analogue <b>11</b> (IC<sub>50</sub> = 9.1 nM) yielded an inactive compound <b>34</b>, whereas 2-methoxy substitution did not diminish activity in combination with 3-bromo (<b>33</b> vs <b>29</b>) and dramatically increased potency of an otherwise inactive monosubstituted <i>meta</i>-methoxyphenyl analogue (<b>32</b>, IC<sub>50</sub> = 4.5 nM vs <b>23</b>). The 2,4-dimethoxyphenyl analogue (<b>31</b>) lost about 2-fold in potency versus the 4-methoxyphenyl comparator (<b>6</b>). Interestingly, a 3-trifluoromethyl group enhanced significantly the activity of the otherwise inactive <i>para</i>-nitrophenyl analogue (<b>35</b>, IC<sub>50</sub> = 56 nM vs <b>7</b>, IC<sub>50</sub> = 981 nM), but diminished the activity of the <i>para</i>-chlorophenyl parent (<b>39</b>, IC<sub>50</sub> = 17 nM vs <b>16</b>, IC<sub>50</sub> = 2.2 nM). Additional introduction of an <i>ortho</i>-ethyl or -chloride substituent slightly enhanced activity (<b>38</b>, IC<sub>50</sub> = 0.6 nM and <b>41</b>, IC<sub>50</sub> = 1 nM vs <b>17</b>, IC<sub>50</sub> = 3.1 nM and <b>16</b>, IC<sub>50</sub> = 2.2 nM respectively), whereas a 2-trifluoromethoxy group had minimal effect (<b>45</b>, IC<sub>50</sub> = 5 nM vs <b>17</b>, IC<sub>50</sub> = 3.1 nM). When attaching an additional methyl, trifluoromethyl, or chlorine to the meta-position, the potency of the corresponding monosubstituted <i>para</i>-methyl, -trifluoromethyl, -chloro, or -bromo analogues was diminished 1.3- to 7.7-fold (<b>37</b>, IC<sub>50</sub> = 24 nM; <b>39</b>, IC<sub>50</sub> = 17 nM; <b>40</b>, IC<sub>50</sub> = 2.9 nM; <b>43</b>, IC<sub>50</sub> = 12 nM vs <b>11</b>, IC<sub>50</sub> = 9.1 nM; <b>16</b>, IC<sub>50</sub> = 2.2 nM; <b>17</b>, IC<sub>50</sub> = 3.1 nM). The 2-cyano-5-methylphenyl analogue <b>36</b> was 11-fold less active than <i>ortho</i>-methylphenyl comparator <b>26</b>. The 3,5-dichlorophenyl analogue <b>42</b> displayed very weak activity, unlike other dihalo substitution patterns (<b>40</b>, <b>41</b>, <b>43</b>). Based on the moderate activity of compounds <b>44</b> and <b>50</b>, fluorine substitution did not appear beneficial.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Arylsulfonamide Analogues <b>5</b>â<b>50</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0006.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">cpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">DLD-1Â IC<sub>50</sub>Â (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">S9Â <i>T</i><sub>1/2</sub>Â (min)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Clogâ<i>D</i><sub>7.4</sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">cpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">DLD-1Â IC<sub>50</sub>Â (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">S9Â <i>T</i><sub>1/2</sub>Â (min)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Clogâ<i>D</i><sub>7.4</sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>5</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">294Â Â±Â 7.6</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">0.69</td><td class="colsep0 rowsep0" align="char" char="."><b>28</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="left">4-MeO</td><td class="colsep0 rowsep0" align="left">63Â Â±Â 5.6</td><td class="colsep0 rowsep0" align="left">182</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char="."><b>29</b></td><td class="colsep0 rowsep0" align="left">3-Br</td><td class="colsep0 rowsep0" align="left">3.2Â Â±Â 0.06</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="char" char=".">1.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>7</b></td><td class="colsep0 rowsep0" align="left">4-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">981Â Â±Â 22.6</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char="."><b>30</b></td><td class="colsep0 rowsep0" align="left">2-Br</td><td class="colsep0 rowsep0" align="left">3Â Â±Â 0.25</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="char" char=".">1.48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>8</b></td><td class="colsep0 rowsep0" align="left">4-MeO<sub>2</sub>C</td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="char" char="."><b>31</b></td><td class="colsep0 rowsep0" align="left">3,4-(OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">138Â Â±Â 12</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="left">2800</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.28</td><td class="colsep0 rowsep0" align="char" char="."><b>32</b></td><td class="colsep0 rowsep0" align="left">2,5-(OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4.5Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="left">9.4</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>10</b></td><td class="colsep0 rowsep0" align="left">4-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">â0.17</td><td class="colsep0 rowsep0" align="char" char="."><b>33</b></td><td class="colsep0 rowsep0" align="left">2-MeO,Â 5-Br</td><td class="colsep0 rowsep0" align="left">2Â Â±Â 0.006</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="char" char=".">1.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>11</b></td><td class="colsep0 rowsep0" align="left">4-Me</td><td class="colsep0 rowsep0" align="left">9.1Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char="."><b>34</b></td><td class="colsep0 rowsep0" align="left">2-MeO,Â 4-Me</td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="left">4-Et</td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.64</td><td class="colsep0 rowsep0" align="char" char="."><b>35</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>,Â 4-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">56Â Â±Â 1.6</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="left">4-<sup><i>i</i></sup>Pr</td><td class="colsep0 rowsep0" align="left">685Â Â±Â 24</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.93</td><td class="colsep0 rowsep0" align="char" char="."><b>36</b></td><td class="colsep0 rowsep0" align="left">2-CN,Â 5-Me</td><td class="colsep0 rowsep0" align="left">285Â Â±Â 3.9</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="left">4-<sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.23</td><td class="colsep0 rowsep0" align="char" char="."><b>37</b></td><td class="colsep0 rowsep0" align="left">3,4-Me<sub>2</sub></td><td class="colsep0 rowsep0" align="left">24Â Â±Â 1.2</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>15</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">185Â Â±Â 8.7</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.57</td><td class="colsep0 rowsep0" align="char" char="."><b>38</b></td><td class="colsep0 rowsep0" align="left">2-Et,Â 4-Br</td><td class="colsep0 rowsep0" align="left">0.6Â Â±Â 0.02</td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="char" char=".">2.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>16</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">2.2Â Â±Â 0.04</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char="."><b>39</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>,Â 4-Cl</td><td class="colsep0 rowsep0" align="left">17Â Â±Â 1.2</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="char" char=".">2.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>17</b></td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="left">3.1Â Â±Â 0.08</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="char" char=".">1.46</td><td class="colsep0 rowsep0" align="char" char="."><b>40</b></td><td class="colsep0 rowsep0" align="left">3,4-Cl<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2.9Â Â±Â 0.34</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="char" char=".">1.91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="left">4-PrO</td><td class="colsep0 rowsep0" align="left">452Â Â±Â 2.6</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char="."><b>41</b></td><td class="colsep0 rowsep0" align="left">2,4-Cl<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="char" char=".">1.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>19</b></td><td class="colsep0 rowsep0" align="left">4-BuO</td><td class="colsep0 rowsep0" align="left">2300</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.85</td><td class="colsep0 rowsep0" align="char" char="."><b>42</b></td><td class="colsep0 rowsep0" align="left">3,5-Cl<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3400</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>20</b></td><td class="colsep0 rowsep0" align="left">4-BnO</td><td class="colsep0 rowsep0" align="left">385Â Â±Â 9.4</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.25</td><td class="colsep0 rowsep0" align="char" char="."><b>43</b></td><td class="colsep0 rowsep0" align="left">3-Cl,Â 4-Br</td><td class="colsep0 rowsep0" align="left">12Â Â±Â 0.5</td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="char" char=".">2.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>21</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>O</td><td class="colsep0 rowsep0" align="left">16Â Â±Â 0.7</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.12</td><td class="colsep0 rowsep0" align="char" char="."><b>44</b></td><td class="colsep0 rowsep0" align="left">2,4-F<sub>2</sub></td><td class="colsep0 rowsep0" align="left">102Â Â±Â 3.5</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>22</b></td><td class="colsep0 rowsep0" align="left">4-CHF<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">4.8Â Â±Â 0.5</td><td class="colsep0 rowsep0" align="left">>240</td><td class="colsep0 rowsep0" align="char" char=".">1.46</td><td class="colsep0 rowsep0" align="char" char="."><b>45</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub>O,Â 4-Br</td><td class="colsep0 rowsep0" align="left">5Â Â±Â 0.07</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="char" char=".">2.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>23</b></td><td class="colsep0 rowsep0" align="left">3-MeO</td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="char" char="."><b>46</b></td><td class="colsep0 rowsep0" align="left">2-Me,Â 4-MeO,Â 5-<sup><i>i</i></sup>Pr</td><td class="colsep0 rowsep0" align="left">3Â Â±Â 0.23</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="char" char=".">2.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>24</b></td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td><td class="colsep0 rowsep0" align="char" char="."><b>47</b></td><td class="colsep0 rowsep0" align="left">2,4,6-Me<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.03Â Â±Â 0.0001</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>25</b></td><td class="colsep0 rowsep0" align="left">3-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3400</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">â0.14</td><td class="colsep0 rowsep0" align="char" char="."><b>48</b></td><td class="colsep0 rowsep0" align="left">2,4-Cl<sub>2</sub>,Â 5-Me</td><td class="colsep0 rowsep0" align="left">2Â Â±Â 0.05</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="char" char=".">2.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>26</b></td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="left">25Â Â±Â 2.1</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char="."><b>49</b></td><td class="colsep0 rowsep0" align="left">2,4-Cl<sub>2</sub>,Â 6-Me</td><td class="colsep0 rowsep0" align="left">0.6Â Â±Â 0.01</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="char" char=".">2.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>27</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>5000</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.58</td><td class="colsep0 rowsep0" align="char" char="."><b>50</b></td><td class="colsep0 rowsep0" align="left">3,5-F<sub>2</sub>,Â 4-Br</td><td class="colsep0 rowsep0" align="left">107Â Â±Â 5.3</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.78</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values represent the half-maximal (50%) inhibitory concentration as determined in the CellTiter-Glo (Promega) assay. Error represents standard deviation (SD) (<i>n</i> = 3). All compounds were inactive when counterscreened against the HCT116 cell line (IC<sub>50</sub> > 5 Î¼M).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last"><i>T</i><sub>1/2</sub> values represent the half life for compound phase I metabolic stability using female ICR/CD-1 mouse liver S9 fractions. NA = not assayed.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Calculated using MarvinSketch (version 6.3.0).</p></div></div></div><div class="NLM_p last">Although not perfect and with some exceptions (e.g., <b>16</b>, <b>17</b>, <b>37</b>, <b>42</b>), the SAR patterns of substituted arylphenylsulfonamide analogues correlated best with a Hansch-type ÏâÏ parameter dependency,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> in addition to steric restrictions at the 4-position. Specifically, potent analogues in this series are characterized by substitution with relatively apolar substituents with low electron-withdrawing ability (Br, Cl, alkyl, MeO, CF<sub>3</sub>O, CHF<sub>2</sub>O), particularly beneficial at the ortho- and para-positions, but restricted in size at the 4-position. Combining these features in a set of trisubstituted arylsulfonamides resulted in a series of very potent compounds (<b>46</b>â<b>49</b>, IC<sub>50</sub> = 0.03â3.0 nM). Overall, 15 analogues displayed IC<sub>50</sub> values below 5 nM against the DLD-1 colon cancer cell line, with two breaking the picomolar barrier (<b>47</b>, IC<sub>50</sub> = 30 pM and <b>49</b>, IC<sub>50</sub> = 600 pM). None of the compounds tested registered any activity in the corresponding colon cancer cell line with wild-type APC status (HCT116), attesting to their highly specific genotype-selective mode of action. Unfortunately, 11 were rapidly metabolized with half-lives between 5 and 30 min when subjected to murine S9 microsomal fractions, and another 3 with half-lives between 32 and 41 min. Only the 4-difluoromethoxyphenyl analogue <b>22</b> retained very potent cellular activity (IC<sub>50</sub> = 4.8 nM) while exhibiting excellent microsomal stability (<i>T</i><sub>1/2</sub> >240 min). The 3-chloro-4-bromophenyl analogue <b>43</b> was slightly less potent (IC<sub>50</sub> = 12 nM) but also exhibited acceptable microsomal stability (<i>T</i><sub>1/2</sub> = 43 min). Not surprisingly, given the bipiperidinyl moiety, the Clogâ<i>D</i><sub>7.4</sub> value for all potent analogues was below 2.93 (range, 0.41â2.93; Clogâ<i>P</i> range, 3.21â4.91). Other parameters such as rotatable bonds, hydrogen bond donors and acceptors, total polar surface area (range, 40.62â59.08), and molecular weight (MW) (range, 336â485) are also within the range of druglike properties for orally available small molecules.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> SAR of Biarylsulfonamides</h3><div class="NLM_p">Next, we decided to briefly explore <i>ortho</i>-, <i>meta</i>-, and <i>para</i>-aryl-substituted phenylsulfonamides (biaryl analogues, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In the ortho-series, only the unsubstituted biphenyl analogue <b>51</b> displayed potent selective cytotoxicity against the DLD-1 cell line with truncating APC mutations. <i>Ortho</i>-biphenyl analogues with additional substituents at the 4â²-position (<b>52</b>â<b>55</b>) were >120-fold less active, indicating a potential size restriction along the 4â²-vector. For <i>para</i>-biphenyls, the unsubstituted biphenyl analogue <b>56</b> and those with additional 4â²-substitution (<b>57</b>, <b>58</b>) were significantly less potent than those with additional 2â²-substituents (<b>59</b>, <b>60</b>). We had previously observed that bulkier substituents in the para-position of the arylsulfonamide were dendrimental to activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <b>12</b>â<b>14</b> and <b>18</b>â<b>20</b>). However, given the potent activity of <b>59</b> and <b>60</b>, both containing a large aryl group in the para-position, one might speculate that this size restriction is limited to three-dimensional substituents, and space is allowed for a flat properly oriented aryl ring. For the biaryl series of analogues, the meta-position appears to be the sweet spot for connecting the additional aromatic ring, and all <i>meta</i>-biaryl analogues <b>61</b>â<b>70</b> displayed potent activity with IC<sub>50</sub>âs between 2 and 41 nM. The biaryl series of analogues also appeared to provide opportunities to improve metabolism. Indeed, with the exception of analogues <b>51</b>, <b>66</b>, and <b>67</b>, all other potent biaryl analogues had acceptable half-lives between 31 and 289 min in the in vitro murine S9 microsomal stability assay. Despite these initial promising results within the biaryl series, we decided not to further pursue them in light of the significant price to be paid in terms of increased molecular weight and lipophilicity (Clogâ<i>D</i><sub>7.4</sub> range, 2.19â3.37; Clogâ<i>P</i> range, 4.8â5.7; ClipE range, 3.58â6.67).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of Biaryl Sulfonamide Analogues <b>51</b>â<b>70</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0007.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">cpd</th><th class="colsep0 rowsep0" align="center">Ar</th><th class="colsep0 rowsep0" align="center">DLD-1Â IC<sub>50</sub>Â (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">S9Â <i>T</i><sub>1/2</sub>Â (min)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Clogâ<i>D</i><sub>7.4</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>51</b></td><td class="colsep0 rowsep0" align="left">2-Ph</td><td class="colsep0 rowsep0" align="left">0.96Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="left"><6</td><td class="colsep0 rowsep0" align="char" char=".">2.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>52</b></td><td class="colsep0 rowsep0" align="left">2-(4â²-ClPh)</td><td class="colsep0 rowsep0" align="left">202Â Â±Â 7.6</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>53</b></td><td class="colsep0 rowsep0" align="left">2-(4â²-MeOPh)</td><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>54</b></td><td class="colsep0 rowsep0" align="left">2-(4â²-MePh)</td><td class="colsep0 rowsep0" align="left">366Â Â±Â 9.6</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>55</b></td><td class="colsep0 rowsep0" align="left">2-(4â²-CF<sub>3</sub>Ph)</td><td class="colsep0 rowsep0" align="left">122Â Â±Â 8.6</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">3.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>56</b></td><td class="colsep0 rowsep0" align="left">4-Ph</td><td class="colsep0 rowsep0" align="left">258Â Â±Â 14</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>57</b></td><td class="colsep0 rowsep0" align="left">4-(4â²-ClPh)</td><td class="colsep0 rowsep0" align="left">105Â Â±Â 7.6</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>58</b></td><td class="colsep0 rowsep0" align="left">4-(4â²-MeOPh)</td><td class="colsep0 rowsep0" align="left">263Â Â±Â 25</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">2.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>59</b></td><td class="colsep0 rowsep0" align="left">4-(2â²-MeOPh)</td><td class="colsep0 rowsep0" align="left">26Â Â±Â 0.5</td><td class="colsep0 rowsep0" align="left">289</td><td class="colsep0 rowsep0" align="char" char=".">2.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>60</b></td><td class="colsep0 rowsep0" align="left">4-(2â²-FPh)</td><td class="colsep0 rowsep0" align="left">5Â Â±Â 0.06</td><td class="colsep0 rowsep0" align="left">210</td><td class="colsep0 rowsep0" align="char" char=".">2.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>61</b></td><td class="colsep0 rowsep0" align="left">3-Ph</td><td class="colsep0 rowsep0" align="left">2Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="char" char=".">2.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>62</b></td><td class="colsep0 rowsep0" align="left">3-(4â²-ClPh)</td><td class="colsep0 rowsep0" align="left">15Â Â±Â 2.1</td><td class="colsep0 rowsep0" align="left">147</td><td class="colsep0 rowsep0" align="char" char=".">2.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>63</b></td><td class="colsep0 rowsep0" align="left">3-(4â²MeOPh)</td><td class="colsep0 rowsep0" align="left">23Â Â±Â 0.9</td><td class="colsep0 rowsep0" align="left">144</td><td class="colsep0 rowsep0" align="char" char=".">2.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>64</b></td><td class="colsep0 rowsep0" align="left">3-(4â²-MePh)</td><td class="colsep0 rowsep0" align="left">11Â Â±Â 1.0</td><td class="colsep0 rowsep0" align="left">115</td><td class="colsep0 rowsep0" align="char" char=".">2.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>65</b></td><td class="colsep0 rowsep0" align="left">3-(4â²-FPh)</td><td class="colsep0 rowsep0" align="left">12Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="char" char=".">2.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>66</b></td><td class="colsep0 rowsep0" align="left">3-(2â²-MeOPh)</td><td class="colsep0 rowsep0" align="left">21Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="char" char=".">2.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>67</b></td><td class="colsep0 rowsep0" align="left">3-(2â²-FPh)</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 0.9</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="char" char=".">2.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>68</b></td><td class="colsep0 rowsep0" align="left">3-(2â²-CF<sub>3</sub>Ph)</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="char" char=".">3.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>69</b></td><td class="colsep0 rowsep0" align="left">3-(3â²,5â²-Me<sub>2</sub>Ph)</td><td class="colsep0 rowsep0" align="left">41Â Â±Â 1.1</td><td class="colsep0 rowsep0" align="left">>240</td><td class="colsep0 rowsep0" align="char" char=".">3.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>70</b></td><td class="colsep0 rowsep0" align="left">3-(2â²-naphthyl)</td><td class="colsep0 rowsep0" align="left">2Â Â±Â 0.0001</td><td class="colsep0 rowsep0" align="left">204</td><td class="colsep0 rowsep0" align="char" char=".">3.33</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values represent the half-maximal (50%) inhibitory concentration as determined in the CellTiter-Glo (Promega) assay. Error represents SD (<i>n</i> = 3). All compounds were inactive when counterscreened against the HCT116 cell line (IC<sub>50</sub> > 5 Î¼M).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last"><i>T</i><sub>1/2</sub> values represent the half-life for compound phase I metabolic stability using female ICR/CD-1 mouse liver S9 fractions. NA = not assayed.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Calculated using MarvinSketch (version 6.3.0).</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> SAR of Heterocyclic and Fused Bicyclic Sulfonamides</h3><div class="NLM_p">In our search for heterocyclic and fused bicyclic replacements for the arylsulfonamide ring, it became quickly apparent that the more desirable (druglike properties) heterocyclic ring systems such as pyridines, imidazoles, thiazoles, and isoxazoles were not a fruitful avenue of pursuit (see <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). With the exception of thiazole <b>81</b>, all such heterocyclic replacements led to inactive compounds (<b>71</b>â<b>80</b>, <b>82</b>). Interestingly, although the methyl-substituted chlorothiazole <b>81</b> was very potent (IC<sub>50</sub> = 1.6 nM), removing the methyl substituent (<b>80</b>), orÂ replacement with an isopropyl substituentÂ (<b>82</b>) largely abolished activity of these chlorothiazoles. Despite the potency and excellent Clogâ<i>D</i><sub>7.4</sub> of 0.63 (ClipE 8.17), the chlorothiazole analogue <b>81</b> was rapidly metabolized in murine S9 microsomal fractions (<i>T</i><sub>1/2</sub> = 10 min). On the other hand, activity results for the relatively apolar fused benzodioxoles and dihydrobenzofurans were more in alignment with the results displayed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Although benzodioxole <b>83</b> displayed mediocre activity (IC<sub>50</sub> = 853 nM), the corresponding isomeric benzodioxole <b>84</b> exhibited a 14-fold improvement (IC<sub>50</sub> = 62 nM). Bromo-dihydrobenzopyran <b>86</b> was of intermediate potency (IC<sub>50</sub> = 96 nM), while introduction of additional methyl groups led to the very potent and metabolically stable analogue <b>85</b> (IC<sub>50</sub> = 1.2 nM; <i>T</i><sub>1/2</sub> (S9) = 67 min) but increased lipophilicity (Clogâ<i>D</i><sub>7.4</sub> = 2.78; Clogâ<i>P</i> = 5.4; ClipE = 6.14). Finally, lipophilic naphtyl analogues <b>87</b> and <b>88</b> were very potent (0.1â0.65 nM; ClipE 7.50â7.70) but metabolically labile (<i>T</i><sub>1/2</sub> < 5â14 min), while the more polar acetamidonaphtyl and isoquinoline analogues <b>89</b> and <b>90</b> largely lost activity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of Heterocyclic and Fused Bicyclic Sulfonamide Analogues <b>71</b>â<b>90</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0008.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0009.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values represent the half-maximal (50%) inhibitory concentration as determined in the CellTiter-Glo (Promega) assay. Error represents SD (<i>n</i> = 3). All compounds were inactive when counterscreened against the HCT116 cell line (IC<sub>50</sub> > 10 Î¼M).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last"><i>T</i><sub>1/2</sub> values represent the half-life for compound phase I metabolic stability using female ICR/CD-1 mouse liver S9 fractions. NA = not assayed (compounds <b>71</b>â<b>80</b> were also not assayed for microsomal stability).</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Calculated using MarvinSketch (version 6.3.0).</p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> SAR of the Terminal Piperidine Ring</h3><div class="NLM_p">With a rather extensive survey of the arylsulfonamide moiety completed, the next phase entailed evaluation of the terminal piperidine ring. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, moving the terminal methyl group from the 4- to the 3-position as in analogue <b>91</b> reduced activity â¼20-fold versus the comparator <b>22</b> (105 vs 4.8 nM). Replacement of the 4-methyl with a propargyl (<b>92</b>) or propargyloxyethyl (<b>94</b>) increased activity significantly versus comparators <b>17</b> and <b>5</b> (0.2 and 85 nM vs 3.1 and 294 nM). Moving those two substituents to the 2-position as in analogues <b>93</b> and <b>95</b> on the other hand was not tolerated. Other groups that were tolerated in the 4-position in decreasing order of potency are isopropyl (<b>98</b>, 0.3 nM), benzyl (<b>108</b>, 3.5 nM), 2-oxohex-5-yn-1-yl (<b>96</b>, 3 nM), (4-fluorophenyl)methyl (<b>110</b>, 18 nM), 2-hydroxyethyl (<b>100</b>, 19 nM), (2-fluorophenyl)methyl (<b>109</b>, 74 nM), and hydroxy (<b>101</b>, 106 nM). A phenyl (<b>111</b>) or 2-cyanoethyl (<b>99</b>) in that position greatly diminished activity (865â7400 nM). The unsubstituted piperidine <b>102</b> lost almost all activity, whereas the 3,5-Me<sub>2</sub>-substituted analogue <b>97</b> was active at 17 nM. When other nitrogen-containing ring systems were evaluated, it was revealed that pyrrolidine <b>104</b>, morpholine <b>107</b>, and piperazine <b>106</b> all lost activity, whereas 1,3-oxazinane <b>105</b> was of intermediate potency (IC<sub>50</sub> = 92 nM). Only azepane <b>103</b> retained single-digit nanomolar potency. Removing the ring-nitrogen altogether, such as in 1,3-dioxane analogue <b>112</b> and phenyl or tolyl analogues <b>115</b> and <b>116</b>, led to a complete loss of activity. Introducing a carbonyl between the two piperidine ring systems (<b>113</b>) or replacing the terminal piperidine ring with acyclic substituents such as aniline <b>114</b>, or amides <b>117</b> and <b>118</b> were also unproductive. To conclude this section, the above results indicate that a basic nitrogen within a six- to seven-membered ring (piperidine or azepine) is crucial for retaining cellular activity. A number of substituents, mostly hydrophobic in nature that can include aliphatic, hydroxylated alkyl, propargylic, ether, ketone, or benzylic substitution are well tolerated. Introduction of an additional polar nitrogen or oxygen in the terminal azacycle is contraindicated for bioactivity. Of the single-digit nanomolar compounds, azepane <b>103</b> had the lowest Clogâ<i>D</i><sub>7.4</sub> (2.09) and an acceptable ClipE of 6.19. Other analogues within this series with similar ClipE values are <b>94</b>, <b>98</b>, and <b>100</b> (ClipE 6.40â6.69). The alkyne-containing analogue <b>92</b> displayed the best lipophilic efficiency (ClipE 8.15) within this series and is only matched by analogues <b>47</b> and <b>81</b> (see <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of Terminal Piperidine Ring Analogues <b>91</b>â<b>118</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0010.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0011.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values represent the half-maximal (50%) inhibitory concentration as determined in the CellTiter-Glo (Promega) assay. Error represents SD (<i>n</i> = 3).</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Error represents SD (<i>n</i> = 2). All compounds were inactive when counterscreened against the HCT116 cell line (IC<sub>50</sub> > 5 Î¼M).</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Calculated using MarvinSketch (version 6.3.0).</p></div></div><div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Miscellaneous SAR</h3><div class="NLM_p">The final structural attributes to be explored are the role of the sulfonamide functionality and the central piperidine ring. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, replacement of the sulfonamide linker with an amide (<b>119</b>, IC<sub>50</sub> = 426 nM), urea (<b>121</b>, IC<sub>50</sub> = 1360 nM), or sulfamamide linker (<b>122</b>, IC<sub>50</sub> = 814 nM) led to a significant 13- to 90-fold reduction in activity compared to their sulfonamide congeners <b>22</b> and <b>6</b> (IC<sub>50</sub> = 4.8 and 63 nM). The carbamate replacement <b>120</b> fared better with a more marginal 4-fold drop versus sulfonamide <b>6</b>âa modification that further lowered the Clogâ<i>D</i><sub>7.4</sub> to 0.5. Substitution of the central piperidine ring with an aminocyclohexyl (<b>123</b>), aminoethyl (<b>124</b>), or phenyl linker (<b>125</b>) led to a substantial or complete loss of activity. Finally, replacement of the bipiperidine with an amino-bipiperidine (<b>129</b>), <i>N</i>-(<i>N</i>-methylpiperidin-4-yl)piperazine (<b>126</b>), or adamantanylpiperazine (<b>128</b>) led to compounds with mediocre potency. Of interest for future analogue design, a quinuclidine analogue <b>127</b> with altered position of the tertiary nitrogen retained significant activity (IC<sub>50</sub> = 83 nM), was metabolically stable (S9 <i>T</i><sub>1/2</sub> = 193 min), and decreased Clogâ<i>D</i><sub>7.4</sub> significantly to 0.87.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Miscellaneous SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0012.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values represent the half-maximal (50%) inhibitory concentration as determined in the CellTiter-Glo (Promega) assay. Error represents SD (<i>n</i> = 3). All compounds were inactive when counterscreened against the HCT116 cell line (IC<sub>50</sub> > 5 Î¼M).</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Calculated using MarvinSketch (version 6.3.0).</p></div></div><div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Activity in Other Cell Lines</h3><div class="NLM_p">As disclosed previously, TASIN-1 (<b>6</b>) was identified as a selective cytotoxin that specifically kills colon cancer cell lines with truncating mutations in the APC tumor suppressor gene. Above we described an extensive medicinal chemistry effort to identify analogues of TASIN-1 with improved potency and physicochemical properties. To ensure that these analogues remained on target, we have additionally counterscreened them for activity against the HCT-116 cell line with wild-type APC. In <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, we represent additional cytotoxicity data for a selection of 23 analogues that displayed single-digit nanomolar activity against the DLD-1 cell line. All 23 analogues were found to be equally effective against another human colon cancer cell line with truncating APC mutations (HT29). Given the heterogeneous genetic background between all of these cultured human colon cancer cell lines (DLD-1, HT29, HCT116), we further evaluated these analogues against an isogenic cell line pair derived from primary human colonic epithelial (HCEC) cells. As disclosed previously,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> introduction of cyclin-dependent kinase 4 (<b>C</b>DK4), telomerase (<b>T</b>), into primary HCEC cells was sufficient to produce an immortalized, nontransformed diploid cell line (<b>CT</b>) with multipotent stemlike characteristics that can differentiate in three-dimensional culture conditions. Additional introduction of oncogenic K<b>R</b>AS<sup>V12</sup>, mutant T<b>P</b>53 (key-alterations in CRC), and knockdown of <b>A</b>PC established the <b>CTRPA</b> cell line.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Additional ectopic expression of mutant APC truncated at amino acid 1309 led to the isogenic APC<sup>mut</sup> cell line (CTRPA A1309).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> As can be seen from data in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, all compounds retained exquisite selectivity for cells with truncating APC mutations with low nanomolar IC<sub>50</sub>âs in CTRPA A1309 and no apparent effect on the isogenic cell line CTRPA (IC<sub>50</sub> > 5 Î¼M).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Antiproliferative Activity of Selected Analogues in Cell Lines with Truncated APC</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="rowsep1 colsep0" colspan="3" align="center" char="Â±">IC<sub>50</sub>Â Â±Â (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">cpd</th><th class="colsep0 rowsep0" align="center" char="Â±">DLD-1</th><th class="colsep0 rowsep0" align="center" char="Â±">HT-29</th><th class="colsep0 rowsep0" align="center" char="Â±">CTRPAÂ A1309<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">CLipE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="char" char="Â±">63Â Â±Â 5.6</td><td class="colsep0 rowsep0" align="char" char="Â±">53Â Â±Â 2.3</td><td class="colsep0 rowsep0" align="char" char="Â±">122Â Â±Â 6.5</td><td class="colsep0 rowsep0" align="char" char=".">6.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>22</b></td><td class="colsep0 rowsep0" align="char" char="Â±">4.8Â Â±Â 0.5</td><td class="colsep0 rowsep0" align="char" char="Â±">2Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char="Â±">3.8Â Â±Â 0.7</td><td class="colsep0 rowsep0" align="char" char=".">6.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>29</b></td><td class="colsep0 rowsep0" align="char" char="Â±">3.2Â Â±Â 0.06</td><td class="colsep0 rowsep0" align="char" char="Â±">1.2Â Â±Â 0.07</td><td class="colsep0 rowsep0" align="char" char="Â±">6.9Â Â±Â 0.8</td><td class="colsep0 rowsep0" align="char" char=".">7.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>30</b></td><td class="colsep0 rowsep0" align="char" char="Â±">3Â Â±Â 0.25</td><td class="colsep0 rowsep0" align="char" char="Â±">3Â Â±Â 0.05</td><td class="colsep0 rowsep0" align="char" char="Â±">2.8Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char=".">7.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>32</b></td><td class="colsep0 rowsep0" align="char" char="Â±">4.5Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">4Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char="Â±">10.5Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char=".">7.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>33</b></td><td class="colsep0 rowsep0" align="char" char="Â±">2Â Â±Â 0.006</td><td class="colsep0 rowsep0" align="char" char="Â±">2Â Â±Â 0.004</td><td class="colsep0 rowsep0" align="char" char="Â±">0.7Â Â±Â 0.02</td><td class="colsep0 rowsep0" align="char" char=".">7.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>38</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.6Â Â±Â 0.02</td><td class="colsep0 rowsep0" align="char" char="Â±">0.5Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char="Â±">0.8Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char=".">6.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>40</b></td><td class="colsep0 rowsep0" align="char" char="Â±">2.9Â Â±Â 0.34</td><td class="colsep0 rowsep0" align="char" char="Â±">2.2Â Â±Â 0.06</td><td class="colsep0 rowsep0" align="char" char="Â±">8.2Â Â±Â 0.63</td><td class="colsep0 rowsep0" align="char" char=".">6.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>45</b></td><td class="colsep0 rowsep0" align="char" char="Â±">5Â Â±Â 0.07</td><td class="colsep0 rowsep0" align="char" char="Â±">4Â Â±Â 0.02</td><td class="colsep0 rowsep0" align="char" char="Â±">9.6Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char=".">5.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>46</b></td><td class="colsep0 rowsep0" align="char" char="Â±">3Â Â±Â 0.23</td><td class="colsep0 rowsep0" align="char" char="Â±">2.2Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">3.4Â Â±Â 0.7</td><td class="colsep0 rowsep0" align="char" char=".">6.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>47</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.03Â Â±Â 0.0001</td><td class="colsep0 rowsep0" align="char" char="Â±">0.9Â Â±Â 0.08</td><td class="colsep0 rowsep0" align="char" char="Â±">0.04Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="char" char=".">8.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>48</b></td><td class="colsep0 rowsep0" align="char" char="Â±">2Â Â±Â 0.05</td><td class="colsep0 rowsep0" align="char" char="Â±">1.1Â Â±Â 0.04</td><td class="colsep0 rowsep0" align="char" char="Â±">3.2Â Â±Â 0.4</td><td class="colsep0 rowsep0" align="char" char=".">6.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>49</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.6Â Â±Â 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.45Â Â±Â 0.01</td><td class="colsep0 rowsep0" align="char" char="Â±">0.7Â Â±Â 0.05</td><td class="colsep0 rowsep0" align="char" char=".">6.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>51</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.96Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="char" char="Â±">0.74Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">1.2Â Â±Â 0.06</td><td class="colsep0 rowsep0" align="char" char=".">6.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>60</b></td><td class="colsep0 rowsep0" align="char" char="Â±">5Â Â±Â 0.06</td><td class="colsep0 rowsep0" align="char" char="Â±">6Â Â±Â 0.07</td><td class="colsep0 rowsep0" align="char" char="Â±">10.2Â Â±Â 0.8</td><td class="colsep0 rowsep0" align="char" char=".">5.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>61</b></td><td class="colsep0 rowsep0" align="char" char="Â±">2Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">2Â Â±Â 0.07</td><td class="colsep0 rowsep0" align="char" char="Â±">1.6Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char=".">6.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>81</b></td><td class="colsep0 rowsep0" align="char" char="Â±">1.6Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">1.5Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">3.4Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char=".">8.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>85</b></td><td class="colsep0 rowsep0" align="char" char="Â±">1.2Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">0.8Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">1.5Â Â±Â 0.08</td><td class="colsep0 rowsep0" align="char" char=".">6.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>87</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.65Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="char" char="Â±">0.34Â Â±Â 0.02</td><td class="colsep0 rowsep0" align="char" char="Â±">0.94Â Â±Â 0.01</td><td class="colsep0 rowsep0" align="char" char=".">7.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>92</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.2Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">0.12Â Â±Â 0.05</td><td class="colsep0 rowsep0" align="char" char="Â±">0.9Â Â±Â 0.07</td><td class="colsep0 rowsep0" align="char" char=".">8.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>96</b></td><td class="colsep0 rowsep0" align="char" char="Â±">3Â Â±Â 0.04</td><td class="colsep0 rowsep0" align="char" char="Â±">2.1Â Â±Â 0.07</td><td class="colsep0 rowsep0" align="char" char="Â±">3.4Â Â±Â 0.8</td><td class="colsep0 rowsep0" align="char" char=".">5.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>98</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.3Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="char" char="Â±">0.2Â Â±Â 0.001</td><td class="colsep0 rowsep0" align="char" char="Â±">0.6Â Â±Â 0.003</td><td class="colsep0 rowsep0" align="char" char=".">6.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>108</b></td><td class="colsep0 rowsep0" align="char" char="Â±">3.5Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="char" char="Â±">3Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="char" char="Â±">4.3Â Â±Â 0.1</td><td class="colsep0 rowsep0" align="char" char=".">4.70</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values represent the half-maximal (50%) inhibitory concentration as determined in the CellTiter-Glo (Promega) assay. Error represents SD (<i>n</i> = 3). All compounds were inactive when counterscreened against the HCT116 cell line with wild-type APC status (IC<sub>50</sub> > 5 Î¼M).</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">All compounds were inactive when counterscreened against the isogenic CTRPA cell line with wild-type APC status (IC<sub>50</sub> > 5 Î¼M).</p></div></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> PK Properties of Select Compounds</h3><div class="NLM_p">As a prelude for future in vivo efficacy studies in xenografts and genetic models of CRC,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> we selected compounds <b>16</b>, <b>22</b>, and <b>92</b> for in vivo pharmacokinetic (PK) analysis because of their cellular potency (IC<sub>50</sub> < 5 nM) and low microsomal clearance (murine S9 <i>T</i><sub>1/2</sub>, 41â240 min; CL<sub>int</sub>, 2.9â16.9 Î¼L/(min mg protein)). As can be seen from the data compiled in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>, the PK characteristics of analogues <b>16</b>, <b>22</b>, and <b>92</b> mirrored those of the previously characterized TASIN-1 (<b>6</b>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> When dosed intravenously (i.v.), analogues <b>16</b> (5 mg/kg), <b>22</b> (10 mg/kg), and <b>92</b> (10 mg/kg) had low to moderate plasma clearance between 0.58 and 10.6 mL/min, a half-life between 1.35 and 2.8 h, and a <i>C</i><sub>max</sub> between 191 and 742 ng/mL 10â30 min after dosing. Plasma exposure for analogues <b>16</b> and <b>92</b>, while good, was significantly lower than for analogue <b>22</b> and TASIN-1 (<b>6</b>). Intraperitoneal (i.p.) dosing led to similar plasma clearance, <i>C</i><sub>max</sub>, terminal half-life, and exposure as for the i.v. route. The % plasma protein binding was determined using ultrafiltration (<b>22</b>, 69% bound) or rapid equilibrium dialysis (RED) (<b>92</b>, 83% bound; <b>6</b>, 8% bound). We selected compound <b>22</b> for oral bioavailablity, which was determined to be excellent (52%, 20 mg/kg) and leading to higher plasma and intestinal exposures than when dosed i.v. at 5 mg/kg. Future efficacy studies will include evaluation of select compounds in a genetically engineered mouse <i>apc</i> inactivation model of colonic adenoma-carcinoma progression (<i>CPC</i>;<i>APC</i> mice).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Therefore, we assessed the PK of these compounds in the large intestine, the intended target organ. Gratifyingly, large intestinal exposure was excellent, irrespective of the delivery method and between 2.6- and 23-fold higher than the plasma exposure. The <i>T</i><sub>max</sub> was achieved 10 min after dosing with a terminal half-life between 8 and 15 h except analogue <b>16</b> with an extraordinarily long half-life of 231 h. Examination of the concentrationâtime curves indicated that elimination reached a plateau phase after an initial seemingly normally decaying half-lifeÂ (e.g. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). This behavior results in the apparent high AUC numbers for this class of compounds. The observed accumulation in the large intestine is likely not limited to this organ. For example, a PK analysis of analogue <b>22</b> indicated similar levels of accumulation in the lung (5.7-fold higher than plasma) and probably other highly perfused organs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). As a result, the volume of distribution for analogues <b>22</b>, <b>16</b>, and <b>92</b> was large, ranging from 5.87 to 63 L/kg. This phenomenon is not unexpected as many lipohilic amine drugsÂ are known to be deposited in highly perfused, lysosome-rich organs via lysosomal trapping.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> Together with their ability to bind phospholipids, this lysosomal trapping contributes to presystemic extraction and the large volume of distribution of many cationic amphiphilic drugs, including imipramine, tamoxifen, propranolol, and others.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Although we have not yet experimentally assessed lysosomal trapping for the analogues described herein, a future evaluation is warranted as lysosomal accumulation has, in some instances, been implicated as a cause for phospholipidosis.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> These studies will include a comprehensive histological evaluation of tissues after repeat dosing experiments as part of a full toxicological evaluation of potential lead compounds.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Concentrationâtime curve in the large intestine for analogue <b>92</b> when dosed 10 mg/kg i.v. or i.p. (B) Concentrationâtime curve in the plasma and lung for analogue <b>22</b> when dosed 5 mg/kg i.v.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetics of Compounds <b>6</b>, <b>16</b>, <b>22</b>, and <b>92</b> in Mouse<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="rowsep1 colsep0" colspan="6" align="center" char=".">plasma PK</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">large intestinal PK</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">cpd</th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>last</sub> (ngÂ min/mL)</th><th class="colsep0 rowsep0" align="center" char=".">Vz (mL)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/g)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>last</sub> (ngÂ min/g)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="left">i.p.</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">2390</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">104â103</td><td class="colsep0 rowsep0" align="char" char=".">162</td><td class="colsep0 rowsep0" align="char" char=".">2.32</td><td class="colsep0 rowsep0" align="char" char=".">570</td><td class="colsep0 rowsep0" align="char" char=".">10â678</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">737â709</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>22</b></td><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">162</td><td class="colsep0 rowsep0" align="char" char=".">742</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">197â571</td><td class="colsep0 rowsep0" align="char" char=".">135</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">912</td><td class="colsep0 rowsep0" align="char" char=".">1816</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">511â878</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>22</b></td><td class="colsep0 rowsep0" align="left">i.p.</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">168</td><td class="colsep0 rowsep0" align="char" char=".">1117</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">205â914</td><td class="colsep0 rowsep0" align="char" char=".">156</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td><td class="colsep0 rowsep0" align="char" char=".">903</td><td class="colsep0 rowsep0" align="char" char=".">10â146</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">790â425</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>22</b></td><td class="colsep0 rowsep0" align="left">p.o.</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">182</td><td class="colsep0 rowsep0" align="char" char=".">691</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">328â296</td><td class="colsep0 rowsep0" align="char" char=".">153</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">506</td><td class="colsep0 rowsep0" align="char" char=".">3252</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">890â969</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>16</b></td><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">191</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">21â581</td><td class="colsep0 rowsep0" align="char" char=".">1243</td><td class="colsep0 rowsep0" align="char" char=".">10.6</td><td class="colsep0 rowsep0" align="char" char=".">13â861</td><td class="colsep0 rowsep0" align="char" char=".">1414</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">262â874</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>92</b></td><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">135</td><td class="colsep0 rowsep0" align="char" char=".">303</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">39â146</td><td class="colsep0 rowsep0" align="char" char=".">1152</td><td class="colsep0 rowsep0" align="char" char=".">5.92</td><td class="colsep0 rowsep0" align="char" char=".">504</td><td class="colsep0 rowsep0" align="char" char=".">2974</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">559â037</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>92</b></td><td class="colsep0 rowsep0" align="left">i.p.</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">171</td><td class="colsep0 rowsep0" align="char" char=".">145</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">27â904</td><td class="colsep0 rowsep0" align="char" char=".">1390</td><td class="colsep0 rowsep0" align="char" char=".">5.64</td><td class="colsep0 rowsep0" align="char" char=".">678</td><td class="colsep0 rowsep0" align="char" char=".">5754</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">633â289</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Elimination half-life (<i>T</i><sub>1/2</sub>), maximum observed concentration (<i>C</i><sub>max</sub>), time to <i>C</i><sub>max</sub> (<i>T</i><sub>max</sub>), apparent volume of distribution during terminal phase (Vz), area under the concentrationâtime curve from time zero to the last measured concentration (AUC<sub>last</sub>), clearance (CL), intravenous (i.v.), intraperitoneal (i.p.), per os (p.o.).</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67742" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67742" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">There are currently no small molecule therapeutics that target specifically oncogenotypes that drive the development and progression of colorectal cancers. Germline truncating mutations in the APC tumor suppressor gene lead to familial adenomatous polyposis (FAP) and early development of CRC, whereas somatic truncating APC mutations are observed in the vast majority of sporadic CRC patients. We previously disclosed the discovery of TASIN-1, a small molecule that selectively targets human colorectal cancer cell lines expressing mutant-APC with high specificity through inhibition of endogenous cholesterol biosynthesis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Here, we reported an extensive structureâactivity relationship study through the design of analogues of TASIN-1 exploring the structural determinants responsible for cellular activity and selectivity. This study identified several very potent analogues with good druglike properties that inhibit CRC cells with mutant APC in the single-digit nanomolar to picomolar range, while being innocuous for cells with wild-type APC. Several of these potent analogues exhibited acceptable metabolically stability in murine microsomal fractions, and excellent in vivo exposure whether dosed i.v., i.p., or orally. The high intestinal exposure and half-life of this class bodes well for future efficacy studies in genetic or orthotopic animal models of CRC. However, we note that this significant intestinal accumulation and long half-life could indicate a potential lysosomal trapping of these lipophilic amines, an issue that will be explored in future studies. Lipophilic basic amine drugs are also potentially liable for off-target activity against potassium and sodium channels. Given that our SAR studies indicate that a protonatable amine is absolutely essential for activity, we will have to evaluate our compound collection against these and other potential off-target interactions. In this context, future studies will focus on analogues that perturb the p<i>K</i><sub>a</sub> to the 7.5â8.5 range, which is known to limit potassium and sodium channel activity and also may limit the effect of lysosomal accumulation. The SAR studies described herein have not attempted to address these specific issues yet, but indicate that the TASINs represent an excellent scaffold for such SAR-driven optimization, and we are therefore confident that ongoing studies will enable the identification of novel translatable leads for a potential targeted therapy for colorectal cancer.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Cytotoxicity Assay</h3><div class="NLM_p last">Activity of each analogue was evaluated as described before.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Briefly, DLD-1, HT29, HCT116, CTRPA, or CTRPA A1309 cells were seeded in a 96-well plate in triplicate at a density of 3000 cells/well in HCEC medium supplemented with 0.2% fetal bovine serum and treated with compound at nine-point 3-fold dilution series for 72 h. Cell viability was determined using the CellTiter-Glo (Promega) assay according to manufacturerâs instruction. Each value was normalized to cells treated with DMSO, and the IC<sub>50</sub> values were calculated using GraphPad Prism software.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> In Vitro Liver S9 Stability</h3><div class="NLM_p last">Female ICR/CD-1 mouse S9 fractions were purchased from Bioreclamation/IVT (Chestertown, MD). S9 protein (0.025 mL, 0.5 mg) was added on ice to a 15 mL glass screw cap tube followed by 0.350 mL of a 50 mM Tris, pH 7.5 solution, containing the compound of interest. The tube was then placed in a 37 Â°C shaking water bath for 5 min and 0.125 mL of an reduced nicotinamide adenine dinucleotide phosphate (NADPH)-regenerating system (1.7 mg/mL NADP, 7.8 mg/mL glucose 6-phosphate, 6 U/mL glucose 6-phosphate dehydrogenase in 2% w/v NaHCO<sub>3</sub>/10 mm MgCl<sub>2</sub>) was added for analysis of phase I metabolism. After addition of all reagents, the final concentration of compound was 2 Î¼M, and S9 protein 1 mg/mL. At varying time points after addition of phase I cofactors, the reaction was stopped by the addition of 0.5 mL of methanol containing 0.2% formic acid and either tolbutamide or <i>n</i>-benzylbenzamide as internal standard. Time 0 samples were stopped prior to placing the samples at 37 Â°C, and the NADPH-regenerating system was added immediately thereafter. The samples were incubated for 10 min at rt and then spun at 16â100<i>g</i> for 5 min in a microcentrifuge. The supernatant was analyzed by liquid chromatography (LC)âtandem mass spectrometry (MS/MS) using a Sciex 3200 or 4000 Qtrap mass spectrometer coupled to a Shimadzu Prominence LC with the mass spectrometer in multiple reaction monitoring (MRM) mode. The method described by McNaney et al.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> was used with modification for the determination of metabolic stability half-life by substrate depletion. A â% remainingâ value was used to assess metabolic stability of a compound over time. The LCâMS/MS peak area of the incubated sample at each time point was divided by the LCâMS/MS peak area of the time 0 (<i>T</i><sub>0</sub>) sample and multiplied by 100. The natural logarithm (ln) of the % remaining of compound was then plotted versus time (in min), and a linear regression curve plotted going through <i>y</i>-intercept at ln(100). The metabolism of some compounds failed to show linear kinetics at a later time point, so those time points were excluded. The half-life (<i>T</i><sub>1/2</sub>) was calculated as <i>T</i><sub>1/2</sub> = 0.693/slope. Compound stability was also evaluated at 0 and 240 min in reaction buffer only minus S9 protein to determine chemical stability.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Protein Binding</h3><div class="NLM_p last">Protein binding was determined using either ultrafiltration (<b>22</b>) or rapid equilibrium dialysis (RED; <b>92</b>), as described in Wang et al.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Binding in plasma was evaluated using undiluted plasma and plasma diluted with one part plasma and three parts phosphate-buffered saline (PBS), while binding in large intestine was evaluated using large intestinal tissue homogenates prepared using a 3-fold volume of PBS. Values were corrected for dilution as described<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> by the following equation<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_m001.gif" alt="" id="_i28" /></img></span>where <i>D</i> = dilution factor of 4 and fu<sub>2</sub> = free fraction using diluted matrix</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Mouse PK Analysis</h3><div class="NLM_p last">Animal work for the pharmacokinetic studies described in this manuscript has been approved and conducted under the oversight of the UT Southwestern Institutional Animal Care and Use Committee. UT Southwestern uses the âGuide for the Care and Use of Laboratory Animalsâ when establishing animal research standards. Seven PK experiments are reported in the manuscript. Each PK experiment utilized 24 female CD1 mice at 5â6 weeks of age (obtained from Charles River), which were euthanized in groups of three at eight time points for collection of blood and tissues. Thus, a total of 168 mice were used. The animals were housed in standard microisolator cages and were administered inhibitor compounds in 0.2 mL by i.p. (10 mg/kg) or i.v. (5 or 10 mg/kg) injection or oral gavage (20 mg/kg) formulated as follows: <b>16</b> and <b>92</b>: 10% DMSO/10% poly(ethylene glycol) (PEG)-400/80% 50 mM citrate buffer, pH 5.4; <b>22</b>: 10% ethanol/10% PEG-400/80% 50 mM citrate buffer, pH 4.4. The animals were euthanized by inhalation overdose of CO<sub>2</sub> in groups of three at 10, 30, 90, 180, 360, 960, and 1440 min post dose, and blood was collected by cardiac puncture, using acidified citrate dextrose as the anticoagulant. In some cases, large intestine was also isolated, intestinal contents flushed, and the tissue snap-frozen. Plasma was isolated from blood by centrifugation at 9600<i>g</i> for 10 min and stored at â80 Â°C until analysis. Tissues were homogenized in a 3-fold volume of PBS (final homogenate volume in mL = weight of tissue in g Ã 4). Plasma or tissue homogenate (0.1 mL) was precipitated with 0.2 mL of an organic crash solution containing either methanol or acetonitrile, 0.15% formic acid, and an internal standard (<i>n</i>-benzylbenzamide). Extraction conditions were optimized prior to PK analysis for efficient and reproducible recovery over a 3âlog range of concentrations. The solution was centrifuged twice at 16â100<i>g</i> for 5 min. The final supernatant was analyzed by LCâMS/MS as described above, and compound concentrations were determined in reference to a standard curve prepared by addition of the appropriate compound to blank plasma or tissue homogenate. A value of 3Ã above the signal obtained in the blank plasma was designated the limit of detection (LOD). The limit of quantitation (LOQ) was defined as the lowest concentration at which back calculation yielded a concentration within 20% of the theoretical value and above the LOD signal. The LOQ values were as follows: 0.5 ng/mL for <b>16</b> and <b>92</b>, and 5 ng/mL for <b>22</b>. Compound concentrations in large intestine were calculated by subtracting the amount of compound in the residual blood in that tissue based on reference values for large intestinal vasculature.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Pharmacokinetic parameters were determined using the noncompartmental analysis tool in Phoenix WinNonlin (Certara, Corp., Princeton, NJ).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Chemistry</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Information</h4><div class="NLM_p last">Unless otherwise specified, all commercially available reagents were used as received. All reactions using dried solvents were carried out under an atmosphere of argon in flame-dried glassware with magnetic stirring. Dry solvent was dispensed from a solvent purification system that passes solvent through two columns of dry neutral alumina. Silica gel chromatographic purifications were performed by flash chromatography with silica gel (Sigma, grade 60, 230â400 mesh) packed in glass columns (the eluting solvent was determined by thin-layer chromatography, TLC), or with an Isco CombiFlash system using Redisep Rf Flash columns with size ranging from 4 to 80 g. Analytical TLC was performed on glass plates coated with 0.25 mm silica gel using UV or by iodide or KMnO<sub>4</sub> staining for visualization. Melting points are uncorrected. Routine <sup>1</sup>H and proton-decoupled <sup>13</sup>C NMR spectra were obtained on a Bruker 400 MHz NMR spectrometer. Chemical shifts (Î´) are reported in parts per million (ppm) from low to high field relative to residual solvent. Multiplicities are given as: singlet (s), doublet (d), triplet (t), quartet (q), doublet of doublets (dd), and multiplet (m). All synthetic compounds exhibited >95% purity, as determined by LCâMS analysis performed on an Agilent 1100 high-performance liquid chromatography system using an Eclipse XDB-C18 column (4.6 Ã 150 mm<sup>2</sup>, 5 Î¼m; Agilent) that was coupled to an Agilent G1956A (or 6120) electrospray ionization (ESI) mass spectrometer run in the positive mode with a scan range of 100â1100 <i>m</i>/<i>z</i>. Liquid chromatography was carried out at a flow rate of 0.5 mL/min at 20 Â°C with a 5 Î¼L injection volume, using the gradient elution with aqueous acetonitrile containing 0.1% formic acid. The gradient was adjusted based on the different polarities of different compounds. High-resolution mass spectrometry (HRMS) data were obtained from the Shimadzu Center for Advanced Analytical Chemistry (SCAAC) at UT Arlington.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Procedure A for the Preparation of Sulfonamides <b>4</b>â<b>9</b>, <b>11</b>â<b>24</b>, <b>26</b>â<b>51</b>, <b>57</b>, <b>58</b>, <b>71</b>â<b>91</b>, <b>104</b>, <b>115</b>, <b>116</b>, <b>124</b>, and <b>126</b>â<b>128</b> from Sulfonyl Chlorides and Amines</h3><div class="NLM_p last">A mixture of amine (1.0 equiv), sulfonyl chloride (1.1 equiv), and <i>N</i>,<i>N</i>-diisopropyl ethylamine (1.5 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL/mmol amine) was stirred at room temperature overnight. The reaction solution was then poured into a saturated aqueous NaHCO<sub>3</sub> solution (20 mL/mmol amine) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 20 mL/mmol amine). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified through flash chromatography or Isco CombiFlash (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, or MeOH/EtOAc eluent mixture; gradient adjusted based on the different polarity of different compounds), or by recrystallization to provide the corresponding sulfonamides with >95% purity.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure B for the Preparation of Sulfonamides <b>3a</b>â<b>c</b>, <b>103</b>, and <b>113</b> from Sulfonyl Chlorides and Amine Hydrochloride Salts</h3><div class="NLM_p last">A biphasic mixture of sulfonyl chloride (1.2 equiv), amine hydrochloride salt (1.0 equiv), and K<sub>2</sub>CO<sub>3</sub> (2.5 equiv) in CHCl<sub>3</sub> (2 mL/mmol amine hydrochloride salt) and water (2 mL/mmol amine hydrochloride salt) was stirred vigorously at room temperature for 20 h followed by the addition of saturated aqueous NaHCO<sub>3</sub> (25 mL/mmol of amine hydrochloride salt). The resulting solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 20 mL/mmol of amine hydrochloride salt) and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified through flash chromatography or Isco CombiFlash (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, or hexanes/EtOAc eluent mixture; gradient adjusted based on the different polarities of different compounds) to provide the corresponding sulfonamides with >95% purity.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Procedure C for the Preparation of Biarylsulfonamides <b>52</b>â<b>56</b> and <b>59</b>â<b>70</b> via Suzuki Cross-Coupling</h3><div class="NLM_p last">To a flame-dried flask equipped with a reflux condenser were added (bromophenylsulfonyl)-4-methyl-1,4â²-bipiperidine (1.0 equiv), phenylboronic acid (1.58 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.1 equiv), THF (14.5 mL/mmol sulfonamide), and aqueous Na<sub>2</sub>CO<sub>3</sub> (2 M; 1.45 mL/mmol sulfonamide). The mixture was degassed through freezeâpumpâthaw cycling and was refluxed for 3â12 h. After being cooled down to room temperature, the reaction suspension was diluted with water (45.5 mL/mmol sulfonamide), stirred for 10 min, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 54.5 mL/mmol sulfonamide). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified through flash chromatography or Isco CombiFlash (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, or MeOH/EtOAc eluent mixture; gradient adjusted based on the different polarity of different compounds) to provide the corresponding biarylsulfonamides with >95% purity.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedure D for the Reductive Amination of <i>N</i>-Arylsulfonyl-piperidin-4-ones <b>3a</b>â<b>c</b>, or <i>N</i>-Mesitylsulphonyl-4-aminocyclohexanone</h3><div class="NLM_p last">A mixture of ketone (1.0 equiv), amine (1.0 equiv), AcOH (1.0 equiv), and CH<sub>2</sub>Cl<sub>2</sub> (or DCE) (5 mL/mmol amine) was stirred at room temperature for 15 min before NaBH(OAc)<sub>3</sub> (1.5 equiv) was added. The resulting suspension was stirred at room temperature with a reaction time ranging from 20 to 89 h. The reaction was then quenched by dropwise addition of saturated aqueous NaHCO<sub>3</sub> (30 mL/mmol of amine) at 0 Â°C, and the resulting biphasic solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 30 mL/mmol amine). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified through flash chromatography or Isco CombiFlash (MeOH/CH<sub>2</sub>Cl<sub>2</sub>, or hexanes/EtOAc eluent mixture; gradient adjusted based on the different polarity of different compounds) to provide the corresponding reductive amination product with >95% purity.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-(Phenylsulfonyl)piperidin-4-one (<b>3a</b>)</h3><div class="NLM_p last">Reaction of amine hydrochloride salt <b>2a</b> with benzenesulfonyl chloride (Procedure B) yielded <b>3a</b> as a white solid (93%); mp 105â108 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.85â7.73 (m, 2H), 7.66â7.58 (m, 1H), 7.58â7.48 (m, 2H), 3.39 (t, <i>J</i> = 6.2 Hz, 4H), 2.52 (t, <i>J</i> = 6.2 Hz, 4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) Î´ 205.6, 136.3, 133.2, 129.3, 127.5, 45.9, 40.7. The analytical data were consistent with the literature report.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-(4-Bromophenylsulfonyl)piperidin-4-one (<b>3b</b>)</h3><div class="NLM_p last">Reaction of amine hydrochloride salt <b>2a</b> with 4-bromobenzene-1-sulfonyl chloride (Procedure B) yielded <b>3b</b> as a white solid (82%); mp 155â158 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.79â7.57 (m, 4H), 3.39 (t, <i>J</i> = 6.3 Hz, 4H), 2.54 (t, <i>J</i> = 6.3 Hz, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 205.1, 135.5, 132.6, 128.9, 128.4, 45.8, 40.6.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(Mesitylsulfonyl)piperidin-4-one (<b>3c</b>)</h3><div class="NLM_p last">Reaction of amine hydrochloride salt <b>2a</b> with 2,4,6-trimethylbenzene-1-sulfonyl chloride (Procedure B) yielded <b>3c</b> as a white solid (95%); mp 102â105 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.95 (s, 2H), 3.50 (t, <i>J</i> = 6.2 Hz, 4H), 2.61 (s, 6H), 2.52 (t, <i>J</i> = 6.2 Hz, 4H), 2.29 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 201.6, 138.3, 135.6, 127.4, 126.8, 39.6, 36.3, 18.1, 16.2. LCâMS (ESI) calcd for C<sub>14</sub>H<sub>20</sub>NO<sub>3</sub>S [M + H]<sup>+</sup> 282.1, found 282.1.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (1-(Mesitylsulfonyl)piperidin-4-yl)methanol (<b>4</b>)</h3><div class="NLM_p last">Reaction of amine <b>2c</b> with 2,4,6-trimethylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>4</b> as a white solid (78%); mp 85â88 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.91 (s, 2H), 3.56 (d, <i>J</i> = 12.3 Hz, 2H), 3.43 (d, <i>J</i> = 6.3 Hz, 2H), 2.71 (td, <i>J</i> = 12.3, 2.6 Hz, 2H), 2.57 (s, 6H), 2.26 (s, 3H), 2.00â1.80 (m, 1H), 1.73 (dd, <i>J</i> = 13.6, 2.9 Hz, 2H), 1.63â1.48 (m, 1H), 1.18 (qd, <i>J</i> = 11.9, 4.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 140.3, 131.9, 131.7, 67.0, 44.1, 38.3, 28.1, 22.8, 20.9. HRMS (ESI-time-of-flight (TOF)) calcd for C<sub>15</sub>H<sub>23</sub>NO<sub>3</sub>SNa [M + Na]<sup>+</sup> 320.1291, found 320.1280.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-Methyl-1â²-(phenylsulfonyl)-1,4â²-bipiperidine (<b>5</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with PhSO<sub>2</sub>Cl (Procedure A) yielded <b>5</b> as a pale yellow solid (92%); mp 154â156 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.77 (d, <i>J</i> = 7.3 Hz, 2H), 7.65â7.58 (m, 1H), 7.54 (t, <i>J</i> = 7.7 Hz, 2H), 3.87 (d, <i>J</i> = 11.9 Hz, 2H), 2.80 (d, <i>J</i> = 11.8 Hz, 2H), 2.32â2.20 (m, 3H), 2.14 (t, <i>J</i> = 11.4 Hz, 2H), 1.86 (d, <i>J</i> = 11.7 Hz, 2H), 1.72â1.59 (m, 4H), 1.40 â 1.28 (m, 1H), 1.27â1.12 (m, 2H), 0.91 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 136.0, 132.7, 129.0, 127.6, 61.3, 49.1, 46.1, 33.9, 30.8, 26.9, 21.7. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 323.1788, found 323.1774.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1â²-((4-Methoxyphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>6</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-methoxybenzene-1-sulfonyl chloride (Procedure A) yielded <b>6</b> as a white solid (94%); mp 109â112 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.67 (d, <i>J</i> = 8.8 Hz, 2H), 6.97 (d, <i>J</i> = 8.8 Hz, 2H), 3.85 (s, 3H), 3.83â3.74 (d, <i>J</i> = 12.0 Hz, 2H), 2.76 (d, <i>J</i> = 11.7 Hz, 2H), 2.28â2.04 (m, 5H), 1.88â1.75 (d, <i>J</i> = 12.9 Hz, 2H), 1.72â1.54 (m, 4H), 1.36â1.23 (m, 1H), 1.23â1.08 (m, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 162.9, 129.8, 127.6, 114.1, 61.5, 55.6, 49.5, 46.2, 34.6, 31.0, 27.3, 21.9. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 353.1893, found 353.1883.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-Methyl-1â²-((4-nitrophenyl)sulfonyl)-1,4â²-bipiperidine (<b>7</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-nitrobenzene-1-sulfonyl chloride (Procedure A) yielded <b>7</b> as a yellow solid (76%); mp 165â168 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.35 (d, <i>J</i> = 8.8 Hz, 2H), 7.91 (d, <i>J</i> = 8.8 Hz, 2H), 3.85 (d, <i>J</i> = 12.3 Hz, 2H), 2.76 (d, <i>J</i> = 11.6 Hz, 2H), 2.31 (td, <i>J</i> = 12.0, 2.5 Hz, 2H), 2.21 (tt, <i>J</i> = 11.5, 3.7 Hz, 1H), 2.10 (td, <i>J</i> = 11.5, 2.5 Hz, 2H), 1.84 (d, <i>J</i> = 12.0 Hz, 2H), 1.62 (qd, <i>J</i> = 12.0, 4.0 Hz, 4H), 1.38â1.21 (m, 1H), 1.14 (qd, <i>J</i> = 12.0, 3.7 Hz, 2H), 0.86 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 150.1, 142.4, 128.7, 124.3, 61.2, 49.5, 46.1, 34.5, 30.9, 27.4, 21.8. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 368.1639, found 368.1633.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Methyl 4-((4-Methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)benzoate (<b>8</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with methyl 4-(chlorosulfonyl)benzoate (Procedure A) yielded <b>8</b> as a white solid (54%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.16 (d, <i>J</i> = 8.1 Hz, 2H), 7.80 (d, <i>J</i> = 8.7 Hz, 2H), 3.93 (s, 3H), 3.84 (d, <i>J</i> = 12.1 Hz, 2H), 2.76 (d, <i>J</i> = 11.0 Hz, 2H), 2.38â2.02 (m, 5H), 1.83 (d, <i>J</i> = 11.9 Hz, 2H), 1.71â1.51 (m, 4H), 1.37â1.23 (m, 1H), 1.16 (qd, <i>J</i> = 12.0, 3.8 Hz, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 165.6, 140.2, 133.8, 130.2, 127.6, 61.4, 52.6, 49.4, 46.1, 34.4, 30.9, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>29</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 381.1843, found 381.1843.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-((4-Methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)benzonitrile (<b>9</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-cyanobenzene-1-sulfonyl chloride (Procedure A) yielded <b>9</b> as a white solid (92%); mp 184â186 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.84 (q, <i>J</i> = 8.5 Hz, 4H), 3.85 (d, <i>J</i> = 12.1 Hz, 2H), 2.77 (d, <i>J</i> = 11.6 Hz, 2H), 2.31 (t, <i>J</i> = 12.0 Hz, 2H), 2.22 (tt, <i>J</i> = 11.6, 3.6 Hz, 1H), 2.11 (t, <i>J</i> = 12.2 Hz, 2H), 1.85 (d, <i>J</i> = 11.6 Hz, 2H), 1.71â1.55 (m, 4H), 1.37â1.24 (m, 1H), 1.25â1.10 (m, 2H), 0.89 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 140.9, 132.8, 128.1, 117.3, 116.4, 61.2, 49.5, 46.1, 34.6, 31.0, 27.4, 21.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 348.1740, found 348.1737.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 4-((4-Methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)aniline (<b>10</b>)</h3><div class="NLM_p last">To a 50 mL flask were added 4-methyl-1â²-((4-nitrophenyl)sulfonyl)-1,4â²-bipiperidine <b>7</b> (0.1004 g, 0.33 mmol), methanol (3 mL), and Pd/C (one spatula, 10% on active carbon). The reaction flask was sealed by a septum, and after the removal of air using vacuum, a hydrogen balloon was fitted on the top of the septum. The reaction suspension was then stirred at room temperature for 22 h and filtered through a pad of celite. The filtrate was concentrated under reduced pressure to provide the desired product (0.09 g, >95%) as a colorless gel. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.41 (d, <i>J</i> = 8.7 Hz, 2H), 6.69 (d, <i>J</i> = 8.7 Hz, 2H), 3.84â3.63 (m, 2H), 2.83 (d, <i>J</i> = 11.7 Hz, 2H), 2.31â2.06 (m, 5H), 1.87 (d, <i>J</i> = 14.5 Hz, 2H), 1.62 (d, <i>J</i> = 14.1 Hz, 2H), 1.51 (qd, <i>J</i> = 12.2, 4.1 Hz, 2H), 1.41â1.23 (m, 1H), 1.16 (qd, <i>J</i> = 12.4, 3.7 Hz, 2H), 0.89 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) Î´ 153.1, 129.4, 121.2, 112.9, 61.3, 49.1, 45.9, 33.7, 30.7, 26.9, 20.8. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 360.1716, found 360.1719.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-Methyl-1â²-tosyl-1,4â²-bipiperidine (<b>11</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-methylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>11</b> as a white solid (67%); mp 139â142 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.59 (d, <i>J</i> = 8.2 Hz, 2H), 7.28 (d, <i>J</i> = 8.2 Hz, 2H), 3.80 (d, <i>J</i> = 11.9 Hz, 2H), 2.79 (d, <i>J</i> = 11.1 Hz, 2H), 2.39 (s, 3H), 2.30â2.07 (m, 5H), 1.84 (d, <i>J</i> = 10.9 Hz, 2H), 1.69â1.53 (m, 4H), 1.40â1.09 (m, 3H), 0.86 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 143.5, 132.9, 129.6, 127.7, 61.6, 49.4, 46.0, 34.1, 30.8, 27.1, 21.7, 21.5. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 337.1944, found 337.1937.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1â²-((4-Ethylphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>12</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-ethylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>12</b> as a brown solid (>95%); mp 108â110 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.63 (d, <i>J</i> = 7.9 Hz, 2H), 7.31 (d, <i>J</i> = 7.9 Hz, 2H), 3.82 (d, <i>J</i> = 11.6 Hz, 2H), 2.78 (d, <i>J</i> = 11.2 Hz, 2H), 2.70 (q, <i>J</i> = 7.6 Hz, 2H), 2.22 (t, <i>J</i> = 12.1 Hz, 3H), 2.12 (t, <i>J</i> = 10.8 Hz, 2H), 1.82 (d, <i>J</i> = 12.2 Hz, 2H), 1.62 (td, <i>J</i> = 12.3, 8.2 Hz, 4H), 1.39â1.08 (m, 6H), 0.87 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 149.5, 133.3, 128.4, 127.8, 61.5, 49.4, 46.1, 34.4, 30.9, 28.8, 27.2, 21.8, 15.1. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>31</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 351.2101, found 351.2093.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1â²-((4-Isopropylphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>13</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-isopropylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>13</b> as a yellow solid (79%); mp 144â147 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.63 (d, <i>J</i> = 8.3 Hz, 2H), 7.33 (d, <i>J</i> = 8.3 Hz, 2H), 3.81 (d, <i>J</i> = 12.3 Hz, 2H), 2.94 (p, <i>J</i> = 6.9 Hz, 1H), 2.75 (d, <i>J</i> = 11.7 Hz, 2H), 2.31â2.15 (m, 3H), 2.09 (td, <i>J</i> = 11.7, 2.7 Hz, 2H), 1.80 (d, <i>J</i> = 11.7 Hz, 2H), 1.68â1.52 (m, 4H), 1.36â1.03 (m, 3H), 1.24 (d, <i>J</i> = 6.9 Hz, 6H), 0.86 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 154.1, 133.4, 127.8, 127.0, 61.4, 49.4, 46.1, 34.5, 34.1, 30.9, 27.2, 23.6, 21.8. HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>33</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 365.2257, found 365.2247.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1â²-((4-(<i>tert</i>-Butyl)phenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>14</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-(<i>tert</i>-butyl)benzene-1-sulfonyl chloride (Procedure A) yielded <b>14</b> as a yellow solid (85%); mp 173â176 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.64, 7.49 (ABq, <i>J</i><sub>AB</sub> = 8.6 Hz, 4H), 3.83 (d, <i>J</i> = 12.0 Hz, 2H), 2.77 (d, <i>J</i> = 11.2 Hz, 2H), 2.31â2.18 (m, 3H), 2.13 (t, <i>J</i> = 11.3 Hz, 2H), 1.82 (d, <i>J</i> = 12.2 Hz, 2H), 1.70â1.51 (m, 4H), 1.31 (s, 9H), 1.30â1.25 (m, 1H), 1.24â1.11 (m, 2H), 0.86 (d, <i>J</i> = 6.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 156.4, 133.1, 127.5, 125.9, 61.5, 49.4, 46.1, 35.1, 34.3, 31.1, 30.9, 27.1, 21.8. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>35</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 379.2414, found 379.2418.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4-Methyl-1â²-((4-(trifluoromethyl)phenyl)sulfonyl)-1,4â²-bipiperidine (<b>15</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-(trifluoromethyl)benzene-1-sulfonyl chloride (Procedure A) yielded <b>15</b> as a yellow solid (87%); mp 175â178 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.86, 7.77 (ABq, <i>J</i><sub>AB</sub> = 8.2 Hz, 4H), 3.85 (d, <i>J</i> = 12.1 Hz, 2H), 2.75 (d, <i>J</i> = 11.7 Hz, 2H), 2.28 (t, <i>J</i> = 11.4 Hz, 3H), 2.19 (tt, <i>J</i> = 11.5, 3.6 Hz, 1H), 2.09 (td, <i>J</i> = 11.3, 2.4 Hz, 2H), 1.83 (d, <i>J</i> = 11.5 Hz, 2H), 1.62 (qd, <i>J</i> = 12.4, 4.0 Hz, 4H), 1.38â1.21 (m, 1H), 1.14 (qd, <i>J</i> = 11.9, 3.8 Hz, 2H), 0.87 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 140.0, 134.4 (q, <i>J</i> = 33.1 Hz), 128.1, 126.2 (q, <i>J</i> = 3.7 Hz), 123.2 (q, <i>J</i> = 272.9 Hz), 61.3, 49.4, 46.1, 34.4, 30.9, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>26</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 391.1662, found 391.1654.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1â²-((4-Chlorophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>16</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-chlorobenzene-1-sulfonyl chloride (Procedure A) yielded <b>16</b> as a white solid (67%); mp 152â155 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.66 (d, <i>J</i> = 8.5 Hz, 2H), 7.47 (d, <i>J</i> = 8.5 Hz, 2H), 3.93â3.69 (m, 2H), 2.80 (dt, <i>J</i> = 11.6, 3.4 Hz, 2H), 2.23 (td, <i>J</i> = 12.0, 2.5 Hz, 3H), 2.15 (t, <i>J</i> = 11.3 Hz, 2H), 1.84 (d, <i>J</i> = 12.6 Hz, 2H), 1.71â1.54 (m, 4H), 1.42â1.26 (m, 1H), 1.25â1.12 (m, 2H), 0.87 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 139.3, 134.6, 129.3, 129.0, 61.4, 49.4, 46.0, 34.2, 30.8, 27.2, 21.7. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>26</sub>ClN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 357.1398, found 357.1393.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1â²-((4-Bromophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>17</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-bromobenzene-1-sulfonyl chloride (Procedure A) yielded <b>17</b> as a white solid (83%); mp 165â168 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.75â7.45 (m, 4H), 3.81 (d, <i>J</i> = 11.9 Hz, 2H), 2.75 (d, <i>J</i> = 11.5 Hz, 2H), 2.38â1.96 (m, 5H), 1.81 (d, <i>J</i> = 11.8 Hz, 2H), 1.73â1.52 (m, 4H), 1.37â1.22 (m, 1H), 1.22â1.06 (m, 2H), 0.87 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 135.2, 132.3, 129.1, 127.7, 61.3, 49.5, 46.1, 34.6, 31.0, 27.3, 21.9. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>26</sub> BrN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 401.0893, found 401.0886.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 4-Methyl-1â²-((4-propoxyphenyl)sulfonyl)-1,4â²-bipiperidine (<b>18</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-propoxybenzene-1-sulfonyl chloride (Procedure A) yielded <b>18</b> as a white solid (>95%); mp 118â121 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.65 (d, <i>J</i> = 8.9 Hz, 2H), 6.95 (d, <i>J</i> = 8.9 Hz, 2H), 3.95 (t, <i>J</i> = 6.6 Hz, 2H), 3.80 (d, <i>J</i> = 11.4 Hz, 2H), 2.76 (d, <i>J</i> = 10.9 Hz, 2H), 2.15 (dt, <i>J</i> = 37.1, 11.5 Hz, 5H), 1.88â1.72 (m, 4H), 1.71â1.52 (m, 4H), 1.37â1.24 (m, 1H), 1.15 (q, <i>J</i> = 11.8 Hz, 2H), 1.03 (t, <i>J</i> = 7.4 Hz, 3H), 0.87 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 162.5, 129.7, 127.3, 114.5, 69.9, 61.5, 49.5, 46.2, 34.6, 31.0, 27.3, 22.4, 21.9, 10.5. HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>33</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 381.2206, found 381.2210.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1â²-((4-Butoxyphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>19</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-butoxybenzene-1-sulfonyl chloride (Procedure A) yielded <b>19</b> as a pink solid (82%); mp 137â139 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.64 (d, <i>J</i> = 8.7 Hz, 2H), 6.94 (d, <i>J</i> = 8.7 Hz, 2H), 3.99 (t, <i>J</i> = 6.5 Hz, 2H), 3.80 (d, <i>J</i> = 12.3 Hz, 2H), 2.78 (d, <i>J</i> = 11.3 Hz, 2H), 2.27â2.06 (m, 5H), 1.88â1.72 (m, 4H), 1.70â1.55 (m, 4H), 1.47 (h, <i>J</i> = 7.4 Hz, 2H), 1.39â1.24 (m, 1H), 1.24â1.10 (m, 2H), 0.96 (t, <i>J</i> = 7.4 Hz, 3H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 162.5, 129.7, 127.2, 114.5, 68.1, 61.6, 49.4, 46.1, 34.4, 31.0, 30.9, 27.2, 21.8, 19.1, 13.8. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>35</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 395.2363, found 395.2361.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1â²-((4-(Benzyloxy)phenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>20</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-(benzyloxy)benzene-1-sulfonyl chloride (Procedure A) yielded <b>20</b> as a white solid (84%); mp 157â159 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.67 (d, <i>J</i> = 8.8 Hz, 2H), 7.48â7.27 (m, 4H), 7.04 (d, <i>J</i> = 8.8 Hz, 2H), 5.10 (s, 2H), 3.81 (d, <i>J</i> = 11.5 Hz, 2H), 2.77 (d, <i>J</i> = 10.9 Hz, 2H), 2.31â2.04 (m, 5H), 1.89â1.76 (m, 2H), 1.68â1.53 (m, 4H), 1.37â1.08 (m, 3H), 0.88 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 162.1, 135.8, 129.8, 128.7, 128.4, 127.9, 127.5, 115.0, 70.4, 61.5, 49.5, 46.2, 34.5, 31.0, 27.3, 21.9. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>33</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 429.2206, found 429.2195.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-Methyl-1â²-((4-(trifluoromethoxy)phenyl)sulfonyl)-1,4â²-bipiperidine (<b>21</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-(trifluoromethoxy)benzene-1-sulfonyl chloride (Procedure A) yielded <b>21</b> as a yellow solid (>95%); mp 168â170 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.79 (d, <i>J</i> = 8.2 Hz, 2H), 7.34 (d, <i>J</i> = 8.2 Hz, 2H), 3.84 (d, <i>J</i> = 12.0 Hz, 2H), 2.79 (d, <i>J</i> = 11.7 Hz, 2H), 2.35â2.19 (m, 3H), 2.13 (t, <i>J</i> = 11.4 Hz, 2H), 1.86 (d, <i>J</i> = 10.8 Hz, 2H), 1.71â1.55 (m, 4H), 1.39â1.11 (m, 3H), 0.88 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 152.1 (q, <i>J</i> = 1.8 Hz), 134.7, 129.7, 120.8 (q, <i>J</i> = 1.1 Hz), 120.2 (q, <i>J</i> = 259.5 Hz), 61.3, 49.5, 46.1, 34.6, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>26</sub> F<sub>3</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 407.1611, found 407.1615.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1â²-((4-(Difluoromethoxy)phenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>22</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-(difluoromethoxy)benzene-1-sulfonyl chloride (Procedure A) yielded <b>22</b> as a light orange solid (69%); mp 132â135 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.76 (d, <i>J</i> = 8.8 Hz, 2H), 7.24 (d, <i>J</i> = 8.8 Hz, 2 H), 6.61 (t, <i>J</i> = 72.6 Hz, 1H), 3.83 (d, <i>J</i> = 12.1 Hz, 2H), 2.77 (d, <i>J</i> = 11.7 Hz, 2H), 2.33â2.16 (m, 3 H), 2.11 (td, <i>J</i> = 11.6, 2.5 Hz, 2H), 1.84 (d, <i>J</i> = 13.2 Hz, 2H), 1.69â1.52 (m, 4 H), 1.30 (dddt, <i>J</i> = 13.3, 9.7, 6.5, 3.5 Hz, 1H), 1.16 (qd, <i>J</i> = 12.0, 3.8 Hz, 2H), 0.89 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 154.1 (t, <i>J</i> = 2.9 Hz), 132.9, 129.8, 119.3, 115.2 (t, <i>J</i> = 262.5 Hz), 61.4, 49.5, 46.1, 34.6, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>26</sub> F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>SNa [M + Na]<sup>+</sup> 411.1524, found 411.1529.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1â²-((3-Methoxyphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>23</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3-methoxybenzene-1-sulfonyl chloride (Procedure A) yielded <b>23</b> as a yellow solid (85%); mp 81â83 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.40 (t, <i>J</i> = 8.0 Hz, 1H), 7.29 (ddd, <i>J</i> = 7.7, 1.6, 0.9 Hz, 1H), 7.22 (dd, <i>J</i> = 2.6, 1.6 Hz, 1H), 7.08 (ddt, <i>J</i> = 8.3, 2.6, 0.8 Hz, 1H), 3.83 (s, 3H), 3.82 (d, <i>J</i> = 12.0 Hz, 2H), 2.79 (d, <i>J</i> = 11.7 Hz, 2H), 2.25 (td, <i>J</i> = 12.0, 2.6 Hz, 3H), 2.18â2.07 (m, 2H), 1.84 (d, <i>J</i> = 12.3 Hz, 2H), 1.72â1.53 (m, 4H), 1.37â1.13 (m, 3H), 0.87 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 159.8, 137.2, 130.0, 119.7, 118.8, 112.5, 61.5, 55.6, 49.4, 46.1, 34.3, 30.9, 27.2, 21.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 353.1893, found 353.1898.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 4-Methyl-1â²-((3-nitrophenyl)sulfonyl)-1,4â²-bipiperidine (<b>24</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3-nitrobenzene-1-sulfonyl chloride (Procedure A) yielded <b>24</b> as a yellow solid (77%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.55 (s, 1H), 8.42 (d, <i>J</i> = 8.2 Hz, 1H), 8.06 (d, <i>J</i> = 7.8 Hz, 1H), 7.74 (t, <i>J</i> = 8.0 Hz, 1H), 3.86 (d, <i>J</i> = 12.1 Hz, 2H), 2.75 (d, <i>J</i> = 11.6 Hz, 2H), 2.32 (td, <i>J</i> = 12.0, 2.5 Hz, 2H), 2.19 (tt, <i>J</i> = 11.5, 3.6 Hz, 1H), 2.09 (td, <i>J</i> = 11.6, 2.5 Hz, 2H), 1.84 (d, <i>J</i> = 12.5 Hz, 2H), 1.71â1.52 (m, 4H), 1.37â1.20 (m, 1H), 1.13 (qd, <i>J</i> = 12.1, 4.0 Hz, 2H), 0.86 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 148.3, 138.8, 133.0, 130.4, 127.1, 122.6, 61.2, 49.5, 46.1, 34.5, 31.0, 27.4, 21.8. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 368.1639, found 368.1630.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 3-((4-Methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)aniline (<b>25</b>)</h3><div class="NLM_p last">This compound was prepared as a yellow gel (55%) by hydrogenation of <b>24</b> in the same manner as for the preparation of <b>10</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.24 (t, <i>J</i> = 7.9 Hz, 1H), 7.01 (t, <i>J</i> = 2.0 Hz, 1H), 6.91 (dddd, <i>J</i> = 23.6, 8.1, 2.0, 1.0 Hz, 2H), 3.76 (d, <i>J</i> = 12.3 Hz, 2H), 3.29 (p, <i>J</i> = 1.7 Hz, 1H), 2.83 (d, <i>J</i> = 10.7 Hz, 2H), 2.28 (td, <i>J</i> = 12.4, 2.4 Hz, 2H), 2.23â2.07 (m, 3H), 1.87 (d, <i>J</i> = 12.9 Hz, 2H), 1.62 (dd, <i>J</i> = 13.3, 3.5 Hz, 2H), 1.52 (qd, <i>J</i> = 12.3, 4.1 Hz, 2H), 1.40â1.23 (m, 2H), 1.16 (qd, <i>J</i> = 12.1, 3.8 Hz, 2H), 0.89 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) Î´ 149.1, 136.3, 129.3, 118.5, 115.4, 112.5, 61.2, 49.1, 45.9, 33.7, 30.7, 26.9, 20.7. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>27</sub>N<sub>3</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 360.1716, found 360.1703.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 4-Methyl-1â²-(<i>m</i>-tolylsulfonyl)-1,4â²-bipiperidine (<b>26</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3-methylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>26</b> as a yellow solid (86%); mp 90â93 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.62â7.43 (m, 2H), 7.41â7.31 (m, 2H), 3.81 (d, <i>J</i> = 12.0 Hz, 2H), 2.80 (d, <i>J</i> = 11.8 Hz, 2H), 2.39 (s, 3H), 2.34â2.06 (m, 5H), 1.85 (d, <i>J</i> = 12.3 Hz, 2H), 1.68â1.55 (m, 4H), 1.37â1.13 (m, 3H), 0.86 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 139.2, 135.8, 133.5, 128.8, 127.9, 124.8, 61.6, 49.4, 46.0, 34.1, 30.8, 27.1, 21.7, 21.4. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 337.1944, found 337.1937.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 4-Methyl-1â²-((3-(trifluoromethyl)phenyl)sulfonyl)-1,4â²-bipiperidine (<b>27</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3-(trifluoromethyl)benzene-1-sulfonyl chloride (Procedure A) yielded <b>27</b> as a pink solid (90%); mp 123â125 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.98 (s, 1H), 7.92 (d, <i>J</i> = 7.9 Hz, 1H), 7.83 (d, <i>J</i> = 7.8 Hz, 1H), 7.67 (t, <i>J</i> = 7.9 Hz, 1H), 3.85 (d, <i>J</i> = 12.0 Hz, 2H), 2.79 (d, <i>J</i> = 11.6 Hz, 2H), 2.27 (tt, <i>J</i> = 11.8, 3.7 Hz, 3H), 2.19â2.06 (m, 2H), 1.86 (d, <i>J</i> = 11.5 Hz, 2H), 1.70â1.48 (m, 4H), 1.35â1.25 (m, 1H), 1.18 (qd, <i>J</i> = 11.9, 3.7 Hz, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 137.6, 131.8 (q, <i>J</i> = 33.4 Hz), 130.8, 129.9, 129.4 (q, <i>J</i> = 3.5 Hz), 124.5 (q, <i>J</i> = 3.7 Hz), 121.8, 61.3, 49.4, 46.0, 34.2, 30.8, 27.2, 21.7. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>26</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 391.1661, found 391.1666.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1â²-((3-Chlorophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>28</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3-chlorobenzene-1-sulfonyl chloride (Procedure A) yielded <b>28</b> as a yellow solid (74%); mp 122â124 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.71 (s, 1H), 7.61 (d, <i>J</i> = 7.7 Hz, 1H), 7.54 (d, <i>J</i> = 8.1 Hz, 1H), 7.45 (t, <i>J</i> = 7.9 Hz, 1H), 3.83 (d, <i>J</i> = 11.7 Hz, 2H), 2.80 (d, <i>J</i> = 10.9 Hz, 2H), 2.28 (td, <i>J</i> = 11.8, 2.5 Hz, 3H), 2.15 (t, <i>J</i> = 11.3 Hz, 2H), 1.87 (d, <i>J</i> = 12.7 Hz, 2H), 1.72â1.56 (m, 4H), 1.40â1.14 (m, 3H), 0.88 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 138.0, 135.3, 132.8, 130.3, 127.5, 125.7, 61.4, 49.4, 46.1, 34.2, 30.8, 27.2, 21.7. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>26</sub>ClN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 357.1398, found 357.1386.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1â²-((3-Bromophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>29</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3-bromobenzene-1-sulfonyl chloride (Procedure A) yielded <b>29</b> as a white solid (65%); mp 125â126 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.85 (s, 1H), 7.66 (dd, <i>J</i> = 13.3, 7.9 Hz, 2H), 7.37 (t, <i>J</i> = 7.9 Hz, 1H), 3.80 (d, <i>J</i> = 11.7 Hz, 2H), 2.74 (d, <i>J</i> = 11.0 Hz, 2H), 2.16 (dt, <i>J</i> = 73.4, 11.4 Hz, 5H), 1.81 (d, <i>J</i> = 12.7 Hz, 2H), 1.60 (td, <i>J</i> = 12.4, 8.1 Hz, 4H), 1.34â1.22 (m, 1H), 1.20â1.02 (m, 2H), 0.85 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 138.2, 135.7, 130.5, 130.3, 126.1, 123.1, 61.3, 49.5, 46.1, 34.6, 31.0, 27.4, 21.9. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>26</sub>BrN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 401.0893, found 401.0886.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1â²-((2-Bromophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>30</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2-bromobenzene-1-sulfonyl chloride (Procedure A) yielded <b>30</b> as a white solid (>95%); mp 82â84 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.05 (dd, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.70 (dd, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.37 (dtd, <i>J</i> = 24.2, 7.5, 1.6 Hz, 2H), 3.85 (d, <i>J</i> = 12.8 Hz, 2H), 2.91â2.62 (m, 4H), 2.33 (tt, <i>J</i> = 11.5, 3.5 Hz, 1H), 2.11 (td, <i>J</i> = 11.5, 2.4 Hz, 2H), 1.80 (d, <i>J</i> = 12.2 Hz, 2H), 1.65â1.50 (m, 4H), 1.35â1.22 (m, 1H), 1.15 (qd, <i>J</i> = 12.2, 3.8 Hz, 2H), 0.86 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 138.0, 135.7, 133.5, 132.2, 127.4, 120.4, 61.7, 49.5, 45.6, 34.6, 31.0, 27.8, 21.9. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>26</sub>BrN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 401.0893, found 401.0891.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1â²-((3,4-Dimethoxyphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>31</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3,4-dimethoxybenzene-1-sulfonyl chloride (Procedure A) yielded <b>31</b> as a white solid (78%); mp 132â134 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.34 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 7.18 (d, <i>J</i> = 2.1 Hz, 1H), 6.92 (d, <i>J</i> = 8.5 Hz, 1H), 3.91 (s, 3H), 3.90 (s, 3H), 3.80 (d, <i>J</i> = 11.9 Hz, 2H), 2.77 (d, <i>J</i> = 11.7 Hz, 2H), 2.30â2.04 (m, 5H), 1.82 (d, <i>J</i> = 11.2 Hz, 2H), 1.69â1.54 (m, 4H), 1.37â1.25 (m, 1H), 1.16 (qd, <i>J</i> = 12.1, 3.8 Hz, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H), <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 152.5, 148.9, 127.8, 121.5, 110.5, 110.1, 61.5, 56.2, 56.1, 49.5, 46.2, 34.5, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>31</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 383.1999, found 383.1991.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 1â²-((2,5-Dimethoxyphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>32</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2,5-dimethoxybenzenesulfonyl chloride (Procedure A) yielded <b>32</b> as a white solid (95%); mp 75â78 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.39 (d, <i>J</i> = 3.1 Hz, 1H), 7.00 (dd, <i>J</i> = 9.0, 3.1 Hz, 1H), 6.90 (d, <i>J</i> = 9.0 Hz, 1H), 3.87 (d, <i>J</i> = 12.8 Hz, 2H), 3.83 (s, 3H), 3.75 (s, 3H), 2.77 (d, <i>J</i> = 11.6 Hz, 2H), 2.57 (t, <i>J</i> = 12.4 Hz, 2H), 2.27 (t, <i>J</i> = 11.5 Hz, 1H), 2.10 (t, <i>J</i> = 11.5 Hz, 2H), 1.77 (d, <i>J</i> = 13.8 Hz, 2H), 1.64â1.47 (m, 4H), 1.36â1.22 (m, 1H), 1.21â1.08 (m, 2H), 0.86 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 152.9, 151.0, 127.3, 120.0, 115.9, 113.9, 61.9, 56.6, 56.0, 49.5, 45.9, 34.6, 31.0, 27.9, 21.9. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>31</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 383.1999, found 383.1991.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 1â²-((5-Bromo-2-methoxyphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>33</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 5-bromo-2-methoxybenzene-1-sulfonyl chloride (Procedure A) yielded <b>33</b> as a yellow solid (92%); mp 98â102 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.01 (d, <i>J</i> = 2.6, Hz, 1H), 7.59 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 6.88 (d, <i>J</i> = 8.8 Hz, 1H), 3.96â3.88 (d, <i>J</i> = 13.6 Hz, 2H), 3.90 (s, 3H), 2.84 (d, <i>J</i> = 10.9 Hz, 2H), 2.64 (td, <i>J</i> = 12.5, 2.5 Hz, 2H), 2.38 (d, <i>J</i> = 12.2 Hz, 1H), 2.17 (t, <i>J</i> = 11.7 Hz, 2H), 1.85 (d, <i>J</i> = 12.7 Hz, 2H), 1.68â1.52 (m, 4H), 1.40â1.14 (m, 3H), 0.91 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 155.9, 136.8, 133.8, 128.7, 114.1, 112.3, 61.8, 56.3, 49.5, 45.9, 34.6, 31.0, 28.0, 21.9. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>27</sub>BrN<sub>2</sub>O<sub>3</sub>SNa [M + Na]<sup>+</sup> 453.0818, found 453.0805.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 1â²-((2-Methoxy-4-methylphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>34</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2-methoxy-4-methylphenylsulfonyl chloride (Procedure A) yielded <b>34</b> as a yellow solid (88%); mp 95â98 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.70 (d, <i>J</i> = 7.9 Hz, 1H), 6.85â6.69 (m, 2H), 3.87 (d, <i>J</i> = 12.4 Hz, 2H), 3.85 (s, 3H), 2.78 (d, <i>J</i> = 11.1 Hz, 2H), 2.54 (d, <i>J</i> = 12.4 Hz, 2H), 2.35 (s, 3H), 2.27 (tt, <i>J</i> = 11.8, 3.6 Hz, 1H), 2.12 (td, <i>J</i> = 11.5, 2.7 Hz, 2H), 1.78 (d, <i>J</i> = 12.5 Hz, 2H), 1.64â1.47 (m, 4H), 1.37â1.23 (m, 1H), 1.22â1.08 (m, 2H), 0.86 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 156.8, 145.5, 131.6, 123.5, 121.0, 112.9, 61.9, 55.8, 49.5, 45.9, 34.5, 31.0, 27.9, 21.9, 21.8. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>31</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 367.2050, found 367.2061.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 4-Methyl-1â²-((4-nitro-3-(trifluoromethyl)phenyl)sulfonyl)-1,4â²-bipiperidine (<b>35</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-nitro-3-(trifluoromethyl)benzene-1-sulfonyl chloride (Procedure A) yielded <b>35</b> as a yellow solid (86%); mp 175â178 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.15 (s, 1H), 8.08 (dd, <i>J</i> = 8.4, 1.8 Hz, 1H), 7.98 (d, <i>J</i> = 8.3 Hz, 1H), 3.87 (d, <i>J</i> = 11.7 Hz, 2H), 2.77 (d, <i>J</i> = 11.7 Hz, 2H), 2.38 (td, <i>J</i> = 12.0, 2.5 Hz, 2H), 2.25 (tt, <i>J</i> = 11.4, 3.6 Hz, 1H), 2.11 (td, <i>J</i> = 11.4, 2.6 Hz, 2H), 1.87 (d, <i>J</i> = 12.1 Hz, 2H), 1.73â1.56 (m, 4H), 1.38â1.24 (m, 1H), 1.16 (qd, <i>J</i> = 11.7, 3.5 Hz, 2H), 0.88 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 150.0, 141.4, 132.2, 127.1 (q, <i>J</i> = 5.2 Hz), 125.9, 124.7 (d, <i>J</i> = 35.3 Hz). 121.1 (d, <i>J</i> = 274.2 Hz), 61.0, 49.5, 46.0, 34.5, 30.9, 27.4, 21.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>25</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 436.1512, found 436.1515.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 4-Methyl-2-((4-methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)benzonitrile (<b>36</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2-cyano-5-methylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>36</b> as a light pink solid (94%); mp 118â121 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.80 (s, 1H), 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.44 (d, <i>J</i> = 7.8 Hz, 1H), 3.92 (d, <i>J</i> = 12.2 Hz, 2H), 2.78 (d, <i>J</i> = 12.3 Hz, 2H), 2.59 (t, <i>J</i> = 12.2 Hz, 2H), 2.47 (s, 3H), 2.31 (t, <i>J</i> = 11.7 Hz, 1H), 2.12 (t, <i>J</i> = 11.3 Hz, 2H), 1.84 (d, <i>J</i> = 14.5 Hz, 2H), 1.71â1.51 (m, 4H), 1.37â1.24 (m, 1H), 1.17 (q, <i>J</i> = 12.5 Hz, 2H), 0.87 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 144.4, 140.3, 135.4, 133.2, 130.8, 116.5, 107.8, 61.5, 49.5, 45.8, 34.5, 31.0, 27.5, 21.8. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 362.1897, found 362.1885.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 1â²-((3,4-Dimethylphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>37</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3,4-dimethylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>37</b> as a yellow solid (89%); mp 87â89 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.47 (s, 1H), 7.45 (d, <i>J</i> = 7.9 Hz, 1H), 7.24 (d, <i>J</i> = 7.8 Hz, 1H), 3.81 (d, <i>J</i> = 12.0 Hz, 2H), 2.78 (d, <i>J</i> = 11.5 Hz, 2H), 2.30 (s, 6H), 2.16 (m, 5H), 1.82 (d, <i>J</i> = 11.5 Hz, 2H), 1.69â1.54 (m, 4H), 1.38â1.24 (m, 1H), 1.17 (qd, <i>J</i> = 12.0, 3.6 Hz, 2H), 0.87 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.2, 137.7, 133.1, 130.1, 128.4, 125.3, 61.5, 49.4, 46.2, 34.4, 30.9, 27.2, 21.8, 19.9, 19.9. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>31</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 351.2101, found 351.2091.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1â²-((4-Bromo-2-ethylphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>38</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-bromo-2-ethylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>38</b> as a white solid (92%); mp 87â91 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.50 (d, <i>J</i> = 2.0 Hz, 1H), 7.42 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 3.75 (d, <i>J</i> = 12.4 Hz, 2H), 2.96 (q, <i>J</i> = 7.6 Hz, 2H), 2.83 (d, <i>J</i> = 7.6 Hz, 2H), 2.60 (td, <i>J</i> = 12.4, 2.4 Hz, 2H), 2.40â2.27 (m, 1H), 2.20â2.05 (m, 2H), 1.84 (d, <i>J</i> = 7.6 Hz, 2H), 1.68â1.48 (m, 4H), 1.38â1.13 (m, 6H), 0.89 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 145.2, 134.8, 133.9, 131.7, 129.0, 127.8, 61.6, 49.5, 45.1, 34.4, 30.9,27.7, 25.9, 21.8, 15.4. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>30</sub>Br N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 429.1206, found 429.1202.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 1â²-((4-Chloro-3-(trifluoromethyl)phenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>39</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-chloro-3-(trifluoromethyl)benzene-1-sulfonyl chloride (Procedure A) yielded <b>39</b> as a light brown solid (>95%); mp 118â120 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.03 (s, 1H), 7.84 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 7.66 (d, <i>J</i> = 8.4 Hz, 1H), 3.84 (d, <i>J</i> = 12.1 Hz, 2H), 2.78 (d, <i>J</i> = 11.1 Hz, 2H), 2.37â2.18 (m, 3H), 2.12 (td, <i>J</i> = 11.5, 2.7 Hz, 2H), 1.86 (d, <i>J</i> = 11.8 Hz, 2H), 1.71â1.52 (m, 4H), 1.36â1.24 (m, 1H), 1.17 (qd, <i>J</i> = 11.9, 3.8 Hz, 2H), 0.88 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 137.3, 135.7, 132.4, 131.7, 129.5 (q, <i>J</i> = 32.6 Hz), 126.7 (q, <i>J</i> = 5.3 Hz), 122.0 (q, <i>J</i> = 274.1 Hz), 61.3, 49.4, 45.9, 34.1, 30.8, 27.1, 21.7. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>25</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 425.1261, found 425.1272.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 1â²-((3,4-Dichlorophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>40</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3,4-dichlorobenzene-1-sulfonyl chloride (Procedure A) yielded <b>40</b> as a light brown solid (86%); mp 160â162 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.81 (d, <i>J</i> = 1.9 Hz, 1H), 7.66â7.44 (m, 2H), 3.81 (d, <i>J</i> = 12.1 Hz, 2H), 2.76 (d, <i>J</i> = 11.2 Hz, 2H), 2.29 (td, <i>J</i> = 11.9, 2.5 Hz, 2H), 2.20 (tt, <i>J</i> = 11.5, 3.5 Hz, 1H), 2.10 (td, <i>J</i> = 11.5, 2.4 Hz, 2H), 1.84 (d, <i>J</i> = 11.5 Hz, 2H), 1.62 (ddt, <i>J</i> = 16.3, 12.5, 5.6 Hz, 4H), 1.36â1.23 (m, 1H), 1.15 (qd, <i>J</i> = 11.8, 11.2, 3.7 Hz, 2H), 0.87 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 137.5, 136.2, 133.8, 131.1, 129.4, 126.6, 61.3, 49.5, 46.1, 34.6, 31.0, 27.4, 21.8. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 391.1008, found 391.1018.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 1â²-((2,4-Dichlorophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>41</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2,4-dichlorobenzene-1-sulfonyl chloride (Procedure A) yielded <b>41</b> as a light orange solid (88%); mp 75â78 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.94 (d, <i>J</i> = 8.6 Hz, 1H), 7.49 (d, <i>J</i> = 2.0 Hz, 1H), 7.33 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 3.85 (d, <i>J</i> = 12.9 Hz, 2H), 2.81 (d, <i>J</i> = 11.7 Hz, 2H), 2.71 (td, <i>J</i> = 12.5, 2.4 Hz, 2H), 2.37 (tt, <i>J</i> = 11.7, 3.5 Hz, 1H), 2.14 (td, <i>J</i> = 11.0, 2.2 Hz, 2H), 1.83 (d, <i>J</i> = 12.1 Hz, 2H), 1.67â1.47 (m, 4H), 1.38â1.25 (m, 1H), 1.25â1.11 (m, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 139.2, 135.2, 133.2, 132.9, 131.8, 127.2, 61.6, 49.5, 45.6, 34.4, 30.9, 27.8, 21.8. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 391.1008, found 391.1013.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 1â²-((3,5-Dichlorophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>42</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3,5-dichlorobenzene-1-sulfonyl chloride (Procedure A) yielded <b>42</b> as a pink solid (92%); mp 128â131 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.61 (d, <i>J</i> = 2.0 Hz, 2H), 7.57 (t, <i>J</i> = 1.9 Hz, 1H), 3.92â3.76 (m, 2H), 2.83 (d, <i>J</i> = 6.2 Hz, 2H), 2.47â2.25 (m, 3H), 2.17 (t, <i>J</i> = 11.3 Hz, 2H), 1.90 (d, <i>J</i> = 14.2 Hz, 2H), 1.65 (td, <i>J</i> = 12.6, 4.1 Hz, 4H), 1.37â1.27 (m, 1H), 1.27â1.13 (m, 2H), 0.90 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 139.3, 136.1, 132.7, 125.8, 61.3, 49.5, 46.0, 34.2, 30.8, 27.2, 21.7. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 391.1008, found 391.1001.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 1â²-((4-Bromo-3-chlorophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>43</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-bromo-3-chlorobenzene-1-sulfonyl chloride (Procedure A) yielded <b>43</b> as a white solid (95%); mp 169â171 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.87â7.70 (m, 2H), 7.46 (d, <i>J</i> = 8.4 Hz, 1H), 3.81 (d, <i>J</i> = 11.8 Hz, 2H), 2.76 (d, <i>J</i> = 10.7 Hz, 2H), 2.29 (t, <i>J</i> = 12.3 Hz, 2H), 2.20 (tt, <i>J</i> = 11.5, 4.1 Hz, 1H), 2.15â2.05 (m, 2H), 1.84 (d, <i>J</i> = 12.3 Hz, 2H), 1.74â1.52 (m, 4H), 1.38â1.23 (m, 1H), 1.22â1.07 (m, 2H), 0.87 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 136.9, 135.8, 134.4, 129.1, 127.9, 126.6, 61.3, 49.5, 46.1, 34.6, 31.0, 27.4, 21.8. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>25</sub>ClBrN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 435.0503, found 435.0515.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 1â²-((2,4-Difluorophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>44</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2,4-difluorobenzene-1-sulfonyl chloride (Procedure A) yielded <b>44</b> as a white solid (88%); mp 165â168 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.89â7.73 (m, 2H), 7.63 (dd, <i>J</i> = 8.5, 1.6 Hz, 2H), 7.41 (td, <i>J</i> = 8.7, 6.3 Hz, 1H), 7.05â6.83 (m, 2H), 3.87 (d, <i>J</i> = 12.0 Hz, 2H), 2.77 (d, <i>J</i> = 11.6 Hz, 2H), 2.31 (td, <i>J</i> = 12.0, 2.5 Hz, 2H), 2.27â2.17 (m, 1H), 2.12 (td, <i>J</i> = 11.6, 2.4 Hz, 2H), 1.84 (d, <i>J</i> = 12.9 Hz, 2H), 1.71â1.53 (m, 4H), 1.37â1.24 (m, 1H), 1.24â1.09 (m, 2H), 0.88 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 162.9 (dd, <i>J</i> = 251.0, 11.9 Hz), 159.8 (dd, <i>J</i> = 251.8, 11.9 Hz), 139.4 (d, <i>J</i> = 1.6 Hz), 135.4, 131.5 (dd, <i>J</i> = 9.6, 4.6 Hz), 129.4 (d, <i>J</i> = 3.1 Hz), 127.9, 123.5 (dd, <i>J</i> = 13.3, 3.9 Hz), 112.0 (dd, <i>J</i> = 21.3, 3.8 Hz), 104.7 (t, <i>J</i> = 10.0 Hz), 61.4, 49.5, 46.2, 34.5, 31.0, 27.3, 21.8. MS (ESI) calcd for C<sub>17</sub>H<sub>25</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 359.2, found 359.2.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 1â²-((4-Bromo-2-(trifluoromethoxy)phenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>45</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-bromo-2-(trifluoromethoxy)benzene-1-sulfonyl chloride (Procedure A) yielded <b>45</b> as a yellow solid (67%); mp 108â110 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.83 (d, <i>J</i> = 8.9 Hz, 1H), 7.58â7.45 (m, 2H), 3.85 (d, <i>J</i> = 12.7 Hz, 2H), 2.78 (dt, <i>J</i> = 11.9, 3.3 Hz, 2H), 2.59 (td, <i>J</i> = 12.5, 2.5 Hz, 2H), 2.29 (tt, <i>J</i> = 11.5, 3.6 Hz, 1H), 2.11 (td, <i>J</i> = 11.5, 2.4 Hz, 2H), 1.82 (dt, <i>J</i> = 12.7, 2.7 Hz, 2H), 1.69â1.45 (m, 4H), 1.40â1.24 (m, 1H), 1.23â1.05 (m, 2H), 0.88 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 146.2, 132.7, 130.1, 129.8, 127.9, 123.90, 121.3, 61.5, 49.5, 45.7, 34.59, 31.0, 27.8, 21.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>25</sub>BrF<sub>3</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 485.0716, found 485.0724.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 1â²-((5-Isopropyl-4-methoxy-2-methylphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>46</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 5-isopropyl-4-methoxy-2-methylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>46</b> as a brown solid (94%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.65 (s, 1H), 6.71 (s, 1H), 3.88â3.84 (d, <i>J</i> = 12.8 Hz, 2H), 3.83 (s, 3H), 3.02 (p, <i>J</i> = 6.9 Hz, 1H), 2.80 (d, <i>J</i> = 11.0 Hz, 2H), 2.51 (td, <i>J</i> = 12.5, 2.5 Hz, 2H), 2.34â2.26 (m, 1H), 2.32 (s, 3H), 2.15 (td, <i>J</i> = 11.4, 2.5 Hz, 2H), 1.80 (d, <i>J</i> = 11.8 Hz, 2H), 1.67â1.51 (m, 4H), 1.37â1.11 (m, 3H), 1.16 (d, <i>J</i> = 6.8 Hz, 6H), 0.86 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 154.3, 142.3, 139.1, 128.0, 123.8, 114.1, 62.0, 56.0, 49.4, 45.8, 34.3, 30.9, 28.7, 27.7, 23.2, 21.8, 19.7. HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>37</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 409.2519, found 409.2511.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 1â²-(Mesitylsulfonyl)-4-methyl-1,4â²-bipiperidine (<b>47</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2,4,6-trimethylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>47</b> as a yellow solid (>95%); mp 62â65 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 6.94 (s, 2H), 3.62 (d, <i>J</i> = 12.5 Hz, 2H), 2.85 (d, <i>J</i> = 12.4 Hz, 2H), 2.75 (t, <i>J</i> = 12.4 Hz, 2H), 2.61 (s, 6H), 2.34 (t, <i>J</i> = 11.5 Hz, 1H), 2.29 (s, 3H), 2.12 (t, <i>J</i> = 11.4 Hz, 2H), 1.86 (d, <i>J</i> = 11.1 Hz, 2H), 1.63 (d, <i>J</i> = 13.4 Hz, 2H), 1.50 (qd, <i>J</i> = 12.3, 4.0 Hz, 2H), 1.39â1.27 (br, 1H), 1.27â1.13 (m, 2H), 0.90 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.4, 140.4, 131.8, 131.7, 61.8, 49.6, 44.0, 34.6, 31.0, 27.7, 22.8, 21.9, 20.9. HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>33</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 365.2257, found 365.2252.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 1â²-((2,4-Dichloro-5-methylphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>48</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2,4-dichloro-5-methylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>48</b> as a white solid (83%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.89 (s, 1H), 7.49 (s, 1H), 3.87 (d, <i>J</i> = 12.9 Hz, 2H), 2.82 (d, <i>J</i> = 11.2 Hz, 2H), 2.71 (td, <i>J</i> = 12.4, 2.4 Hz, 2H), 2.38 (s, 3H), 2.36â2.26 (m, 1H), 2.15 (t, <i>J</i> = 11.2 Hz, 2H), 1.83 (d, <i>J</i> = 11.6 Hz, 2H), 1.65â1.51 (m, 4H), 1.39â1.25 (m, 1H), 1.06 (t, <i>J</i> = 12.0 Hz, 2H), 0.89 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 139.3, 135.5, 134.6, 133.6, 132.0, 129.9, 61.7, 49.5, 45.6, 34.5, 31.0, 27.7, 21.8, 19.6. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 405.1165, found 405.1165.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 1â²-((2,4-Dichloro-6-methylphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>49</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2,4-dichloro-6-methylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>49</b> as a white solid (93%); mp 89â91 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.37 (d, <i>J</i> = 2.3 Hz, 1H), 7.19 (dd, <i>J</i> = 2.3, 0.9 Hz, 1H), 3.79 (d, <i>J</i> = 12.7 Hz, 2H), 2.93â2.73 (m, 4H), 2.67 (s, 3H), 2.45â2.27 (m, 1H), 2.14 (td, <i>J</i> = 11.3, 2.5 Hz, 2H), 1.83 (dd, <i>J</i> = 12.3, 3.4 Hz, 2H), 1.57 (dtd, <i>J</i> = 24.4, 11.6, 4.0 Hz, 4H), 1.30 (ddt, <i>J</i> = 12.8, 6.4, 3.7 Hz, 1H), 1.18 (qd, <i>J</i> = 12.0, 3.9 Hz, 2H), 0.89 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 143.7, 137.7, 135.3, 134.2, 131.6, 130.2, 61.7, 49.5, 45.0, 34.6, 31.0, 27.9, 24.0, 21.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 405.1165, found 405.1161.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 1â²-((4-Bromo-3,5-difluorophenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>50</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-bromo-3,5-difluorobenzene-1-sulfonyl chloride (Procedure A) yielded <b>50</b> as a white solid (73%); mp 161â163 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.36â7.27 (m, 2H), 3.81 (d, <i>J</i> = 12.0 Hz, 2H), 2.77 (d, <i>J</i> = 11.7 Hz, 2H), 2.34 (td, <i>J</i> = 12.0, 2.5 Hz, 2H), 2.22 (tt, <i>J</i> = 11.4, 3.6 Hz, 1H), 2.10 (td, <i>J</i> = 11.5, 2.5 Hz, 2H), 1.85 (d, <i>J</i> = 11.4 Hz, 2H), 1.71â1.55 (m, 4H), 1.37â1.24 (m, 1H), 1.16 (qd, <i>J</i> = 11.8, 3.8 Hz, 2H), 0.88 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 159.9 (dd, <i>J</i> = 255.0, 3.8 Hz), 137.9 (t, <i>J</i> = 7.6 Hz), 111.0 (m), 103.9, 103.7 (t, <i>J</i> = 96.4 Hz), 61.2, 49.5, 46.1, 34.5, 31.0, 27.4, 21.8. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>24</sub>BrF<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 437.0704, found 437.0695.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 1â²-([1,1â²-Biphenyl]-2-ylsulfonyl)-4-methyl-1,4â²-bipiperidine (<b>51</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with [1,1â²-biphenyl]-2-sulfonyl chloride (Procedure A) yielded <b>51</b> as a yellow solid (>95%); mp 106â109 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.12 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.56 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.46 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.43â7.36 (m, 5H), 7.30 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 3.29 (d, <i>J</i> = 12.8, 2H), 2.71 (d, <i>J</i> = 10.8 Hz, 2H), 2.22 (td, <i>J</i> = 12.6, 2.5 Hz, 3H), 2.09 (t, <i>J</i> = 10.4 Hz, 2H), 1.90â1 49 (m, 4H), 1.36â1.13 (m, 5H), 0.88 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 141.6, 139.7, 137.1, 133.0, 132.2, 130.3, 129.6, 127.7, 127.5, 61.7, 49.3, 44.4, 34.4, 31.0, 27.2, 21.8. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>31</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 399.2101, found 399.2101.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 1â²-((4â²-Chloro-[1,1â²-biphenyl]-2-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>52</b>)</h3><div class="NLM_p last">Reaction of <b>30</b> with 4-(chlorophenyl)boronic acid (Procedure C) yielded <b>52</b> as a black gel (66%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.08 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.55 (td, <i>J</i> = 7.5, 1.4 Hz, 1H), 7.47 (td, <i>J</i> = 7.8, 1.5 Hz, 1H), 7.34 (s, 4H), 7.26 (dd, <i>J</i> = 7.6, 1.4 Hz, 1H), 3.32 (d, <i>J</i> = 12.4 Hz, 2H), 2.70 (d, <i>J</i> = 11.6 Hz, 2H), 2.36â2.15 (m, 3H), 2.08 (td, <i>J</i> = 11.7, 2.5 Hz, 2H), 1.60 (s, 4H), 1.38â1.02 (m, 5H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl3) Î´ 140.3, 138.1, 137.0, 133.8, 132.8, 132.4, 131.0, 130.3, 127.8, 127.6, 61.5, 49.3, 44.6, 34.5, 31.0, 27.3, 21.8. LCâMS (ESI) calcd for C<sub>23</sub>H<sub>30</sub>ClN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 433.2, found 433.2.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 1â²-((4â²-Methoxy-[1,1â²-biphenyl]-2-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>53</b>)</h3><div class="NLM_p last">Reaction of <b>30</b> with (4-methoxyphenyl)boronic acid (Procedure C) yielded <b>53</b> as a black gel (59%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.08 (dd, <i>J</i> = 7.9, 1.4 Hz, 1H), 7.52 (td, <i>J</i> = 7.5, 1.4 Hz, 1H), 7.44â7.40 (m, 1H), 7.35â7.31 (m, 2H), 7.30â7.23 (m, 1H), 6.93â6.87 (m, 2H), 3.81 (s, 3H), 3.31 (d, <i>J</i> = 12.9 Hz, 2H), 2.68 (d, <i>J</i> = 11.6 Hz, 2H), 2.34â2.12 (m, 3H), 2.06 (td, <i>J</i> = 11.6, 2.5 Hz, 2H), 1.57 (d, <i>J</i> = 12.5 Hz, 4H), 1.39â1.01 (m, 5H), 0.86 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 159.2, 141.4, 137.1, 133.2, 132.2, 132.0, 130.9, 130.3, 128.5, 128.4, 127.2, 112.9, 61.6, 55.3, 49.3, 44.6, 34.6, 31.0, 27.3, 21.9. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>33</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 429.2206, found 429.2199.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 4-Methyl-1â²-((4â²-methyl-[1,1â²-biphenyl]-2-yl)sulfonyl)-1,4â²-bipiperidine (<b>54</b>)</h3><div class="NLM_p last">Reaction of <b>30</b> with <i>p</i>-tolylboronic acid (Procedure C) yielded <b>54</b> as a brown gel (23%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.08 (dd, <i>J</i> = 8.0, 1.4 Hz, 1H), 7.54 (td, <i>J</i> = 7.5, 1.4 Hz, 1H), 7.44 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 7.28 (d, <i>J</i> = 7.9 Hz, 3H), 7.18 (d, <i>J</i> = 7.8 Hz, 2H), 3.33 (d, <i>J</i> = 13.1 Hz, 2H), 2.84 (d, <i>J</i> = 10.7 Hz, 2H), 2.43 (t, <i>J</i> = 12.6 Hz, 1H), 2.37 (s, 3H), 2.22 (td, <i>J</i> = 12.6, 2.4 Hz, 4H), 1.76â1.58 (m, 4H), 1.47â1.19 (m, 5H), 0.90 (d, <i>J</i> = 4.8 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 141.7, 137.5, 136.9, 136.7, 133.1, 132.3, 130.2, 129.4, 128.2, 127.3, 62.0, 49.1, 44.2, 33.4, 30.6, 26.7, 21.5, 21.2. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>33</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 413.2257, found 413.2264.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 4-Methyl-1â²-((4â²-(trifluoromethyl)-[1,1â²-biphenyl]-2-yl)sulfonyl)-1,4â²-bipiperidine (<b>55</b>)</h3><div class="NLM_p last">Reaction of <b>30</b> with (4-(trifluoromethyl)phenyl)boronic acid (Procedure C) yielded <b>55</b> as a black solid (12%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.10 (dd, <i>J</i> = 8.0, 1.4 Hz, 1H), 7.65 (d, <i>J</i> = 8.1 Hz, 2H), 7.59 (tt, <i>J</i> = 7.5, 1.1 Hz, 1H), 7.56â7.49 (m, 3H), 7.29 (dd, <i>J</i> = 7.7, 1.4 Hz, 1H), 3.30 (d, <i>J</i> = 12.8 Hz, 2H), 2.73 (d, <i>J</i> = 11.0 Hz, 2H), 2.31 (td, <i>J</i> = 12.6, 2.4 Hz, 3H), 2.10 (t, <i>J</i> = 12.3 Hz, 2H), 1.64 (t, <i>J</i> = 12.4 Hz, 4H), 1.35â1.12 (m, 5H), 0.88 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 143.4, 140.1, 136.9, 132.7, 132.5, 130.3, 130.1, 130.0, 129.8, 128.2, 124. 4 (q, <i>J</i> = 3.7 Hz), 61.6, 49.3, 44.5, 34.3, 30.9, 27.1, 21.7. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>30</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 467.1975, found 467.1967.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 1â²-([1,1â²-Biphenyl]-4-ylsulfonyl)-4-methyl-1,4â²-bipiperidine (<b>56</b>)</h3><div class="NLM_p last">Reaction of <b>17</b> with phenylboronic acid (Procedure C) yielded <b>56</b> as a white solid (21%); mp 178â181 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.81 (d, <i>J</i> = 8.4 Hz, 2H), 7.72 (d, <i>J</i> = 8.4 Hz, 2H), 7.64â7.56 (m, 2H), 7.52â7.45 (m, 2H), 7.45â7.37 (m, 1H), 3.90 (d, <i>J</i> = 12.1 Hz, 2H), 2.84 (d, <i>J</i> = 10.8 Hz, 2H), 2.32 (td, <i>J</i> = 12.1, 2.5 Hz, 3H), 2.20 (t, <i>J</i> = 11.9 Hz, 2H), 1.91 (d, <i>J</i> = 12.6 Hz, 2H), 1.77â1.57 (m, 4H), 1.42â1.12 (m, 3H), 0.90 (d, <i>J</i> = 5.9 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 145.6, 139.2, 134.6, 129.1, 129.1, 128.5, 128.2, 127.6, 127.3, 61.6, 49.4, 46.1, 34.1, 30.8, 27.1, 21.7. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>31</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 399.2101, found 399.2097.</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 1â²-((4â²-Chloro-[1,1â²-biphenyl]-4-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>57</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4â²-chloro-[1,1â²-biphenyl]-4-sulfonyl chloride (Procedure A) yielded <b>57</b> as a white solid (87%); mp 205â207 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.88â7.75 (m, 2H), 7.67 (d, <i>J</i> = 8.4 Hz, 2H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 7.43 (d, <i>J</i> = 8.5 Hz, 2H), 3.87 (d, <i>J</i> = 12.0 Hz, 2H), 2.76 (d, <i>J</i> = 10.9 Hz, 2H), 2.41â2.02 (m, 5H), 1.83 (dd, <i>J</i> = 12.3, 3.6 Hz, 2H), 1.70â1.46 (m, 4H), 1.37â1.05 (m, 3H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 144.2, 137.7, 135.1, 134.7, 129.2, 128.5, 128.3, 127.4, 61.4, 49.5, 46.2, 34.6, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>30</sub>ClN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 433.1711, found 433.1706.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 1â²-((4â²-Methoxy-[1,1â²-biphenyl]-4-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>58</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4â²-methoxy-[1,1â²-biphenyl]-4-sulfonyl chloride (Procedure A) yielded <b>58</b> as a white solid (92%); mp 195â198 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.85â7.72 (m, 2H), 7.66 (d, <i>J</i> = 8.5 Hz, 2H), 7.53 (d, <i>J</i> = 8.7 Hz, 2H), 7.04â6.88 (m, 2H), 3.88 (d, <i>J</i> = 12.0 Hz, 2H), 3.84 (s, 3H), 2.76 (d, <i>J</i> = 11.6 Hz, 2H), 2.40â1.95 (m, 5H), 1.83 (d, <i>J</i> = 10.7 Hz, 2H), 1.71â1.48 (m, 4H), 1.36â1.23 (m, 1H), 1.23â1.04 (m, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 160.0, 145.1, 133.9, 131.6, 128.4, 128.2, 126.9, 114.5, 61.5, 55.4, 49.5, 46.2, 34.6, 31.0, 27.4, 21.9. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>33</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 429.2206, found 429.2203.</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 1â²-((2â²-Methoxy-[1,1â²-biphenyl]-4-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>59</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2â²-methoxy-[1,1â²-biphenyl]-4-sulfonyl chloride (Procedure A) yielded <b>59</b> as a colorless gel (88%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.74 (d, <i>J</i> = 8.3 Hz, 2H), 7.66 (d, <i>J</i> = 8.4 Hz, 2H), 7.35 (t, <i>J</i> = 7.9 Hz, 1H), 7.29 (d, <i>J</i> = 7.5 Hz, 1H), 7.07â6.91 (m, 2H), 3.86 (d, <i>J</i> = 11.6 Hz, 2H), 3.80 (s, 3H), 2.77 (d, <i>J</i> = 11.4 Hz, 2H), 2.32 (t, <i>J</i> = 11.3 Hz, 2H), 2.22 (tt, <i>J</i> = 11.6, 3.7 Hz, 1H), 2.11 (t, <i>J</i> = 10.8 Hz, 2H), 1.83 (d, <i>J</i> = 11.2 Hz, 2H), 1.73â1.52 (m, 4H), 1.37â1.23 (m, 1H), 1.16 (qd, <i>J</i> = 11.9, 3.7 Hz, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 156.3, 143.2, 134.2, 130.7, 130.0, 129.8, 128.6, 127.3, 121.0, 111.3, 61.4, 55.5, 49.4, 46.1, 34.5, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>33</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 429.2206, found 429.2205.</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 1â²-((2â²-Fluoro-[1,1â²-biphenyl]-4-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>60</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2â²-fluoro-[1,1â²-biphenyl]-4-sulfonyl chloride (Procedure A) yielded <b>60</b> as a colorless gel (73%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.85â7.76 (m, 2H), 7.72â7.64 (m, 2H), 7.42 (td, <i>J</i> = 7.7, 1.8 Hz, 1H), 7.39â7.33 (m, 1H), 7.24 (dd, <i>J</i> = 6.3, 1.3 Hz, 1H), 7.22â7.12 (m, 1H), 3.87 (d, <i>J</i> = 12.0 Hz, 2H), 2.77 (d, <i>J</i> = 11.5 Hz, 2H), 2.42â2.17 (m, 3H), 2.11 (td, <i>J</i> = 11.7, 2.4 Hz, 2H), 1.84 (d, <i>J</i> = 13.6 Hz, 2H), 1.72â1.54 (m, 4H), 1.36â1.23 (m, 1H), 1.24â1.09 (m, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 159.6 (d, <i>J</i> = 249.1 Hz), 140.3 (d, <i>J</i> = 1.3 Hz), 135.2, 130.6 (d, <i>J</i> = 3.1 Hz), 130.2 (d, <i>J</i> = 8.3 Hz), 129.5 (d, <i>J</i> = 3.2 Hz), 127.8, 127.2 (d, <i>J</i> = 13.0 Hz), 124.7 (d, <i>J</i> = 3.7 Hz), 116.3 (d, <i>J</i> = 22.6 Hz), 61.4, 49.4, 46.2, 34.5, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>30</sub>FN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 417.2007, found 417.1995.</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 1â²-([1,1â²-Biphenyl]-3-ylsulfonyl)-4-methyl-1,4â²-bipiperidine (<b>61</b>)</h3><div class="NLM_p last">Reaction of <b>29</b> with phenylboronic acid (Procedure C) yielded <b>61</b> as a black gel (58%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.94 (t, <i>J</i> = 1.8 Hz, 1H), 7.79 (ddd, <i>J</i> = 7.8, 1.9, 1.1 Hz, 1H), 7.71 (ddd, <i>J</i> = 7.8, 1.8, 1.1 Hz, 1H), 7.62â7.55 (m, 3H), 7.50â7.43 (m, 1H), 7.43â7.36 (m, 1H), 3.87 (d, <i>J</i> = 12.0 Hz, 2H), 2.77 (d, <i>J</i> = 11.7 Hz, 2H), 2.28 (td, <i>J</i> = 12.0, 2.5 Hz, 2H), 2.20 (td, <i>J</i> = 8.1, 4.1 Hz, 1H), 2.11 (td, <i>J</i> = 11.5, 2.4 Hz, 2H), 1.83 (d, <i>J</i> = 11.6 Hz, 2H), 1.72â1.54 (m, 4H), 1.37â1.23 (m, 1H), 1.17 (qd, <i>J</i> = 12.1, 3.8 Hz, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl3) Î´ 142.3, 139.2, 136.7, 131.3, 129.4, 129.1, 128.3, 127.2, 126.2, 126.1, 61.4, 49.4, 46.2, 34.4, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>31</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 399.2101, found 399.2096.</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 1â²-((4â²-Chloro-[1,1â²-biphenyl]-3-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>62</b>)</h3><div class="NLM_p last">Reaction of <b>29</b> with 4-(chlorophenyl)boronic acid (Procedure C) yielded <b>62</b> as a pink solid (58%); mp 124â126 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.89 (t, <i>J</i> = 1.8 Hz, 1H), 7.72 (ddt, <i>J</i> = 15.7, 7.9, 1.4 Hz, 2H), 7.58 (t, <i>J</i> = 7.8 Hz, 1H), 7.54â7.48 (m, 2H), 7.45â7.39 (m, 2H), 3.86 (d, <i>J</i> = 12.1 Hz, 2H), 2.80 (dt, <i>J</i> = 11.5, 3.1 Hz, 2H), 2.27 (td, <i>J</i> = 12.1, 2.4 Hz, 3H), 2.13 (t, <i>J</i> = 10.6 Hz, 2H), 1.86 (d, <i>J</i> = 13.3 Hz, 2H), 1.72â1.52 (m, 4H), 1.38â1.14 (m, 3H), 0.87 (d, <i>J</i> = 6.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 141.1, 137.6, 136.9, 134.5, 131.1, 129.6, 129.2, 128.5, 126.5, 125.8, 61.5, 49.4, 46.1, 34.2, 30.8, 27.1, 21.7. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>30</sub>ClN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 433.1711, found 433.1705.</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 1â²-((4â²-Methoxy-[1,1â²-biphenyl]-3-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>63</b>)</h3><div class="NLM_p last">Reaction of <b>29</b> with (4-methoxyphenyl)boronic acid (Procedure C) yielded <b>63</b> as a yellow solid (44%); mp 107â109 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.89 (s, 1H), 7.74 (d, <i>J</i> = 7.8 Hz, 1H), 7.65 (d, <i>J</i> = 8.0 Hz, 1H), 7.58â7.47 (m, 3H), 6.98 (d, <i>J</i> = 8.5 Hz, 2H), 3.87 (d, <i>J</i> = 12.2 Hz, 2H), 3.84 (s, 3H), 2.80 (d, <i>J</i> = 10.0 Hz, 2H), 2.27 (td, <i>J</i> = 12.0, 2.4 Hz, 3H), 2.15 (t, <i>J</i> = 11.9 Hz, 2H), 1.87 (d, <i>J</i> = 11.7 Hz, 2H), 1.75â1.53 (m, 4H), 1.38â1.19 (m, 3H), 0.88 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 159.9, 141.9, 136.6, 131.6, 130.8, 129.4, 128.3, 125.6, 125.5, 114.5, 61.5, 55.4, 49.4, 46.1, 34.2, 30.8, 27.1, 21.7. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>33</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 429.2206, found 429.2206.</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 4-Methyl-1â²-((4â²-methyl-[1,1â²-biphenyl]-3-yl)sulfonyl)-1,4â²-bipiperidine (<b>64</b>)</h3><div class="NLM_p last">Reaction of <b>29</b> with <i>p</i>-tolylboronic acid (Procedure C) yielded <b>64</b> as a yellow solid (95%); mp 103â105 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.92 (s, 1H), 7.78 (d, <i>J</i> = 7.8 Hz, 1H), 7.68 (d, <i>J</i> = 7.8 Hz, 1H), 7.57 (t, <i>J</i> = 7.8 Hz, 1H), 7.49 (d, <i>J</i> = 8.1 Hz, 2H), 7.27 (d, <i>J</i> = 7.9 Hz, 2H), 3.87 (d, <i>J</i> = 11.9 Hz, 2H), 2.81 (d, <i>J</i> = 11.2 Hz, 2H), 2.40 (s, 3H), 2.31â2.20 (m, 3H), 2.17 (t, <i>J</i> = 11.8 Hz, 2H), 1.86 (d, <i>J</i> = 12.4 Hz, 2H), 1.74â1.55 (m, 4H), 1.40â1.12 (m, 3H), 0.88 (d, <i>J</i> = 6.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.2, 138.3, 136.6, 136.3, 131.1, 129.8, 129.4, 127.0, 125.9, 125.8, 61.5, 49.4, 46.1, 34.1, 30.8, 27.1, 21.7, 21.1. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>33</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 413.2257, found 413.2258.</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 1â²-((4â²-Fluoro-[1,1â²-biphenyl]-3-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>65</b>)</h3><div class="NLM_p last">Reaction of <b>29</b> with (4-fluorophenyl)boronic acid (Procedure C) yielded <b>65</b> as a white solid (63%); mp 131â134 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.88 (s, 1H), 7.76â7.66 (m, 2H), 7.60â7.50 (m, 3H), 7.14 (t, <i>J</i> = 8.6 Hz, 2H), 3.86 (d, <i>J</i> = 11.9 Hz, 2H), 2.75 (d, <i>J</i> = 11.5 Hz, 2H), 2.28 (td, <i>J</i> = 12.1, 2.5 Hz, 2H), 2.18 (tt, <i>J</i> = 11.5, 3.6 Hz, 1H), 2.09 (td, <i>J</i> = 11.5, 2.4 Hz, 2H), 1.82 (d, <i>J</i> = 11.8 Hz, 2H), 1.70â1.51 (m, 4H), 1.38â1.20 (m, 1H), 1.21â1.06 (m, 2H), 0.86 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 162.94 (d, <i>J</i> = 248.1 Hz), 141.27, 136.89, 135.39 (d, <i>J</i> = 3.3 Hz), 131.11, 129.53, 128.89 (d, <i>J</i> = 8.3 Hz), 126.26, 125.88, 116.02 (d, <i>J</i> = 21.6 Hz), 61.40, 49.47, 46.20, 34.58, 31.01, 27.36, 21.86. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>30</sub>FN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 417.2007, found 417.2018.</div></div><div id="sec4_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 1â²-((2â²-Methoxy-[1,1â²-biphenyl]-3-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>66</b>)</h3><div class="NLM_p last">Reaction of <b>29</b> with (2-methoxyphenyl)boronic acid (Procedure C) yielded <b>66</b> as an orange gel (53%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.93 (s, 1H), 7.73 (dt, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.67 (dt, <i>J</i> = 8.0, 1.4 Hz, 1H), 7.52 (t, <i>J</i> = 7.8 Hz, 1H), 7.39â7.27 (m, 2H), 7.08â6.94 (m, 2H), 3.86 (d, <i>J</i> = 12.0 Hz, 2H), 3.78 (s, 3H), 2.77 (d, <i>J</i> = 11.6 Hz, 2H), 2.43â2.17 (m, 3H), 2.13 (t, <i>J</i> = 11.0 Hz, 2H), 1.82 (d, <i>J</i> = 12.1 Hz, 2H), 1.71â1.52 (m, 4H), 1.38â1.24 (m, 1H), 1.24â1.10 (m, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 156.3, 139.5, 135.5, 133.7, 130.7, 129.6, 128.7, 128.6, 128.5, 125.8, 121.0, 111.3, 61.5, 55.5, 49.4, 46.2, 34.5, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>33</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 429.2206, found 429.2192.</div></div><div id="sec4_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 1â²-((2â²-Fluoro-[1,1â²-biphenyl]-3-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>67</b>)</h3><div class="NLM_p last">Reaction of <b>29</b> with (2-fluorophenyl)boronic acid (Procedure C) yielded <b>67</b> as a yellow gel (74%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.89 (d, <i>J</i> = 1.6 Hz, 1H), 7.79â7.68 (m, 2H), 7.57 (t, <i>J</i> = 7.8 Hz, 1H), 7.41 (td, <i>J</i> = 7.7, 1.9 Hz, 1H), 7.38â7.31 (m, 1H), 7.25â7.18 (m, 1H), 7.14 (ddd, <i>J</i> = 10.8, 8.2, 1.2 Hz, 1H), 3.86 (d, <i>J</i> = 12.1 Hz, 2H), 2.80 (d, <i>J</i> = 11.8 Hz, 2H), 2.29 (td, <i>J</i> = 12.1, 2.5 Hz, 3H), 2.21â2.08 (m, 2H), 1.87 (d, <i>J</i> = 12.6 Hz, 2H), 1.70â1.46 (m, 4H), 1.39â1.05 (m, 3H), 0.86 (d, <i>J</i> = 5.9 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl3) Î´ 159.58 (d, <i>J</i> = 248.6 Hz), 136.83, 136.38, 133.19 (d, <i>J</i> = 3.0 Hz), 132.03 (d, <i>J</i> = 9.9 Hz), 130.55 (d, <i>J</i> = 3.0 Hz), 130.06 (d, <i>J</i> = 8.3 Hz), 129.15, 127.94 (d, <i>J</i> = 3.1 Hz), 126.64, 124.69 (d, <i>J</i> = 3.7 Hz), 116.27 (d, <i>J</i> = 22.5 Hz), 61.50, 49.38, 46.06, 34.11, 30.78, 27.10, 21.71. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>30</sub>FN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 417.2007, found 417.1999.</div></div><div id="sec4_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> 4-Methyl-1â²-((2â²-(trifluoromethyl)-[1,1â²-biphenyl]-3-yl)sulfonyl)-1,4â²-bipiperidine (<b>68</b>)</h3><div class="NLM_p last">Reaction of <b>29</b> with (2-(trifluoromethyl)phenyl)boronic acid (Procedure C) yielded <b>68</b> as a yellow solid (37%); mp 110â112 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.80â7.68 (m, 3H), 7.61â7.47 (m, 4H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 3.82 (d, <i>J</i> = 12.1 Hz, 1H), 2.79 (d, <i>J</i> = 11.7 Hz, 2H), 2.35â2.18(m, 3H), 2.13 (td, <i>J</i> = 11.5, 2.4 Hz, 2H), 1.84 (d, <i>J</i> = 10.8 Hz, 2H), 1.70â1.53 (m, 4H), 1.38â1.25 (m, 1H), 1.25â1.12 (qd, <i>J</i> = 12.0, 3.8 Hz, 2H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 140.7, 139.3 (q, <i>J</i> = 2.1 Hz), 135.8, 133.2, 131.8, 131.7, 128.6, 128.2, 128.1 (q, <i>J</i> = 1.6 Hz), 126.9, 126.2 (q, <i>J</i> = 5.3 Hz), 124.0 (q, <i>J</i> = 274.0 Hz), 61.5, 49.4, 46.1, 34.3, 30.9, 27.2, 21.8. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>30</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 467.1975, found 467.1981.</div></div><div id="sec4_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> 1â²-((3â²,5â²-Dimethyl-[1,1â²-biphenyl]-3-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>69</b>)</h3><div class="NLM_p last">Reaction of <b>29</b> with (3,5-dimethylphenyl)boronic acid (Procedure C) yielded <b>69</b> as a yellow solid (45%); mp 120â123 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.92 (s, 1H), 7.77 (dt, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.68 (dd, <i>J</i> = 7.8, 3.0 Hz, 1H), 7.55 (t, <i>J</i> = 7.8 Hz, 1H), 7.19 (s, 2H), 7.03 (s, 1H), 3.86 (d, <i>J</i> = 12.0 Hz, 2H), 2.77 (d, <i>J</i> = 11.3 Hz, 2H), 2.37 (s, 6H), 2.33â2.16 (m, 3H), 2.11 (t, <i>J</i> = 11.1 Hz, 2H), 1.83 (dt, <i>J</i> = 12.2, 3.1 Hz, 2H), 1.72â1.54 (m, 4H), 1.39â1.08 (m, 3H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 139.2, 138.7, 136.5, 131.3, 129.9, 129.3, 126.1, 125.1, 61.4, 49.4, 46.2, 34.4, 30.9, 27.2, 21.8, 21.4. HRMS (ESI-TOF) calcd for C<sub>25</sub>H<sub>35</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 427.2414, found 427.2407.</div></div><div id="sec4_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> 4-Methyl-1â²-((3-(naphthalen-2-yl)phenyl)sulfonyl)-1,4â²-bipiperidine (<b>70</b>)</h3><div class="NLM_p last">Reaction of <b>29</b> with naphthalen-2-ylboronic acid (Procedure C) yielded <b>70</b> as a yellow gel (29%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.06 (d, <i>J</i> = 9.7 Hz, 2H), 7.96â7.82 (m, 4H), 7.72 (ddd, <i>J</i> = 10.5, 8.2, 1.6 Hz, 2H), 7.62 (t, <i>J</i> = 7.8 Hz, 1H), 7.56â7.47 (m, 2H), 3.90 (d, <i>J</i> = 11.9 Hz, 2H), 2.79 (d, <i>J</i> = 11.2 Hz, 2H), 2.38â2.20 (m, 3H), 2.13 (t, <i>J</i> = 10.8 Hz, 2H), 1.87 (d, <i>J</i> = 12.5 Hz, 2H), 1.74â1.51 (m, 4H), 1.39â1.13 (m, 3H), 0.88 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.2, 136.8, 136.5, 133.5, 132.9, 131.5, 129.6, 128.9, 128.3, 127.7, 126.7, 126.6, 126.3, 126.3, 125.0, 61.5, 49.4, 46.2, 34.3, 30.9, 27.2, 21.8. HRMS (ESI-TOF) calcd for C<sub>27</sub>H<sub>33</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 449.2257, found 449.2254.</div></div><div id="sec4_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> 4-Methyl-1â²-(pyridin-3-ylsulfonyl)-1,4â²-bipiperidine (<b>71</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with pyridine-3-sulfonyl chloride (Procedure A) yielded <b>71</b> as a yellow solid (86%); mp 144â147 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 8.98 (s, 1H), 8.82 (d, <i>J</i> = 4.9 Hz, 1H), 8.04 (d, <i>J</i> = 8.1 Hz, 1H), 7.49 (dd, <i>J</i> = 8.0, 4.9 Hz, 1H), 3.88 (d, <i>J</i> = 12.3 Hz, 2H), 2.78 (d, <i>J</i> = 11.9 Hz, 2H), 2.32 (td, <i>J</i> = 12.0, 2.4 Hz, 2H), 2.22 (tt, <i>J</i> = 11.6, 3.6 Hz, 1H), 2.12 (t, <i>J</i> = 11.6 Hz, 2H), 1.86 (d, <i>J</i> = 11.9 Hz, 2H), 1.75â1.55 (m, 4H), 1.38â1.23 (m, 1H), 1.17 (qd, <i>J</i> = 12.0, 3.7 Hz, 2H), 0.89 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 153.3, 148.4, 135.2, 133.1, 123.7, 61.3, 49.5, 46.0, 34.5, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>16</sub>H<sub>25</sub>ClN<sub>3</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 346.1560, found 346.1566.</div></div><div id="sec4_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> 1â²-((2-Chloropyridin-3-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>72</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2-chloropyridine-3-sulfonyl chloride (Procedure A) yielded <b>72</b> as a white solid (71%); mp 122â124 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 8.55 (d, <i>J</i> = 4.9 Hz, 1H), 8.38 (d, <i>J</i> = 7.8 Hz, 1H), 7.40 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 3.92 (d, <i>J</i> = 13.0 Hz, 2H), 2.83 (t, <i>J</i> = 12.5 Hz, 4H), 2.38 (t, <i>J</i> = 11.5 Hz, 1H), 2.15 (t, <i>J</i> = 11.0 Hz, 2H), 1.86 (d, <i>J</i> = 12.5 Hz, 2H)., 1.72â1.53 (m, 4H), 1.38â1.26 (m, 1H), 1.25â1.13 (m, 2H), 0.90 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 148.4, 144.5, 136.9, 130.5, 118.5, 57.6, 45.6, 41.9, 30.7, 27.1, 24.0, 17.9. HRMS (ESI-TOF) calcd for C<sub>16</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 380.1170, found 380.1160.</div></div><div id="sec4_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> 1â²-((2-Fluoropyridin-3-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>73</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2-fluoropyridine-3-sulfonyl chloride (Procedure A) yielded <b>73</b> as a white solid (>95%); mp 120â123 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 8.41 (d, <i>J</i> = 4.9 Hz, 1H), 8.29 (dd, <i>J</i> = 9.2, 7.6 Hz, 1H), 7.37 (dd, <i>J</i> = 7.6, 4.9 Hz, 1H), 3.96 (d, <i>J</i> = 12.6 Hz, 2H), 2.81 (d, <i>J</i> = 11.5 Hz, 2H),, 2.67 (t, <i>J</i> = 12.4 Hz, 2H), 2.34 (ddd, <i>J</i> = 11.5, 8.0, 3.5 Hz, 1H), 2.15 (t, <i>J</i> = 10.4 Hz, 2H), 1.87 (d, <i>J</i> = 12.1 Hz, 2H), 1.74â1.55 (m, 4H), 1.32 (ddt, <i>J</i> = 10.3, 6.9, 4.1 Hz, 1H), 1.27â1.11 (m, 2H), 0.91 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 154.75 (d, <i>J</i> = 244.0 Hz), 147.68 (d, <i>J</i> = 14.3 Hz), 138.2, 118.2, 117.9, 57.5, 45.6, 41.9, 30.7, 27.1, 23.8, 17.9. HRMS (ESI-TOF) calcd for C<sub>16</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 364.1465, found 364.1462.</div></div><div id="sec4_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> 1â²-((6-Chloropyridin-3-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>74</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 6-chloropyridine-3-sulfonyl chloride (Procedure A) yielded <b>74</b> as a white solid (80%); mp 178â182 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 8.75 (s, 1H), 7.99 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 7.51 (d, <i>J</i> = 8.3 Hz, 1H), 3.87 (d, <i>J</i> = 12.0 Hz, 2H), 2.81 (d, <i>J</i> = 8.5 Hz, 2H), 2.35 (t, <i>J</i> = 12.0 Hz, 2H), 2.25 (t, <i>J</i> = 11.4 Hz, 1H), 2.14 (t, <i>J</i> = 11.3 Hz, 2H), 1.89 (d, <i>J</i> = 11.3 Hz, 2H), 1.75â1.58 (m, 4H), 1.33 (br, 1H), 1.28â1.10 (m, 2H), 0.91 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 155.6, 148.6, 137.7, 132.1, 124.7, 61.3, 49.5, 46.0, 34.4, 30.9, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>16</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 380.1170, found 380.1171.</div></div><div id="sec4_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> 1â²-((5-Bromopyridin-3-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>75</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 5-bromopyridine-3-sulfonyl chloride (Procedure A) yielded <b>75</b> as a white solid (79%); mp 171â173 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 8.81 (s, 2H), 8.18 (t, <i>J</i> = 2.0 Hz, 1H), 3.89 (d, <i>J</i> = 11.6 Hz, 2H), 2.81 (d, <i>J</i> = 11.0 Hz, 2H), 2.39 (td, <i>J</i> = 12.0, 2.5 Hz, 2H), 2.25 (d, <i>J</i> = 11.9 Hz, 1H), 2.14 (t, <i>J</i> = 11.6 Hz, 2H), 1.90 (d, <i>J</i> = 12.8 Hz, 2H), 1.78â1.57 (m, 4H), 1.43â1.29 (m, 1H), 1.28â1.11 (m, 2H), 0.91 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 154.4, 146.2, 137.4, 134.5, 121.0, 61.2, 49.5, 46.0, 34.5, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>16</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 424.0665, found 424.0668.</div></div><div id="sec4_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> 1,3-Dimethyl-5-((4-methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>76</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-sulfonyl chloride (Procedure A) yielded <b>76</b> as a white solid (78%); mp 212â215 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 8.07 (s, 1H), 3.94 (d, <i>J</i> = 12.8 Hz, 2H), 3.50 (s, 3H), 3.35 (s, 3H), 2.93 (d, <i>J</i> = 11.6 Hz, 2H), 2.85 (t, <i>J</i> = 12.7 Hz, 2H), 2.56 (t, <i>J</i> = 11.7 Hz, 1H), 2.26 (t, <i>J</i> = 11.9 Hz, 2H), 1.92 (d, <i>J</i> = 11.9 Hz, 2H), 1.75â1.58 (m, 4H), 1.48â1.20 (m, 3H), 0.93 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 158.2, 150.8, 148.1, 112.6, 61.6, 49.2, 46.0, 37.9, 33.8, 30.7, 28.3, 27.5, 21.7. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>SNa [M + Na]<sup>+</sup> 407.1723, found 407.1725.</div></div><div id="sec4_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> 4-Methyl-1â²-((1-methyl-1<i>H</i>-imidazol-2-yl)sulfonyl)-1,4â²-bipiperidine (<b>77</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 1-methyl-1<i>H</i>-imidazole-2-sulfonyl chloride (Procedure A) yielded <b>77</b> as a white solid (51%); mp 153â156 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.03 (d, <i>J</i> = 1.1 Hz, 1H), 6.92 (d, <i>J</i> = 1.1 Hz, 1H), 3.96 (d, <i>J</i> = 12.2 Hz, 2H), 3.89 (s, 3H), 3.05 (t, <i>J</i> = 12.5 Hz, 2H), 2.89 (d, <i>J</i> = 10.8 Hz, 2H), 2.54 (s, 1H), 2.24 (s, 2H), 1.94 (d, <i>J</i> = 12.5 Hz, 2H), 1.81â1.58 (m, 4H), 1.31 (s, 3H), 1.06â0.79 (d, <i>J</i> = 8.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.8, 128.2, 124.4, 61.8, 49.4, 46.6, 34.8, 34.1, 30.9, 27.3, 21.7. HRMS (ESI-TOF) calcd for C<sub>15</sub>H<sub>26</sub>N<sub>4</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 349.1669, found 349.1673.</div></div><div id="sec4_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> 4-Methyl-1â²-((1-methyl-1<i>H</i>-imidazol-4-yl)sulfonyl)-1,4â²-bipiperidine (<b>78</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 1-methyl-1<i>H</i>-imidazole-4-sulfonyl chloride (Procedure A) yielded <b>78</b> as a yellow solid (61%); mp 139â142 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.48 (s, 1H), 7.42 (s, 1H), 3.90 (d, <i>J</i> = 13.0 Hz, 2H), 3.75 (s, 3H), 2.80 (d, <i>J</i> = 9.9 Hz, 2H), 2.57 (t, <i>J</i> = 12.1 Hz, 2H), 2.26 (t, <i>J</i> = 11.5 Hz, 1H), 2.13 (t, <i>J</i> = 10.5 Hz, 2H), 1.83 (d, <i>J</i> = 12.1 Hz, 2H), 1.69â1.57 (m, 4H), 1.31 (br, 1H), 1.26â1.12 (m, 2H), 0.90 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 139.0, 138.3, 124.4, 61.7, 49.5, 46.3, 34.6, 34.0, 31.1, 27.4, 21.9. HRMS (ESI-TOF) calcd for C<sub>15</sub>H<sub>26</sub>N<sub>24</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 349.1669, found 349.1660.</div></div><div id="sec4_88" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> 3,5-Dimethyl-4-((4-methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)isoxazole (<b>79</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 3,5-dimethylisoxazole-4-sulfonyl chloride (Procedure A) yielded <b>79</b> as a white solid (28%); mp 158â161 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 3.78 (d, <i>J</i> = 11.9 Hz, 2H), 2.80 (d, <i>J</i> = 11.5 Hz, 2H), 2.61 (s, 3H), 2.50 (t, <i>J</i> = 12.0 Hz, 2H), 2.38 (s, 3H), 2.27 (tt, <i>J</i> = 11.4, 3.5 Hz, 1H), 2.14â2.06 (m, 2H), 1.87 (d, <i>J</i> = 11.6 Hz, 2H), 1.72â1.50 (m, 4H), 1.38â1.24 (m, 1H), 1.25â1.09 (m, 2H), 0.89 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 173.5, 158.0, 113.7, 61.3, 49.6, 45.4, 34.6, 31.0, 27.5, 21.9, 13.0, 11.4. HRMS (ESI-TOF) calcd for C<sub>16</sub>H<sub>28</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 342.1846, found 342.1854.</div></div><div id="sec4_89" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> 2-Chloro-5-((4-methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)thiazole (<b>80</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2-chlorothiazole-5-sulfonyl chloride (Procedure A) yielded <b>80</b> as a pale yellow solid (51%); mp 141â143 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 7.87 (s, 1H), 3.82 (d, <i>J</i> = 10.4 Hz, 2H), 2.83 (d, <i>J</i> = 8.6 Hz, 2H), 2.45 (td, <i>J</i> = 12.3, 2.7 Hz, 2H), 2.32 (t, <i>J</i> = 11.4 Hz, 1H), 2.16 (t, <i>J</i> = 11.5 Hz, 2H), 1.92 (d, <i>J</i> = 12.3 Hz, 2H), 1.74â1.56 (m, 4H), 1.39â1.13 (m, 3H), 0.89 (d, <i>J</i> = 6.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 157.2, 144.9, 134.4, 61.2, 49.5, 46.0, 34.2, 30.8, 27.1, 21.7. HRMS (ESI-TOF) calcd for C<sub>14</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>2</sub>S<sub>2</sub>Na [M + Na]<sup>+</sup> 386.0734, found 386.0745.</div></div><div id="sec4_90" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> 2-Chloro-4-methyl-5-((4-methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)thiazole (<b>81</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2-chloro-4-methylthiazole-5-sulfonyl chloride (Procedure A) yielded <b>81</b> as a white solid (64%); mp 117â119 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 3.85 (d, <i>J</i> = 13.5 Hz, 2H), 2.82 (d, <i>J</i> = 11.0 Hz, 2H), 2.60 (s, 3H), 2.53 (t, <i>J</i> = 12.0 Hz, 2H), 2.34 (t, <i>J</i> = 11.9 Hz, 1H), 2.15 (t, <i>J</i> = 11.4 Hz, 2H), 1.91 (d, <i>J</i> = 12.7 Hz, 2H), 1.65 (m, 4H), 1.45â1.29 (m, 1H), 1.28â1.12 (m, 2H), 0.89 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 155.4, 154.4, 128.9, 61.3, 49.5, 46.0, 34.3, 30.9, 27.3, 21.8, 16.8. HRMS (ESI-TOF) calcd for C<sub>15</sub>H<sub>25</sub>ClN<sub>3</sub>O<sub>2</sub>S<sub>2</sub> [M + H]<sup>+</sup> 378.1071, found 378.1060.</div></div><div id="sec4_91" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> 2-Chloro-4-cyclopropyl-5-((4-methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)thiazole (<b>82</b>)</h3><div class="NLM_p last">2-Chloro-4-cyclopropylthiazole (0.3531 g, 2.21 mmol; see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">SI</a> for synthesis) was dissolved in anhydrous THF (7 mL) at â78 Â°C, followed by dropwise addition of <i>n</i>-BuLi (2.5 M in hexane, 1.0 mL, 2.50 mmol) under argon in 10 min. The solution mixture was stirred for 20 min at â78 Â°C and anhydrous SO<sub>2</sub> gas (generated from dropwise addition of sodium sulfite to concentrated aq HCl; the generated SO<sub>2</sub> gas was passed through concentrated H<sub>2</sub>SO<sub>4</sub>) was bubbled through the reaction solution at â78 Â°C for 10 min and then at room temperature for 1 h. Upon the evaporation of solvents, the residue was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (6 mL) and NCS (0.4726 g, 3.54 mmol) was added. The resulting suspension was stirred at room temperature for 16 h. The suspension was then filtered and the filtrate was concentrated to about 10 mL, followed by addition of DIPEA (1.0 mL, 5.75 mmol) and 4-methyl-1,4â²-bipiperidine <b>1a</b> (0.4998 g, 2.75 mmol). The reaction mixture was stirred at room temperature for 5.5 h and then poured into saturated NaHCO<sub>3</sub> solution (60 mL). The biphasic solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 60 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified through flash chromatography on silica gel (1:19 CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>), followed by recrystallization from a mixture of CH<sub>2</sub>Cl<sub>2</sub> and hexane to afford the desired product as a yellow solid (0.5398 g, 60% over two steps); mp 139â141 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 3.85 (d, <i>J</i> = 12.2 Hz, 2H), 2.80 (d, <i>J</i> = 11.6 Hz, 2H), 2.62â2.44 (m, 3H), 2.31 (tt, <i>J</i> = 11.6, 3.5 Hz, 1H), 2.12 (td, <i>J</i> = 11.6, 2.6 Hz, 2H), 1.88 (d, <i>J</i> = 12.6 Hz, 2H), 1.70â1.53 (m, 4H), 1.38â1.24 (m, 1H), 1.18 (qd, <i>J</i> = 11.8, 3.7 Hz, 2H), 1.11â0.99 (m, 4H), 0.87 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 161.2, 154.6, 126.3, 61.2, 49.4, 46.1, 34.4, 30.9, 27.3, 21.8, 11.4, 10.9. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>27</sub>ClN<sub>3</sub>O<sub>2</sub>S<sub>2</sub> [M + H]<sup>+</sup> 404.1228, found 404.1226.</div></div><div id="sec4_92" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> 1â²-(Benzo[<i>d</i>][1,3]dioxol-4-ylsulfonyl)-4-methyl-1,4â²-bipiperidine (<b>83</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with benzo[<i>d</i>][1,3]dioxole-4-sulfonyl chloride (Procedure A) yielded <b>83</b> as a yellow solid (86%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.12 (dd, <i>J</i> = 8.1, 1.2 Hz, 1H), 6.96 (dd, <i>J</i> = 7.8, 1.3 Hz, 1H), 6.89 (t, <i>J</i> = 8.0 Hz, 1H), 6.06 (s, 2H), 3.88 (d, <i>J</i> = 12.4 Hz, 2H), 2.79 (d, <i>J</i> = 11.7 Hz, 2H), 2.43 (td, <i>J</i> = 12.3, 2.4 Hz, 2H), 2.28 (tt, <i>J</i> = 11.6, 3.6 Hz, 1H), 2.13 (td, <i>J</i> = 11.6, 2.4 Hz, 2H), 1.84 (d, <i>J</i> = 14.8 Hz, 2H), 1.71â1.50 (m, 4H), 1.36â1.25 (m, 1H), 1.19 (qd, <i>J</i> = 11.9, 3.7 Hz, 2H), 0.87 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 148.9, 145.2, 121.7, 121.5, 118.8, 112.5, 102.2, 61.6, 49.4, 45.9, 34.3, 30.9, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 367.1686, found 367.1686.</div></div><div id="sec4_93" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> 1â²-((3,4-Dimethoxyphenyl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>84</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with benzo[<i>d</i>][1,3]dioxole-5-sulfonyl chloride (Procedure A) yielded <b>84</b> as a light orange solid (82%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.28 (dt, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.13 (t, <i>J</i> = 1.6 Hz, 1H), 6.87 (dd, <i>J</i> = 8.1, 1.2 Hz, 1H), 6.05 (s, 2H), 3.78 (d, <i>J</i> = 10.9 Hz, 2H), 2.77 (d, <i>J</i> = 11.0 Hz, 2H), 2.30â2.04 (m, 5H), 1.82 (d, <i>J</i> = 10.7 Hz, 2H), 1.70â1.53 (m, 4H), 1.38â1.23 (m, 1H), 1.22â1.08 (m, 2H), 0.87 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 151.3, 148.1, 129.3, 123.2, 108.2, 107.9, 102.3, 61.5, 49.5, 46.2, 34.5, 31.0, 27.3, 21.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 367.1681, found 367.1686.</div></div><div id="sec4_94" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> 4-Methyl-1â²-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)-1,4â²-bipiperidine (<b>85</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-sulfonyl chloride (Procedure A) yielded <b>85</b> as a pale yellow oil (95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 3.63 (d, <i>J</i> = 12.0 Hz, 2H), 2.97 (s, 2H), 2.89 (br, 2H), 2.75 (dt, <i>J</i> = 12.0, 4.0 Hz, 2H), 2.50 (s, 3H), 2.46 (s, 3H), 2.41 (br, 1H), 2.14 (br, 2H), 2.10 (s, 3H), 1.90 (d, <i>J</i> = 12.0 Hz, 2H), 1.64 (d, <i>J</i> = 12.0 Hz, 2H), 1.58â1.43 (m, 2H), 1.48 (s, 6H), 1.40â1.08 (m, 3H), 0.87 (d, <i>J</i> = 4.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 159.9, 140.8, 135.3, 125.8, 125.0, 117.9, 86.8, 61.9, 49.6, 43.9, 43.1, 34.5, 31.0, 28.6, 27.7, 21.8, 19.2, 17.6, 12.5. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>39</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 435.2676, found 435.2664.</div></div><div id="sec4_95" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> 1â²-((5-Bromo-2,3-dihydrobenzofuran-7-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>86</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 5-bromo-2,3-dihydrobenzofuran-7-sulfonyl chloride (Procedure A) yielded <b>86</b> as a white solid (86%); mp 128â132 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.62 (s, 1H), 7.43 (s, 1H), 4.70 (t, <i>J</i> = 8.9 H z, 2H), 3.89 (d, <i>J</i> = 12.3Hz, 2H), 3.24 (t, <i>J</i> = 9.0 Hz, 2H), 2.79 (d, <i>J</i> = 11.9 Hz, 2H), 2.50 (t, <i>J</i> = 12.4 Hz, 2H), 2.27 (tt, <i>J</i> = 11.7, 3.7 Hz, 1H), 2.12 (t, <i>J</i> = 11.5 Hz, 2H), 1.82 (d, <i>J</i> = 11.2 Hz, 2H), 1.67â1.51 (m, 4H), 1.38â1.25 (m, 1H), 1.17 (qd, <i>J</i> = 11.9, 3.7 Hz, 2H), 0.88 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 156.4, 132.3, 132.2, 130.7, 121.0, 111.8, 73.0, 61.7, 49.5, 46.0, 34.6, 31.0, 29.0, 27.6, 21.9. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>28</sub>Br N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 443.0999, found 443.0989.</div></div><div id="sec4_96" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> 4-Methyl-1â²-(naphthalen-1-ylsulfonyl)-1,4â²-bipiperidine (<b>87</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with naphthalene-1-sulfonyl chloride (Procedure A) yielded <b>87</b> as a yellow gel (79%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.74 (d, <i>J</i> = 8.6 Hz, 1H), 8.20 (d, <i>J</i> = 7.4 Hz, 1H), 8.05 (d, <i>J</i> = 8.4 Hz, 1H), 7.91 (d, <i>J</i> = 8.3 Hz, 1H), 7.69â7.44 (m, 3H), 3.91 (d, <i>J</i> = 12.5 Hz, 2H), 2.74 (d, <i>J</i> = 11.4 Hz, 2H), 2.53 (td, <i>J</i> = 12.3, 2.1 Hz, 2H), 2.20 (tt, <i>J</i> = 11.3, 3.5 Hz, 1H), 2.06 (t, <i>J</i> = 11.5 Hz, 2H), 1.80 (d, <i>J</i> = 12.3 Hz, 2H), 1.65â1.43 (m, 4H), 1.38â1.21 (m, 1H), 1.22â1.06 (m, 2H), 0.87 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 134.3, 133.0, 130.4, 128.9, 128.8, 128.0, 126.8, 125.2, 124.1, 61.5, 49.5, 45.5, 34.6, 31.0, 27.7, 21.9. HRMS (ESI-TOF) (ESI) calcd for C<sub>21</sub>H<sub>28</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 373.1950, found 373.1944.</div></div><div id="sec4_97" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> 1â²-((4-Chloronaphthalen-1-yl)sulfonyl)-4-methyl-1,4â²-bipiperidine (<b>88</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-chloronaphthalene-1-sulfonyl chloride (Procedure A) yielded <b>88</b> as a white solid (71%); mp 129â132 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.80â8.72 (m, 1H), 8.43â8.36 (m, 1H), 8.11 (d, <i>J</i> = 8.0 Hz, 1H), 7.69 (dd, <i>J</i> = 6.6, 3.3 Hz, 2H), 7.64 (d, <i>J</i> = 8.0 Hz, 1H), 3.87 (d, <i>J</i> = 12.4 Hz, 2H), 2.75 (d, <i>J</i> = 11.0 Hz, 2H), 2.55 (td, <i>J</i> = 12.2, 2.4 Hz, 2H), 2.23 (t, <i>J</i> = 12.0 Hz, 1H), 2.06 (t, <i>J</i> = 11.3 Hz, 2H), 1.81 (d, <i>J</i> = 13.1 Hz, 2H), 1.66â1.45 (m, 4H), 1.35â1.21 (m, 1H), 1.15 (dd, <i>J</i> = 13.4, 9.6 Hz, 2H), 0.87 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 138.4, 132.3, 131.5, 130.1, 130.0, 128.7, 127.9, 125.7, 125.4, 124.6, 61.5, 49.5, 45.5, 34.5, 31.0, 27.7, 21.8. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>28</sub>ClN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 407.1555, found 407.1551.</div></div><div id="sec4_98" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> <i>N</i>-(4-((4-Methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)naphthalen-1-yl)acetamide (<b>89</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with 4-acetamidonaphthalene-1-sulfonyl chloride (Procedure A) yielded <b>89</b> as a yellow solid (64%); mp 113â117 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.51 (d, <i>J</i> = 8.8 Hz, 1H), 8.17â8.05 (m, 2H), 7.87 (s, 1H), 7.66 (d, <i>J</i> = 7.6 Hz, 1H), 7.57â7.37 (m, 2H), 3.86 (d, <i>J</i> = 9.6 Hz, 2H), 2.80 (d, <i>J</i> = 11.6 Hz, 2H), 2.52 (t, <i>J</i> = 12.4 Hz, 2H), 2.36 (t, <i>J</i> = 12.8 Hz, 1H), 2.31 (s, 3H), 2.15 ( t, <i>J</i> = 11.6 Hz, 3H), 1.83 (d, <i>J</i> =13.6 Hz, 2H), 1.66â1.45 (m, 4H), 1.35â1.20 (m, 3H), 0.88 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 169.5, 133.3, 133.2, 130.6, 129.5, 129.4, 128.1, 127.7, 124.3, 123.9,123.4, 61.6, 49.3, 45.3, 33.7, 30.7, 27.2, 24.0, 21.6. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>32</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 430.2159, found 430.2165.</div></div><div id="sec4_99" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> 5-((4-Methyl-[1,4â²-bipiperidin]-1â²-yl)sulfonyl)isoquinoline (<b>90</b>)</h3><div class="NLM_p last">Reaction of amine <b>1a</b> with isoquinoline-5-sulfonyl chloride (Procedure A) yielded <b>90</b> as a white solid (51%); mp 123â126 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 9.33 (s, 1H), 8.66 (d, <i>J</i> = 6.0 Hz, 1H), 8.48 (d, <i>J</i> = 6.0 Hz, 1H), 8.36 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 8.19 (d, <i>J</i> = 6.0 Hz, 1H), 7.69 (dd, <i>J</i> = 8.2, 7.4 Hz, 1H), 3.90 (d, <i>J</i> = 12.4 Hz, 2H), 2.74 (d, <i>J</i> = 10.8 Hz, 2H), 2.51 (td, <i>J</i> = 12.0, 2.4 Hz, 2H), 2.26â2.15 (m, 1H), 2.12â2.03 (m, 2H), 1.81 (d, <i>J</i> = 11.6 Hz, 2H), 1.64â1.45 (m, 4H), 1.36â1.20 (m, 1H), 1.19â1.06 (m, 2H), 0.86 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 153.2, 145.1, 134.0, 133.7, 132.6, 131.9, 129.1, 125.8, 117.7, 61.4, 49.9, 45.6, 34.5, 31.0, 27.7, 21.6. HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 396.1716, found 396.1710.</div></div><div id="sec4_100" class="NLM_sec NLM_sec_level_2"><div id="ac_i126" class="anchor-spacer"></div><h3 class="article-section__title" id="_i126"> 1â²-((4-(Difluoromethoxy)phenyl)sulfonyl)-3-methyl-1,4â²-bipiperidine (<b>91</b>)</h3><div class="NLM_p last">Reaction of amine <b>1b</b> with 4-(difluoromethoxy)benzenesulfonyl chloride (Procedure A) yielded <b>91</b> as a pale yellow solid (76%); mp 88â91 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.77 (d, <i>J</i> = 8.8 Hz, 2H), 7.24 (d, <i>J</i> = 8.8 Hz, 2H), 6.60 (t, <i>J</i> = 72.6 Hz, 1H), 3.84 (d, <i>J</i> = 11.9 Hz, 2H), 2.85â2.56 (m, 2H), 2.37â2.15 (m, 3H), 2.04 (t, <i>J</i> = 11.4 Hz, 1H), 1.83 (d, <i>J</i> = 11.3 Hz, 2H), 1.78â1.42 (m, 7H), 0.90â0.73 (m, 1H), 0.82 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 154.1, 133.0, 129.8, 119.3, 115.2 (t, <i>J</i> = 262.7 Hz), 61.5, 57.6, 49.5, 46.2, 33.3, 31.5, 27.2, 27.1, 25.9, 19.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>26</sub>N<sub>2</sub>O<sub>3</sub>F<sub>2</sub>S [M + H]<sup>+</sup> 389.1699, found 389.1705.</div></div><div id="sec4_101" class="NLM_sec NLM_sec_level_2"><div id="ac_i127" class="anchor-spacer"></div><h3 class="article-section__title" id="_i127"> 1â²-((4-Bromophenyl)sulfonyl)-4-(prop-2-yn-1-yl)-1,4â²-bipiperidine (<b>92</b>)</h3><div class="NLM_p last">The synthesis of <b>92</b> is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">Supporting Information (SI)</a>. mp 161â164 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.78â7.54 (m, 4H), 3.83 (d, <i>J</i> = 12.0, 2H), 2.83 (dt, <i>J</i> = 11.8 Hz, 2H), 2.33â2.17 (m, 3H), 2.19â2.04 (m, 4H), 1.96 (t, <i>J</i> = 2.7 Hz, 1H), 1.88â1.73 (m, 4H), 1.64 (qd, <i>J</i> = 12.2, 4.1 Hz, 2H), 1.53â1.37 (m, 1H), 1.37â1.17 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 135.2, 132.3, 129.1, 127.8, 82.7, 69.4, 61.3, 49.2, 46.1, 35.5, 31.9, 27.3, 25.4. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>26</sub>BrN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 425.0893, found 425.0894.</div></div><div id="sec4_102" class="NLM_sec NLM_sec_level_2"><div id="ac_i128" class="anchor-spacer"></div><h3 class="article-section__title" id="_i128"> 1â²-(Phenylsulfonyl)-2-(prop-2-yn-1-yl)-1,4â²-bipiperidine (<b>93</b>)</h3><div class="NLM_p last">The synthesis of <b>93</b> is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">Supporting Information</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.82â7.70 (m, 2H), 7.63â7.57 (m, 1H), 7.57â7.50 (m, 2H), 3.85 (d, <i>J</i> = 12.1 Hz, 2H), 2.78â2.57 (m, 3H), 2.36â2.19 (m, 4H), 1.94 (t, <i>J</i> = 2.7 Hz, 1H), 1.89â1.39 (m, 9H), 1.35â1.19 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 136.2, 232.7, 129.0, 127.6, 82.1, 70.0, 56.4, 55.5, 46.5, 46.0, 45.2, 31.8, 30.1, 26.0, 24.2, 23.2, 21.7. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 347.1788, found 347.1799.</div></div><div id="sec4_103" class="NLM_sec NLM_sec_level_2"><div id="ac_i129" class="anchor-spacer"></div><h3 class="article-section__title" id="_i129"> 1â²-(Phenylsulfonyl)-4-(2-(prop-2-yn-1-yloxy)ethyl)-1,4â²-bipiperidine (<b>94</b>)</h3><div class="NLM_p last">To a solution of 2-(1â²-(phenylsulfonyl)-[1,4â²-bipiperidin]-4-yl)ethanol (0.0585 g, 0.17 mmol; prepared from <b>3a</b> with 4-piperidineethanol; see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">SI</a>) in anhydrous THF (1 mL) was added a suspension of KH (30% in mineral oil, 0.0275 g, 0.21 mmol) in anhydrous THF (0.5 mL) via a syringe at room temperature. After stirring for 45 min, propargyl bromide (80% in toluene, 0.038 mL, 0.43 mmol) was added dropwise via a syringe and the solution was stirred at room temperature for 7.5 h. After the evaporation of solvents, the residue was purified by flash chromatography (1/19 CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) to afford the desired product <b>94</b> as a yellow gel (0.0072 g, 11%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.83â7.69 (m, 2H), 7.63â7.57 (m, 1H), 7.57â7.49 (m, 2H), 4.11 (d, <i>J</i> = 2.3 Hz, 2H), 3.95â3.80 (m, 2H), 3.53 (t, <i>J</i> = 6.4 Hz, 2H), 2.85 (d, <i>J</i> = 10.7 Hz, 2H), 2.41 (t, <i>J</i> = 2.4 Hz, 1H), 2.30â2.13 (m, 5H), 1.87 (d, <i>J</i> = 12.6 Hz, 2H), 1.79â1.59 (m, 4H), 1.52 (q, <i>J</i> = 6.5 Hz, 2H), 1.45â1.36 (m, 1H), 1.32â1.22 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 136.1, 132.7, 129.0, 127.6, 79.9, 74.2, 67.6, 61.6, 58.1, 49.3, 46.1, 35.9, 32.6, 32.2, 27.1. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>30</sub>N<sub>2</sub>O<sub>3</sub>SNa [M + Na]<sup>+</sup> 413.1869, found 413.1863.</div></div><div id="sec4_104" class="NLM_sec NLM_sec_level_2"><div id="ac_i130" class="anchor-spacer"></div><h3 class="article-section__title" id="_i130"> 1â²-(Phenylsulfonyl)-2-(2-(prop-2-yn-1-yloxy)ethyl)-1,4â²-bipiperidine (<b>95</b>)</h3><div class="NLM_p last">To a solution of 2-(1â²-(phenylsulfonyl)-[1,4â²-bipiperidin]-2-yl)ethan-1-ol (0.0830 g, 0.24 mmol; prepared from <b>3a</b> with 2-piperidineethanol; see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">SI</a>) in anhydrous THF (2 mL) was added NaH (60%, 0.0192 g, 0.48 mmol) at 0 Â°C. The reaction solution was stirred at 0 Â°C for 15 min and propargyl bromide (80% in toluene, 0.075 mL, 0.67 mmol) was added via a syringe. The reaction solution was stirred at 0 Â°C for another 30 min and was allowed to warm up to room temperature and stirred for 3 h before a second portion of NaH (60%, 0.0175 g, 0.44 mmol) in anhydrous THF (1 mL) was introduced. The reaction solution was then stirred for 18 h at room temperature, and water (10 mL) was added to quench the reaction, followed by the extraction with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 10 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. After the purification by flash chromatography (1/19 CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>), the product <b>95</b> was obtained as a yellow gel (0.0132 g, 18%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.82â7.69 (m, 2H), 7.64â7.56 (m, 1H), 7.56â7.48 (m, 2H), 4.06 (d, <i>J</i> = 2.4 Hz, 2H), 3.83 (d, <i>J</i> = 11.9 Hz, 2H), 3.58â3.37 (m, 2H), 2.73 (dd, <i>J</i> = 39.3, 10.5 Hz, 3H), 2.35 (t, <i>J</i> = 2.4 Hz, 1H), 2.33â2.16 (m, 3H), 1.88â1.70 (m, 4H), 1.69â1.19 (m, 8H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 136.0, 132.8, 129.1, 127.6, 79.6, 74.4, 67.1, 58.2, 55.5, 55.0, 46.4, 45.9, 45.4, 30.3, 29.8, 29.7, 25.6, 24.2, 23.0. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>31</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 391.2050, found 391.2048.</div></div><div id="sec4_105" class="NLM_sec NLM_sec_level_2"><div id="ac_i131" class="anchor-spacer"></div><h3 class="article-section__title" id="_i131"> 1-(1â²-(Mesitylsulfonyl)-[1,4â²-bipiperidin]-4-yl)hex-5-yn-2-one (<b>96</b>)</h3><div class="NLM_p last">The synthesis of <b>96</b> is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">Supporting Information</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.91 (s, 2H), 3.61 (d, <i>J</i> = 12.8 Hz, 2H), 2.88 (d, <i>J</i> = 11.2 Hz, 2H), 2.71 (td, <i>J</i> = 12.2, 2.4 Hz, 2H), 2.63â2.58 (m, 2H), 2.57 (s, 6H), 2.41 (qd, <i>J</i> = 8.4, 7.0, 3.5 Hz, 3H), 2.32 (d, <i>J</i> = 6.8 Hz, 2H), 2.26 (s, 3H), 2.19 (t, <i>J</i> = 12.3 Hz, 2H), 1.90 (t, <i>J</i> = 2.7 Hz, 1H), 1.84 (d, <i>J</i> = 16.0 Hz, 3H), 1.67 (d, <i>J</i> = 10.9 Hz, 2H), 1.49 (qd, <i>J</i> = 12.2, 4.2 Hz, 2H), 1.34â1.22 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 207.7, 142.5, 140.4, 131.9, 131.6, 83.0, 68.7, 61.8, 49.2, 43.9, 41.9, 32.0, 31.7, 27.4, 22.8, 20.9, 12.9. HRMS (ESI-TOF) calcd for C<sub>25</sub>H<sub>37</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 445.2519, found 445.2524.</div></div><div id="sec4_106" class="NLM_sec NLM_sec_level_2"><div id="ac_i132" class="anchor-spacer"></div><h3 class="article-section__title" id="_i132"> 1â²-(Mesitylsulfonyl)-3,5-dimethyl-1,4â²-bipiperidine (<b>97</b>)</h3><div class="NLM_p last">Reaction of <b>3c</b> with 3,5-dimethylpiperidine (Procedure D) yielded <b>97</b> as a colorless oil (37%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.92 (s, 2H), 3.61 (d, <i>J</i> = 12.4 Hz, 2H), 2.87â2.66 (m, 4H), 2.59 (s, 6H), 2.47â2.29 (m, 1H), 2.27 (s, 3H), 1.82 (d, <i>J</i> = 13.6 Hz, 2H), 1.74â1.39 (m, 7H), 0.81 (d, <i>J</i> = 5.8 Hz, 6H), 0.47 (q, <i>J</i> = 11.4 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.4, 140.4, 131.8, 131.8, 61.8, 57.2, 44.1, 42.3, 31.4, 27.5, 22.8, 20.9, 19.7. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>35</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 379.2414, found 379.2406.</div></div><div id="sec4_107" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> 4-Isopropyl-1â²-(mesitylsulfonyl)-1,4â²-bipiperidine (<b>98</b>)</h3><div class="NLM_p last">Reaction of <b>3c</b> with 4-isopropylpiperidine (Procedure D) yielded <b>98</b> as a yellow oil (46%); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.91 (s, 2H), 3.60 (d, <i>J</i> = 12.7 Hz, 2H), 2.90 (dd, <i>J</i> = 11.5 Hz, 2H), 2.72 (t, <i>J</i> = 12.4 Hz, 2H), 2.59 (d, <i>J</i> = 2.3 Hz, 6H), 2.38â2.29 (m, 1H), 2.28 (s, 3H), 2.06 (t, <i>J</i> = 10.6 Hz, 2H), 1.85 (d, <i>J</i> = 11.2 Hz, 2H), 1.63 (d, <i>J</i> = 11.3 Hz, 2H), 1.49 (td, <i>J</i> = 12.1, 4.1 Hz, 2H), 1.44â1.32 (m, 1H), 1.30â1.14 (m, 2H), 1.01â0.87 (m, 1H), 0.83 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.4, 140.4, 131.8, 131.7, 61.8, 50.0, 44.0, 42.6, 32.4, 29.6, 27.7, 22.8, 20.9, 19.8. HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>37</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 393.2570, found 393.2567.</div></div><div id="sec4_108" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134"> 3-(1â²-(Mesitylsulfonyl)-[1,4â²-bipiperidin]-4-yl)propanenitrile (<b>99</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl 4-(2-cyanoethyl)piperidine-1-carboxylate (<b>S10</b>, 0.328 g, 1.38 mmol; see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">SI</a> for synthesis) was stirred with HCl (1 mL) in 1,4-dioxane (4 mL) at room temperature for 2 h. After the evaporation of the solvents, the 4-(2-cyanoethyl)piperidine hydrochloride acid salt was neutralized by shaking with saturated NaHCO<sub>3</sub> solution at 0 Â°C, followed by extraction with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 25 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to provide 3-(piperidin-4-yl)propanenitrile, which was used for the next step without further purification. Reaction of the above-prepared 3-(piperidin-4-yl)propanenitrile and 1-(mesitylsulfonyl)piperidin-4-one (<b>3c</b>) (Procedure D) yielded <b>99</b> as a white gel. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.94 (s, 2H), 3.63 (d, <i>J</i> = 12.3 Hz, 2H), 2.90 (d, <i>J</i> = 10.7 Hz, 2H), 2.74 (td, <i>J</i> = 12.4, 2.4 Hz, 2H), 2.60 (s, 6H), 2.35 (t, <i>J</i> = 7.2 Hz, 3H), 2.29 (s, 3H), 2.14 (t, <i>J</i> = 9.6 Hz, 2H), 1.84 (d, <i>J</i> = 12.7 Hz, 2H), 1.71 (d, <i>J</i> = 12.3 Hz, 2H), 1.63â1.34 (m, 5H), 1.27â1.16 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 140.4, 131.9, 131.7, 119.7, 61.8, 49.2, 44.0, 34.8, 31.8, 31.7, 27.6, 22.8, 21.0, 14.6. HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>34</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 404.2366, found 404.2361.</div></div><div id="sec4_109" class="NLM_sec NLM_sec_level_2"><div id="ac_i135" class="anchor-spacer"></div><h3 class="article-section__title" id="_i135"> 2-(1â²-(Mesitylsulfonyl)-[1,4â²-bipiperidin]-4-yl)ethanol (<b>100</b>)</h3><div class="NLM_p last">Reaction of <b>3c</b> with 4-piperidineethanol (Procedure D) yielded <b>100</b> as a white solid (66%); mp 82â85 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.93 (s, 2H), 3.66 (t, <i>J</i> = 6.6 Hz, 2H), 3.62 (d, <i>J</i> = 12.6 Hz, 2H), 2.86 (d, <i>J</i> = 11.6 Hz, 2H), 2.73 (td, <i>J</i> = 12.5, 2.4 Hz, 2H), 2.60 (s, 6H), 2.40â2.28 (m, 1H), 2.28 (s, 3H), 2.11 (td, <i>J</i> = 11.6, 2.4 Hz, 2H), 1.84 (d, <i>J</i> = 12.7 Hz, 2H), 1.69 (d, <i>J</i> = 13.2 Hz, 2H), 1.63 (s, 1H), 1.55â1.33 (m, 5H), 1.21 (qd, <i>J</i> = 11.7, 11.0, 3.8 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.4, 140.4, 131.9, 131.7, 61.8, 60.4, 49.5, 44.0, 39.4, 32.6, 32.5, 27.7, 22.8, 21.0. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>35</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 395.2363, found 395.2365.</div></div><div id="sec4_110" class="NLM_sec NLM_sec_level_2"><div id="ac_i136" class="anchor-spacer"></div><h3 class="article-section__title" id="_i136"> 1â²-(Mesitylsulfonyl)-[1,4â²-bipiperidin]-4-ol (<b>101</b>)</h3><div class="NLM_p last">To a mixture of [1,4â²-bipiperidin]-4-ol (<b>1c</b>, 0.2075 g, 1.13 mmol) and <sup><i>i</i></sup>Pr<sub>2</sub>NEt (0.27 mL, 1.55 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was dropwise added 2,4,6-trimethylbenzene-1-sulfonyl chloride (0.2154 g, 0.98 mmol, in 2 mL CH<sub>2</sub>Cl<sub>2</sub>) over 10 min. The reaction mixture was stirred at room temperature overnight and then poured into saturated aqueous NaHCO<sub>3</sub> (20 mL). The biphasic solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 20 mL). The combined organic layers were dried by Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified via flash chromatography (1/19 MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford the desired product (0.214 g, 65%) as a white solid; mp 120â123 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.92 (s, 2H), 3.74â3.59 (br, 1H), 3.60 (d, <i>J</i> = 12.9 Hz, 2H), 2.85â2.65 (m, 4H), 2.59 (s, 6H), 2.46â2.22 (m, 3H), 2.28 (s, 3H), 1.96â1.78 (m, 4H), 1.64â1.30 (m, 5H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 140.3, 131.9, 131.6, 67.6, 61.4, 46.7, 43.9, 34.5, 27.6, 22.8, 20.9. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>31</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 367.2050, found 367.2058.</div></div><div id="sec4_111" class="NLM_sec NLM_sec_level_2"><div id="ac_i137" class="anchor-spacer"></div><h3 class="article-section__title" id="_i137"> 1â²-(Mesitylsulfonyl)-1,4â²-bipiperidine (<b>102</b>)</h3><div class="NLM_p last">Reaction of <b>3c</b> with piperidine (Procedure D) yielded <b>102</b> as a colorless gel (67%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 6.93 (s, 2H), 3.62 (d, <i>J</i> = 11.7 Hz, 2H), 2.74 (t, <i>J</i> = 12.1 Hz, 2H), 2.60 (s, 6H), 2.47 (s, 4H), 2.38â2.30 (m, 1H), 2.28 (s, 3H), 1.85 (d, <i>J</i> = 11.5 Hz, 2H), 1.52â1.60 (m, 4H), 1.52â1.44 (m, 2H), 1.44â1.37 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.4, 140.4, 131.8, 131.8, 62.2, 50.2, 44.1, 27.5, 26.3, 24.6, 22.8, 20.9. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 373.1920, found 373.1910.</div></div><div id="sec4_112" class="NLM_sec NLM_sec_level_2"><div id="ac_i138" class="anchor-spacer"></div><h3 class="article-section__title" id="_i138"> 1-(1-(Mesitylsulfonyl)piperidin-4-yl)azepane (<b>103</b>)</h3><div class="NLM_p last">Reaction of amine hydrochloride salt <b>1e</b> with 2,4,6-trimethylbenzene-1-sulfonyl chloride (Procedure B) yielded <b>103</b> as an orange gel (90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.94 (s, 2H), 3.71 (d, <i>J</i> = 11.8 Hz, 2H), 3.62 (br, 1H), 3.18â2.89 (br, 4H), 2.77 (t, <i>J</i> = 12.7 Hz, 2H), 2.58 (s, 6H), 2.29 (s, 3H), 2.10 (d, <i>J</i> = 12.5 Hz, 2H), 1.82 (s, 4H), 1.76â1.54 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.8, 140.3, 132.0, 132.0, 132.0, 131.5, 63.3, 51.2, 43.8, 26.9, 26.6, 26.4, 22.8, 21.0. HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>33</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 365.2257, found 365.2253.</div></div><div id="sec4_113" class="NLM_sec NLM_sec_level_2"><div id="ac_i139" class="anchor-spacer"></div><h3 class="article-section__title" id="_i139"> 1-((4-Methoxyphenyl)sulfonyl)-4-(pyrrolidin-1-yl)piperidine (<b>104</b>)</h3><div class="NLM_p last">Reaction of amine <b>1d</b> with 4-methoxybenzene-1-sulfonyl chloride (Procedure A) yielded <b>104</b> as a pale yellow oil (70%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.68 (d, <i>J</i> = 8.0 Hz, 2H), 6.97 (d, <i>J</i> = 8.0 Hz, 2H), 3.86 (s, 3H), 3.68 (d, <i>J</i> = 12.0 Hz, 2H), 2.51 (s, 4H), 2.36 (dt, <i>J</i> = 12.0, 4.0 Hz, 2H), 2.04â1.86 (m, 3H), 1.75 (s, 4H), 1.61 (q, <i>J</i> = 12.0 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 162.9, 129.8, 127.8, 114.1, 60.8, 55.6, 51.3, 45.0, 30.4, 23.2. HRMS (ESI-TOF) calcd for C<sub>16</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 325.1580, found 325.1571.</div></div><div id="sec4_114" class="NLM_sec NLM_sec_level_2"><div id="ac_i140" class="anchor-spacer"></div><h3 class="article-section__title" id="_i140"> 3-(1-(Mesitylsulfonyl)piperidin-4-yl)-6-methyl-1,3-oxazinane (<b>105</b>)</h3><div class="NLM_p">Reaction of <b>3c</b> with 4-aminobutan-2-ol (Procedure D) yielded 4-((1-(mesitylsulfonyl)piperidin-4-yl)amino)butan-2-ol as a white solid (82%); mp 105â108 Â°C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 6.95 (s, 2H), 3.96 (ddd, <i>J</i> = 8.9, 5.8, 2.4 Hz, 1H), 3.55 (d, <i>J</i> = 12.5 Hz, 2H), 3.05 (dt, <i>J</i> = 11.9, 4.2 Hz, 1H), 2.83 (tt, <i>J</i> = 12.5, 3.3 Hz, 2H), 2.76 (td, <i>J</i> = 11.1, 2.9 Hz, 1H), 2.61 (s, 7H), 2.30 (s, 3H), 1.96 (t, <i>J</i> = 12.8 Hz, 2H), 1.63 (d, <i>J</i> = 14.9 Hz, 1H), 1.53â1.42 (m, 1H), 1.39â1.27 (m, 2H), 1.16 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.6, 140.4, 131.9, 131.6, 69.5, 54.4, 45.5, 43.1, 43.0, 37.0, 31.8, 31.5, 23.6, 22.8, 21.0. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>30</sub>N<sub>2</sub>O<sub>3</sub>SNa [M + Na]<sup>+</sup> 377.1869, found 377.1856.</div><div class="NLM_p last">A solution of the above-prepared 4-((1-(mesitylsulfonyl)piperidin-4-yl)amino)butan-2-ol (0.119 g, 0.34 mmol), paraformaldehyde (0.0143 g, 0.48 mmol), Mg<sub>2</sub>SO<sub>4</sub> (0.2091 g, 1.74 mmol), and pyridinium <i>p</i>-toluenesulfonate (PPTS) (0.0025 g, 0.01 mmol) in anhydrous toluene (4 mL) was refluxed for 3 h and then cooled to room temperature. The suspension was poured into saturated aqueous NaHCO<sub>3</sub> (30 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 30 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified via flash chromatography (1/19 MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to provide the desired product <b>105</b> as a colorless gel (0.0555 g, 45%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.91 (s, 2H), 4.61 (dd, <i>J</i> = 10.0, 2.3 Hz, 1H), 4.16 (d, <i>J</i> = 10.1 Hz, 1H), 3.63â3.50 (m, 3H), 3.11 (ddt, <i>J</i> = 13.4, 4.4, 2.2 Hz, 1H), 2.89â2.68 (m, 4H), 2.58 (s, 6H), 2.27 (s, 3H), 1.92 (dp, <i>J</i> = 12.2, 2.8 Hz, 2H), 1.65â1.29 (m, 4H), 1.15 (d, <i>J</i> = 6.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 140.4, 131.9, 131.6, 81.6, 73.6, 55.0, 46.5, 43.4, 30.3, 29.8, 29.2, 22.8, 21.8, 20.9. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>30</sub>N<sub>2</sub>O<sub>3</sub>SNa [M + Na]<sup>+</sup> 389.1869, found 389.1874.</div></div><div id="sec4_115" class="NLM_sec NLM_sec_level_2"><div id="ac_i141" class="anchor-spacer"></div><h3 class="article-section__title" id="_i141"> 1-(1-(Mesitylsulfonyl)piperidin-4-yl)-4-methylpiperazine (<b>106</b>)</h3><div class="NLM_p last">Reaction of <b>3c</b> with 1-methylpiperazine (Procedure D) yielded <b>106</b> as a colorless gel (74%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.91 (s, 2H), 3.59 (d, <i>J</i> = 12.6 Hz, 2H), 2.73 (t, <i>J</i> = 12.3 Hz, 2H), 2.58 (s, 6H), 2.55 (s, 4H), 2.49â2.35 (br, 4H), 2.36â2.29 (s, 1H), 2.26 (s, 3H), 2.25 (s, 3H), 1.84 (d, <i>J</i> = 11.6 Hz, 2H), 1.59â1.34 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 140.4, 131.8, 131.7, 61.2, 55.3, 48.9, 45.9, 43.7, 27.8, 22.8, 20.9. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>32</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 366.2210, found 366.2199.</div></div><div id="sec4_116" class="NLM_sec NLM_sec_level_2"><div id="ac_i142" class="anchor-spacer"></div><h3 class="article-section__title" id="_i142"> 4-(1-(Mesitylsulfonyl)piperidin-4-yl)morpholine (<b>107</b>)</h3><div class="NLM_p last">Reaction of <b>3c</b> with morpholine (Procedure D) yielded <b>107</b> as a colorless gel (74%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 6.92 (s, 2H), 3.68 (s, 4H), 3.60 (d, <i>J</i> = 12.9 Hz, 2H), 2.75 (t, <i>J</i> = 12.3 Hz, 2H), 2.59 (s, 6H), 2.50 (s, 4H), 2.27 (s, 4H), 1.87 (d, <i>J</i> = 14.5 Hz, 2H), 1.46 (qd, <i>J</i> = 11.6, 3.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 140.4, 140.4, 131.9, 131.6, 67.1, 61.5, 49.7, 43.6, 27.7, 22.8, 20.9. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 353.1893, found 353.1889.</div></div><div id="sec4_117" class="NLM_sec NLM_sec_level_2"><div id="ac_i143" class="anchor-spacer"></div><h3 class="article-section__title" id="_i143"> 4-Benzyl-1â²-(mesitylsulfonyl)-1,4â²-bipiperidine (<b>108</b>)</h3><div class="NLM_p last">Reaction of <b>3c</b> with 4-benzylpiperidine (Procedure D) yielded <b>108</b> as a light brown oil (68%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.36â7.22 (m, 2H), 7.21â7.06 (m, 3H), 6.92 (s, 2H), 3.61 (d, <i>J</i> = 12.4 Hz, 2H), 2.92 (s, 2H), 2.72 (td, <i>J</i> = 12.5, 2.4 Hz, 2H), 2.58 (s, 6H), 2.50 (d, <i>J</i> = 7.0 Hz, 2H), 2.40â2.26 (br, 1H), 2.28 (s, 3H), 2.08 (t, <i>J</i> = 17.9 Hz, 1H), 1.85 (d, <i>J</i> = 12.8 Hz, 2H), 1.64 (d, <i>J</i> = 12.8 Hz, 2H), 1.49 (d, <i>J</i> = 11.5 Hz, 3H), 1.41â1.12 (br, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 140.5, 140.4, 131.9, 131.7, 129.1, 128.2, 125.8, 61.9, 49.6, 44.0, 43.1, 38.1, 32.3, 27.6, 22.8, 21.0. HRMS (ESI-TOF) calcd for C<sub>26</sub>H<sub>37</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 441.2570, found 441.2567.</div></div><div id="sec4_118" class="NLM_sec NLM_sec_level_2"><div id="ac_i144" class="anchor-spacer"></div><h3 class="article-section__title" id="_i144"> 4-(2-Fluorobenzyl)-1â²-(mesitylsulfonyl)-1,4â²-bipiperidine (<b>109</b>)</h3><div class="NLM_p last">To a solution of 1-(mesitylsulfonyl)piperidin-4-one (<b>3c</b>, 0.2855 g, 1.02 mmol) and 4-(2-fluorobenzyl)piperidine (0.1936 g, 1.00 mmol) in anhydrous DCE (6 mL) was added Ti(O<i>i</i>-Pr)<sub>4</sub> (0.60 mL, 2.05 mmol) and the solution was stirred at 80 Â°C for 6.5 h. After cooling to 0 Â°C, NaBH<sub>4</sub> (0.1271 g, 3.34 mmol) in EtOH (6 mL) was added dropwise and the solution was stirred at room temperature overnight. The reaction was quenched with saturated aqueous NaHCO<sub>3</sub> (30 mL), extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified via flash chromatography (1/19 MeOH/CH<sub>2</sub>Cl<sub>2</sub> then 100% EtOAc) to afford the product <b>109</b> as a light brown gel (0.1444 g, 35%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.17â7.05 (m, 2H), 7.03â6.92 (m, 2H), 6.90 (s, 2H), 3.59 (d, <i>J</i> = 12.5 Hz, 2H), 2.86 (d, <i>J</i> = 11.7 Hz, 2H), 2.70 (td, <i>J</i> = 12.4, 2.4 Hz, 2H), 2.57 (s, 6H), 2.55â2.48 (m, 2H), 2.44â2.30 (m, 1H), 2.25 (s, 3H), 2.09 (td, <i>J</i> = 11.7, 2.4 Hz, 2H), 1.83 (d, <i>J</i> = 14.5 Hz, 2H), 1.61 (d, <i>J</i> = 13.1 Hz, 2H), 1.58â1.41 (m, 3H), 1.39â1.22 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 161.2 (d, <i>J</i> = 244.6 Hz), 142.5, 140.4, 131.9, 131.7, 131.5 (d, <i>J</i> = 5.1 Hz), 127.6 (d, <i>J</i> = 8.1 Hz), 127.2 (d, <i>J</i> = 16.2 Hz), 123.7 (d, <i>J</i> = 3.5 Hz), 115.1 (d, <i>J</i> = 22.5 Hz), 61.8, 49.4, 43.9, 36.8, 35.9, 32.0, 27.5, 22.8, 20.9. HRMS (ESI-TOF) calcd for C<sub>26</sub>H<sub>36</sub>FN<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 459.2476, found 459.2470.</div></div><div id="sec4_119" class="NLM_sec NLM_sec_level_2"><div id="ac_i145" class="anchor-spacer"></div><h3 class="article-section__title" id="_i145"> 4-(4-Fluorobenzyl)-1â²-(mesitylsulfonyl)-1,4â²-bipiperidine (<b>110</b>)</h3><div class="NLM_p last">Reaction of <b>3c</b> and 4-(4-fluorobenzyl)piperidine in the same manner as for the preparation of <b>109</b> yielded <b>110</b> as a colorless gel (31%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.09â7.00 (m, 2H), 6.97â6.87 (m, 4H), 3.60 (d, <i>J</i> = 12.6 Hz, 2H), 2.86 (d, <i>J</i> = 11.5 Hz, 2H), 2.72 (td, <i>J</i> = 12.5, 2.4 Hz, 2H), 2.58 (s, 6H), 2.46 (d, <i>J</i> = 7.0 Hz, 2H), 2.35 (t, <i>J</i> = 11.8 Hz, 1H), 2.27 (s, 3H), 2.08 (dd, <i>J</i> = 12.8, 10.2 Hz, 2H), 1.83 (d, <i>J</i> = 12.1 Hz, 2H), 1.61 (d, <i>J</i> = 12.8 Hz, 2H), 1.55â1.36 (m, 3H), 1.34â1.15 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 161.2 (d, <i>J</i> = 243.4 Hz), 142.5, 140.4, 136.1 (d, <i>J</i> = 3.3 Hz), 131.9, 131.7, 130.3 (d, <i>J</i> = 7.7 Hz), 114.9 (d, <i>J</i> = 21.0 Hz), 61.8, 49.5, 44.0, 42.2, 38.1, 32.2, 27.6, 22.8, 20.9. HRMS (ESI-TOF) calcd for C<sub>26</sub>H<sub>36</sub>FN<sub>2</sub>O<sub>2</sub>S [M + H]+ 459.2476, found 459.2477.</div></div><div id="sec4_120" class="NLM_sec NLM_sec_level_2"><div id="ac_i146" class="anchor-spacer"></div><h3 class="article-section__title" id="_i146"> 1â²-(Mesitylsulfonyl)-4-phenyl-1,4â²-bipiperidine (<b>111</b>)</h3><div class="NLM_p last">Reaction of <b>3c</b> with 4-phenylpiperidine (Procedure D) yielded <b>111</b> as a white solid (90%); mp 141â144 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.34â7.26 (m, 2H), 7.25â7.16 (m, 3H), 6.95 (s, 2H), 3.66 (d, <i>J</i> = 12.5 Hz, 2H), 3.03 (d, <i>J</i> = 11.0 Hz, 2H), 2.78 (t, <i>J</i> = 12.5 Hz, 2H), 2.62 (s, 6H), 2.54â2.37 (m, 2H), 2.30 (s, 3H), 2.30â2.20 (m, 2H), 1.99â1.66 (m, 6H), 1.56 (qd, <i>J</i> = 12.2, 4.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 140.5, 131.9, 131.7, 128.4, 126.8, 126.2, 61.9, 50.0, 44.0, 42.9, 33.7, 27.7, 22.8, 21.0. HRMS (ESI-TOF) calcd for C<sub>25</sub>H<sub>35</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 427.2414, found 427.2405.</div></div><div id="sec4_121" class="NLM_sec NLM_sec_level_2"><div id="ac_i147" class="anchor-spacer"></div><h3 class="article-section__title" id="_i147"> 1-(Mesitylsulfonyl)-4-(5-methyl-1,3-dioxan-2-yl)piperidine (<b>112</b>)</h3><div class="NLM_p last">The synthesis of compound <b>112</b>, obtained as a mixture of cis/trans isomers (1:1.56), is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">Supporting Information</a>. Trans: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.91 (s, 2H), 4.16 (d, <i>J</i> = 5.4 Hz, 1H), 3.97 (dd, <i>J</i> = 11.8, 4.7 Hz, 2H), 3.55 (d, <i>J</i> = 10.2 Hz, 2H), 3.20 (t, <i>J</i> = 11.5 Hz, 2H), 2.70 (t, <i>J</i> = 12.4 Hz, 2H), 2.58 (s, 6H), 2.26 (s, 3H), 2.07â1.90 (m, 1H), 1.77 (d, <i>J</i> = 14.4 Hz, 2H), 1.64â1.54 (m, 1H), 1.42â1.24 (m, 2H), 0.66 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.3, 140.5, 140.4, 131.8, 103.4, 71.8, 44.0, 40.3, 29.5, 26.1, 22.8, 20.9, 12.3. Cis: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.91 (s, 2H), 4.26 (d, <i>J</i> = 5.1 Hz, 1H), 3.84 (d, <i>J</i> = 11.5 Hz, 2H), 3.74 (d, <i>J</i> = 10.1 Hz, 2H), 3.55 (d, <i>J</i> = 10.2 Hz, 2H), 2.70 (t, <i>J</i> = 12.4 Hz, 2H), 2.58 (s, 6H), 2.26 (s, 3H), 1.77 (d, <i>J</i> = 14.4 Hz, 2H), 1.64â1.54 (m, 1H), 1.54â1.47 (m, 1H), 1.42â1.24 (m, 2H), 1.20 (d, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.3, 140.5, 140.4, 103.9, 73.2, 44.0, 40.3, 29.1, 25.9, 22.8, 20.9, 15.8. HRMS (ESI-TOF) (ESI) calcd for C<sub>19</sub>H<sub>29</sub>NO<sub>4</sub>SNa [M + Na]<sup>+</sup> 390.1710, found 390.1706.</div></div><div id="sec4_122" class="NLM_sec NLM_sec_level_2"><div id="ac_i148" class="anchor-spacer"></div><h3 class="article-section__title" id="_i148"> (1-(Mesitylsulfonyl)piperidin-4-yl)(4-methylpiperidin-1-yl)methanone (<b>113</b>)</h3><div class="NLM_p last">Reaction of amine <b>1k</b> (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">SI</a> for synthesis) with 2,4,6-trimethylbenzene-1-sulfonyl chloride (Procedure B) yielded <b>113</b> as a light brown solid (86%); mp 122â124 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.89 (s, 2H), 4.49 (d, <i>J</i> = 13.2 Hz, 1H), 3.77 (d, <i>J</i> = 15.5 Hz, 1H), 3.53 (dt, <i>J</i> = 12.1, 3.6 Hz, 2H), 2.94 (td, <i>J</i> = 12.5, 11.6, 2.3 Hz, 1H), 2.85â2.70 (m, 2H), 2.56 (s, 6H), 2.54â2.38 (m, 2H), 2.24 (s, 3H), 1.82â1.45 (m, 7H), 1.08â0.92 (m, 2H), 0.88 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 172.1, 142.6, 140.5, 131.8, 131.3, 45.7, 43.6, 42.2, 38.0, 34.9, 33.8, 31.1, 28.1, 27.8, 22.7, 21.6, 20.9; HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>32</sub>N<sub>2</sub>O<sub>3</sub>SNa [M + Na]<sup>+</sup> 415.2026, found 415.2017.</div></div><div id="sec4_123" class="NLM_sec NLM_sec_level_2"><div id="ac_i149" class="anchor-spacer"></div><h3 class="article-section__title" id="_i149"> 1-(Mesitylsulfonyl)-<i>N</i>-(<i>p</i>-tolyl)piperidin-4-amine (<b>114</b>)</h3><div class="NLM_p last">Reaction of <b>3c</b> with <i>p</i>-toluidine (Procedure D) yielded <b>114</b> as a white solid (61%); mp 148â151 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.03â6.89 (m, 4H), 6.51 (d, <i>J</i> = 8.3 Hz, 2H), 3.56 (dt, <i>J</i> = 13.2, 3.5 Hz, 2H), 3.36 (tt, <i>J</i> = 10.1, 3.9 Hz, 1H), 2.91 (ddd, <i>J</i> = 12.8, 11.2, 2.7 Hz, 2H), 2.61 (s, 6H), 2.29 (s, 3H), 2.21 (s, 3H), 2.06 (dd, <i>J</i> = 13.2, 3.8 Hz, 2H), 1.54â1.32 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 144.0, 142.6, 140.5, 131.9, 131.6, 129.9, 127.2, 113.8, 50.0, 43.2, 31.8, 22.8, 21.0, 20.4. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>28</sub>N<sub>2</sub>O<sub>2</sub>SNa [M + Na]<sup>+</sup> 395.1764, found 395.1771.</div></div><div id="sec4_124" class="NLM_sec NLM_sec_level_2"><div id="ac_i150" class="anchor-spacer"></div><h3 class="article-section__title" id="_i150"> 1-(Mesitylsulfonyl)-4-(<i>p</i>-tolyl)piperidine (<b>115</b>)</h3><div class="NLM_p last">Reaction of amine <b>1f</b> with 2,4,6-trimethylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>115</b> as a pale yellow solid (73%); mp 87â90 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.08 (q, <i>J</i> = 8.1 Hz, 4H), 6.95 (s, 2H), 3.69 (d, <i>J</i> = 12.1 Hz, 2H), 2.86 (t, <i>J</i> = 12.5 Hz, 2H), 2.64 (s, 6H), 2.62â2.51 (m, 1H), 2.30 (d, <i>J</i> = 1.9 Hz, 6H), 1.86 (d, <i>J</i> = 13.0 Hz, 2H), 1.67 (dtd, <i>J</i> = 13.4, 12.2, 4.1 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.4, 142.1, 140.5, 136.0, 131.9, 131.8, 129.2, 126.6, 44.9, 41.8, 32.7, 22.9, 21.0. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>27</sub>NO<sub>2</sub>SNa [M + Na]<sup>+</sup> 380.1655, found 380.1652.</div></div><div id="sec4_125" class="NLM_sec NLM_sec_level_2"><div id="ac_i151" class="anchor-spacer"></div><h3 class="article-section__title" id="_i151"> 1-(Mesitylsulfonyl)-4-phenylpiperidine (<b>116</b>)</h3><div class="NLM_p last">Reaction of amine <b>1g</b> with 2,4,6-trimethylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>116</b> as a yellow solid (93%); mp 88â90 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.36â7.26 (m, 2H), 7.23â7.14 (m, 3H), 6.96 (s, 2H), 3.71 (d, <i>J</i> = 12.3 Hz, 2H), 2.87 (t, <i>J</i> = 12.4 Hz, 2H), 2.65 (s, 6H), 2.64â2.54 (m, 1H), 2.30 (s, 3H), 1.88 (d, <i>J</i> = 13.2 Hz, 2H), 1.70 (dtd, <i>J</i> = 13.7, 12.1, 4.1 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 145.1, 142.5, 140.5, 131.9, 131.8, 128.5, 126.7, 126.5, 44.9, 42.2, 32.6, 22.9, 21.0. HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>25</sub>NO<sub>2</sub>SNa [M + Na]<sup>+</sup> 366.1498, found 366.1489.</div></div><div id="sec4_126" class="NLM_sec NLM_sec_level_2"><div id="ac_i152" class="anchor-spacer"></div><h3 class="article-section__title" id="_i152"> <i>N</i>-Benzyl-<i>N</i>-(1-(mesitylsulfonyl)piperidin-4-yl)butyramide (<b>117</b>)</h3><div class="NLM_p">Reaction of <b>3c</b> with benzylamine (Procedure D) yielded <i>N</i>-benzyl-1-(mesitylsulfonyl)piperidin-4-amine as a yellow oil (>95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.45â7.19 (m, 5H), 6.92 (s, 2H), 3.77 (s, 2H), 3.52 (d, <i>J</i> = 13.3 Hz, 2H), 3.52 (d, <i>J</i> = 13.3 Hz, 2H), 2.68â2.58 (m, 1H), 2.59 (s, 6H), 2.27 (s, 3H), 1.90 (d, <i>J</i> = 12.1 Hz, 2H), 1.45â1.22 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 140.4, 131.9, 131.7, 128.6, 128.5, 128.0, 127.8, 127.1, 53.7, 50.8, 42.9, 31.7, 22.8, 21.0. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 373.1944, found 373.1942.</div><div class="NLM_p last">A mixture of the above-prepared <i>N</i>-benzyl-1-(mesitylsulfonyl)piperidin-4-amine (0.4135 g, 1.11 mmol), butyryl chloride (0.13 mL, 1.24 mmol), and <sup><i>i</i></sup>Pr<sub>2</sub>NEt (0.28 mL, 1.70 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was stirred at room temperature for 23 h. CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was added and the solution was washed with saturated aqueous NaHCO<sub>3</sub> (25 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified via flash chromatography (1/9 MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford the desired product <b>117</b> as a yellow gel (4:1 ratio of two rotamers; 0.2351 g, 48%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> at 50 Â°C) Î´ 7.62â7.18 (m, 3H), 7.15 (d, <i>J</i> = 7.4 Hz, 2H), 6.90 (s, 2H), 4.70â4.35 (m, 1H), 4.48 (s, 2H), 3.63 (d, <i>J</i> = 11.6 Hz, 2H), 2.96â2.68 (m, 2H), 2.56 (s, 6H), 2.35â2.10 (br, 2H), 2.26 (s, 3H), 1.65 (s, 6H), 0.89 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) major rotamer Î´ 174.0, 142.5, 140.2, 138.1, 131.9, 131.8, 128.8, 127.3, 125.7, 51.7, 46.9, 44.2, 35.7, 29.1, 22.8, 20.9, 18.7, 13.8. HRMS (ESI-TOF) calcd for C<sub>25</sub>H<sub>34</sub>N<sub>2</sub>O<sub>3</sub>SNa [M + Na]<sup>+</sup> 465.2182, found 465.2190.</div></div><div id="sec4_127" class="NLM_sec NLM_sec_level_2"><div id="ac_i153" class="anchor-spacer"></div><h3 class="article-section__title" id="_i153"> <i>N</i>-(1-(Mesitylsulfonyl)piperidin-4-yl)butyramide (<b>118</b>)</h3><div class="NLM_p last">To a solution of <i>N</i>-benzyl-<i>N</i>-(1-(mesitylsulfonyl)piperidin-4-yl)butyramide <b>117</b> (0.1338 g, 0.30 mmol) in methanol (4 mL) was added palladium on carbon (10 wt %). The flask was evacuated by vacuum and refilled by a hydrogen balloon. This evacuation/refill was repeated three times and the reaction suspension was stirred under hydrogen at room temperature for 18 h. The reaction suspension was then filtered through a pad of celite and washed with methanol. Upon evaporation of the solvent, compound <b>118</b> was obtained as a yellow solid (0.0662 g, 62%); mp 144â147 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.94 (s, 2H), 5.82â5.25 (br, 1H), 3.95 (s, 1H), 3.58 (d, <i>J</i> = 11.4 Hz, 2H), 2.90 (s, 2H), 2.60 (s, 6H), 2.29 (s, 3H), 2.25â2.06 (br, 2H), 1.95 (s, 2H), 1.73â1.59 (br, 2H), 1.58â1.40 (br, 2H), 1.04â0.83 (br, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 172.5, 142.6, 140.3, 132.0, 131.7, 46.1, 43.4, 39.0, 31.7, 22.9, 21.0, 19.3, 13.8. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>28</sub>N<sub>2</sub>O<sub>3</sub>SNa [M + Na]<sup>+</sup> 375.1713, found 375.1715.</div></div><div id="sec4_128" class="NLM_sec NLM_sec_level_2"><div id="ac_i154" class="anchor-spacer"></div><h3 class="article-section__title" id="_i154"> (4-Methyl-[1,4â²-bipiperidin]-1â²-yl)(4-(trifluoromethoxy)phenyl)methanone (<b>119</b>)</h3><div class="NLM_p last">A mixture of 4-(trifluoromethoxy)benzoic acid (0.2024 g, 0.98 mmol), DMAP (0.0200 g, 0.16 mmol), and EDC hydrochloride (0.2166 g, 1.13 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) was stirred at room temperature for 0.5 h. 4-Methyl-1,4â²-bipiperidine (0.1847 g, 1.01 mmol) was added and the resulting solution was stirred at room temperature for 26.5 h. The reaction solution was diluted with CH<sub>2</sub>Cl<sub>2</sub> (60 mL) and washed with brine (60 mL) and saturated aqueous NaHCO<sub>3</sub> (60 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (1:19 MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford compound <b>119</b> (0.2434 g, 67%) as a white solid; mp 72â75 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.42 (d, <i>J</i> = 8.6 Hz, 2H), 7.23 (d, <i>J</i> = 8.3 Hz, 2H), 4.73 (d, <i>J</i> = 12.8 Hz, 1H), 3.75 (d, <i>J</i> = 13.6 Hz, 1H), 3.00 (s, 1H), 2.87 (d, <i>J</i> = 11.4 Hz, 2H), 2.75 (s, 1H), 2.50 (t, <i>J</i> = 11.4 Hz, 1H), 2.14 (t, <i>J</i> = 11.5 Hz, 2H), 1.87 (d, <i>J</i> = 49.0 Hz, 2H), 1.70â1.28 (m, 5H), 1.20 (qd, <i>J</i> = 11.8, 3.8 Hz, 2H), 0.90 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 168.8, 149.9 (q, <i>J</i> = 1.8 Hz), 134.7, 128.7, 120.9, 120.3 (q, <i>J</i> = 258.0 Hz), 62.1, 49.8 and 49.5 (rotamers), 47.4 and 42.0 (rotamers), 34.6, 31.0, 29.2 and 27.8 (rotamers), 21.9. HRMS (ESI-TOF) (ESI) calcd for C<sub>19</sub>H<sub>25</sub>N<sub>2</sub>O<sub>2</sub>F3 [M + Na]<sup>+</sup> 393.1754, found 393.1760.</div></div><div id="sec4_129" class="NLM_sec NLM_sec_level_2"><div id="ac_i155" class="anchor-spacer"></div><h3 class="article-section__title" id="_i155"> 4-Methoxyphenyl 4-Methyl-[1,4â²-bipiperidine]-1â²-carboxylate (<b>120</b>)</h3><div class="NLM_p last">To a solution of 4-methyl-1,4â²-bipiperidine (0.1831g, 1.01 mmol) and K<sub>2</sub>CO<sub>3</sub> (0.1522 g, 1.10 mmol) in Et<sub>2</sub>O (15 mL) was added 4-methoxyphenyl carbonochloridate (0.15 mL, 1.00 mmol) at 0 Â°C. The resulting suspension was allowed to warm up to room temperature gradually and stirred for 5 h. The suspension was then poured into H<sub>2</sub>O (30 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 30 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (9/1 CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH) to afford compound <b>120</b> as a white solid (0.2647 g, 79%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.97 (d, <i>J</i> = 9.1 Hz, 2H), 6.83 (d, <i>J</i> = 9.1 Hz, 2H), 4.33 (s, 2H), 3.75 (s, 3H), 3.09 (d, <i>J</i> = 11.0 Hz, 2H), 2.93 (s, 1H), 2.79 (t, <i>J</i> = 11.8 Hz, 2H), 2.41 (s, 2H), 2.05 (s, 2H), 1.84â1.37 (m, 7H), 0.94 (d, <i>J</i> = 6.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 156.9, 153.8, 144.8, 122.5, 114.3, 62.7, 55.6, 49.6, 49.2, 43.7, 32.8, 30.3, 27.5, 26.8, 21.4. HRMS (ESI-TOF) (ESI) calcd for C<sub>19</sub>H<sub>29</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 333.2173, found 333.2189.</div></div><div id="sec4_130" class="NLM_sec NLM_sec_level_2"><div id="ac_i156" class="anchor-spacer"></div><h3 class="article-section__title" id="_i156"> <i>N</i>-(4-Methoxyphenyl)-4-methyl-[1,4â²-bipiperidine]-1â²-carboxamide (<b>121</b>)</h3><div class="NLM_p last">To a 15 mL flame-dried flask were added 4-methyl-1,4â²-bipiperidine (0.1889 g, 1.04 mmol), DCM (6 mL), and 1-isocyanato-4-methoxybenzene (0.1674 g, 1.12 mmol) at 0 Â°C sequentially. The resulting solution was then allowed to warm to room temperature and stirred for 22 h. After the evaporation of solvents, the residue was purified through flash chromatography on silica gel (1:19 MeOH/CH<sub>2</sub>Cl<sub>2</sub>) to afford the entitled product as a white solid (0.2032 g, 59%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.21 (d, <i>J</i> = 8.9 Hz, 2H), 6.80 (d, <i>J</i> = 8.9 Hz, 2H), 6.38 (s, 1H), 4.08 (d, <i>J</i> = 13.2 Hz, 2H), 3.75 (s, 3H), 2.93â2.72 (m, 4H), 2.53â2.33 (m, 1H), 2.14 (t, <i>J</i> = 11.6 Hz, 2H), 1.83 (d, <i>J</i> = 11.9 Hz, 2H), 1.64 (d, <i>J</i> = 13.8 Hz, 1H), 1.49 (qd, <i>J</i> = 12.4, 4.2 Hz, 2H), 1.42â1.26 (m, 1H), 1.20 (qd, <i>J</i> = 11.9, 3.5 Hz, 2H), 0.90 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 155.7, 155.4, 132.2, 122.3, 114.0, 62.2, 55.5, 49.6, 44.0, 34.7, 31.1, 28.0, 21.9. HRMS (ESI-TOF) (ESI) calcd for C<sub>19</sub>H<sub>30</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 332.2333, found 332.2326.</div></div><div id="sec4_131" class="NLM_sec NLM_sec_level_2"><div id="ac_i157" class="anchor-spacer"></div><h3 class="article-section__title" id="_i157"> <i>N</i>-(4-Methoxyphenyl)-4-oxopiperidine-1-sulfonamide (<b>122</b>)</h3><div class="NLM_p">A solution of 4-methoxyaniline (1.8932 g, 15.39 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (18 mL) was cooled to â10 Â°C and chlorosulfonic acid (0.34 mL, 5.13 mmol) was added dropwise in 10 min. The resulting suspension was allowed to warm to room temperature and stirred for 3 h. After filtration, the solid was dried under reduced pressure and suspended in toluene (15 mL), followed by addition of PCl<sub>5</sub> (1.0239 g, 4.92 mmol). The reaction mixture was stirred at 75 Â°C for 3.5 h and filtered. The filtrate was concentrated under reduced pressure to afford 4-MeOPhNHSO<sub>2</sub>Cl, which was used without further purification.</div><div class="NLM_p">A suspension of piperidin-4-one hydrochloride hydrate (<b>2a</b>, 0.7689 g, 5.03 mmol), Na<sub>2</sub>SO<sub>4</sub> (1.2132 g, 7.19 mmol), and Et<sub>3</sub>N (2.9 mL, 2.1054 g, 20.85 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was stirred vigorously, followed by addition of 4-MeOPhNHSO<sub>2</sub>Cl as prepared above. The reaction mixture was stirred at room temperature for 20 h and poured into 0.5 N aqueous HCl (50 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 50 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (1/1 EtOAc/hexane) to afford <i>N</i>-(4-methoxyphenyl)-4-oxopiperidine-1-sulfonamide as a brown gel (0.1552 g, 11% over two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.17 (d, <i>J</i> = 8.9 Hz, 2H), 7.02 (s, 1H), 6.84 (d, <i>J</i> = 8.9 Hz, 2H), 3.77 (s, 3H), 3.53 (t, <i>J</i> = 6.2 Hz, 4H), 2.42 (t, <i>J</i> = 6.2 Hz, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 206.4, 157.7, 129.2, 124.2, 114.6, 55.5, 46.0, 40.8. MS (ESI) calcd for C<sub>12</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 285.1, found 285.1.</div><div class="NLM_p last">Reaction of the above-prepared <i>N</i>-(4-methoxyphenyl)-4-oxopiperidine-1-sulfonamide (0.1102 g, 0.39 mmol) with 4-methylpiperidine (Procedure D) yielded <b>122</b> as a pale yellow gel (0.0217 g, 15%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.21 (d, <i>J</i> = 8.8 Hz, 2H), 6.84 (dd, <i>J</i> = 8.9, 2.3 Hz, 2H), 3.88 (d, <i>J</i> = 12.7 Hz, 2H), 3.79 (d, <i>J</i> = 1.8 Hz, 3H), 3.16 (d, <i>J</i> = 11.7 Hz, 2H), 2.92 (s, 1H), 2.74 (t, <i>J</i> = 12.2 Hz, 2H), 2.50 (t, <i>J</i> = 11.5 Hz, 2H), 2.13â1.93 (m, 3H), 1.88â1.56 (m, 6H), 1.55â1.39 (m, 1H), 0.97 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 157.2, 130.1, 123.9, 114.4, 62.3, 55.5, 49.0, 45.5, 31.4, 29.6, 25.9, 21.0. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>30</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 368.2002, found 368.1991.</div></div><div id="sec4_132" class="NLM_sec NLM_sec_level_2"><div id="ac_i158" class="anchor-spacer"></div><h3 class="article-section__title" id="_i158"> 2,4,6-Trimethyl-<i>N</i>-(4-(4-methylpiperidin-1-yl)cyclohexyl)benzenesulfonamide (<b>123</b>)</h3><div class="NLM_p">A mixture of <i>tert-</i>butyl (4-oxocyclohexyl)carbamate (0.4296 g, 2.02 mmol), HCl (37%, 2 mL), and 1,4-dioxane (6 mL) was stirred at room temperature for 3.5 h. Upon evaporation of solvents, the residue (<b>2b</b>) was reacted with 2-mesitylenesulfonyl chloride according to Procedure B to yield 2,4,6-trimethyl-<i>N</i>-(4-oxocyclohexyl)benzenesulfonamide as a light yellow gel (83%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.94 (s, 2H), 5.36â5.26 (br, 1H), 3.64â3.40 (m, 1H), 2.63 (s, 6H), 2.40â2.31 (m, 2H), 2.30â2.20 (m, 5H), 2.04â1.93 (m, 2H), 1.79â1.67 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.4, 138.9, 134.3, 132.1, 49.6, 38.4, 32.2, 22.9, 20.9.</div><div class="NLM_p last">Reaction of the above-prepared 2,4,6-trimethyl-<i>N</i>-(4-oxocyclohexyl)benzenesulfonamide with 4-methylpiperidine (Procedure D) yielded <b>123</b> as a light yellow gel (13%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.91 (s, 2H), 6.36 (s, 1H), 3.45â3.20 (m, 3H), 3.02 (t, <i>J</i> = 11.7, 1H), 2.74 (dt, <i>J</i> = 13.9, 7.9 Hz, 2H), 2.59 (s, 6H), 2.26 (s, 3H), 2.10â1.65 (m, 10H), 1.62â1.35 (m, 3H), 0.94 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.4, 139.0, 133.7, 132.1, 64.0, 49.1, 47.1, 30.9, 29.9, 23.0, 20.9, 20.8. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>35</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 379.2414, found 379.2427.</div></div><div id="sec4_133" class="NLM_sec NLM_sec_level_2"><div id="ac_i159" class="anchor-spacer"></div><h3 class="article-section__title" id="_i159"> 2,4,6-Trimethyl-<i>N</i>-(2-(4-methylpiperidin-1-yl)ethyl)benzenesulfonamide (<b>124</b>)</h3><div class="NLM_p last">Reaction of amine <b>1h</b> with 2,4,6-trimethylbenzene-1-sulfonyl chloride (Procedure A) yielded <b>124</b> as a yellow gel (>95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.91 (s, 2H), 2.86 (d, <i>J</i> = 5.2 Hz, 2H), 2.61 (s, 6H), 2.52 (d, <i>J</i> = 11.6 Hz, 2H), 2.28 (d, <i>J</i> = 5.9 Hz, 2H), 2.26 (s, 3H), 1.82 (td, <i>J</i> = 11.9, 2.6 Hz, 2H), 1.52 (d, <i>J</i> = 13.1 Hz, 2H), 1.36â1.20 (m, 1H), 1.07 (qd, <i>J</i> = 12.5, 3.7 Hz, 2H), 0.86 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.0, 139.0, 133.3, 131.8, 55.8, 53.3, 39.0, 34.2, 30.6, 22.9, 21.8, 20.9. HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>29</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 325.1944, found 325.1947.</div></div><div id="sec4_134" class="NLM_sec NLM_sec_level_2"><div id="ac_i160" class="anchor-spacer"></div><h3 class="article-section__title" id="_i160"> 1-(4-(Mesitylsulfonyl)phenyl)-4-methylpiperidine (<b>125</b>)</h3><div class="NLM_p">On the basis of a literature report,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> a mixture of 4-iodobenzenesulfonyl chloride (0.9232 g, 3.02 mmol), mesitylene (120 mg, 3.09 mmol), and AlCl<sub>3</sub> (0.4956 g, 3.73 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was stirred for 3 h at room temperature. The mixture was then poured into 45 mL of 5% aqueous HCl and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 30 mL). The combined organic layers were concentrated under reduced pressure to about 50 mL and then washed with saturated aqueous NaHCO<sub>3</sub> (45 mL) and brine (45 mL). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (10/1 hexane/EtOAc) to give the desired product 2-((4-iodophenyl)sulfonyl)-1,3,5-trimethylbenzene (0.5707 mg, 48%) as pale yellow solid. mp 118â121 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.91â7.72 (d, <i>J</i> = 8.0 Hz, 2H), 7.57â7.35 (d, <i>J</i> = 7.8 Hz, 2H), 6.93 (s, 2H), 2.56 (s, 6H), 2.27 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 143.7, 143.2, 140.0, 138.1, 133.3, 132.3, 127.6, 99.9, 22.8, 21.0.</div><div class="NLM_p last">To a solution of the above-prepared 2-((4-iodophenyl)sulfonyl)-1,3,5-trimethylbenzene (0.2879 g, 0.75 mmol), CuI (0.0145 g, 0.076 mmol), <span class="smallcaps smallerCapital">l</span>-proline (0.0176 g, 0.15 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.2160 g, 1.57 mmol) in DMSO (6 mL) was added 4-methylpiperidine (0.18 mL, 1.52 mmol), and the reaction suspension was stirred vigorously at 90 Â°C for 67 h. After cooling to room temperature, water (30 mL) was added followed by extraction with CH<sub>2</sub>Cl<sub>2</sub> (3 Ã 30 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated, and the residue was purified by flash chromatography (10/1 hexane/EtOAc) to afford the title compound <b>125</b> as a white solid (0.0636 g, 24%); mp 103â105 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.62 (d, <i>J</i> = 8.9 Hz, 2H), 6.90 (s, 2H), 6.84 (d, <i>J</i> = 8.6 Hz, 2H), 3.79 (d, <i>J</i> = 12.9 Hz, 2H), 2.84 (t, <i>J</i> = 13.4 Hz, 2H), 2.61 (s, 6H), 2.27 (s, 3H), 1.71 (d, <i>J</i> = 13.0 Hz, 2H), 1.64â1.47 (m, 1H), 1.25 (q, <i>J</i> = 12.3 Hz, 2H), 0.96 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 139.6, 135.3, 132.0, 128.2, 113.7, 48.1, 33.5, 30.7, 22.9, 21.8, 21.0. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>27</sub>NO<sub>2</sub>SNa [M + Na]<sup>+</sup> 380.1655, found 380.1660.</div></div><div id="sec4_135" class="NLM_sec NLM_sec_level_2"><div id="ac_i161" class="anchor-spacer"></div><h3 class="article-section__title" id="_i161"> 1-(Mesitylsulfonyl)-4-(1-methylpiperidin-4-yl)piperazine (<b>126</b>)</h3><div class="NLM_p last">Reaction of amine <b>1i</b> with 2,4,6-trimethylbenzenesulfonyl chloride (Procedure A) yielded <b>126</b> as a colorless gel (>95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.91 (s, 2H), 3.23â3.04 (m, 4H), 2.85 (d, <i>J</i> = 12.2 Hz, 2H), 2.59 (s, 6H), 2.57â2.48 (m, 4H), 2.26 (s, 3H), 2.22 (s, 3H), 2.22â2.15 (m, 1H), 1.89 (t, <i>J</i> = 12.0 Hz, 2H), 1.69 (d, <i>J</i> = 11.0 Hz, 2H), 1.51 (qd, <i>J</i> = 12.3, 3.9 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.5, 140.4, 131.9, 131.3, 61.4, 55.3, 48.4, 46.1, 44.7, 28.0, 23.0, 21.0. LCâMS (ESI) calcd for C<sub>19</sub>H<sub>32</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 366.2, found 366.2.</div></div><div id="sec4_136" class="NLM_sec NLM_sec_level_2"><div id="ac_i162" class="anchor-spacer"></div><h3 class="article-section__title" id="_i162"> 3-(4-(Mesitylsulfonyl)piperazin-1-yl)quinuclidine (<b>127</b>)</h3><div class="NLM_p last">Reaction of amine <b>1j</b> with 2,4,6-trimethylbenzenesulfonyl chloride (Procedure A) yielded <b>127</b> as a white solid (42%); mp > 300 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.96 (s, 2H), 3.34â3.12 (m, 9H), 3.04 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 2.60 (s, 6H), 2.45 (s, 5H), 2.30 (s, 4H), 2.16â1.95 (m, 2H), 1.85â1.75 (m, 1H), 1.74â1.62 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.8, 140.5, 132.0, 131.0, 59.1, 52.8, 50.3, 46.6, 45.6, 44.1, 23.0, 22.9, 22.1, 20.9, 17.7. HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>32</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 378.2210, found 378.2200.</div></div><div id="sec4_137" class="NLM_sec NLM_sec_level_2"><div id="ac_i163" class="anchor-spacer"></div><h3 class="article-section__title" id="_i163"> 1-(Adamantan-1-yl)-4-(mesitylsulfonyl)piperazine (<b>128</b>)</h3><div class="NLM_p last">Reaction of amine <b>1l</b> with 2,4,6-trimethylbenzene-1-sulfonyl chloride (Procedure B) yielded <b>128</b> as a yellow solid (70%); mp 182â184 Â°C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.92 (s, 2H), 3.20â3.02 (m, 4H), 2.68â2.61 (m, 4H), 2.60 (s, 6H), 2.27 (s, 3H), 2.05 (s, 3H), 1.70â1.49 (m, 14H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.4, 140.4, 131.9, 131.4, 54.0, 45.2, 43.7, 38.5, 36.8, 29.5, 23.1, 20.9. HRMS calcd for C<sub>23</sub>H<sub>35</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 403.2414, found 403.2407.</div></div><div id="sec4_138" class="NLM_sec NLM_sec_level_2"><div id="ac_i164" class="anchor-spacer"></div><h3 class="article-section__title" id="_i164"> 2,4,6-Trimethyl-<i>N</i>-(1â²-methyl-[1,4â²-bipiperidin]-4-yl)benzenesulfonamide (<b>129</b>)</h3><div class="NLM_p last">Reaction of amine hydrochloride salt <b>1m</b> with 2,4,6-trimethylbenzene-1-sulfonyl chloride (Procedure B) yielded <b>128</b> as a yellow gel (81%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.89 (s, 2H), 4.73 (s, 1H), 3.04 (s, 1H), 2.84 (d, <i>J</i> = 12.1 Hz, 2H), 2.69 (d, <i>J</i> = 12.0 Hz, 2H), 2.59 (s, 6H), 2.25 (s, 3H), 2.20 (s, 3H), 2.19â2.05 (m, 3H), 1.87 (t, <i>J</i> = 10.6 Hz, 2H), 1.76â1.59 (m, 4H), 1.50 (qd, <i>J</i> = 12.2, 3.8 Hz, 2H), 1.44â1.31 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 142.0, 138.7, 135.0, 131.9, 61.4, 55.4, 50.7, 47.6, 46.0, 33.2, 27.7, 22.9, 20.9. HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>34</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 380.2366, found 380.2359.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i165"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00532" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13748" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13748" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00532" class="ext-link">10.1021/acs.jmedchem.9b00532</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Biological assay data and SMILES structures for all tested compounds (Table S1); procedures and characterization of synthetic intermediates; and copies of <sup>1</sup>H and <sup>13</sup>C spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf">jm9b00532_si_001.pdf (17.71 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_002.csv">jm9b00532_si_002.csv (12.87 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00532" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jef K. De Brabander</span> - <span class="hlFld-Affiliation affiliation">Departments
of Biochemistry and , University
of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8816-5798" title="Orcid link">http://orcid.org/0000-0001-8816-5798</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#eea48b88c0aa8bac9c8f8c8f808a8b9caebbbabd819b9a86998b9d9a8b9c80c08b8a9b"><span class="__cf_email__" data-cfemail="236946450d674661514241424d474651637677704c56574b5446505746514d0d464756">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wentian Wang</span> - <span class="hlFld-Affiliation affiliation">Departments
of Biochemistry and , University
of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lu Zhang</span> - <span class="hlFld-Affiliation affiliation">Cell Biology and , University
of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorraine Morlock</span> - <span class="hlFld-Affiliation affiliation">Departments
of Biochemistry and , University
of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noelle S. Williams</span> - <span class="hlFld-Affiliation affiliation">Departments
of Biochemistry and , University
of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerry W. Shay</span> - <span class="hlFld-Affiliation affiliation">Cell Biology and , University
of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Jef K. De Brabander and Jerry W. Shay are scientific cofounders and hold equity in Barricade Therapeutics, Inc. whom holds the license to the TASIN compounds disclosed in this manuscript.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e13908-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i167">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Cancer Prevention and Research Institute of Texas (grants RP130189 and RP160180). J.K.D.B. acknowledges the support of the Welch Foundation (Grant I-1422). N.S.W. and the Preclinical Pharmacology Core were supported in part by institutional funds from the Institute for Innovations in Medicine. HRMS data were obtained from the Shimadzu Center for Advanced Analytical Chemistry (SCAAC) at UT Arlington. J.K.D.B. holds the Julie and Louis Beecherl, Jr., Chair in Medical Science, and J.W.S. holds the distinguished Southland Financial Corporation Chair in Geriatrics Research. The authors thank Karen MacMillan for the synthesis of select analogues.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">adenomatous polyposis coli</p></td></tr><tr><td class="NLM_term">CRC</td><td class="NLM_def"><p class="first last">colorectal cancer</p></td></tr><tr><td class="NLM_term">FAP</td><td class="NLM_def"><p class="first last">familial adenomatous polyposis</p></td></tr><tr><td class="NLM_term">HCEC</td><td class="NLM_def"><p class="first last">human colonic epithelial cell</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screen</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">TASIN</td><td class="NLM_def"><p class="first last">truncated APC-selective inhibitor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i169">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><a href="https://seer.cancer.gov/statfacts/html/colorect.html" class="extLink">https://seer.cancer.gov/statfacts/html/colorect.html</a> (accessed March 26, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fseer.cancer.gov%2Fstatfacts%2Fhtml%2Fcolorect.html+%28accessed+March+26%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troiani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitiello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sforza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napolitano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Corte, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgillo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuomo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaggi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, E.</span></span> <span> </span><span class="NLM_article-title">Present and future of metastatic colorectal cancer treatment: A review of new candidate targets</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4675</span>â <span class="NLM_lpage">4688</span>, <span class="refDoi">Â DOI: 10.3748/wjg.v23.i26.4675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.3748%2Fwjg.v23.i26.4675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=28765689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFKqtr3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=4675-4688&author=G.+Martiniauthor=T.+Troianiauthor=C.+Cardoneauthor=P.+Vitielloauthor=V.+Sforzaauthor=D.+Ciardielloauthor=S.+Napolitanoauthor=C.+M.+Della+Corteauthor=F.+Morgilloauthor=A.+Raucciauthor=A.+Cuomoauthor=F.+Selvaggiauthor=F.+Ciardielloauthor=E.+Martinelli&title=Present+and+future+of+metastatic+colorectal+cancer+treatment%3A+A+review+of+new+candidate+targets&doi=10.3748%2Fwjg.v23.i26.4675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Present and future of metastatic colorectal cancer treatment: a review of new candidate targets</span></div><div class="casAuthors">Martini, Giulia; Troiani, Teresa; Cardone, Claudia; Vitiello, Pietropaolo; Sforza, Vincenzo; Ciardiello, Davide; Napolitano, Stefania; Della Corte, Carminia Maria; Morgillo, Floriana; Raucci, Antonio; Cuomo, Antonio; Selvaggi, Francesco; Ciardiello, Fortunato; Martinelli, Erika</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4675-4688</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">2219-2840</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Inc.</span>)
        </div><div class="casAbstract">In the last two decades, great efforts have been made in the treatment of metastatic colorectal cancer (mCRC) due to the approval of new target agents for cytotoxic drugs.  Unfortunately, a large percentage of patients present with metastasis at the time of diagnosis or relapse after a few months.  The complex mol. heterogeneity of this disease is not completely understood; to date, there is a lack of predictive biomarkers that can be used to select subsets of patients who may respond to target drugs.  Only the RAS-mutation status is used to predict resistance to anti-epidermal growth factor receptor agents in patients with mCRC.  In this review, we describe approved targeted therapies for the management of metastatic mCRC and discuss new candidate targets on the horizon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIFbSUzrvLq7Vg90H21EOLACvtfcHk0ljb76kjJd7edg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFKqtr3P&md5=a8f3a8bb8854b11ca2b65cff461bf0b3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v23.i26.4675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v23.i26.4675%26sid%3Dliteratum%253Aachs%26aulast%3DMartini%26aufirst%3DG.%26aulast%3DTroiani%26aufirst%3DT.%26aulast%3DCardone%26aufirst%3DC.%26aulast%3DVitiello%26aufirst%3DP.%26aulast%3DSforza%26aufirst%3DV.%26aulast%3DCiardiello%26aufirst%3DD.%26aulast%3DNapolitano%26aufirst%3DS.%26aulast%3DDella%2BCorte%26aufirst%3DC.%2BM.%26aulast%3DMorgillo%26aufirst%3DF.%26aulast%3DRaucci%26aufirst%3DA.%26aulast%3DCuomo%26aufirst%3DA.%26aulast%3DSelvaggi%26aufirst%3DF.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DMartinelli%26aufirst%3DE.%26atitle%3DPresent%2520and%2520future%2520of%2520metastatic%2520colorectal%2520cancer%2520treatment%253A%2520A%2520review%2520of%2520new%2520candidate%2520targets%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2017%26volume%3D23%26spage%3D4675%26epage%3D4688%26doi%3D10.3748%2Fwjg.v23.i26.4675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarotra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhi, B.</span></span> <span> </span><span class="NLM_article-title">Current status of pharmacological treatment of colorectal cancer</span>. <i>World J. Gastrointest. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">177</span>â <span class="NLM_lpage">183</span>, <span class="refDoi">Â DOI: 10.4251/wjgo.v6.i6.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.4251%2Fwjgo.v6.i6.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=24936228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A280%3ADC%252BC2cfjtFyrtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=177-183&author=R.+Akhtarauthor=S.+Chandelauthor=P.+Sarotraauthor=B.+Medhi&title=Current+status+of+pharmacological+treatment+of+colorectal+cancer&doi=10.4251%2Fwjgo.v6.i6.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Current status of pharmacological treatment of colorectal cancer</span></div><div class="casAuthors">Akhtar Reyhan; Chandel Shammy; Sarotra Pooja; Medhi Bikash</div><div class="citationInfo"><span class="NLM_cas:title">World journal of gastrointestinal oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">177-83</span>
        ISSN:<span class="NLM_cas:issn">1948-5204</span>.
    </div><div class="casAbstract">AIM:  To review the clinical trials for the development in drugs for chemotherapeutic treatment of colorectal cancer (CRC).  METHODS:  A systematic review identified randomized controlled trials (RCTs) assessing drugs for the treatment of CRC or adenomatous polyps from www.clinicaltrials.gov.  Various online medical databases were searched for relevant publications.  RESULTS:  Combination treatment regimens of standard drugs with newer agents have been shown to improve overall survival, disease-free survival, time to progression and quality of life compared to that with standard drugs alone in patients with advanced colorectal cancer.  The FOLFOXIRI regimen has been associated with a significantly higher response rate, progression-free survival and overall survival compared to the FOLFIRI regimen.  CONCLUSION:  Oxaliplatin plus intravenous bolus fluorouracil and leucovorin has been shown to be superior for disease-free survival when compared to intravenous bolus fluorouracil and leucovorin.  In addition, oxaliplatin regimens were more likely to result in successful surgical resections.  First line treatment with cetuximab plus fluorouracil, leucovorin and irinotecan has been found to reduce the risk of metastatic progression in patients with epidermal growth factor receptor-positive colorectal cancer with unresectable metastases.  The addition of bevacizumab has been shown to significantly increase overall and progression-free survival when given in combination with standard therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6-zoVGkAq_kNoizSOkG_FfW6udTcc2eaDri1dq0ACAbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfjtFyrtg%253D%253D&md5=c85509e051b1a856392251d8ce922219</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4251%2Fwjgo.v6.i6.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4251%252Fwjgo.v6.i6.177%26sid%3Dliteratum%253Aachs%26aulast%3DAkhtar%26aufirst%3DR.%26aulast%3DChandel%26aufirst%3DS.%26aulast%3DSarotra%26aufirst%3DP.%26aulast%3DMedhi%26aufirst%3DB.%26atitle%3DCurrent%2520status%2520of%2520pharmacological%2520treatment%2520of%2520colorectal%2520cancer%26jtitle%3DWorld%2520J.%2520Gastrointest.%2520Oncol.%26date%3D2014%26volume%3D6%26spage%3D177%26epage%3D183%26doi%3D10.4251%2Fwjgo.v6.i6.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriarity, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâSullivan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehigan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, P.</span></span> <span> </span><span class="NLM_article-title">Current targeted therapies in the treatment of advanced colorectal cancer: a review</span>. <i>Ther. Adv. Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">276</span>â <span class="NLM_lpage">293</span>, <span class="refDoi">Â DOI: 10.1177/1758834016646734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1177%2F1758834016646734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=27482287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOrsLzM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=276-293&author=A.+Moriarityauthor=J.+O%E2%80%99Sullivanauthor=J.+Kennedyauthor=B.+Mehiganauthor=P.+McCormick&title=Current+targeted+therapies+in+the+treatment+of+advanced+colorectal+cancer%3A+a+review&doi=10.1177%2F1758834016646734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Current targeted therapies in the treatment of advanced colorectal cancer: a review</span></div><div class="casAuthors">Moriarity, Andrew; O'Sullivan, Jacintha; Kennedy, John; Mehigan, Brian; McCormick, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Medical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">276-293</span>CODEN:
                <span class="NLM_cas:coden">TAMOB8</span>;
        ISSN:<span class="NLM_cas:issn">1758-8340</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Treatment strategies for metastatic colorectal cancer (mCRC) patients have undergone dramatic changes in the past decade and despite improved patient outcomes, there still exist areas for continued development.  The introduction of targeted agents has provided clinicians with addnl. treatment options in mCRC, however, results have been mixed at best.  These novel therapies were designed to interfere with specific mols. involved in the cellular carcinogenesis pathway and ultimately deliver a more focused treatment.  Currently, their use in mCRC has been limited primarily as an adjunct to conventional chemotherapy regimens.  This review explores the relevant cell-signaling networks in colorectal cancer, provides focus on the current targeted agent armamentarium approved for use in mCRC and explores the usefulness of predictive mCRC biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryzFnB9lz3w7Vg90H21EOLACvtfcHk0ljb76kjJd7edg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOrsLzM&md5=f54766897f176a287bf324296a4abe36</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1177%2F1758834016646734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1758834016646734%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarity%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DJ.%26aulast%3DMehigan%26aufirst%3DB.%26aulast%3DMcCormick%26aufirst%3DP.%26atitle%3DCurrent%2520targeted%2520therapies%2520in%2520the%2520treatment%2520of%2520advanced%2520colorectal%2520cancer%253A%2520a%2520review%26jtitle%3DTher.%2520Adv.%2520Med.%2520Oncol.%26date%3D2016%26volume%3D8%26spage%3D276%26epage%3D293%26doi%3D10.1177%2F1758834016646734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamlum, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilyas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straub, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bicknell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodmer, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, I. P. M.</span></span> <span> </span><span class="NLM_article-title"><i>APC</i> mutations in sporadic colorectal tumors: A mutational âhotspotâ and interdependence of the âtwo hitsâ</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">3352</span>â <span class="NLM_lpage">3357</span>, <span class="refDoi">Â DOI: 10.1073/pnas.97.7.3352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1073%2Fpnas.97.7.3352" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=3352-3357&author=A.+J.+Rowanauthor=H.+Lamlumauthor=M.+Ilyasauthor=J.+Wheelerauthor=J.+Straubauthor=A.+Papadopoulouauthor=D.+Bicknellauthor=W.+F.+Bodmerauthor=I.+P.+M.+Tomlinson&title=APC+mutations+in+sporadic+colorectal+tumors%3A+A+mutational+%E2%80%9Chotspot%E2%80%9D+and+interdependence+of+the+%E2%80%9Ctwo+hits%E2%80%9D&doi=10.1073%2Fpnas.97.7.3352"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.7.3352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.7.3352%26sid%3Dliteratum%253Aachs%26aulast%3DRowan%26aufirst%3DA.%2BJ.%26aulast%3DLamlum%26aufirst%3DH.%26aulast%3DIlyas%26aufirst%3DM.%26aulast%3DWheeler%26aufirst%3DJ.%26aulast%3DStraub%26aufirst%3DJ.%26aulast%3DPapadopoulou%26aufirst%3DA.%26aulast%3DBicknell%26aufirst%3DD.%26aulast%3DBodmer%26aufirst%3DW.%2BF.%26aulast%3DTomlinson%26aufirst%3DI.%2BP.%2BM.%26atitle%3DAPC%2520mutations%2520in%2520sporadic%2520colorectal%2520tumors%253A%2520A%2520mutational%2520%25E2%2580%259Chotspot%25E2%2580%259D%2520and%2520interdependence%2520of%2520the%2520%25E2%2580%259Ctwo%2520hits%25E2%2580%259D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D3352%26epage%3D3357%26doi%3D10.1073%2Fpnas.97.7.3352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nieuwenhuis, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasen, H. F. A.</span></span> <span> </span><span class="NLM_article-title">Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature</span>. <i>Crit. Rev. Oncol. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">153</span>â <span class="NLM_lpage">161</span>, <span class="refDoi">Â DOI: 10.1016/j.critrevonc.2006.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2Fj.critrevonc.2006.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=17064931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FisVyqsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=153-161&author=M.+H.+Nieuwenhuisauthor=H.+F.+A.+Vasen&title=Correlations+between+mutation+site+in+APC+and+phenotype+of+familial+adenomatous+polyposis+%28FAP%29%3A+A+review+of+the+literature&doi=10.1016%2Fj.critrevonc.2006.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature</span></div><div class="casAuthors">Nieuwenhuis M H; Vasen H F A</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-61</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Mutations in the adenomatous polyposis coli (APC) gene cause familial adenomatous polyposis (FAP).  Disease severity and the presence of extracolonic manifestations seem to be correlated with the location of the mutation on the APC gene.  In this review, large studies describing genotype-phenotype correlations in FAP were evaluated and categorized.  Attenuated FAP (AFAP, <100 colorectal adenomas) is correlated with mutations before codon 157, after codon 1595 and in the alternatively spliced region of exon 9.  Severe polyposis (>1000 adenomas) is found in patients with mutations between codons 1250 and 1464.  Mutations in the remainder of the APC gene cause an intermediate phenotype (hundred to thousands of adenomas).  Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and desmoid tumours are associated with mutations between codons 311 and 1444 and after codon 1444, respectively.  No consistent correlations were found for upper gastrointestinal tumours.  Genotype-phenotype correlations in FAP will be useful in decisions concerning screening and surgical management of FAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRB1GvNhTlKxz0SWnHPWbmmfW6udTcc2eYy8AqUp1A44bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FisVyqsQ%253D%253D&md5=a0dff62b01ce2052bf275dfbd34ad6a3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2006.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2006.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DNieuwenhuis%26aufirst%3DM.%2BH.%26aulast%3DVasen%26aufirst%3DH.%2BF.%2BA.%26atitle%3DCorrelations%2520between%2520mutation%2520site%2520in%2520APC%2520and%2520phenotype%2520of%2520familial%2520adenomatous%2520polyposis%2520%2528FAP%2529%253A%2520A%2520review%2520of%2520the%2520literature%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2007%26volume%3D61%26spage%3D153%26epage%3D161%26doi%3D10.1016%2Fj.critrevonc.2006.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamlum, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilyas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frayling, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efstathiou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pack, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roylance, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodmer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, I.</span></span> <span> </span><span class="NLM_article-title">The type of somatic mutation at <i>APC</i> in familial adenomatous polyposis is determined by the site of the germline mutation: A new facet to Knudsonâs âtwo-hitâ hypothesis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1071</span>â <span class="NLM_lpage">1075</span>, <span class="refDoi">Â DOI: 10.1038/12511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1038%2F12511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10470088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaK1MXlslKltrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=1071-1075&author=H.+Lamlumauthor=M.+Ilyasauthor=A.+Rowanauthor=S.+Clarkauthor=V.+Johnsonauthor=J.+Bellauthor=I.+Fraylingauthor=J.+Efstathiouauthor=K.+Packauthor=S.+Payneauthor=R.+Roylanceauthor=P.+Gormanauthor=D.+Sheerauthor=K.+Nealeauthor=R.+Phillipsauthor=I.+Talbotauthor=W.+Bodmerauthor=I.+Tomlinson&title=The+type+of+somatic+mutation+at+APC+in+familial+adenomatous+polyposis+is+determined+by+the+site+of+the+germline+mutation%3A+A+new+facet+to+Knudson%E2%80%99s+%E2%80%98two-hit%E2%80%99+hypothesis&doi=10.1038%2F12511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis</span></div><div class="casAuthors">Lamlum, Hanan; Ilyas, Mohammad; Rowan, Andrew; Clark, Susan; Johnson, Victoria; Bell, Jennie; Frayling, Ian; Efstathiou, Jason; Pack, Kevin; Payne, Stewart; Roylance, Rebecca; Gorman, Patricia; Sheer, Denise; Neale, Kay; Phillips, Robin; Talbot, Ian; Bodmer, Walter; Tomlinson, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1071-1075</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">APC is often cited as a prime example of a tumor suppressor gene.  Truncating germline and somatic mutations (or, infrequently, allelic loss) occur in tumors in FAP (familial adenomatous polyposis).  Most sporadic colorectal cancers also have two APC mutations.  Clues from attenuated polyposis, missense germline variants with mild disease and the somatic mutation cluster region (codons 1250-1450) indicate, however, that APC mutations might not result in simple loss of protein function.  We have found that FAP patients with germline APC mutations within a small region (codons 1194-1392 at most) mainly show allelic loss in their colorectal adenomas, in contrast to other FAP patients, whose 'second hits' tend to occur by truncating mutations in the mutation cluster region.  Our results indicate that different APC mutations provide cells with different selective advantages, with mutations close to codon 1300 providing the greatest advantage.  Allelic loss is selected strongly in cells with one mutation near codon 1300.  A different germline-somatic APC mutation assocn. exists in FAP desmoids.  APC is not, therefore, a classical tumor suppressor.  Our findings also indicate a new mechanism for disease severity: if a broader spectrum of mutations is selected in tumors, the somatic mutation rate is effectively higher and more tumors grow.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKHZNlufH_vbVg90H21EOLACvtfcHk0lhyvIZ10uoMCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslKltrk%253D&md5=de7284c5d97bb8115a1430b9100dc290</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F12511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F12511%26sid%3Dliteratum%253Aachs%26aulast%3DLamlum%26aufirst%3DH.%26aulast%3DIlyas%26aufirst%3DM.%26aulast%3DRowan%26aufirst%3DA.%26aulast%3DClark%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DV.%26aulast%3DBell%26aufirst%3DJ.%26aulast%3DFrayling%26aufirst%3DI.%26aulast%3DEfstathiou%26aufirst%3DJ.%26aulast%3DPack%26aufirst%3DK.%26aulast%3DPayne%26aufirst%3DS.%26aulast%3DRoylance%26aufirst%3DR.%26aulast%3DGorman%26aufirst%3DP.%26aulast%3DSheer%26aufirst%3DD.%26aulast%3DNeale%26aufirst%3DK.%26aulast%3DPhillips%26aufirst%3DR.%26aulast%3DTalbot%26aufirst%3DI.%26aulast%3DBodmer%26aufirst%3DW.%26aulast%3DTomlinson%26aufirst%3DI.%26atitle%3DThe%2520type%2520of%2520somatic%2520mutation%2520at%2520APC%2520in%2520familial%2520adenomatous%2520polyposis%2520is%2520determined%2520by%2520the%2520site%2520of%2520the%2520germline%2520mutation%253A%2520A%2520new%2520facet%2520to%2520Knudson%25E2%2580%2599s%2520%25E2%2580%2598two-hit%25E2%2580%2599%2520hypothesis%26jtitle%3DNat.%2520Med.%26date%3D1999%26volume%3D5%26spage%3D1071%26epage%3D1075%26doi%3D10.1038%2F12511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poiwell, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zilz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beazer-Barclay, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibodeau, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span> <span> </span><span class="NLM_article-title">APC mutations occur early during colorectal tumorigenesis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">235</span>â <span class="NLM_lpage">237</span>, <span class="refDoi">Â DOI: 10.1038/359235a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1038%2F359235a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1992&pages=235-237&author=S.+M.+Poiwellauthor=N.+Zilzauthor=Y.+Beazer-Barclayauthor=T.+M.+Bryanauthor=S.+R.+Hamiltonauthor=S.+N.+Thibodeauauthor=B.+Vogelsteinauthor=K.+W.+Kinzler&title=APC+mutations+occur+early+during+colorectal+tumorigenesis&doi=10.1038%2F359235a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F359235a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F359235a0%26sid%3Dliteratum%253Aachs%26aulast%3DPoiwell%26aufirst%3DS.%2BM.%26aulast%3DZilz%26aufirst%3DN.%26aulast%3DBeazer-Barclay%26aufirst%3DY.%26aulast%3DBryan%26aufirst%3DT.%2BM.%26aulast%3DHamilton%26aufirst%3DS.%2BR.%26aulast%3DThibodeau%26aufirst%3DS.%2BN.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DAPC%2520mutations%2520occur%2520early%2520during%2520colorectal%2520tumorigenesis%26jtitle%3DNature%26date%3D1992%26volume%3D359%26spage%3D235%26epage%3D237%26doi%3D10.1038%2F359235a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span> <span> </span><span class="NLM_article-title">A genetic model for colorectal tumorigenesis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">759</span>â <span class="NLM_lpage">767</span>, <span class="refDoi">Â DOI: 10.1016/0092-8674(90)90186-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2F0092-8674%2890%2990186-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=2188735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaK3cXktlyhtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1990&pages=759-767&author=E.+R.+Fearonauthor=B.+Vogelstein&title=A+genetic+model+for+colorectal+tumorigenesis&doi=10.1016%2F0092-8674%2890%2990186-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A genetic model for colorectal tumorigenesis</span></div><div class="casAuthors">Fearon, Eric R.; Vogelstein, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">759-67</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A review with 76 refs. on various genetic aspects of colonic neoplasia, including genetic alterations of oncogenes, clonal selection, allelic losses and tumor suppressor genes, multiple allelic losses, and accumulation and multistep tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe4CC_sLtNt7Vg90H21EOLACvtfcHk0ljwuGIGtWKO3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlyhtrg%253D&md5=d88588a58ce05a327c3e7ff8afccd3a7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2890%2990186-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252890%252990186-I%26sid%3Dliteratum%253Aachs%26aulast%3DFearon%26aufirst%3DE.%2BR.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DA%2520genetic%2520model%2520for%2520colorectal%2520tumorigenesis%26jtitle%3DCell%26date%3D1990%26volume%3D61%26spage%3D759%26epage%3D767%26doi%3D10.1016%2F0092-8674%2890%2990186-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taketo, M. M.</span></span> <span> </span><span class="NLM_article-title">Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">3327</span>â <span class="NLM_lpage">3335</span>, <span class="refDoi">Â DOI: 10.1242/jcs.03485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1242%2Fjcs.03485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=17881494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ygtbfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=3327-3335&author=K.+Aokiauthor=M.+M.+Taketo&title=Adenomatous+polyposis+coli+%28APC%29%3A+a+multi-functional+tumor+suppressor+gene&doi=10.1242%2Fjcs.03485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene</span></div><div class="casAuthors">Aoki, Koji; Taketo, Makoto M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3327-3335</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  The adenomatous polyposis coli (APC) gene is a key tumor suppressor gene.  Mutations in the gene were found not only in most colon cancers but also in some other cancers, such as those of the liver.  The APC gene product is a 312 kDa protein that has multiple domains, through which it binds to various proteins, including Î²-catenin, axin, CtBP, Asefs, IQGAP1, EB1 and microtubules.  Studies using mutant mice and cultured cells have demonstrated that APC suppresses canonical Wnt signaling, which is essential for tumorigenesis, development and homeostasis of a variety of cell types, such as epithelial and lymphoid cells.  Further studies have suggested that APC plays roles in several other fundamental cellular processes.  These include cell adhesion and migration, organization of the actin and microtubule networks, spindle formation and chromosome segregation.  Deregulation of these processes caused by mutations in APC is implicated in the initiation and expansion of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw1-zJvwW4abVg90H21EOLACvtfcHk0ljwuGIGtWKO3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ygtbfJ&md5=1be7d62111279782a9a5ac69d357b543</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1242%2Fjcs.03485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.03485%26sid%3Dliteratum%253Aachs%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DTaketo%26aufirst%3DM.%2BM.%26atitle%3DAdenomatous%2520polyposis%2520coli%2520%2528APC%2529%253A%2520a%2520multi-functional%2520tumor%2520suppressor%2520gene%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2007%26volume%3D120%26spage%3D3327%26epage%3D3335%26doi%3D10.1242%2Fjcs.03485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronobis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulton, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peifer, M.</span></span> <span> </span><span class="NLM_article-title">Deconstructing the Î²-catenin destruction complex: Mechanistic roles for the tumor suppressor APC in regulating Wnt signaling</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1845</span>â <span class="NLM_lpage">1863</span>, <span class="refDoi">Â DOI: 10.1091/mbc.e10-11-0871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1091%2Fmbc.e10-11-0871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=21471006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFKktbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1845-1863&author=D.+M.+Robertsauthor=M.+I.+Pronobisauthor=J.+S.+Poultonauthor=J.+D.+Waldmannauthor=E.+M.+Stephensonauthor=S.+Hannaauthor=M.+Peifer&title=Deconstructing+the+%CE%B2-catenin+destruction+complex%3A+Mechanistic+roles+for+the+tumor+suppressor+APC+in+regulating+Wnt+signaling&doi=10.1091%2Fmbc.e10-11-0871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Deconstructing the sscatenin destruction complex: mechanistic roles for the tumor suppressor APC in regulating Wnt signaling</span></div><div class="casAuthors">Roberts, David M.; Pronobis, Mira I.; Poulton, John S.; Waldmann, Jon D.; Stephenson, Elise M.; Hanna, Shahnaz; Peifer, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1845-1863</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Neg. regulating signaling by targeting key effectors for ubiquitination/destruction is essential for development and oncogenesis.  The tumor suppressor adenomatous polyposis coli (APC), an essential neg. regulator of Wnt signaling, provides a paradigm.  APC mutations occur in most colon cancers.  Acting in the "destruction complex" with Axin, glycogen synthase kinase 3, and casein kinase, APC targets Î²-catenin (Î²cat) for phosphorylation and recognition by an E3 ubiquitin-ligase.  Despite 20 years of work, the internal workings of the destruction complex and APC's role remain largely mysterious.  We use both Drosophila and colon cancer cells to test hypotheses for APC's mechanism of action.  Our data are inconsistent with current models suggesting that high-affinity Î²cat-binding sites on APC play key roles.  Instead, they suggest that multiple Î²cat-binding sites act additively to fine-tune signaling via cytoplasmic retention.  We identify essential roles for two putative binding sites for new partners-20-amino-acid repeat 2 and conserved sequence B-in destruction complex action.  Finally, we demonstrate that APC interacts with Axin by two different modes and provide evidence that conserved sequence B helps ensure release of APC from Axin, with disassembly crit. in regulating sscat levels.  Using these data, we suggest a new model for destruction complex action in development, which also provides new insights into functions of truncated APC proteins in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq75g7oED20UbVg90H21EOLACvtfcHk0ljwuGIGtWKO3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFKktbY%253D&md5=9710e65791db974fce7f072b2bc01b0f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e10-11-0871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e10-11-0871%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DD.%2BM.%26aulast%3DPronobis%26aufirst%3DM.%2BI.%26aulast%3DPoulton%26aufirst%3DJ.%2BS.%26aulast%3DWaldmann%26aufirst%3DJ.%2BD.%26aulast%3DStephenson%26aufirst%3DE.%2BM.%26aulast%3DHanna%26aufirst%3DS.%26aulast%3DPeifer%26aufirst%3DM.%26atitle%3DDeconstructing%2520the%2520%25CE%25B2-catenin%2520destruction%2520complex%253A%2520Mechanistic%2520roles%2520for%2520the%2520tumor%2520suppressor%2520APC%2520in%2520regulating%2520Wnt%2520signaling%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2011%26volume%3D22%26spage%3D1845%26epage%3D1863%26doi%3D10.1091%2Fmbc.e10-11-0871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
de Wetering, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sancho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lau, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oving, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurlstone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Horn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batlle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudreuse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haramis, A.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjon-Pon-Fong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moerer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Born, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soete, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pals, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">The Î²-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">241</span>â <span class="NLM_lpage">250</span>, <span class="refDoi">Â DOI: 10.1016/S0092-8674(02)01014-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2FS0092-8674%2802%2901014-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=12408868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotlahsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2002&pages=241-250&author=M.+van%0Ade+Weteringauthor=E.+Sanchoauthor=C.+Verweijauthor=W.+de+Lauauthor=I.+Ovingauthor=A.+Hurlstoneauthor=K.+van+der+Hornauthor=E.+Batlleauthor=D.+Coudreuseauthor=A.-P.+Haramisauthor=M.+Tjon-Pon-Fongauthor=P.+Moererauthor=M.+van+den+Bornauthor=G.+Soeteauthor=S.+Palsauthor=M.+Eilersauthor=R.+Medemaauthor=H.+Clevers&title=The+%CE%B2-catenin%2FTCF-4+complex+imposes+a+crypt+progenitor+phenotype+on+colorectal+cancer+cells&doi=10.1016%2FS0092-8674%2802%2901014-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Î²-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells</span></div><div class="casAuthors">Van de Wetering, Marc; Sancho, Elena; Verweij, Cornelis; De Lau, Wim; Oving, Irma; Hurlstone, Adam; Van der Horn, Karin; Batlle, Eduard; Coudreuse, Damien; Haramis, Anna-Pavlina; Tjon-Pon-Fong, Menno; Moerer, Petra; Van den Born, Maaike; Soete, Gwen; Pals, Steven; Eilers, Martin; Medema, Rene; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-250</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The transactivation of TCF target genes induced by Wnt pathway mutations constitutes the primary transforming event in colorectal cancer (CRC).  The authors show that disruption of Î²-catenin/TCF-4 activity in CRC cells induces a rapid G1 arrest and blocks a genetic program that is physiol. active in the proliferative compartment of colon crypts.  Coincidently, an intestinal differentiation program is induced.  The TCF-4 target gene c-MYC plays a central role in this switch by direct repression of the p21CIP1/WAF1 promoter.  Following disruption of Î²-catenin/TCF-4 activity, the decreased expression of c-MYC releases p21CIP1/WAF1 transcription, which in turn mediates G1 arrest and differentiation.  Thus, the Î²-catenin/TCF-4 complex constitutes the master switch that controls proliferation vs. differentiation in healthy and malignant intestinal epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVqLagkm3jcLVg90H21EOLACvtfcHk0lgNMH1tnkJ3AQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotlahsrg%253D&md5=d3b611aa88ba8ea40d333774f844038e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2901014-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252901014-0%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BWetering%26aufirst%3DM.%26aulast%3DSancho%26aufirst%3DE.%26aulast%3DVerweij%26aufirst%3DC.%26aulast%3Dde%2BLau%26aufirst%3DW.%26aulast%3DOving%26aufirst%3DI.%26aulast%3DHurlstone%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BHorn%26aufirst%3DK.%26aulast%3DBatlle%26aufirst%3DE.%26aulast%3DCoudreuse%26aufirst%3DD.%26aulast%3DHaramis%26aufirst%3DA.-P.%26aulast%3DTjon-Pon-Fong%26aufirst%3DM.%26aulast%3DMoerer%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BBorn%26aufirst%3DM.%26aulast%3DSoete%26aufirst%3DG.%26aulast%3DPals%26aufirst%3DS.%26aulast%3DEilers%26aufirst%3DM.%26aulast%3DMedema%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DThe%2520%25CE%25B2-catenin%252FTCF-4%2520complex%2520imposes%2520a%2520crypt%2520progenitor%2520phenotype%2520on%2520colorectal%2520cancer%2520cells%26jtitle%3DCell%26date%3D2002%26volume%3D111%26spage%3D241%26epage%3D250%26doi%3D10.1016%2FS0092-8674%2802%2901014-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goss, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groden, J.</span></span> <span> </span><span class="NLM_article-title">Biology of the adenomatous polyposis coli tumor suppressor</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1967</span>â <span class="NLM_lpage">1979</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2000.18.9.1967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1200%2FJCO.2000.18.9.1967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10784639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A280%3ADC%252BD3c3ksleltg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=1967-1979&author=K.+H.+Gossauthor=J.+Groden&title=Biology+of+the+adenomatous+polyposis+coli+tumor+suppressor&doi=10.1200%2FJCO.2000.18.9.1967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Biology of the adenomatous polyposis coli tumor suppressor</span></div><div class="casAuthors">Goss K H; Groden J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1967-79</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">The adenomatous polyposis coli (APC) gene was first identified as the gene mutated in an inherited syndrome of colon cancer predisposition known as familial adenomatous polyposis coli (FAP).  Mutation of APC is also found in 80% of all colorectal adenomas and carcinomas and is one of the earliest mutations in colon cancer progression.  Similar to other tumor suppressor genes, both APC alleles are inactivated by mutation in colon tumors, resulting in the loss of full-length protein in tumor cells.  The functional significance of altering APC is the dysregulation of several physiologic processes that govern colonic epithelial cell homeostasis, which include cell cycle progression, migration, differentiation, and apoptosis.  Roles for APC in some of these processes are in large part attributable to its ability to regulate cytosolic levels of the signaling molecule beta-catenin and to affect the transcriptional profile in cells.  This article summarizes numerous genetic, biochemical, and cell biologic studies on the mechanisms of APC-mediated tumor suppression.  Mouse models of FAP, in which the APC gene has been genetically inactivated, have been particularly useful in testing therapeutic and chemopreventive strategies.  These data have significant implications for colorectal cancer treatment approaches as well as for understanding other disease genes and cancers of other tissue types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8oLHgrmJuaub6AVA-44PTfW6udTcc2ebu1NS8IX60gbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3ksleltg%253D%253D&md5=53c1a322d859e7b01392265426fa99b4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1200%2FJCO.2000.18.9.1967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2000.18.9.1967%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DK.%2BH.%26aulast%3DGroden%26aufirst%3DJ.%26atitle%3DBiology%2520of%2520the%2520adenomatous%2520polyposis%2520coli%2520tumor%2520suppressor%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2000%26volume%3D18%26spage%3D1967%26epage%3D1979%26doi%3D10.1200%2FJCO.2000.18.9.1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span> <span> </span><span class="NLM_article-title">The adenomatous polyposis coli (APC) tumor suppressor</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1332</i></span>,  <span class="NLM_fpage">F127</span>â <span class="NLM_lpage">F147</span>, <span class="refDoi">Â DOI: 10.1016/S0304-419X(97)00008-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2FS0304-419X%2897%2900008-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=9196022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlWgsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1332&publication_year=1997&pages=F127-F147&author=P.+Polakis&title=The+adenomatous+polyposis+coli+%28APC%29+tumor+suppressor&doi=10.1016%2FS0304-419X%2897%2900008-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The adenomatous polyposis coli (APC) tumor suppressor</span></div><div class="casAuthors">Polakis, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1332</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">F127-F148</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 149 refs.  Defects in the APC gene are inarguably linked to the progression of colon cancers that arise both sporadically and through the transmission of germline mutations.  Genetic evidence from humans and mouse models suggest that APC is a classic tumor suppressor in that both alleles likely require inactivation for tumor growth to ensue.  Nearly all of the mutations, germline and somatic, result in premature termination of the single polypeptide chain, normally consisting of 2843 amino acids.  Several definable motifs have now been mapped to the linear amino acid sequence of the APC polypeptide.  These include an oligomerization domain, armadillo repeats, binding sites for Î²-catenin, the human disks large protein, microtubules, and other proteins of unknown function.  Inactivation of APC in cancer is likely due to loss of function(s) normally assocd. with the deleted protein structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoawqiOHp4e7LVg90H21EOLACvtfcHk0lgNMH1tnkJ3AQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlWgsr4%253D&md5=6987765aef43d416e4bd482418048d4f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0304-419X%2897%2900008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-419X%252897%252900008-5%26sid%3Dliteratum%253Aachs%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DThe%2520adenomatous%2520polyposis%2520coli%2520%2528APC%2529%2520tumor%2520suppressor%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D1997%26volume%3D1332%26spage%3DF127%26epage%3DF147%26doi%3D10.1016%2FS0304-419X%2897%2900008-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagse, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horii, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span> <span> </span><span class="NLM_article-title">Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the <i>APC</i> gene</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">229</span>â <span class="NLM_lpage">233</span>, <span class="refDoi">Â DOI: 10.1093/hmg/1.4.229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1093%2Fhmg%2F1.4.229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1338904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaK38XlsVyhurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1992&pages=229-233&author=Y.+Moriauthor=H.+Nagseauthor=H.+Andoauthor=A.+Horiiauthor=S.+Ichiiauthor=S.+Nakatsuruauthor=T.+Aokiauthor=Y.+Mikiauthor=T.+Moriauthor=Y.+Nakamura&title=Somatic+mutations+of+the+APC+gene+in+colorectal+tumors%3A+Mutation+cluster+region+in+the+APC+gene&doi=10.1093%2Fhmg%2F1.4.229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations of the APC gene in colorectal tumors:  mutation cluster region in the APC gene</span></div><div class="casAuthors">Miyoshi, Yasuo; Nagase, Hiroki; Ando, Hiroshi; Horii, Akira; Ichii, Shigetoshi; Nakatsuru, Shuichi; Aoki, Takahisa; Miki, Yoshio; Mori, Takesada; Nakamura, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">229-33</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    </div><div class="casAbstract">This study examd. somatic mutations of the adenomatous polyposis coli (APC) gene in 63 colorectal tumors (16 adenomas and 47 carcinomas) developed in familial adenomatous polyposis (FAP) and non-FAP patients.  In addn. to loss of heterozygosity (LOH) at the APC locus in 30 tumors, 43 other somatic mutations were detected.  Twenty-one of them were point mutations; 16 nonsense and two missense mutations, and three occurred in introns at the splicing site.  Twenty-two tumors had frameshift mutations due to deletion or insertion; nineteen of them were deletions of one to 31 bp and three were a 1-bp insertion.  One tumor had a 1-bp deletion in an intron near the splicing site.  Hence, 41 (95%) of 43 mutations resulted in truncation of the APC protein.  Over 60% of the somatic mutations in the APC gene were clustered within a small region of exon 15, designated as MCR (mutation cluster region), which accounted for less than 10% of the coding region.  Combining these data and the results of LOH, more than 80% of tumors (14 adenomas and 39 carcinomas) had at least one mutation in the APC gene, of which more than 60% (9 adenomas and 23 carcinomas) had two mutations.  These results strongly suggest that somatic mutations of the APC gene are assocd. with development of a great majority of colorectal tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1_TFSQZ0goLVg90H21EOLACvtfcHk0lj_XTqLFfIkTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlsVyhurc%253D&md5=b999a51d316f9a2b6e9e438cef0237bc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F1.4.229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F1.4.229%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DY.%26aulast%3DNagse%26aufirst%3DH.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DHorii%26aufirst%3DA.%26aulast%3DIchii%26aufirst%3DS.%26aulast%3DNakatsuru%26aufirst%3DS.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DSomatic%2520mutations%2520of%2520the%2520APC%2520gene%2520in%2520colorectal%2520tumors%253A%2520Mutation%2520cluster%2520region%2520in%2520the%2520APC%2520gene%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D1992%26volume%3D1%26spage%3D229%26epage%3D233%26doi%3D10.1093%2Fhmg%2F1.4.229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span> <span> </span><span class="NLM_article-title">Mutated APC and Asef are involved in the migration of colorectal tumour cells</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">211</span>â <span class="NLM_lpage">215</span>, <span class="refDoi">Â DOI: 10.1038/ncb937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1038%2Fncb937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=12598901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFKmsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=211-215&author=Y.+Kawasakiauthor=R.+Satoauthor=T.+Akiyama&title=Mutated+APC+and+Asef+are+involved+in+the+migration+of+colorectal+tumour+cells&doi=10.1038%2Fncb937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mutated APC and Asef are involved in the migration of colorectal tumor cells</span></div><div class="casAuthors">Kawasaki, Yoshihiro; Sato, Rina; Akiyama, Tetsu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-215</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The tumor suppressor adenomatous polyposis coli (APC) is mutated in sporadic and familial colorectal tumors.  APC binds to Î²-catenin, a key component of the Wnt signaling pathway, and induces its degrdn.  APC interacts with microtubules and accumulates at their plus ends in membrane protrusions, and assocs. with the plasma membrane in an actin-dependent manner.  In addn., APC interacts with the Rac-specific guanine nucleotide exchange factor Asef and stimulates its activity, thereby regulating the actin cytoskeletal network and cell morphol.  Here we show that overexpression of Asef decreases E-cadherin-mediated cell-cell adhesion and promotes the migration of epithelial Madin-Darby canine kidney cells.  Both of these activities are stimulated by truncated APC proteins expressed in colorectal tumor cells.  Expts. based on RNA interference and dominant-neg. mutants show that both Asef and mutated APC are required for the migration of colorectal tumor cells expressing truncated APC.  These results suggest that the APC-Asef complex functions in cell migration as well as in E-cadherin-mediated cell-cell adhesion, and that truncated APC present in colorectal tumor cells contributes to their aberrant migratory properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdLjSC6kQOLbVg90H21EOLACvtfcHk0lj_XTqLFfIkTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFKmsbw%253D&md5=8d7c2a5b6ea5e4ddaac76fd65b8a8604</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fncb937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb937%26sid%3Dliteratum%253Aachs%26aulast%3DKawasaki%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DR.%26aulast%3DAkiyama%26aufirst%3DT.%26atitle%3DMutated%2520APC%2520and%2520Asef%2520are%2520involved%2520in%2520the%2520migration%2520of%2520colorectal%2520tumour%2520cells%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D211%26epage%3D215%26doi%3D10.1038%2Fncb937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishidate, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span> <span> </span><span class="NLM_article-title">Asef, a link between the tumor suppressor APC and G-protein signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">1194</span>â <span class="NLM_lpage">1197</span>, <span class="refDoi">Â DOI: 10.1126/science.289.5482.1194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1126%2Fscience.289.5482.1194" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1194-1197&author=Y.+Kawasakiauthor=T.+Sendaauthor=T.+Ishidateauthor=R.+Koyamaauthor=T.+Morishitaauthor=Y.+Iwayamaauthor=O.+Higuchiauthor=T.+Akiyama&title=Asef%2C+a+link+between+the+tumor+suppressor+APC+and+G-protein+signaling&doi=10.1126%2Fscience.289.5482.1194"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5482.1194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5482.1194%26sid%3Dliteratum%253Aachs%26aulast%3DKawasaki%26aufirst%3DY.%26aulast%3DSenda%26aufirst%3DT.%26aulast%3DIshidate%26aufirst%3DT.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DMorishita%26aufirst%3DT.%26aulast%3DIwayama%26aufirst%3DY.%26aulast%3DHiguchi%26aufirst%3DO.%26aulast%3DAkiyama%26aufirst%3DT.%26atitle%3DAsef%252C%2520a%2520link%2520between%2520the%2520tumor%2520suppressor%2520APC%2520and%2520G-protein%2520signaling%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1194%26epage%3D1197%26doi%3D10.1126%2Fscience.289.5482.1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, K. B.</span></span> <span> </span><span class="NLM_article-title">Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in <i>APC</i></span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">949</span>â <span class="NLM_lpage">961</span>, <span class="refDoi">Â DOI: 10.1083/jcb.200307070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1083%2Fjcb.200307070" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2003&pages=949-961&author=R.+A.+Greenauthor=K.+B.+Kaplan&title=Chromosome+instability+in+colorectal+tumor+cells+is+associated+with+defects+in+microtubule+plus-end+attachments+caused+by+a+dominant+mutation+in+APC&doi=10.1083%2Fjcb.200307070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200307070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200307070%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DR.%2BA.%26aulast%3DKaplan%26aufirst%3DK.%2BB.%26atitle%3DChromosome%2520instability%2520in%2520colorectal%2520tumor%2520cells%2520is%2520associated%2520with%2520defects%2520in%2520microtubule%2520plus-end%2520attachments%2520caused%2520by%2520a%2520dominant%2520mutation%2520in%2520APC%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D163%26spage%3D949%26epage%3D961%26doi%3D10.1083%2Fjcb.200307070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tighe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. S.</span></span> <span> </span><span class="NLM_article-title">Truncating <i>APC</i> mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">6339</span>â <span class="NLM_lpage">6353</span>, <span class="refDoi">Â DOI: 10.1242/jcs.01556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1242%2Fjcs.01556" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=15561772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFert74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=6339-6353&author=A.+Tigheauthor=V.+L.+Johnsonauthor=S.+S.+Taylor&title=Truncating+APC+mutations+have+dominant+effects+on+proliferation%2C+spindle+checkpoint+control%2C+survival+and+chromosome+stability&doi=10.1242%2Fjcs.01556"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability</span></div><div class="casAuthors">Tighe, Anthony; Johnson, Victoria L.; Taylor, Stephen S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6339-6353</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">The majority of human tumor cells are aneuploid owing to an underlying chromosome instability phenotype.  While the genetic lesions that cause chromosome instability remain undefined, mouse ES cells harboring homozygous adenomatous polyposis coli (APC) mutations are frequently tetraploid.  In addn., colon cancer cells with APC mutations have weakened kinetochore-microtubule interactions.  Furthermore, mitotic spindles assembled in APC-depleted Xenopus egg exts. are aberrant.  Therefore, to det. whether APC mutations can initiate chromosome instability in human cells, we expressed N-terminal APC fragments in HCT-116 cells, a near diploid colon cancer cell line with two wild-type APC alleles.  We show that cells expressing N-APC mutants exit mitosis prematurely in the presence of spindle toxins, consistent with a spindle checkpoint defect.  In addn., N-APC cells show enhanced survival following prolonged spindle damage.  In contrast to controls, the N-APC survivors frequently contain dicentric chromosomes and then go on to become highly aneuploid.  These observations suggest that truncating APC mutations can exert dominant effects which in turn can initiate chromosome instability.  As such, APC mutation not only compromises tumor suppressor function but may also have oncogenic properties.  We suggest therefore that the initial APC mutation acts as a 'double whammy', destabilizing the genome and setting the stage for deregulated proliferation upon loss of the second APC allele.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9ze5tEvWforVg90H21EOLACvtfcHk0lh3R22GWY_YZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFert74%253D&md5=4269f74448b9efbea81ddbd3412832ce</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1242%2Fjcs.01556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.01556%26sid%3Dliteratum%253Aachs%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DV.%2BL.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DTruncating%2520APC%2520mutations%2520have%2520dominant%2520effects%2520on%2520proliferation%252C%2520spindle%2520checkpoint%2520control%252C%2520survival%2520and%2520chromosome%2520stability%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2004%26volume%3D117%26spage%3D6339%26epage%3D6353%26doi%3D10.1242%2Fjcs.01556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, Y.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, J. W.</span></span> <span> </span><span class="NLM_article-title">Truncated adenomatous polyposis coli mutation induces Asef-activated Golgi fragmentation</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>, <span class="NLM_elocation-id">e00135-18</span> <span class="refDoi">Â DOI: 10.1128/MCB.00135-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1128%2FMCB.00135-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=29866653" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&author=S.+B.+Kimauthor=L.+Zhangauthor=J.+Yoonauthor=J.+Leeauthor=J.+Minauthor=W.+Liauthor=N.+V.+Grishinauthor=Y.-A.+Moonauthor=W.+E.+Wrightauthor=J.+W.+Shay&title=Truncated+adenomatous+polyposis+coli+mutation+induces+Asef-activated+Golgi+fragmentation&doi=10.1128%2FMCB.00135-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FMCB.00135-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00135-18%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BB.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYoon%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGrishin%26aufirst%3DN.%2BV.%26aulast%3DMoon%26aufirst%3DY.-A.%26aulast%3DWright%26aufirst%3DW.%2BE.%26aulast%3DShay%26aufirst%3DJ.%2BW.%26atitle%3DTruncated%2520adenomatous%2520polyposis%2520coli%2520mutation%2520induces%2520Asef-activated%2520Golgi%2520fragmentation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2018%26volume%3D38%26doi%3D10.1128%2FMCB.00135-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâRourke, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschaharganeh, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Es, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span> <span> </span><span class="NLM_article-title">Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1539</span>â <span class="NLM_lpage">1552</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2015.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2Fj.cell.2015.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=26091037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Squ7zF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2015&pages=1539-1552&author=L.+E.+Dowauthor=K.+P.+O%E2%80%99Rourkeauthor=J.+Simonauthor=D.+F.+Tschaharganehauthor=J.+H.+van+Esauthor=H.+Cleversauthor=S.+W.+Lowe&title=Apc+restoration+promotes+cellular+differentiation+and+reestablishes+crypt+homeostasis+in+colorectal+cancer&doi=10.1016%2Fj.cell.2015.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer</span></div><div class="casAuthors">Dow, Lukas E.; O'Rourke, Kevin P.; Simon, Janelle; Tschaharganeh, Darjus F.; van Es, Johan H.; Clevers, Hans; Lowe, Scott W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1539-1552</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The adenomatous polyposis coli (APC) tumor suppressor is mutated in the vast majority of human colorectal cancers (CRC) and leads to deregulated Wnt signaling.  To det. whether Apc disruption is required for tumor maintenance, we developed a mouse model of CRC whereby Apc can be conditionally suppressed using a doxycycline-regulated shRNA.  Apc suppression produces adenomas in both the small intestine and colon that, in the presence of Kras and p53 mutations, can progress to invasive carcinoma.  In established tumors, Apc restoration drives rapid and widespread tumor-cell differentiation and sustained regression without relapse.  Tumor regression is accompanied by the re-establishment of normal crypt-villus homeostasis, such that once aberrantly proliferating cells reacquire self-renewal and multi-lineage differentiation capability.  Our study reveals that CRC cells can revert to functioning normal cells given appropriate signals and provide compelling in vivo validation of the Wnt pathway as a therapeutic target for treatment of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOJhLhIEo70LVg90H21EOLACvtfcHk0lh3R22GWY_YZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Squ7zF&md5=c5bdedbcfb89050521a0316438327b5a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DL.%2BE.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DK.%2BP.%26aulast%3DSimon%26aufirst%3DJ.%26aulast%3DTschaharganeh%26aufirst%3DD.%2BF.%26aulast%3Dvan%2BEs%26aufirst%3DJ.%2BH.%26aulast%3DClevers%26aufirst%3DH.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DApc%2520restoration%2520promotes%2520cellular%2520differentiation%2520and%2520reestablishes%2520crypt%2520homeostasis%2520in%2520colorectal%2520cancer%26jtitle%3DCell%26date%3D2015%26volume%3D161%26spage%3D1539%26epage%3D1552%26doi%3D10.1016%2Fj.cell.2015.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theodoropoulos, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskiocak, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, Y.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijhawan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Brabander, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, J. W.</span></span> <span> </span><span class="NLM_article-title">Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">361ra140</span> <span class="refDoi">Â DOI: 10.1126/scitranslmed.aaf8127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1126%2Fscitranslmed.aaf8127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=27798265" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&author=L.+Zhangauthor=P.+C.+Theodoropoulosauthor=U.+Eskiocakauthor=W.+Wangauthor=Y.-A.+Moonauthor=B.+Posnerauthor=N.+S.+Williamsauthor=W.+E.+Wrightauthor=S.+B.+Kimauthor=D.+Nijhawanauthor=J.+K.+De+Brabanderauthor=J.+W.+Shay&title=Selective+targeting+of+mutant+adenomatous+polyposis+coli+%28APC%29+in+colorectal+cancer&doi=10.1126%2Fscitranslmed.aaf8127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaf8127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaf8127%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DTheodoropoulos%26aufirst%3DP.%2BC.%26aulast%3DEskiocak%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMoon%26aufirst%3DY.-A.%26aulast%3DPosner%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DWright%26aufirst%3DW.%2BE.%26aulast%3DKim%26aufirst%3DS.%2BB.%26aulast%3DNijhawan%26aufirst%3DD.%26aulast%3DDe%2BBrabander%26aufirst%3DJ.%2BK.%26aulast%3DShay%26aufirst%3DJ.%2BW.%26atitle%3DSelective%2520targeting%2520of%2520mutant%2520adenomatous%2520polyposis%2520coli%2520%2528APC%2529%2520in%2520colorectal%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26doi%3D10.1126%2Fscitranslmed.aaf8127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinoi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akyol, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theisen, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span> <span> </span><span class="NLM_article-title">Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">9721</span>â <span class="NLM_lpage">9730</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-07-2735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1158%2F0008-5472.CAN-07-2735" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=9721-9730&author=T.+Hinoiauthor=A.+Akyolauthor=B.+K.+Theisenauthor=D.+O.+Fergusonauthor=J.+K.+Greensonauthor=B.+O.+Williamsauthor=K.+R.+Choauthor=E.+R.+Fearon&title=Mouse+model+of+colonic+adenoma-carcinoma+progression+based+on+somatic+Apc+inactivation&doi=10.1158%2F0008-5472.CAN-07-2735"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-2735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-2735%26sid%3Dliteratum%253Aachs%26aulast%3DHinoi%26aufirst%3DT.%26aulast%3DAkyol%26aufirst%3DA.%26aulast%3DTheisen%26aufirst%3DB.%2BK.%26aulast%3DFerguson%26aufirst%3DD.%2BO.%26aulast%3DGreenson%26aufirst%3DJ.%2BK.%26aulast%3DWilliams%26aufirst%3DB.%2BO.%26aulast%3DCho%26aufirst%3DK.%2BR.%26aulast%3DFearon%26aufirst%3DE.%2BR.%26atitle%3DMouse%2520model%2520of%2520colonic%2520adenoma-carcinoma%2520progression%2520based%2520on%2520somatic%2520Apc%2520inactivation%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D9721%26epage%3D9730%26doi%3D10.1158%2F0008-5472.CAN-07-2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engler, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, J.</span></span> <span> </span><span class="NLM_article-title">Lewis acid-directed cyclocondensation of piperidone enol ethers with 2-methoxy-4-(<i>N</i>-phenylsulfonyl)-1,4-benzoquinoneimine: A new regioselective synthesis of oxygenated carbolines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">2444</span>â <span class="NLM_lpage">2457</span>, <span class="refDoi">Â DOI: 10.1021/jo9916176</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9916176" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=2444-2457&author=T.+A.+Englerauthor=J.+Wanner&title=Lewis+acid-directed+cyclocondensation+of+piperidone+enol+ethers+with+2-methoxy-4-%28N-phenylsulfonyl%29-1%2C4-benzoquinoneimine%3A+A+new+regioselective+synthesis+of+oxygenated+carbolines&doi=10.1021%2Fjo9916176"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo9916176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9916176%26sid%3Dliteratum%253Aachs%26aulast%3DEngler%26aufirst%3DT.%2BA.%26aulast%3DWanner%26aufirst%3DJ.%26atitle%3DLewis%2520acid-directed%2520cyclocondensation%2520of%2520piperidone%2520enol%2520ethers%2520with%25202-methoxy-4-%2528N-phenylsulfonyl%2529-1%252C4-benzoquinoneimine%253A%2520A%2520new%2520regioselective%2520synthesis%2520of%2520oxygenated%2520carbolines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D2444%26epage%3D2457%26doi%3D10.1021%2Fjo9916176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominquez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stouten, P. F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knabb, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of potent and selective amidino bicyclic factor xa inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4398</span>â <span class="NLM_lpage">4415</span>, <span class="refDoi">Â DOI: 10.1021/jm000113t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000113t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4398-4415&author=Q.+Hanauthor=C.+Dominquezauthor=P.+F.+W.+Stoutenauthor=J.+M.+Parkauthor=D.+E.+Duffyauthor=R.+A.+Galemmoauthor=K.+A.+Rossiauthor=R.+S.+Alexanderauthor=A.+M.+Smallwoodauthor=P.+C.+Wongauthor=M.+M.+Wrightauthor=J.+M.+Luettgenauthor=R.+M.+Knabbauthor=R.+R.+Wexler&title=Design%2C+synthesis%2C+and+biological+evaluation+of+potent+and+selective+amidino+bicyclic+factor+xa+inhibitors&doi=10.1021%2Fjm000113t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm000113t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000113t%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DDominquez%26aufirst%3DC.%26aulast%3DStouten%26aufirst%3DP.%2BF.%2BW.%26aulast%3DPark%26aufirst%3DJ.%2BM.%26aulast%3DDuffy%26aufirst%3DD.%2BE.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWright%26aufirst%3DM.%2BM.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520potent%2520and%2520selective%2520amidino%2520bicyclic%2520factor%2520xa%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4398%26epage%3D4415%26doi%3D10.1021%2Fjm000113t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Magid, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maryanoff, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R. D.</span></span> <span> </span><span class="NLM_article-title">Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3849</span>â <span class="NLM_lpage">3862</span>, <span class="refDoi">Â DOI: 10.1021/jo960057x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+amination+of+aldehydes+and+ketones+with+sodium+triacetoxyborohydride.+Studies+on+direct+and+indirect+reductive+amination+procedures&doi=10.1021%2Fjo960057x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0liRrT5bBpbiig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520amination%2520of%2520aldehydes%2520and%2520ketones%2520with%2520sodium%2520triacetoxyborohydride.%2520Studies%2520on%2520direct%2520and%2520indirect%2520reductive%2520amination%2520procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862%26doi%3D10.1021%2Fjo960057x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Mild method for UIImann coupling reaction of amines and aryl halides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2453</span>â <span class="NLM_lpage">2455</span>, <span class="refDoi">Â DOI: 10.1021/ol0346584</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0346584" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=2453-2455&author=D.+Maauthor=Q.+Caiauthor=H.+Zhang&title=Mild+method+for+UIImann+coupling+reaction+of+amines+and+aryl+halides&doi=10.1021%2Fol0346584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fol0346584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0346584%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DMild%2520method%2520for%2520UIImann%2520coupling%2520reaction%2520of%2520amines%2520and%2520aryl%2520halides%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D2453%26epage%3D2455%26doi%3D10.1021%2Fol0346584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Topliss, J. G.</span></span> <span> </span><span class="NLM_article-title">Utilization of operational schemes for analog synthesis in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1006</span>â <span class="NLM_lpage">1011</span>, <span class="refDoi">Â DOI: 10.1021/jm00280a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00280a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1006-1011&author=J.+G.+Topliss&title=Utilization+of+operational+schemes+for+analog+synthesis+in+drug+design&doi=10.1021%2Fjm00280a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Utilization of operational schemes for analog synthesis in drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1006-11</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Proposals were presented for stepwise selection for synthesis of new analogs of a biol. active compd. which were designed to maximize the chances of synthesizing the most potent compds. in the series as early as possible.  The schemes were based on a fundamental assumption of the Hansch method that a particular substituent may modify activity relative to the parent compd. by virtue of resulting changes in hydrophobic, electronic, and steric effects.  The effectiveness of the method was illustrated by retrospective application to several existing series of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zymvXigwSbVg90H21EOLACvtfcHk0ljKKQByQbMDoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D&md5=acf62a05dbdb3d1d17f91097f66ab8c1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00280a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00280a002%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DUtilization%2520of%2520operational%2520schemes%2520for%2520analog%2520synthesis%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D1006%26epage%3D1011%26doi%3D10.1021%2Fjm00280a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Topliss, J. G.</span></span> <span> </span><span class="NLM_article-title">A manual method for applying the Hansch approach to drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">463</span>â <span class="NLM_lpage">469</span>, <span class="refDoi">Â DOI: 10.1021/jm00214a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00214a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaE2sXhtFGgtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=463-469&author=J.+G.+Topliss&title=A+manual+method+for+applying+the+Hansch+approach+to+drug+design&doi=10.1021%2Fjm00214a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A manual method for applying the Hansch approach to drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A procedure is described in which an initial small group of compds. is selected, tested, and ordered according to potency.  The potency order in the group is then compared to the tabulated potency order calcd. for various parameter dependencies relating to hydrophobic, electronic, and steric effects.  From this activity pattern anal. the probable operative parameters can be deduced and a new substituent selection made for the synthesis of potentially more potent analogs.  Application of the method is illustrated with a series of examples.  It differs from a previously described decision tree, single compd. stepwise approach in that it involves the batchwise anal. of small groups of compds., usually the preferred procedure for logistical reasons if the compds. are relatively easy to synthesize.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpILt0RoFSjlbVg90H21EOLACvtfcHk0ljKKQByQbMDoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhtFGgtrk%253D&md5=74658b807e3e45cbee88855eda203bdb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm00214a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00214a001%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DA%2520manual%2520method%2520for%2520applying%2520the%2520Hansch%2520approach%2520to%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D463%26epage%3D469%26doi%3D10.1021%2Fjm00214a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roig, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskiocak, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hight, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spechler, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, J. W.</span></span> <span> </span><span class="NLM_article-title">Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>138</i></span>, <span class="NLM_elocation-id">1012</span> <span class="refDoi">Â DOI: 10.1053/j.gastro.2009.11.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1053%2Fj.gastro.2009.11.052" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2010&author=A.+I.+Roigauthor=U.+Eskiocakauthor=S.+K.+Hightauthor=S.+B.+Kimauthor=O.+Delgadoauthor=R.+F.+Souzaauthor=S.+J.+Spechlerauthor=W.+E.+Wrightauthor=J.+W.+Shay&title=Immortalized+epithelial+cells+derived+from+human+colon+biopsies+express+stem+cell+markers+and+differentiate+in+vitro&doi=10.1053%2Fj.gastro.2009.11.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2009.11.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2009.11.052%26sid%3Dliteratum%253Aachs%26aulast%3DRoig%26aufirst%3DA.%2BI.%26aulast%3DEskiocak%26aufirst%3DU.%26aulast%3DHight%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BB.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DSouza%26aufirst%3DR.%2BF.%26aulast%3DSpechler%26aufirst%3DS.%2BJ.%26aulast%3DWright%26aufirst%3DW.%2BE.%26aulast%3DShay%26aufirst%3DJ.%2BW.%26atitle%3DImmortalized%2520epithelial%2520cells%2520derived%2520from%2520human%2520colon%2520biopsies%2520express%2520stem%2520cell%2520markers%2520and%2520differentiate%2520in%2520vitro%26jtitle%3DGastroenterology%26date%3D2010%26volume%3D138%26doi%3D10.1053%2Fj.gastro.2009.11.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, D. J.</span></span> <span> </span><span class="NLM_article-title">The potential role of lysosomes in tissue distribution of weak bases</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">513</span>â <span class="NLM_lpage">526</span>, <span class="refDoi">Â DOI: 10.1002/bod.2510090602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1002%2Fbod.2510090602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=3067757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaL1MXjtlWlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1988&pages=513-526&author=A.+C.+MacIntyreauthor=D.+J.+Cutler&title=The+potential+role+of+lysosomes+in+tissue+distribution+of+weak+bases&doi=10.1002%2Fbod.2510090602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of lysosomes in tissue distribution of weak bases</span></div><div class="casAuthors">MacIntyre, Anna C.; Cutler, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">513-26</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    </div><div class="casAbstract">A review with 68 refs.  Lysosomal trapping of weak bases, dependence of weak base accumulation on structural integrity of tissues, in vitro studies of weak base distribution in tissues, and pharmacokinetics of lysosomal trapping are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMtNLuz5Y2bVg90H21EOLACvtfcHk0ljKKQByQbMDoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXjtlWlsQ%253D%253D&md5=fbfdb93211453b424daa22355ef88717</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fbod.2510090602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbod.2510090602%26sid%3Dliteratum%253Aachs%26aulast%3DMacIntyre%26aufirst%3DA.%2BC.%26aulast%3DCutler%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potential%2520role%2520of%2520lysosomes%2520in%2520tissue%2520distribution%2520of%2520weak%2520bases%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D1988%26volume%3D9%26spage%3D513%26epage%3D526%26doi%3D10.1002%2Fbod.2510090602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazmi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loewen, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, A.</span></span> <span> </span><span class="NLM_article-title">Lysosomal sequestration (trapping) of lipophylic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells)</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">897</span>â <span class="NLM_lpage">905</span>, <span class="refDoi">Â DOI: 10.1124/dmd.112.050054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1124%2Fdmd.112.050054" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=897-905&author=F.+Kazmiauthor=T.+Hensleyauthor=C.+Popeauthor=R.+S.+Funkauthor=G.+J.+Loewenauthor=D.+B.+Buckleyauthor=A.+Parkinson&title=Lysosomal+sequestration+%28trapping%29+of+lipophylic+amine+%28cationic+amphiphilic%29+drugs+in+immortalized+human+hepatocytes+%28Fa2N-4+cells%29&doi=10.1124%2Fdmd.112.050054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.050054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.050054%26sid%3Dliteratum%253Aachs%26aulast%3DKazmi%26aufirst%3DF.%26aulast%3DHensley%26aufirst%3DT.%26aulast%3DPope%26aufirst%3DC.%26aulast%3DFunk%26aufirst%3DR.%2BS.%26aulast%3DLoewen%26aufirst%3DG.%2BJ.%26aulast%3DBuckley%26aufirst%3DD.%2BB.%26aulast%3DParkinson%26aufirst%3DA.%26atitle%3DLysosomal%2520sequestration%2520%2528trapping%2529%2520of%2520lipophylic%2520amine%2520%2528cationic%2520amphiphilic%2529%2520drugs%2520in%2520immortalized%2520human%2520hepatocytes%2520%2528Fa2N-4%2520cells%2529%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D897%26epage%3D905%26doi%3D10.1124%2Fdmd.112.050054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lien, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solheim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueland, P. M.</span></span> <span> </span><span class="NLM_article-title">Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4837</span>â <span class="NLM_lpage">4844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=4837-4844&author=E.+A.+Lienauthor=E.+Solheimauthor=P.+M.+Ueland&title=Distribution+of+tamoxifen+and+its+metabolites+in+rat+and+human+tissues+during+steady-state+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLien%26aufirst%3DE.%2BA.%26aulast%3DSolheim%26aufirst%3DE.%26aulast%3DUeland%26aufirst%3DP.%2BM.%26atitle%3DDistribution%2520of%2520tamoxifen%2520and%2520its%2520metabolites%2520in%2520rat%2520and%2520human%2520tissues%2520during%2520steady-state%2520treatment%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D4837%26epage%3D4844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reasor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, R. G.</span></span> <span> </span><span class="NLM_article-title">Drug-induced phospholipidosis: issues and future directions</span>. <i>Expert Opin. Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">567</span>â <span class="NLM_lpage">583</span>, <span class="refDoi">Â DOI: 10.1517/14740338.5.4.567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1517%2F14740338.5.4.567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=16774494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSksL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=567-583&author=M.+J.+Reasorauthor=K.+L.+Hastingsauthor=R.+G.+Ulrich&title=Drug-induced+phospholipidosis%3A+issues+and+future+directions&doi=10.1517%2F14740338.5.4.567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced phospholipidosis: issues and future directions</span></div><div class="casAuthors">Reasor, Mark J.; Hastings, Kenneth L.; Ulrich, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">567-583</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Numerous drugs contg. a cationic amphiphilic structure are capable of inducing phospholipidosis in cells under conditions of in vivo administration or ex vivo incubation.  The principal characteristics of this condition include the reversible accumulation of polar phospholipids in assocn. with the development of unicentric or multicentric lamellated bodies within cells.  There is an abundance of data providing an understanding of potential mechanisms for the induction of phospholipidosis; however, the process is likely to be complex and may differ from one drug to another.  The functional consequences of the presence of this condition on cellular or tissue function are not well understood.  The general consensus is that the condition is an adaptive response rather than a toxicol. manifestation; however, addnl. studies to examine this question are needed.  Until this issue is resolved, concerns about phospholipidosis will continue to exist at regulatory agencies.  Procedures for the screening of potential phospholipogenic candidate compds. are available.  In contrast, a clear need exists for the identification of valid biomarkers to assess the development of phospholipidosis in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwYtmd7pqUebVg90H21EOLACvtfcHk0lifKzdzIOJFEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSksL8%253D&md5=a2801d85bc4f1730f69272eaea3ce17b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1517%2F14740338.5.4.567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.5.4.567%26sid%3Dliteratum%253Aachs%26aulast%3DReasor%26aufirst%3DM.%2BJ.%26aulast%3DHastings%26aufirst%3DK.%2BL.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26atitle%3DDrug-induced%2520phospholipidosis%253A%2520issues%2520and%2520future%2520directions%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2006%26volume%3D5%26spage%3D567%26epage%3D583%26doi%3D10.1517%2F14740338.5.4.567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNaney, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drexler, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hnatyshyn, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvyaga, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belcastro, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M.</span></span> <span> </span><span class="NLM_article-title">An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">121</span>â <span class="NLM_lpage">129</span>, <span class="refDoi">Â DOI: 10.1089/adt.2007.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1089%2Fadt.2007.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=18336089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=121-129&author=C.+A.+McNaneyauthor=D.+M.+Drexlerauthor=S.+Y.+Hnatyshynauthor=T.+A.+Zvyagaauthor=J.+O.+Knipeauthor=J.+V.+Belcastroauthor=M.+Sanders&title=An+automated+liquid+chromatography-mass+spectrometry+process+to+determine+metabolic+stability+half-life+and+intrinsic+clearance+of+drug+candidates+by+substrate+depletion&doi=10.1089%2Fadt.2007.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion</span></div><div class="casAuthors">McNaney, Colleen A.; Drexler, Dieter M.; Hnatyshyn, Serhiy Y.; Zvyaga, Tatyana A.; Knipe, Jay O.; Belcastro, James V.; Sanders, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-129</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">An automated process is described for the detailed assessment of the in vitro metabolic stability properties of drug candidates in support of pharmaceutical property profiling.  Compds. are incubated with liver microsomes using a robotic liq. handler.  Aliquots are taken at various time points, and the resulting samples are quant. analyzed by liq. chromatog.-mass spectrometry utilizing ion trap mass spectrometers to det. the amt. of compd. remaining.  From these data metab. rates can be calcd.  A high degree of automation is achieved through custom software, which is employed for instrument setup, data processing, and results reporting.  The assay setup is highly configurable, allowing for any combination of up to six user-selected time points, variable substrate concn., and microsomes or other biol. active media.  The data, based on relative substrate depletion, affords an est. of metabolic stability through the calcn. of half-life (t1/2) and intrinsic clearance, which are used to differentiate and rank order drug leads.  In general, t1/2 is the time necessary for the metab., following first-order kinetics, of 50 of the initial compd.  Intrinsic clearance is the proportionality const. between rate of metab. of a compd. and its concn. at the enzyme site.  Described here is the setup of the assay, and data from assay test compds. are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEaz4jJWXzM7Vg90H21EOLACvtfcHk0lifKzdzIOJFEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtbs%253D&md5=3833f7d7c4be366bc2d4b3e656ef4ae2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.103%26sid%3Dliteratum%253Aachs%26aulast%3DMcNaney%26aufirst%3DC.%2BA.%26aulast%3DDrexler%26aufirst%3DD.%2BM.%26aulast%3DHnatyshyn%26aufirst%3DS.%2BY.%26aulast%3DZvyaga%26aufirst%3DT.%2BA.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DBelcastro%26aufirst%3DJ.%2BV.%26aulast%3DSanders%26aufirst%3DM.%26atitle%3DAn%2520automated%2520liquid%2520chromatography-mass%2520spectrometry%2520process%2520to%2520determine%2520metabolic%2520stability%2520half-life%2520and%2520intrinsic%2520clearance%2520of%2520drug%2520candidates%2520by%2520substrate%2520depletion%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D121%26epage%3D129%26doi%3D10.1089%2Fadt.2007.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span> <span> </span><span class="NLM_article-title">A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">112</span>â <span class="NLM_lpage">117</span>, <span class="refDoi">Â DOI: 10.1016/j.jpba.2012.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2Fj.jpba.2012.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=23312388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1WnsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=112-117&author=C.+Wangauthor=N.+S.+Williams&title=A+mass+balance+approach+for+calculation+of+recovery+and+binding+enables+the+use+of+ultrafiltration+as+a+rapid+method+for+measurement+of+plasma+protein+binding+for+even+highly+lipophilic+compounds&doi=10.1016%2Fj.jpba.2012.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds</span></div><div class="casAuthors">Wang, Changguang; Williams, Noelle S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112-117</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The aim of this study is to further validate the use of ultrafiltration (UF) as a method for detg. plasma protein binding (PPB) by demonstrating that non-specific binding (NSB) is not a limitation, even for highly lipophilic compds., because NSB sites on the app. are passivated in the presence of plasma.  Mass balance theory was used to calc. recovery of 20 com. and seven investigational compds. during ultrafiltration in the presence and absence of plasma.  PPB was also measured using this mass balance approach for comparison to PPB detd. by rapid equil. dialysis (RED) and as found in the literature.  Compd. recovery during UF was dramatically different in the presence and absence of plasma for compds. with high NSB in PBS only.  A comparison of PPB calcd. by ultrafiltration with literature values or calcd. by RED gave concordant results.  Discrepancies could be explained by changes in pH, insufficient time to equil., or compd. instability during RED, problems which were circumvented by ultrafiltration.  Therefore, NSB, as measured by the traditional incubation of compd. in PBS, need not be an issue when choosing UF as a PPB assay method.  It is more appropriate to calc. compd. recovery from the device in plasma as measured by mass balance to det. the suitability of the method for an individual compd.  The speed with which UF can be conducted addnl. avoids changes in pH or compd. loss that can occur with other methods.  The mass balance approach to UF is thus a preferred method for rapid detn. of PPB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_4BPF0CHgYbVg90H21EOLACvtfcHk0lifKzdzIOJFEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1WnsQ%253D%253D&md5=c5d42f85a2cd8edafae32d9662faabed</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2012.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2012.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26atitle%3DA%2520mass%2520balance%2520approach%2520for%2520calculation%2520of%2520recovery%2520and%2520binding%2520enables%2520the%2520use%2520of%2520ultrafiltration%2520as%2520a%2520rapid%2520method%2520for%2520measurement%2520of%2520plasma%2520protein%2520binding%2520for%2520even%2520highly%2520lipophilic%2520compounds%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2013%26volume%3D75%26spage%3D112%26epage%3D117%26doi%3D10.1016%2Fj.jpba.2012.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span> <span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: Implications for rational drug discovery</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">327</span>â <span class="NLM_lpage">338</span>, <span class="refDoi">Â DOI: 10.1002/bdd.325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+Implications+for+rational+drug+discovery&doi=10.1002%2Fbdd.325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0liW8eJpE7bLqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520Implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338%26doi%3D10.1002%2Fbdd.325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y.</span></span> <i>The Handbook of Essential Pharmacokinetics, Pharmacodynamics, and Drug Metabolism for Industrial Scientists</i>; <span class="NLM_publisher-name">Kluwer Academic/Plenum Publishers</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2001</span>; pp  <span class="NLM_fpage">231</span>â <span class="NLM_lpage">232</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=231-232&author=Y.+Kwon&title=The+Handbook+of+Essential+Pharmacokinetics%2C+Pharmacodynamics%2C+and+Drug+Metabolism+for+Industrial+Scientists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DY.%26btitle%3DThe%2520Handbook%2520of%2520Essential%2520Pharmacokinetics%252C%2520Pharmacodynamics%252C%2520and%2520Drug%2520Metabolism%2520for%2520Industrial%2520Scientists%26pub%3DKluwer%2520Academic%252FPlenum%2520Publishers%26date%3D2001%26spage%3D231%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amewu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charnaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bongard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozanom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JesÃºs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gargallo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, P. M.</span></span> <span> </span><span class="NLM_article-title">Two-step synthesis of achiral dispiro-1,2,4,5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profiles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2170</span>â <span class="NLM_lpage">2177</span>, <span class="refDoi">Â DOI: 10.1021/jm701435h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701435h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlOjsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2170-2177&author=G.+L.+Ellisauthor=R.+Amewuauthor=S.+Sabbaniauthor=P.+A.+Stocksauthor=A.+Shoneauthor=D.+Stanfordauthor=P.+Gibbonsauthor=J.+Daviesauthor=L.+Vivasauthor=S.+Charnaudauthor=E.+Bongardauthor=C.+Hallauthor=K.+Rimmerauthor=S.+Lozanomauthor=M.+Jes%C3%BAsauthor=D.+Gargalloauthor=S.+A.+Wardauthor=P.+M.+O%E2%80%99Neill&title=Two-step+synthesis+of+achiral+dispiro-1%2C2%2C4%2C5-tetraoxanes+with+outstanding+antimalarial+activity%2C+low+toxicity%2C+and+high-stability+profiles&doi=10.1021%2Fjm701435h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Two-Step Synthesis of Achiral Dispiro-1,2,4,5-tetraoxanes with Outstanding Antimalarial Activity, Low Toxicity, and High-Stability Profiles</span></div><div class="casAuthors">Ellis, Gemma L.; Amewu, Richard; Sabbani, Sunil; Stocks, Paul A.; Shone, Alison; Stanford, Deborah; Gibbons, Peter; Davies, Jill; Vivas, Livia; Charnaud, Sarah; Bongard, Emily; Hall, Charlotte; Rimmer, Karen; Lozanom, Sonia; Jesus, Maria; Gargallo, Domingo; Ward, Stephen A.; O'Neill, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2170-2177</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Piperidinedispirotetraoxanes such as I (R = Et, cyclopropyl) are prepd. by a rapid, two-step method; the products have potent antimalarial activity both in vitro and in vivo.  Sulfonylpiperidinones are prepd. by sulfonylation of 4-piperidinone hydrochloride with sulfonyl chlorides; oxidn. of the sulfonylpiperidinones with hydrogen peroxide in the presence of methyltrioxorhenium followed by cyclocondensation with either 2-adamantanone or cyclododecanone in the presence of fluoroboric acid in ether yields the title piperidinedispirotetraoxanes.  The 1,2,4,5-tetraoxanes prepd. are more stable than similar 1,2,4-trioxolanes and are both more stable and more active as antimalarial agents than the corresponding 1,2,4-trioxanes.  I (R = Et, cyclopropyl) showed no mutagenicity or cytotoxicity at the doses tested in a variety of cell lines.  A fluorescent nitrobenzaoxadiazole-tagged tetraoxane is prepd. as a probe; laser scanning confocal microscopy of red blood cells dosed with the probe indicates that tagged mols. accumulate selectively only in parasite infected erythrocytes and that intraparasitic formation of adducts could be inhibited by co-incubation with the iron chelator desferrioxamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgtxzi2qAKTLVg90H21EOLACvtfcHk0liW8eJpE7bLqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlOjsL4%253D&md5=3c4b69f56bbf84ca035f4fe62716073e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm701435h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701435h%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DG.%2BL.%26aulast%3DAmewu%26aufirst%3DR.%26aulast%3DSabbani%26aufirst%3DS.%26aulast%3DStocks%26aufirst%3DP.%2BA.%26aulast%3DShone%26aufirst%3DA.%26aulast%3DStanford%26aufirst%3DD.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DVivas%26aufirst%3DL.%26aulast%3DCharnaud%26aufirst%3DS.%26aulast%3DBongard%26aufirst%3DE.%26aulast%3DHall%26aufirst%3DC.%26aulast%3DRimmer%26aufirst%3DK.%26aulast%3DLozanom%26aufirst%3DS.%26aulast%3DJes%25C3%25BAs%26aufirst%3DM.%26aulast%3DGargallo%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DTwo-step%2520synthesis%2520of%2520achiral%2520dispiro-1%252C2%252C4%252C5-tetraoxanes%2520with%2520outstanding%2520antimalarial%2520activity%252C%2520low%2520toxicity%252C%2520and%2520high-stability%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2170%26epage%3D2177%26doi%3D10.1021%2Fjm701435h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepurny, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holz, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of small molecules as potent and specific EPAC2 antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">952</span>â <span class="NLM_lpage">962</span>, <span class="refDoi">Â DOI: 10.1021/jm3014162</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3014162" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVartA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=952-962&author=H.+Chenauthor=T.+Tsalkovaauthor=O.+G.+Chepurnyauthor=F.+C.+Meiauthor=G.+G.+Holzauthor=X.+Chengauthor=J.+Zhou&title=Identification+and+characterization+of+small+molecules+as+potent+and+specific+EPAC2+antagonists&doi=10.1021%2Fjm3014162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Small Molecules as Potent and Specific EPAC2 Antagonists</span></div><div class="casAuthors">Chen, Haijun; Tsalkova, Tamara; Chepurny, Oleg G.; Mei, Fang C.; Holz, George G.; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">952-962</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EPAC1 and EPAC2, two isoforms of exchange proteins directly activated by cAMP (EPAC), respond to the second messenger cAMP and regulate a wide variety of intracellular processes under physiol. and pathophysiol. circumstances.  Herein, we report the chem. design, synthesis, and pharmacol. characterization of three different scaffolds (diarylsulfones, N,N-diarylamines, and arylsulfonamides) as highly potent and selective antagonists of EPAC2.  Several selective EPAC2 antagonists have been identified including 20i (HJC0350, I), which has an apparent IC50 of 0.3 Î¼M for competing with 8-NBD-cAMP binding of EPAC2 and is about 133-fold more potent than cAMP.  Compds. 1 (ESI-05), 14c (HJC0338), and 20i, selected from each series, have exhibited no inhibition of EPAC1-mediated Rap1-GDP exchange activity at 25 Î¼M, indicating that they are EPAC2-specific antagonists.  Moreover, live-cell imaging studies using EPAC1, EPAC2, or PKA FRET sensor also demonstrate that 20i functions as an EPAC2 specific antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrumM4DblVhxLVg90H21EOLACvtfcHk0liVQAjIMGn9rQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVartA%253D%253D&md5=5f100066fb30778ba2793a8543d4b89a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm3014162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3014162%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DChepurny%26aufirst%3DO.%2BG.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DHolz%26aufirst%3DG.%2BG.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520small%2520molecules%2520as%2520potent%2520and%2520specific%2520EPAC2%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D952%26epage%3D962%26doi%3D10.1021%2Fjm3014162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Panayotis C. Theodoropoulos, Wentian Wang, Albert Budhipramono, Bonne M. Thompson, Nikhil Madhusudhan, Matthew A. Mitsche, Jeffrey G. McDonald, Jef K. De Brabander, <span class="NLM_string-name hlFld-ContribAuthor">Deepak Nijhawan</span>. </span><span class="cited-content_cbyCitation_article-title">A Medicinal Chemistry-Driven Approach Identified the Sterol Isomerase EBP as the Molecular Target of TASIN Colorectal Cancer Toxins. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (13)
                                     , 6128-6138. <a href="https://doi.org/10.1021/jacs.9b13407" title="DOI URL">https://doi.org/10.1021/jacs.9b13407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b13407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b13407%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DA%252BMedicinal%252BChemistry-Driven%252BApproach%252BIdentified%252Bthe%252BSterol%252BIsomerase%252BEBP%252Bas%252Bthe%252BMolecular%252BTarget%252Bof%252BTASIN%252BColorectal%252BCancer%252BToxins%26aulast%3DTheodoropoulos%26aufirst%3DPanayotis%2BC.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D12122019%26date%3D19032020%26date%3D12032020%26volume%3D142%26issue%3D13%26spage%3D6128%26epage%3D6138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philippe  Medina</span>, <span class="hlFld-ContribAuthor ">Khadijetou  Diallo</span>, <span class="hlFld-ContribAuthor ">Emilie  HucâClaustre</span>, <span class="hlFld-ContribAuthor ">Mehdi  Attia</span>, <span class="hlFld-ContribAuthor ">RÃ©gis  SoulÃ¨s</span>, <span class="hlFld-ContribAuthor ">Sandrine  SilventeâPoirot</span>, <span class="hlFld-ContribAuthor ">Marc  Poirot</span>. </span><span class="cited-content_cbyCitation_article-title">The 5,6âepoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2021,</strong> <em>178 </em>
                                    (16)
                                     , 3248-3260. <a href="https://doi.org/10.1111/bph.15205" title="DOI URL">https://doi.org/10.1111/bph.15205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15205%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252B5%25252C6%2525E2%252580%252590epoxycholesterol%252Bmetabolic%252Bpathway%252Bin%252Bbreast%252Bcancer%25253A%252BEmergence%252Bof%252Bnew%252Bpharmacological%252Btargets%26aulast%3DMedina%26aufirst%3DPhilippe%26date%3D2021%26date%3D2020%26volume%3D178%26issue%3D16%26spage%3D3248%26epage%3D3260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Babita  Madan</span>, <span class="hlFld-ContribAuthor ">David M.  Virshup</span>, <span class="hlFld-ContribAuthor ">W. David  Nes</span>, <span class="hlFld-ContribAuthor ">David J.  Leaver</span>. </span><span class="cited-content_cbyCitation_article-title">Unearthing the Janus-face cholesterogenesis pathways in cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>36 </em>, 114611. <a href="https://doi.org/10.1016/j.bcp.2021.114611" title="DOI URL">https://doi.org/10.1016/j.bcp.2021.114611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2021.114611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2021.114611%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DUnearthing%252Bthe%252BJanus-face%252Bcholesterogenesis%252Bpathways%252Bin%252Bcancer%26aulast%3DMadan%26aufirst%3DBabita%26date%3D2021%26volume%3D36%26spage%3D114611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shovan  Mondal</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonamide synthesis under green conditions. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2021,</strong> <em>51 </em>
                                    (7)
                                     , 1023-1044. <a href="https://doi.org/10.1080/00397911.2020.1870238" title="DOI URL">https://doi.org/10.1080/00397911.2020.1870238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2020.1870238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2020.1870238%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSulfonamide%252Bsynthesis%252Bunder%252Bgreen%252Bconditions%26aulast%3DMondal%26aufirst%3DShovan%26date%3D2021%26date%3D2021%26volume%3D51%26issue%3D7%26spage%3D1023%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manjinder Singh  Phull</span>, <span class="hlFld-ContribAuthor ">Surender Singh  Jadav</span>, <span class="hlFld-ContribAuthor ">Rambabu  Gundla</span>, <span class="hlFld-ContribAuthor ">Prathama S.  Mainkar</span>. </span><span class="cited-content_cbyCitation_article-title">A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113149. <a href="https://doi.org/10.1016/j.ejmech.2020.113149" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113149%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bperspective%252Bon%252Bmedicinal%252Bchemistry%252Bapproaches%252Btowards%252Badenomatous%252Bpolyposis%252Bcoli%252Band%252BWnt%252Bsignal%252Bbased%252Bcolorectal%252Bcancer%252Binhibitors%26aulast%3DPhull%26aufirst%3DManjinder%2BSingh%26date%3D2021%26volume%3D212%26spage%3D113149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shovan  Mondal</span>, <span class="hlFld-ContribAuthor ">Suniti  Malakar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of sulfonamide and their synthetic and therapeutic applications: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (48)
                                     , 131662. <a href="https://doi.org/10.1016/j.tet.2020.131662" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131662%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bsulfonamide%252Band%252Btheir%252Bsynthetic%252Band%252Btherapeutic%252Bapplications%25253A%252BRecent%252Badvances%26aulast%3DMondal%26aufirst%3DShovan%26date%3D2020%26volume%3D76%26issue%3D48%26spage%3D131662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongmin  Cai</span>, <span class="hlFld-ContribAuthor ">Hebang  Yao</span>, <span class="hlFld-ContribAuthor ">Tingting  Li</span>, <span class="hlFld-ContribAuthor ">Yannan  Tang</span>, <span class="hlFld-ContribAuthor ">Dianfan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">High-level heterologous expression of the human transmembrane sterol Î8,Î7-isomerase in Pichia pastoris. </span><span class="cited-content_cbyCitation_journal-name">Protein Expression and Purification</span><span> <strong>2019,</strong> <em>164 </em>, 105463. <a href="https://doi.org/10.1016/j.pep.2019.105463" title="DOI URL">https://doi.org/10.1016/j.pep.2019.105463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pep.2019.105463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pep.2019.105463%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Expression%2520and%2520Purification%26atitle%3DHigh-level%252Bheterologous%252Bexpression%252Bof%252Bthe%252Bhuman%252Btransmembrane%252Bsterol%252B%2525CE%2525948%25252C%2525CE%2525947-isomerase%252Bin%252BPichia%252Bpastoris%26aulast%3DCai%26aufirst%3DHongmin%26date%3D2019%26volume%3D164%26spage%3D105463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure, properties, and analogue design of TASIN-1 (<b>6</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Aromatic and Heteroaromatic Sulfonamide Analogues via Sulfonylation/Cross-Coupling<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) amine <b>1a</b>â<b>d</b>, <b>1f</b>â<b>j</b>, RSO<sub>2</sub>Cl, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) amine <b>1e</b>, <b>1k</b>â<b>m</b>, RSO<sub>2</sub>Cl, K<sub>2</sub>CO<sub>3</sub>, CHCl<sub>3</sub>/H<sub>2</sub>O (1/1), rt; (c) Pd/C, H<sub>2</sub>, MeOH, rt; and (d) ArB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> (10 mol %), aqueous (aq) Na<sub>2</sub>CO<sub>3</sub> (2 M)/tetrahydrofuran (THF) (1/10), reflux. Mes, mesitylene, 2,4,6-Me<sub>3</sub>Ph.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Sulfonamide Analogues via Sulfonylation/Reductive Amination</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogues <b>112</b>, <b>125</b>, and <b>119</b>â<b>122</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) amine <b>2c</b>, RSO<sub>2</sub>Cl, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) (COCl)<sub>2</sub>, dimethyl sulfoxide (DMSO), CH<sub>2</sub>Cl<sub>2</sub>; then â78 Â°C, Et<sub>3</sub>N, â78 Â°C â rt; (c) MeC(CH<sub>2</sub>OH)<sub>2</sub>, cat. PPTS, MgSO<sub>4</sub>, PhMe, reflux; (d) AlCl<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (e) 4-Me-piperidine, CuI, proline, K<sub>2</sub>CO<sub>3</sub>, DMSO, 90 Â°C; (f) <b>1a</b>, 4-CF<sub>3</sub>OPhCO<sub>2</sub>H, EDCÂ·HCl, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt; (g) <b>1a</b>, 4-MeOPhOC(O)Cl, K<sub>2</sub>CO<sub>3</sub>, Et<sub>2</sub>O, 0 Â°C â rt; (h) <b>1a</b>, 4-MeOPhNCO, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C â rt; (i) <b>2a</b>, 4-MeOPhNHSO<sub>2</sub>Cl, Et<sub>3</sub>N, Na<sub>2</sub>SO<sub>4</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (j) 4-Me-piperidine, NaBH(OAc)<sub>3</sub>, AcOH, DCE, rt. DCE, 1,2-dichloroethane; DMAP, <i>N</i>,<i>N</i>-dimetylaminopyridine; EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide; Mes, 2,4,6-Me<sub>3</sub>Ph; PPTS, pyridinium <i>para</i>-toluenesulfonic acid.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/medium/jm-2019-00532e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Concentrationâtime curve in the large intestine for analogue <b>92</b> when dosed 10 mg/kg i.v. or i.p. (B) Concentrationâtime curve in the plasma and lung for analogue <b>22</b> when dosed 5 mg/kg i.v.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00532/20190516/images/large/jm-2019-00532e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00532&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i169">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><a href="https://seer.cancer.gov/statfacts/html/colorect.html" class="extLink">https://seer.cancer.gov/statfacts/html/colorect.html</a> (accessed March 26, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fseer.cancer.gov%2Fstatfacts%2Fhtml%2Fcolorect.html+%28accessed+March+26%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troiani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitiello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sforza, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napolitano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Della Corte, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgillo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuomo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvaggi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciardiello, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, E.</span></span> <span> </span><span class="NLM_article-title">Present and future of metastatic colorectal cancer treatment: A review of new candidate targets</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4675</span>â <span class="NLM_lpage">4688</span>, <span class="refDoi">Â DOI: 10.3748/wjg.v23.i26.4675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.3748%2Fwjg.v23.i26.4675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=28765689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFKqtr3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=4675-4688&author=G.+Martiniauthor=T.+Troianiauthor=C.+Cardoneauthor=P.+Vitielloauthor=V.+Sforzaauthor=D.+Ciardielloauthor=S.+Napolitanoauthor=C.+M.+Della+Corteauthor=F.+Morgilloauthor=A.+Raucciauthor=A.+Cuomoauthor=F.+Selvaggiauthor=F.+Ciardielloauthor=E.+Martinelli&title=Present+and+future+of+metastatic+colorectal+cancer+treatment%3A+A+review+of+new+candidate+targets&doi=10.3748%2Fwjg.v23.i26.4675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Present and future of metastatic colorectal cancer treatment: a review of new candidate targets</span></div><div class="casAuthors">Martini, Giulia; Troiani, Teresa; Cardone, Claudia; Vitiello, Pietropaolo; Sforza, Vincenzo; Ciardiello, Davide; Napolitano, Stefania; Della Corte, Carminia Maria; Morgillo, Floriana; Raucci, Antonio; Cuomo, Antonio; Selvaggi, Francesco; Ciardiello, Fortunato; Martinelli, Erika</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4675-4688</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">2219-2840</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Inc.</span>)
        </div><div class="casAbstract">In the last two decades, great efforts have been made in the treatment of metastatic colorectal cancer (mCRC) due to the approval of new target agents for cytotoxic drugs.  Unfortunately, a large percentage of patients present with metastasis at the time of diagnosis or relapse after a few months.  The complex mol. heterogeneity of this disease is not completely understood; to date, there is a lack of predictive biomarkers that can be used to select subsets of patients who may respond to target drugs.  Only the RAS-mutation status is used to predict resistance to anti-epidermal growth factor receptor agents in patients with mCRC.  In this review, we describe approved targeted therapies for the management of metastatic mCRC and discuss new candidate targets on the horizon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIFbSUzrvLq7Vg90H21EOLACvtfcHk0lgyNsO98sRSEg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFKqtr3P&md5=a8f3a8bb8854b11ca2b65cff461bf0b3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v23.i26.4675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v23.i26.4675%26sid%3Dliteratum%253Aachs%26aulast%3DMartini%26aufirst%3DG.%26aulast%3DTroiani%26aufirst%3DT.%26aulast%3DCardone%26aufirst%3DC.%26aulast%3DVitiello%26aufirst%3DP.%26aulast%3DSforza%26aufirst%3DV.%26aulast%3DCiardiello%26aufirst%3DD.%26aulast%3DNapolitano%26aufirst%3DS.%26aulast%3DDella%2BCorte%26aufirst%3DC.%2BM.%26aulast%3DMorgillo%26aufirst%3DF.%26aulast%3DRaucci%26aufirst%3DA.%26aulast%3DCuomo%26aufirst%3DA.%26aulast%3DSelvaggi%26aufirst%3DF.%26aulast%3DCiardiello%26aufirst%3DF.%26aulast%3DMartinelli%26aufirst%3DE.%26atitle%3DPresent%2520and%2520future%2520of%2520metastatic%2520colorectal%2520cancer%2520treatment%253A%2520A%2520review%2520of%2520new%2520candidate%2520targets%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2017%26volume%3D23%26spage%3D4675%26epage%3D4688%26doi%3D10.3748%2Fwjg.v23.i26.4675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarotra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medhi, B.</span></span> <span> </span><span class="NLM_article-title">Current status of pharmacological treatment of colorectal cancer</span>. <i>World J. Gastrointest. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">177</span>â <span class="NLM_lpage">183</span>, <span class="refDoi">Â DOI: 10.4251/wjgo.v6.i6.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.4251%2Fwjgo.v6.i6.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=24936228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A280%3ADC%252BC2cfjtFyrtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=177-183&author=R.+Akhtarauthor=S.+Chandelauthor=P.+Sarotraauthor=B.+Medhi&title=Current+status+of+pharmacological+treatment+of+colorectal+cancer&doi=10.4251%2Fwjgo.v6.i6.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Current status of pharmacological treatment of colorectal cancer</span></div><div class="casAuthors">Akhtar Reyhan; Chandel Shammy; Sarotra Pooja; Medhi Bikash</div><div class="citationInfo"><span class="NLM_cas:title">World journal of gastrointestinal oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">177-83</span>
        ISSN:<span class="NLM_cas:issn">1948-5204</span>.
    </div><div class="casAbstract">AIM:  To review the clinical trials for the development in drugs for chemotherapeutic treatment of colorectal cancer (CRC).  METHODS:  A systematic review identified randomized controlled trials (RCTs) assessing drugs for the treatment of CRC or adenomatous polyps from www.clinicaltrials.gov.  Various online medical databases were searched for relevant publications.  RESULTS:  Combination treatment regimens of standard drugs with newer agents have been shown to improve overall survival, disease-free survival, time to progression and quality of life compared to that with standard drugs alone in patients with advanced colorectal cancer.  The FOLFOXIRI regimen has been associated with a significantly higher response rate, progression-free survival and overall survival compared to the FOLFIRI regimen.  CONCLUSION:  Oxaliplatin plus intravenous bolus fluorouracil and leucovorin has been shown to be superior for disease-free survival when compared to intravenous bolus fluorouracil and leucovorin.  In addition, oxaliplatin regimens were more likely to result in successful surgical resections.  First line treatment with cetuximab plus fluorouracil, leucovorin and irinotecan has been found to reduce the risk of metastatic progression in patients with epidermal growth factor receptor-positive colorectal cancer with unresectable metastases.  The addition of bevacizumab has been shown to significantly increase overall and progression-free survival when given in combination with standard therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6-zoVGkAq_kNoizSOkG_FfW6udTcc2ea9rmGPebt30rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cfjtFyrtg%253D%253D&md5=c85509e051b1a856392251d8ce922219</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4251%2Fwjgo.v6.i6.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4251%252Fwjgo.v6.i6.177%26sid%3Dliteratum%253Aachs%26aulast%3DAkhtar%26aufirst%3DR.%26aulast%3DChandel%26aufirst%3DS.%26aulast%3DSarotra%26aufirst%3DP.%26aulast%3DMedhi%26aufirst%3DB.%26atitle%3DCurrent%2520status%2520of%2520pharmacological%2520treatment%2520of%2520colorectal%2520cancer%26jtitle%3DWorld%2520J.%2520Gastrointest.%2520Oncol.%26date%3D2014%26volume%3D6%26spage%3D177%26epage%3D183%26doi%3D10.4251%2Fwjgo.v6.i6.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriarity, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâSullivan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehigan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, P.</span></span> <span> </span><span class="NLM_article-title">Current targeted therapies in the treatment of advanced colorectal cancer: a review</span>. <i>Ther. Adv. Med. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">276</span>â <span class="NLM_lpage">293</span>, <span class="refDoi">Â DOI: 10.1177/1758834016646734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1177%2F1758834016646734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=27482287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFOrsLzM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=276-293&author=A.+Moriarityauthor=J.+O%E2%80%99Sullivanauthor=J.+Kennedyauthor=B.+Mehiganauthor=P.+McCormick&title=Current+targeted+therapies+in+the+treatment+of+advanced+colorectal+cancer%3A+a+review&doi=10.1177%2F1758834016646734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Current targeted therapies in the treatment of advanced colorectal cancer: a review</span></div><div class="casAuthors">Moriarity, Andrew; O'Sullivan, Jacintha; Kennedy, John; Mehigan, Brian; McCormick, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Medical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">276-293</span>CODEN:
                <span class="NLM_cas:coden">TAMOB8</span>;
        ISSN:<span class="NLM_cas:issn">1758-8340</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Treatment strategies for metastatic colorectal cancer (mCRC) patients have undergone dramatic changes in the past decade and despite improved patient outcomes, there still exist areas for continued development.  The introduction of targeted agents has provided clinicians with addnl. treatment options in mCRC, however, results have been mixed at best.  These novel therapies were designed to interfere with specific mols. involved in the cellular carcinogenesis pathway and ultimately deliver a more focused treatment.  Currently, their use in mCRC has been limited primarily as an adjunct to conventional chemotherapy regimens.  This review explores the relevant cell-signaling networks in colorectal cancer, provides focus on the current targeted agent armamentarium approved for use in mCRC and explores the usefulness of predictive mCRC biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryzFnB9lz3w7Vg90H21EOLACvtfcHk0liKhyTf-FkKUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFOrsLzM&md5=f54766897f176a287bf324296a4abe36</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1177%2F1758834016646734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1758834016646734%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarity%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DJ.%26aulast%3DMehigan%26aufirst%3DB.%26aulast%3DMcCormick%26aufirst%3DP.%26atitle%3DCurrent%2520targeted%2520therapies%2520in%2520the%2520treatment%2520of%2520advanced%2520colorectal%2520cancer%253A%2520a%2520review%26jtitle%3DTher.%2520Adv.%2520Med.%2520Oncol.%26date%3D2016%26volume%3D8%26spage%3D276%26epage%3D293%26doi%3D10.1177%2F1758834016646734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rowan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamlum, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilyas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straub, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bicknell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodmer, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, I. P. M.</span></span> <span> </span><span class="NLM_article-title"><i>APC</i> mutations in sporadic colorectal tumors: A mutational âhotspotâ and interdependence of the âtwo hitsâ</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">3352</span>â <span class="NLM_lpage">3357</span>, <span class="refDoi">Â DOI: 10.1073/pnas.97.7.3352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1073%2Fpnas.97.7.3352" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=3352-3357&author=A.+J.+Rowanauthor=H.+Lamlumauthor=M.+Ilyasauthor=J.+Wheelerauthor=J.+Straubauthor=A.+Papadopoulouauthor=D.+Bicknellauthor=W.+F.+Bodmerauthor=I.+P.+M.+Tomlinson&title=APC+mutations+in+sporadic+colorectal+tumors%3A+A+mutational+%E2%80%9Chotspot%E2%80%9D+and+interdependence+of+the+%E2%80%9Ctwo+hits%E2%80%9D&doi=10.1073%2Fpnas.97.7.3352"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.7.3352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.7.3352%26sid%3Dliteratum%253Aachs%26aulast%3DRowan%26aufirst%3DA.%2BJ.%26aulast%3DLamlum%26aufirst%3DH.%26aulast%3DIlyas%26aufirst%3DM.%26aulast%3DWheeler%26aufirst%3DJ.%26aulast%3DStraub%26aufirst%3DJ.%26aulast%3DPapadopoulou%26aufirst%3DA.%26aulast%3DBicknell%26aufirst%3DD.%26aulast%3DBodmer%26aufirst%3DW.%2BF.%26aulast%3DTomlinson%26aufirst%3DI.%2BP.%2BM.%26atitle%3DAPC%2520mutations%2520in%2520sporadic%2520colorectal%2520tumors%253A%2520A%2520mutational%2520%25E2%2580%259Chotspot%25E2%2580%259D%2520and%2520interdependence%2520of%2520the%2520%25E2%2580%259Ctwo%2520hits%25E2%2580%259D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D3352%26epage%3D3357%26doi%3D10.1073%2Fpnas.97.7.3352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nieuwenhuis, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasen, H. F. A.</span></span> <span> </span><span class="NLM_article-title">Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature</span>. <i>Crit. Rev. Oncol. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">153</span>â <span class="NLM_lpage">161</span>, <span class="refDoi">Â DOI: 10.1016/j.critrevonc.2006.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2Fj.critrevonc.2006.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=17064931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FisVyqsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=153-161&author=M.+H.+Nieuwenhuisauthor=H.+F.+A.+Vasen&title=Correlations+between+mutation+site+in+APC+and+phenotype+of+familial+adenomatous+polyposis+%28FAP%29%3A+A+review+of+the+literature&doi=10.1016%2Fj.critrevonc.2006.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature</span></div><div class="casAuthors">Nieuwenhuis M H; Vasen H F A</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">153-61</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">Mutations in the adenomatous polyposis coli (APC) gene cause familial adenomatous polyposis (FAP).  Disease severity and the presence of extracolonic manifestations seem to be correlated with the location of the mutation on the APC gene.  In this review, large studies describing genotype-phenotype correlations in FAP were evaluated and categorized.  Attenuated FAP (AFAP, <100 colorectal adenomas) is correlated with mutations before codon 157, after codon 1595 and in the alternatively spliced region of exon 9.  Severe polyposis (>1000 adenomas) is found in patients with mutations between codons 1250 and 1464.  Mutations in the remainder of the APC gene cause an intermediate phenotype (hundred to thousands of adenomas).  Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and desmoid tumours are associated with mutations between codons 311 and 1444 and after codon 1444, respectively.  No consistent correlations were found for upper gastrointestinal tumours.  Genotype-phenotype correlations in FAP will be useful in decisions concerning screening and surgical management of FAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRB1GvNhTlKxz0SWnHPWbmmfW6udTcc2ebVYu6z6tBOm7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FisVyqsQ%253D%253D&md5=a0dff62b01ce2052bf275dfbd34ad6a3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.critrevonc.2006.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.critrevonc.2006.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DNieuwenhuis%26aufirst%3DM.%2BH.%26aulast%3DVasen%26aufirst%3DH.%2BF.%2BA.%26atitle%3DCorrelations%2520between%2520mutation%2520site%2520in%2520APC%2520and%2520phenotype%2520of%2520familial%2520adenomatous%2520polyposis%2520%2528FAP%2529%253A%2520A%2520review%2520of%2520the%2520literature%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hematol.%26date%3D2007%26volume%3D61%26spage%3D153%26epage%3D161%26doi%3D10.1016%2Fj.critrevonc.2006.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamlum, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilyas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frayling, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efstathiou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pack, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roylance, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodmer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, I.</span></span> <span> </span><span class="NLM_article-title">The type of somatic mutation at <i>APC</i> in familial adenomatous polyposis is determined by the site of the germline mutation: A new facet to Knudsonâs âtwo-hitâ hypothesis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1071</span>â <span class="NLM_lpage">1075</span>, <span class="refDoi">Â DOI: 10.1038/12511</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1038%2F12511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10470088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaK1MXlslKltrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=1071-1075&author=H.+Lamlumauthor=M.+Ilyasauthor=A.+Rowanauthor=S.+Clarkauthor=V.+Johnsonauthor=J.+Bellauthor=I.+Fraylingauthor=J.+Efstathiouauthor=K.+Packauthor=S.+Payneauthor=R.+Roylanceauthor=P.+Gormanauthor=D.+Sheerauthor=K.+Nealeauthor=R.+Phillipsauthor=I.+Talbotauthor=W.+Bodmerauthor=I.+Tomlinson&title=The+type+of+somatic+mutation+at+APC+in+familial+adenomatous+polyposis+is+determined+by+the+site+of+the+germline+mutation%3A+A+new+facet+to+Knudson%E2%80%99s+%E2%80%98two-hit%E2%80%99+hypothesis&doi=10.1038%2F12511"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis</span></div><div class="casAuthors">Lamlum, Hanan; Ilyas, Mohammad; Rowan, Andrew; Clark, Susan; Johnson, Victoria; Bell, Jennie; Frayling, Ian; Efstathiou, Jason; Pack, Kevin; Payne, Stewart; Roylance, Rebecca; Gorman, Patricia; Sheer, Denise; Neale, Kay; Phillips, Robin; Talbot, Ian; Bodmer, Walter; Tomlinson, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1071-1075</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">APC is often cited as a prime example of a tumor suppressor gene.  Truncating germline and somatic mutations (or, infrequently, allelic loss) occur in tumors in FAP (familial adenomatous polyposis).  Most sporadic colorectal cancers also have two APC mutations.  Clues from attenuated polyposis, missense germline variants with mild disease and the somatic mutation cluster region (codons 1250-1450) indicate, however, that APC mutations might not result in simple loss of protein function.  We have found that FAP patients with germline APC mutations within a small region (codons 1194-1392 at most) mainly show allelic loss in their colorectal adenomas, in contrast to other FAP patients, whose 'second hits' tend to occur by truncating mutations in the mutation cluster region.  Our results indicate that different APC mutations provide cells with different selective advantages, with mutations close to codon 1300 providing the greatest advantage.  Allelic loss is selected strongly in cells with one mutation near codon 1300.  A different germline-somatic APC mutation assocn. exists in FAP desmoids.  APC is not, therefore, a classical tumor suppressor.  Our findings also indicate a new mechanism for disease severity: if a broader spectrum of mutations is selected in tumors, the somatic mutation rate is effectively higher and more tumors grow.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKHZNlufH_vbVg90H21EOLACvtfcHk0liKhyTf-FkKUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslKltrk%253D&md5=de7284c5d97bb8115a1430b9100dc290</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F12511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F12511%26sid%3Dliteratum%253Aachs%26aulast%3DLamlum%26aufirst%3DH.%26aulast%3DIlyas%26aufirst%3DM.%26aulast%3DRowan%26aufirst%3DA.%26aulast%3DClark%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DV.%26aulast%3DBell%26aufirst%3DJ.%26aulast%3DFrayling%26aufirst%3DI.%26aulast%3DEfstathiou%26aufirst%3DJ.%26aulast%3DPack%26aufirst%3DK.%26aulast%3DPayne%26aufirst%3DS.%26aulast%3DRoylance%26aufirst%3DR.%26aulast%3DGorman%26aufirst%3DP.%26aulast%3DSheer%26aufirst%3DD.%26aulast%3DNeale%26aufirst%3DK.%26aulast%3DPhillips%26aufirst%3DR.%26aulast%3DTalbot%26aufirst%3DI.%26aulast%3DBodmer%26aufirst%3DW.%26aulast%3DTomlinson%26aufirst%3DI.%26atitle%3DThe%2520type%2520of%2520somatic%2520mutation%2520at%2520APC%2520in%2520familial%2520adenomatous%2520polyposis%2520is%2520determined%2520by%2520the%2520site%2520of%2520the%2520germline%2520mutation%253A%2520A%2520new%2520facet%2520to%2520Knudson%25E2%2580%2599s%2520%25E2%2580%2598two-hit%25E2%2580%2599%2520hypothesis%26jtitle%3DNat.%2520Med.%26date%3D1999%26volume%3D5%26spage%3D1071%26epage%3D1075%26doi%3D10.1038%2F12511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poiwell, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zilz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beazer-Barclay, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibodeau, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span> <span> </span><span class="NLM_article-title">APC mutations occur early during colorectal tumorigenesis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">235</span>â <span class="NLM_lpage">237</span>, <span class="refDoi">Â DOI: 10.1038/359235a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1038%2F359235a0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=1992&pages=235-237&author=S.+M.+Poiwellauthor=N.+Zilzauthor=Y.+Beazer-Barclayauthor=T.+M.+Bryanauthor=S.+R.+Hamiltonauthor=S.+N.+Thibodeauauthor=B.+Vogelsteinauthor=K.+W.+Kinzler&title=APC+mutations+occur+early+during+colorectal+tumorigenesis&doi=10.1038%2F359235a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F359235a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F359235a0%26sid%3Dliteratum%253Aachs%26aulast%3DPoiwell%26aufirst%3DS.%2BM.%26aulast%3DZilz%26aufirst%3DN.%26aulast%3DBeazer-Barclay%26aufirst%3DY.%26aulast%3DBryan%26aufirst%3DT.%2BM.%26aulast%3DHamilton%26aufirst%3DS.%2BR.%26aulast%3DThibodeau%26aufirst%3DS.%2BN.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DAPC%2520mutations%2520occur%2520early%2520during%2520colorectal%2520tumorigenesis%26jtitle%3DNature%26date%3D1992%26volume%3D359%26spage%3D235%26epage%3D237%26doi%3D10.1038%2F359235a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span> <span> </span><span class="NLM_article-title">A genetic model for colorectal tumorigenesis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">759</span>â <span class="NLM_lpage">767</span>, <span class="refDoi">Â DOI: 10.1016/0092-8674(90)90186-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2F0092-8674%2890%2990186-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=2188735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaK3cXktlyhtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1990&pages=759-767&author=E.+R.+Fearonauthor=B.+Vogelstein&title=A+genetic+model+for+colorectal+tumorigenesis&doi=10.1016%2F0092-8674%2890%2990186-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A genetic model for colorectal tumorigenesis</span></div><div class="casAuthors">Fearon, Eric R.; Vogelstein, Bert</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">759-67</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    </div><div class="casAbstract">A review with 76 refs. on various genetic aspects of colonic neoplasia, including genetic alterations of oncogenes, clonal selection, allelic losses and tumor suppressor genes, multiple allelic losses, and accumulation and multistep tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe4CC_sLtNt7Vg90H21EOLACvtfcHk0lhuvfhD8tybww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXktlyhtrg%253D&md5=d88588a58ce05a327c3e7ff8afccd3a7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2890%2990186-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252890%252990186-I%26sid%3Dliteratum%253Aachs%26aulast%3DFearon%26aufirst%3DE.%2BR.%26aulast%3DVogelstein%26aufirst%3DB.%26atitle%3DA%2520genetic%2520model%2520for%2520colorectal%2520tumorigenesis%26jtitle%3DCell%26date%3D1990%26volume%3D61%26spage%3D759%26epage%3D767%26doi%3D10.1016%2F0092-8674%2890%2990186-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taketo, M. M.</span></span> <span> </span><span class="NLM_article-title">Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">3327</span>â <span class="NLM_lpage">3335</span>, <span class="refDoi">Â DOI: 10.1242/jcs.03485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1242%2Fjcs.03485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=17881494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ygtbfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2007&pages=3327-3335&author=K.+Aokiauthor=M.+M.+Taketo&title=Adenomatous+polyposis+coli+%28APC%29%3A+a+multi-functional+tumor+suppressor+gene&doi=10.1242%2Fjcs.03485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene</span></div><div class="casAuthors">Aoki, Koji; Taketo, Makoto M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3327-3335</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  The adenomatous polyposis coli (APC) gene is a key tumor suppressor gene.  Mutations in the gene were found not only in most colon cancers but also in some other cancers, such as those of the liver.  The APC gene product is a 312 kDa protein that has multiple domains, through which it binds to various proteins, including Î²-catenin, axin, CtBP, Asefs, IQGAP1, EB1 and microtubules.  Studies using mutant mice and cultured cells have demonstrated that APC suppresses canonical Wnt signaling, which is essential for tumorigenesis, development and homeostasis of a variety of cell types, such as epithelial and lymphoid cells.  Further studies have suggested that APC plays roles in several other fundamental cellular processes.  These include cell adhesion and migration, organization of the actin and microtubule networks, spindle formation and chromosome segregation.  Deregulation of these processes caused by mutations in APC is implicated in the initiation and expansion of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw1-zJvwW4abVg90H21EOLACvtfcHk0lhuvfhD8tybww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ygtbfJ&md5=1be7d62111279782a9a5ac69d357b543</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1242%2Fjcs.03485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.03485%26sid%3Dliteratum%253Aachs%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DTaketo%26aufirst%3DM.%2BM.%26atitle%3DAdenomatous%2520polyposis%2520coli%2520%2528APC%2529%253A%2520a%2520multi-functional%2520tumor%2520suppressor%2520gene%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2007%26volume%3D120%26spage%3D3327%26epage%3D3335%26doi%3D10.1242%2Fjcs.03485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronobis, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulton, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peifer, M.</span></span> <span> </span><span class="NLM_article-title">Deconstructing the Î²-catenin destruction complex: Mechanistic roles for the tumor suppressor APC in regulating Wnt signaling</span>. <i>Mol. Biol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1845</span>â <span class="NLM_lpage">1863</span>, <span class="refDoi">Â DOI: 10.1091/mbc.e10-11-0871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1091%2Fmbc.e10-11-0871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=21471006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsFKktbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1845-1863&author=D.+M.+Robertsauthor=M.+I.+Pronobisauthor=J.+S.+Poultonauthor=J.+D.+Waldmannauthor=E.+M.+Stephensonauthor=S.+Hannaauthor=M.+Peifer&title=Deconstructing+the+%CE%B2-catenin+destruction+complex%3A+Mechanistic+roles+for+the+tumor+suppressor+APC+in+regulating+Wnt+signaling&doi=10.1091%2Fmbc.e10-11-0871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Deconstructing the sscatenin destruction complex: mechanistic roles for the tumor suppressor APC in regulating Wnt signaling</span></div><div class="casAuthors">Roberts, David M.; Pronobis, Mira I.; Poulton, John S.; Waldmann, Jon D.; Stephenson, Elise M.; Hanna, Shahnaz; Peifer, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1845-1863</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1939-4586</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">Neg. regulating signaling by targeting key effectors for ubiquitination/destruction is essential for development and oncogenesis.  The tumor suppressor adenomatous polyposis coli (APC), an essential neg. regulator of Wnt signaling, provides a paradigm.  APC mutations occur in most colon cancers.  Acting in the "destruction complex" with Axin, glycogen synthase kinase 3, and casein kinase, APC targets Î²-catenin (Î²cat) for phosphorylation and recognition by an E3 ubiquitin-ligase.  Despite 20 years of work, the internal workings of the destruction complex and APC's role remain largely mysterious.  We use both Drosophila and colon cancer cells to test hypotheses for APC's mechanism of action.  Our data are inconsistent with current models suggesting that high-affinity Î²cat-binding sites on APC play key roles.  Instead, they suggest that multiple Î²cat-binding sites act additively to fine-tune signaling via cytoplasmic retention.  We identify essential roles for two putative binding sites for new partners-20-amino-acid repeat 2 and conserved sequence B-in destruction complex action.  Finally, we demonstrate that APC interacts with Axin by two different modes and provide evidence that conserved sequence B helps ensure release of APC from Axin, with disassembly crit. in regulating sscat levels.  Using these data, we suggest a new model for destruction complex action in development, which also provides new insights into functions of truncated APC proteins in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq75g7oED20UbVg90H21EOLACvtfcHk0lh0ayq0hAj_oQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsFKktbY%253D&md5=9710e65791db974fce7f072b2bc01b0f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1091%2Fmbc.e10-11-0871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.e10-11-0871%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DD.%2BM.%26aulast%3DPronobis%26aufirst%3DM.%2BI.%26aulast%3DPoulton%26aufirst%3DJ.%2BS.%26aulast%3DWaldmann%26aufirst%3DJ.%2BD.%26aulast%3DStephenson%26aufirst%3DE.%2BM.%26aulast%3DHanna%26aufirst%3DS.%26aulast%3DPeifer%26aufirst%3DM.%26atitle%3DDeconstructing%2520the%2520%25CE%25B2-catenin%2520destruction%2520complex%253A%2520Mechanistic%2520roles%2520for%2520the%2520tumor%2520suppressor%2520APC%2520in%2520regulating%2520Wnt%2520signaling%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2011%26volume%3D22%26spage%3D1845%26epage%3D1863%26doi%3D10.1091%2Fmbc.e10-11-0871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
de Wetering, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sancho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lau, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oving, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurlstone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Horn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batlle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudreuse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haramis, A.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjon-Pon-Fong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moerer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Born, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soete, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pals, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">The Î²-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">241</span>â <span class="NLM_lpage">250</span>, <span class="refDoi">Â DOI: 10.1016/S0092-8674(02)01014-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2FS0092-8674%2802%2901014-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=12408868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotlahsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2002&pages=241-250&author=M.+van%0Ade+Weteringauthor=E.+Sanchoauthor=C.+Verweijauthor=W.+de+Lauauthor=I.+Ovingauthor=A.+Hurlstoneauthor=K.+van+der+Hornauthor=E.+Batlleauthor=D.+Coudreuseauthor=A.-P.+Haramisauthor=M.+Tjon-Pon-Fongauthor=P.+Moererauthor=M.+van+den+Bornauthor=G.+Soeteauthor=S.+Palsauthor=M.+Eilersauthor=R.+Medemaauthor=H.+Clevers&title=The+%CE%B2-catenin%2FTCF-4+complex+imposes+a+crypt+progenitor+phenotype+on+colorectal+cancer+cells&doi=10.1016%2FS0092-8674%2802%2901014-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Î²-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells</span></div><div class="casAuthors">Van de Wetering, Marc; Sancho, Elena; Verweij, Cornelis; De Lau, Wim; Oving, Irma; Hurlstone, Adam; Van der Horn, Karin; Batlle, Eduard; Coudreuse, Damien; Haramis, Anna-Pavlina; Tjon-Pon-Fong, Menno; Moerer, Petra; Van den Born, Maaike; Soete, Gwen; Pals, Steven; Eilers, Martin; Medema, Rene; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-250</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The transactivation of TCF target genes induced by Wnt pathway mutations constitutes the primary transforming event in colorectal cancer (CRC).  The authors show that disruption of Î²-catenin/TCF-4 activity in CRC cells induces a rapid G1 arrest and blocks a genetic program that is physiol. active in the proliferative compartment of colon crypts.  Coincidently, an intestinal differentiation program is induced.  The TCF-4 target gene c-MYC plays a central role in this switch by direct repression of the p21CIP1/WAF1 promoter.  Following disruption of Î²-catenin/TCF-4 activity, the decreased expression of c-MYC releases p21CIP1/WAF1 transcription, which in turn mediates G1 arrest and differentiation.  Thus, the Î²-catenin/TCF-4 complex constitutes the master switch that controls proliferation vs. differentiation in healthy and malignant intestinal epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVqLagkm3jcLVg90H21EOLACvtfcHk0lh0ayq0hAj_oQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotlahsrg%253D&md5=d3b611aa88ba8ea40d333774f844038e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2901014-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252901014-0%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BWetering%26aufirst%3DM.%26aulast%3DSancho%26aufirst%3DE.%26aulast%3DVerweij%26aufirst%3DC.%26aulast%3Dde%2BLau%26aufirst%3DW.%26aulast%3DOving%26aufirst%3DI.%26aulast%3DHurlstone%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BHorn%26aufirst%3DK.%26aulast%3DBatlle%26aufirst%3DE.%26aulast%3DCoudreuse%26aufirst%3DD.%26aulast%3DHaramis%26aufirst%3DA.-P.%26aulast%3DTjon-Pon-Fong%26aufirst%3DM.%26aulast%3DMoerer%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BBorn%26aufirst%3DM.%26aulast%3DSoete%26aufirst%3DG.%26aulast%3DPals%26aufirst%3DS.%26aulast%3DEilers%26aufirst%3DM.%26aulast%3DMedema%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DThe%2520%25CE%25B2-catenin%252FTCF-4%2520complex%2520imposes%2520a%2520crypt%2520progenitor%2520phenotype%2520on%2520colorectal%2520cancer%2520cells%26jtitle%3DCell%26date%3D2002%26volume%3D111%26spage%3D241%26epage%3D250%26doi%3D10.1016%2FS0092-8674%2802%2901014-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goss, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groden, J.</span></span> <span> </span><span class="NLM_article-title">Biology of the adenomatous polyposis coli tumor suppressor</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1967</span>â <span class="NLM_lpage">1979</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2000.18.9.1967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1200%2FJCO.2000.18.9.1967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10784639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A280%3ADC%252BD3c3ksleltg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=1967-1979&author=K.+H.+Gossauthor=J.+Groden&title=Biology+of+the+adenomatous+polyposis+coli+tumor+suppressor&doi=10.1200%2FJCO.2000.18.9.1967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Biology of the adenomatous polyposis coli tumor suppressor</span></div><div class="casAuthors">Goss K H; Groden J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1967-79</span>
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    </div><div class="casAbstract">The adenomatous polyposis coli (APC) gene was first identified as the gene mutated in an inherited syndrome of colon cancer predisposition known as familial adenomatous polyposis coli (FAP).  Mutation of APC is also found in 80% of all colorectal adenomas and carcinomas and is one of the earliest mutations in colon cancer progression.  Similar to other tumor suppressor genes, both APC alleles are inactivated by mutation in colon tumors, resulting in the loss of full-length protein in tumor cells.  The functional significance of altering APC is the dysregulation of several physiologic processes that govern colonic epithelial cell homeostasis, which include cell cycle progression, migration, differentiation, and apoptosis.  Roles for APC in some of these processes are in large part attributable to its ability to regulate cytosolic levels of the signaling molecule beta-catenin and to affect the transcriptional profile in cells.  This article summarizes numerous genetic, biochemical, and cell biologic studies on the mechanisms of APC-mediated tumor suppression.  Mouse models of FAP, in which the APC gene has been genetically inactivated, have been particularly useful in testing therapeutic and chemopreventive strategies.  These data have significant implications for colorectal cancer treatment approaches as well as for understanding other disease genes and cancers of other tissue types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8oLHgrmJuaub6AVA-44PTfW6udTcc2eZ7eHDmpoEyB7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3ksleltg%253D%253D&md5=53c1a322d859e7b01392265426fa99b4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1200%2FJCO.2000.18.9.1967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2000.18.9.1967%26sid%3Dliteratum%253Aachs%26aulast%3DGoss%26aufirst%3DK.%2BH.%26aulast%3DGroden%26aufirst%3DJ.%26atitle%3DBiology%2520of%2520the%2520adenomatous%2520polyposis%2520coli%2520tumor%2520suppressor%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2000%26volume%3D18%26spage%3D1967%26epage%3D1979%26doi%3D10.1200%2FJCO.2000.18.9.1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span> <span> </span><span class="NLM_article-title">The adenomatous polyposis coli (APC) tumor suppressor</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>1332</i></span>,  <span class="NLM_fpage">F127</span>â <span class="NLM_lpage">F147</span>, <span class="refDoi">Â DOI: 10.1016/S0304-419X(97)00008-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2FS0304-419X%2897%2900008-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=9196022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaK2sXjtlWgsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1332&publication_year=1997&pages=F127-F147&author=P.+Polakis&title=The+adenomatous+polyposis+coli+%28APC%29+tumor+suppressor&doi=10.1016%2FS0304-419X%2897%2900008-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The adenomatous polyposis coli (APC) tumor suppressor</span></div><div class="casAuthors">Polakis, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">1332</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">F127-F148</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 149 refs.  Defects in the APC gene are inarguably linked to the progression of colon cancers that arise both sporadically and through the transmission of germline mutations.  Genetic evidence from humans and mouse models suggest that APC is a classic tumor suppressor in that both alleles likely require inactivation for tumor growth to ensue.  Nearly all of the mutations, germline and somatic, result in premature termination of the single polypeptide chain, normally consisting of 2843 amino acids.  Several definable motifs have now been mapped to the linear amino acid sequence of the APC polypeptide.  These include an oligomerization domain, armadillo repeats, binding sites for Î²-catenin, the human disks large protein, microtubules, and other proteins of unknown function.  Inactivation of APC in cancer is likely due to loss of function(s) normally assocd. with the deleted protein structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoawqiOHp4e7LVg90H21EOLACvtfcHk0lhGsI0Ip2t1qA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtlWgsr4%253D&md5=6987765aef43d416e4bd482418048d4f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0304-419X%2897%2900008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-419X%252897%252900008-5%26sid%3Dliteratum%253Aachs%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DThe%2520adenomatous%2520polyposis%2520coli%2520%2528APC%2529%2520tumor%2520suppressor%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D1997%26volume%3D1332%26spage%3DF127%26epage%3DF147%26doi%3D10.1016%2FS0304-419X%2897%2900008-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagse, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horii, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichii, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span> <span> </span><span class="NLM_article-title">Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the <i>APC</i> gene</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">229</span>â <span class="NLM_lpage">233</span>, <span class="refDoi">Â DOI: 10.1093/hmg/1.4.229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1093%2Fhmg%2F1.4.229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1338904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaK38XlsVyhurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1992&pages=229-233&author=Y.+Moriauthor=H.+Nagseauthor=H.+Andoauthor=A.+Horiiauthor=S.+Ichiiauthor=S.+Nakatsuruauthor=T.+Aokiauthor=Y.+Mikiauthor=T.+Moriauthor=Y.+Nakamura&title=Somatic+mutations+of+the+APC+gene+in+colorectal+tumors%3A+Mutation+cluster+region+in+the+APC+gene&doi=10.1093%2Fhmg%2F1.4.229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations of the APC gene in colorectal tumors:  mutation cluster region in the APC gene</span></div><div class="casAuthors">Miyoshi, Yasuo; Nagase, Hiroki; Ando, Hiroshi; Horii, Akira; Ichii, Shigetoshi; Nakatsuru, Shuichi; Aoki, Takahisa; Miki, Yoshio; Mori, Takesada; Nakamura, Yusuke</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">229-33</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    </div><div class="casAbstract">This study examd. somatic mutations of the adenomatous polyposis coli (APC) gene in 63 colorectal tumors (16 adenomas and 47 carcinomas) developed in familial adenomatous polyposis (FAP) and non-FAP patients.  In addn. to loss of heterozygosity (LOH) at the APC locus in 30 tumors, 43 other somatic mutations were detected.  Twenty-one of them were point mutations; 16 nonsense and two missense mutations, and three occurred in introns at the splicing site.  Twenty-two tumors had frameshift mutations due to deletion or insertion; nineteen of them were deletions of one to 31 bp and three were a 1-bp insertion.  One tumor had a 1-bp deletion in an intron near the splicing site.  Hence, 41 (95%) of 43 mutations resulted in truncation of the APC protein.  Over 60% of the somatic mutations in the APC gene were clustered within a small region of exon 15, designated as MCR (mutation cluster region), which accounted for less than 10% of the coding region.  Combining these data and the results of LOH, more than 80% of tumors (14 adenomas and 39 carcinomas) had at least one mutation in the APC gene, of which more than 60% (9 adenomas and 23 carcinomas) had two mutations.  These results strongly suggest that somatic mutations of the APC gene are assocd. with development of a great majority of colorectal tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1_TFSQZ0goLVg90H21EOLACvtfcHk0lhGsI0Ip2t1qA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlsVyhurc%253D&md5=b999a51d316f9a2b6e9e438cef0237bc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F1.4.229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F1.4.229%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DY.%26aulast%3DNagse%26aufirst%3DH.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DHorii%26aufirst%3DA.%26aulast%3DIchii%26aufirst%3DS.%26aulast%3DNakatsuru%26aufirst%3DS.%26aulast%3DAoki%26aufirst%3DT.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DSomatic%2520mutations%2520of%2520the%2520APC%2520gene%2520in%2520colorectal%2520tumors%253A%2520Mutation%2520cluster%2520region%2520in%2520the%2520APC%2520gene%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D1992%26volume%3D1%26spage%3D229%26epage%3D233%26doi%3D10.1093%2Fhmg%2F1.4.229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span> <span> </span><span class="NLM_article-title">Mutated APC and Asef are involved in the migration of colorectal tumour cells</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">211</span>â <span class="NLM_lpage">215</span>, <span class="refDoi">Â DOI: 10.1038/ncb937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1038%2Fncb937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=12598901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFKmsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=211-215&author=Y.+Kawasakiauthor=R.+Satoauthor=T.+Akiyama&title=Mutated+APC+and+Asef+are+involved+in+the+migration+of+colorectal+tumour+cells&doi=10.1038%2Fncb937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mutated APC and Asef are involved in the migration of colorectal tumor cells</span></div><div class="casAuthors">Kawasaki, Yoshihiro; Sato, Rina; Akiyama, Tetsu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-215</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The tumor suppressor adenomatous polyposis coli (APC) is mutated in sporadic and familial colorectal tumors.  APC binds to Î²-catenin, a key component of the Wnt signaling pathway, and induces its degrdn.  APC interacts with microtubules and accumulates at their plus ends in membrane protrusions, and assocs. with the plasma membrane in an actin-dependent manner.  In addn., APC interacts with the Rac-specific guanine nucleotide exchange factor Asef and stimulates its activity, thereby regulating the actin cytoskeletal network and cell morphol.  Here we show that overexpression of Asef decreases E-cadherin-mediated cell-cell adhesion and promotes the migration of epithelial Madin-Darby canine kidney cells.  Both of these activities are stimulated by truncated APC proteins expressed in colorectal tumor cells.  Expts. based on RNA interference and dominant-neg. mutants show that both Asef and mutated APC are required for the migration of colorectal tumor cells expressing truncated APC.  These results suggest that the APC-Asef complex functions in cell migration as well as in E-cadherin-mediated cell-cell adhesion, and that truncated APC present in colorectal tumor cells contributes to their aberrant migratory properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdLjSC6kQOLbVg90H21EOLACvtfcHk0liQ4hry24rwNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFKmsbw%253D&md5=8d7c2a5b6ea5e4ddaac76fd65b8a8604</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fncb937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb937%26sid%3Dliteratum%253Aachs%26aulast%3DKawasaki%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DR.%26aulast%3DAkiyama%26aufirst%3DT.%26atitle%3DMutated%2520APC%2520and%2520Asef%2520are%2520involved%2520in%2520the%2520migration%2520of%2520colorectal%2520tumour%2520cells%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D211%26epage%3D215%26doi%3D10.1038%2Fncb937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishidate, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span> <span> </span><span class="NLM_article-title">Asef, a link between the tumor suppressor APC and G-protein signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">1194</span>â <span class="NLM_lpage">1197</span>, <span class="refDoi">Â DOI: 10.1126/science.289.5482.1194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1126%2Fscience.289.5482.1194" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1194-1197&author=Y.+Kawasakiauthor=T.+Sendaauthor=T.+Ishidateauthor=R.+Koyamaauthor=T.+Morishitaauthor=Y.+Iwayamaauthor=O.+Higuchiauthor=T.+Akiyama&title=Asef%2C+a+link+between+the+tumor+suppressor+APC+and+G-protein+signaling&doi=10.1126%2Fscience.289.5482.1194"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5482.1194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5482.1194%26sid%3Dliteratum%253Aachs%26aulast%3DKawasaki%26aufirst%3DY.%26aulast%3DSenda%26aufirst%3DT.%26aulast%3DIshidate%26aufirst%3DT.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DMorishita%26aufirst%3DT.%26aulast%3DIwayama%26aufirst%3DY.%26aulast%3DHiguchi%26aufirst%3DO.%26aulast%3DAkiyama%26aufirst%3DT.%26atitle%3DAsef%252C%2520a%2520link%2520between%2520the%2520tumor%2520suppressor%2520APC%2520and%2520G-protein%2520signaling%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1194%26epage%3D1197%26doi%3D10.1126%2Fscience.289.5482.1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, K. B.</span></span> <span> </span><span class="NLM_article-title">Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in <i>APC</i></span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">949</span>â <span class="NLM_lpage">961</span>, <span class="refDoi">Â DOI: 10.1083/jcb.200307070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1083%2Fjcb.200307070" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2003&pages=949-961&author=R.+A.+Greenauthor=K.+B.+Kaplan&title=Chromosome+instability+in+colorectal+tumor+cells+is+associated+with+defects+in+microtubule+plus-end+attachments+caused+by+a+dominant+mutation+in+APC&doi=10.1083%2Fjcb.200307070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200307070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200307070%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DR.%2BA.%26aulast%3DKaplan%26aufirst%3DK.%2BB.%26atitle%3DChromosome%2520instability%2520in%2520colorectal%2520tumor%2520cells%2520is%2520associated%2520with%2520defects%2520in%2520microtubule%2520plus-end%2520attachments%2520caused%2520by%2520a%2520dominant%2520mutation%2520in%2520APC%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2003%26volume%3D163%26spage%3D949%26epage%3D961%26doi%3D10.1083%2Fjcb.200307070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tighe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. S.</span></span> <span> </span><span class="NLM_article-title">Truncating <i>APC</i> mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">6339</span>â <span class="NLM_lpage">6353</span>, <span class="refDoi">Â DOI: 10.1242/jcs.01556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1242%2Fjcs.01556" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=15561772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFert74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=6339-6353&author=A.+Tigheauthor=V.+L.+Johnsonauthor=S.+S.+Taylor&title=Truncating+APC+mutations+have+dominant+effects+on+proliferation%2C+spindle+checkpoint+control%2C+survival+and+chromosome+stability&doi=10.1242%2Fjcs.01556"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability</span></div><div class="casAuthors">Tighe, Anthony; Johnson, Victoria L.; Taylor, Stephen S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6339-6353</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">The majority of human tumor cells are aneuploid owing to an underlying chromosome instability phenotype.  While the genetic lesions that cause chromosome instability remain undefined, mouse ES cells harboring homozygous adenomatous polyposis coli (APC) mutations are frequently tetraploid.  In addn., colon cancer cells with APC mutations have weakened kinetochore-microtubule interactions.  Furthermore, mitotic spindles assembled in APC-depleted Xenopus egg exts. are aberrant.  Therefore, to det. whether APC mutations can initiate chromosome instability in human cells, we expressed N-terminal APC fragments in HCT-116 cells, a near diploid colon cancer cell line with two wild-type APC alleles.  We show that cells expressing N-APC mutants exit mitosis prematurely in the presence of spindle toxins, consistent with a spindle checkpoint defect.  In addn., N-APC cells show enhanced survival following prolonged spindle damage.  In contrast to controls, the N-APC survivors frequently contain dicentric chromosomes and then go on to become highly aneuploid.  These observations suggest that truncating APC mutations can exert dominant effects which in turn can initiate chromosome instability.  As such, APC mutation not only compromises tumor suppressor function but may also have oncogenic properties.  We suggest therefore that the initial APC mutation acts as a 'double whammy', destabilizing the genome and setting the stage for deregulated proliferation upon loss of the second APC allele.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9ze5tEvWforVg90H21EOLACvtfcHk0liQ4hry24rwNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFert74%253D&md5=4269f74448b9efbea81ddbd3412832ce</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1242%2Fjcs.01556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.01556%26sid%3Dliteratum%253Aachs%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DV.%2BL.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DTruncating%2520APC%2520mutations%2520have%2520dominant%2520effects%2520on%2520proliferation%252C%2520spindle%2520checkpoint%2520control%252C%2520survival%2520and%2520chromosome%2520stability%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2004%26volume%3D117%26spage%3D6339%26epage%3D6353%26doi%3D10.1242%2Fjcs.01556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, Y.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, J. W.</span></span> <span> </span><span class="NLM_article-title">Truncated adenomatous polyposis coli mutation induces Asef-activated Golgi fragmentation</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>, <span class="NLM_elocation-id">e00135-18</span> <span class="refDoi">Â DOI: 10.1128/MCB.00135-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1128%2FMCB.00135-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=29866653" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&author=S.+B.+Kimauthor=L.+Zhangauthor=J.+Yoonauthor=J.+Leeauthor=J.+Minauthor=W.+Liauthor=N.+V.+Grishinauthor=Y.-A.+Moonauthor=W.+E.+Wrightauthor=J.+W.+Shay&title=Truncated+adenomatous+polyposis+coli+mutation+induces+Asef-activated+Golgi+fragmentation&doi=10.1128%2FMCB.00135-18"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FMCB.00135-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00135-18%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BB.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYoon%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGrishin%26aufirst%3DN.%2BV.%26aulast%3DMoon%26aufirst%3DY.-A.%26aulast%3DWright%26aufirst%3DW.%2BE.%26aulast%3DShay%26aufirst%3DJ.%2BW.%26atitle%3DTruncated%2520adenomatous%2520polyposis%2520coli%2520mutation%2520induces%2520Asef-activated%2520Golgi%2520fragmentation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2018%26volume%3D38%26doi%3D10.1128%2FMCB.00135-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâRourke, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschaharganeh, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Es, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span> <span> </span><span class="NLM_article-title">Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1539</span>â <span class="NLM_lpage">1552</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2015.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2Fj.cell.2015.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=26091037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Squ7zF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2015&pages=1539-1552&author=L.+E.+Dowauthor=K.+P.+O%E2%80%99Rourkeauthor=J.+Simonauthor=D.+F.+Tschaharganehauthor=J.+H.+van+Esauthor=H.+Cleversauthor=S.+W.+Lowe&title=Apc+restoration+promotes+cellular+differentiation+and+reestablishes+crypt+homeostasis+in+colorectal+cancer&doi=10.1016%2Fj.cell.2015.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer</span></div><div class="casAuthors">Dow, Lukas E.; O'Rourke, Kevin P.; Simon, Janelle; Tschaharganeh, Darjus F.; van Es, Johan H.; Clevers, Hans; Lowe, Scott W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1539-1552</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The adenomatous polyposis coli (APC) tumor suppressor is mutated in the vast majority of human colorectal cancers (CRC) and leads to deregulated Wnt signaling.  To det. whether Apc disruption is required for tumor maintenance, we developed a mouse model of CRC whereby Apc can be conditionally suppressed using a doxycycline-regulated shRNA.  Apc suppression produces adenomas in both the small intestine and colon that, in the presence of Kras and p53 mutations, can progress to invasive carcinoma.  In established tumors, Apc restoration drives rapid and widespread tumor-cell differentiation and sustained regression without relapse.  Tumor regression is accompanied by the re-establishment of normal crypt-villus homeostasis, such that once aberrantly proliferating cells reacquire self-renewal and multi-lineage differentiation capability.  Our study reveals that CRC cells can revert to functioning normal cells given appropriate signals and provide compelling in vivo validation of the Wnt pathway as a therapeutic target for treatment of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOJhLhIEo70LVg90H21EOLACvtfcHk0liOtHeXejQBpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Squ7zF&md5=c5bdedbcfb89050521a0316438327b5a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DL.%2BE.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DK.%2BP.%26aulast%3DSimon%26aufirst%3DJ.%26aulast%3DTschaharganeh%26aufirst%3DD.%2BF.%26aulast%3Dvan%2BEs%26aufirst%3DJ.%2BH.%26aulast%3DClevers%26aufirst%3DH.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DApc%2520restoration%2520promotes%2520cellular%2520differentiation%2520and%2520reestablishes%2520crypt%2520homeostasis%2520in%2520colorectal%2520cancer%26jtitle%3DCell%26date%3D2015%26volume%3D161%26spage%3D1539%26epage%3D1552%26doi%3D10.1016%2Fj.cell.2015.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theodoropoulos, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskiocak, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, Y.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijhawan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Brabander, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, J. W.</span></span> <span> </span><span class="NLM_article-title">Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">361ra140</span> <span class="refDoi">Â DOI: 10.1126/scitranslmed.aaf8127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1126%2Fscitranslmed.aaf8127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=27798265" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&author=L.+Zhangauthor=P.+C.+Theodoropoulosauthor=U.+Eskiocakauthor=W.+Wangauthor=Y.-A.+Moonauthor=B.+Posnerauthor=N.+S.+Williamsauthor=W.+E.+Wrightauthor=S.+B.+Kimauthor=D.+Nijhawanauthor=J.+K.+De+Brabanderauthor=J.+W.+Shay&title=Selective+targeting+of+mutant+adenomatous+polyposis+coli+%28APC%29+in+colorectal+cancer&doi=10.1126%2Fscitranslmed.aaf8127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaf8127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaf8127%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DTheodoropoulos%26aufirst%3DP.%2BC.%26aulast%3DEskiocak%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMoon%26aufirst%3DY.-A.%26aulast%3DPosner%26aufirst%3DB.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DWright%26aufirst%3DW.%2BE.%26aulast%3DKim%26aufirst%3DS.%2BB.%26aulast%3DNijhawan%26aufirst%3DD.%26aulast%3DDe%2BBrabander%26aufirst%3DJ.%2BK.%26aulast%3DShay%26aufirst%3DJ.%2BW.%26atitle%3DSelective%2520targeting%2520of%2520mutant%2520adenomatous%2520polyposis%2520coli%2520%2528APC%2529%2520in%2520colorectal%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26doi%3D10.1126%2Fscitranslmed.aaf8127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinoi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akyol, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theisen, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span> <span> </span><span class="NLM_article-title">Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">9721</span>â <span class="NLM_lpage">9730</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-07-2735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1158%2F0008-5472.CAN-07-2735" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=9721-9730&author=T.+Hinoiauthor=A.+Akyolauthor=B.+K.+Theisenauthor=D.+O.+Fergusonauthor=J.+K.+Greensonauthor=B.+O.+Williamsauthor=K.+R.+Choauthor=E.+R.+Fearon&title=Mouse+model+of+colonic+adenoma-carcinoma+progression+based+on+somatic+Apc+inactivation&doi=10.1158%2F0008-5472.CAN-07-2735"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-2735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-2735%26sid%3Dliteratum%253Aachs%26aulast%3DHinoi%26aufirst%3DT.%26aulast%3DAkyol%26aufirst%3DA.%26aulast%3DTheisen%26aufirst%3DB.%2BK.%26aulast%3DFerguson%26aufirst%3DD.%2BO.%26aulast%3DGreenson%26aufirst%3DJ.%2BK.%26aulast%3DWilliams%26aufirst%3DB.%2BO.%26aulast%3DCho%26aufirst%3DK.%2BR.%26aulast%3DFearon%26aufirst%3DE.%2BR.%26atitle%3DMouse%2520model%2520of%2520colonic%2520adenoma-carcinoma%2520progression%2520based%2520on%2520somatic%2520Apc%2520inactivation%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D9721%26epage%3D9730%26doi%3D10.1158%2F0008-5472.CAN-07-2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engler, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, J.</span></span> <span> </span><span class="NLM_article-title">Lewis acid-directed cyclocondensation of piperidone enol ethers with 2-methoxy-4-(<i>N</i>-phenylsulfonyl)-1,4-benzoquinoneimine: A new regioselective synthesis of oxygenated carbolines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">2444</span>â <span class="NLM_lpage">2457</span>, <span class="refDoi">Â DOI: 10.1021/jo9916176</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo9916176" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=2444-2457&author=T.+A.+Englerauthor=J.+Wanner&title=Lewis+acid-directed+cyclocondensation+of+piperidone+enol+ethers+with+2-methoxy-4-%28N-phenylsulfonyl%29-1%2C4-benzoquinoneimine%3A+A+new+regioselective+synthesis+of+oxygenated+carbolines&doi=10.1021%2Fjo9916176"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo9916176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9916176%26sid%3Dliteratum%253Aachs%26aulast%3DEngler%26aufirst%3DT.%2BA.%26aulast%3DWanner%26aufirst%3DJ.%26atitle%3DLewis%2520acid-directed%2520cyclocondensation%2520of%2520piperidone%2520enol%2520ethers%2520with%25202-methoxy-4-%2528N-phenylsulfonyl%2529-1%252C4-benzoquinoneimine%253A%2520A%2520new%2520regioselective%2520synthesis%2520of%2520oxygenated%2520carbolines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D2444%26epage%3D2457%26doi%3D10.1021%2Fjo9916176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominquez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stouten, P. F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smallwood, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knabb, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of potent and selective amidino bicyclic factor xa inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4398</span>â <span class="NLM_lpage">4415</span>, <span class="refDoi">Â DOI: 10.1021/jm000113t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000113t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4398-4415&author=Q.+Hanauthor=C.+Dominquezauthor=P.+F.+W.+Stoutenauthor=J.+M.+Parkauthor=D.+E.+Duffyauthor=R.+A.+Galemmoauthor=K.+A.+Rossiauthor=R.+S.+Alexanderauthor=A.+M.+Smallwoodauthor=P.+C.+Wongauthor=M.+M.+Wrightauthor=J.+M.+Luettgenauthor=R.+M.+Knabbauthor=R.+R.+Wexler&title=Design%2C+synthesis%2C+and+biological+evaluation+of+potent+and+selective+amidino+bicyclic+factor+xa+inhibitors&doi=10.1021%2Fjm000113t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm000113t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000113t%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DDominquez%26aufirst%3DC.%26aulast%3DStouten%26aufirst%3DP.%2BF.%2BW.%26aulast%3DPark%26aufirst%3DJ.%2BM.%26aulast%3DDuffy%26aufirst%3DD.%2BE.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWright%26aufirst%3DM.%2BM.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520potent%2520and%2520selective%2520amidino%2520bicyclic%2520factor%2520xa%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4398%26epage%3D4415%26doi%3D10.1021%2Fjm000113t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Magid, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maryanoff, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R. D.</span></span> <span> </span><span class="NLM_article-title">Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3849</span>â <span class="NLM_lpage">3862</span>, <span class="refDoi">Â DOI: 10.1021/jo960057x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+amination+of+aldehydes+and+ketones+with+sodium+triacetoxyborohydride.+Studies+on+direct+and+indirect+reductive+amination+procedures&doi=10.1021%2Fjo960057x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0lgAzkhgM5t4Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520amination%2520of%2520aldehydes%2520and%2520ketones%2520with%2520sodium%2520triacetoxyborohydride.%2520Studies%2520on%2520direct%2520and%2520indirect%2520reductive%2520amination%2520procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862%26doi%3D10.1021%2Fjo960057x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Mild method for UIImann coupling reaction of amines and aryl halides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">2453</span>â <span class="NLM_lpage">2455</span>, <span class="refDoi">Â DOI: 10.1021/ol0346584</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0346584" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=2453-2455&author=D.+Maauthor=Q.+Caiauthor=H.+Zhang&title=Mild+method+for+UIImann+coupling+reaction+of+amines+and+aryl+halides&doi=10.1021%2Fol0346584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fol0346584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0346584%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DMild%2520method%2520for%2520UIImann%2520coupling%2520reaction%2520of%2520amines%2520and%2520aryl%2520halides%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D2453%26epage%3D2455%26doi%3D10.1021%2Fol0346584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Topliss, J. G.</span></span> <span> </span><span class="NLM_article-title">Utilization of operational schemes for analog synthesis in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1006</span>â <span class="NLM_lpage">1011</span>, <span class="refDoi">Â DOI: 10.1021/jm00280a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00280a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1006-1011&author=J.+G.+Topliss&title=Utilization+of+operational+schemes+for+analog+synthesis+in+drug+design&doi=10.1021%2Fjm00280a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Utilization of operational schemes for analog synthesis in drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1006-11</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Proposals were presented for stepwise selection for synthesis of new analogs of a biol. active compd. which were designed to maximize the chances of synthesizing the most potent compds. in the series as early as possible.  The schemes were based on a fundamental assumption of the Hansch method that a particular substituent may modify activity relative to the parent compd. by virtue of resulting changes in hydrophobic, electronic, and steric effects.  The effectiveness of the method was illustrated by retrospective application to several existing series of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zymvXigwSbVg90H21EOLACvtfcHk0lgAzkhgM5t4Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D&md5=acf62a05dbdb3d1d17f91097f66ab8c1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00280a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00280a002%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DUtilization%2520of%2520operational%2520schemes%2520for%2520analog%2520synthesis%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D1006%26epage%3D1011%26doi%3D10.1021%2Fjm00280a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Topliss, J. G.</span></span> <span> </span><span class="NLM_article-title">A manual method for applying the Hansch approach to drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">463</span>â <span class="NLM_lpage">469</span>, <span class="refDoi">Â DOI: 10.1021/jm00214a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00214a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaE2sXhtFGgtrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1977&pages=463-469&author=J.+G.+Topliss&title=A+manual+method+for+applying+the+Hansch+approach+to+drug+design&doi=10.1021%2Fjm00214a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A manual method for applying the Hansch approach to drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A procedure is described in which an initial small group of compds. is selected, tested, and ordered according to potency.  The potency order in the group is then compared to the tabulated potency order calcd. for various parameter dependencies relating to hydrophobic, electronic, and steric effects.  From this activity pattern anal. the probable operative parameters can be deduced and a new substituent selection made for the synthesis of potentially more potent analogs.  Application of the method is illustrated with a series of examples.  It differs from a previously described decision tree, single compd. stepwise approach in that it involves the batchwise anal. of small groups of compds., usually the preferred procedure for logistical reasons if the compds. are relatively easy to synthesize.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpILt0RoFSjlbVg90H21EOLACvtfcHk0lgAzkhgM5t4Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXhtFGgtrk%253D&md5=74658b807e3e45cbee88855eda203bdb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm00214a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00214a001%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DA%2520manual%2520method%2520for%2520applying%2520the%2520Hansch%2520approach%2520to%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1977%26volume%3D20%26spage%3D463%26epage%3D469%26doi%3D10.1021%2Fjm00214a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roig, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eskiocak, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hight, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spechler, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, J. W.</span></span> <span> </span><span class="NLM_article-title">Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>138</i></span>, <span class="NLM_elocation-id">1012</span> <span class="refDoi">Â DOI: 10.1053/j.gastro.2009.11.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1053%2Fj.gastro.2009.11.052" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2010&author=A.+I.+Roigauthor=U.+Eskiocakauthor=S.+K.+Hightauthor=S.+B.+Kimauthor=O.+Delgadoauthor=R.+F.+Souzaauthor=S.+J.+Spechlerauthor=W.+E.+Wrightauthor=J.+W.+Shay&title=Immortalized+epithelial+cells+derived+from+human+colon+biopsies+express+stem+cell+markers+and+differentiate+in+vitro&doi=10.1053%2Fj.gastro.2009.11.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2009.11.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2009.11.052%26sid%3Dliteratum%253Aachs%26aulast%3DRoig%26aufirst%3DA.%2BI.%26aulast%3DEskiocak%26aufirst%3DU.%26aulast%3DHight%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BB.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DSouza%26aufirst%3DR.%2BF.%26aulast%3DSpechler%26aufirst%3DS.%2BJ.%26aulast%3DWright%26aufirst%3DW.%2BE.%26aulast%3DShay%26aufirst%3DJ.%2BW.%26atitle%3DImmortalized%2520epithelial%2520cells%2520derived%2520from%2520human%2520colon%2520biopsies%2520express%2520stem%2520cell%2520markers%2520and%2520differentiate%2520in%2520vitro%26jtitle%3DGastroenterology%26date%3D2010%26volume%3D138%26doi%3D10.1053%2Fj.gastro.2009.11.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, D. J.</span></span> <span> </span><span class="NLM_article-title">The potential role of lysosomes in tissue distribution of weak bases</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">513</span>â <span class="NLM_lpage">526</span>, <span class="refDoi">Â DOI: 10.1002/bod.2510090602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1002%2Fbod.2510090602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=3067757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADyaL1MXjtlWlsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1988&pages=513-526&author=A.+C.+MacIntyreauthor=D.+J.+Cutler&title=The+potential+role+of+lysosomes+in+tissue+distribution+of+weak+bases&doi=10.1002%2Fbod.2510090602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of lysosomes in tissue distribution of weak bases</span></div><div class="casAuthors">MacIntyre, Anna C.; Cutler, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">513-26</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    </div><div class="casAbstract">A review with 68 refs.  Lysosomal trapping of weak bases, dependence of weak base accumulation on structural integrity of tissues, in vitro studies of weak base distribution in tissues, and pharmacokinetics of lysosomal trapping are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMtNLuz5Y2bVg90H21EOLACvtfcHk0lhzVClwqUfwIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXjtlWlsQ%253D%253D&md5=fbfdb93211453b424daa22355ef88717</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fbod.2510090602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbod.2510090602%26sid%3Dliteratum%253Aachs%26aulast%3DMacIntyre%26aufirst%3DA.%2BC.%26aulast%3DCutler%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potential%2520role%2520of%2520lysosomes%2520in%2520tissue%2520distribution%2520of%2520weak%2520bases%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D1988%26volume%3D9%26spage%3D513%26epage%3D526%26doi%3D10.1002%2Fbod.2510090602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazmi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hensley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loewen, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, A.</span></span> <span> </span><span class="NLM_article-title">Lysosomal sequestration (trapping) of lipophylic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells)</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">897</span>â <span class="NLM_lpage">905</span>, <span class="refDoi">Â DOI: 10.1124/dmd.112.050054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1124%2Fdmd.112.050054" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=897-905&author=F.+Kazmiauthor=T.+Hensleyauthor=C.+Popeauthor=R.+S.+Funkauthor=G.+J.+Loewenauthor=D.+B.+Buckleyauthor=A.+Parkinson&title=Lysosomal+sequestration+%28trapping%29+of+lipophylic+amine+%28cationic+amphiphilic%29+drugs+in+immortalized+human+hepatocytes+%28Fa2N-4+cells%29&doi=10.1124%2Fdmd.112.050054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.050054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.050054%26sid%3Dliteratum%253Aachs%26aulast%3DKazmi%26aufirst%3DF.%26aulast%3DHensley%26aufirst%3DT.%26aulast%3DPope%26aufirst%3DC.%26aulast%3DFunk%26aufirst%3DR.%2BS.%26aulast%3DLoewen%26aufirst%3DG.%2BJ.%26aulast%3DBuckley%26aufirst%3DD.%2BB.%26aulast%3DParkinson%26aufirst%3DA.%26atitle%3DLysosomal%2520sequestration%2520%2528trapping%2529%2520of%2520lipophylic%2520amine%2520%2528cationic%2520amphiphilic%2529%2520drugs%2520in%2520immortalized%2520human%2520hepatocytes%2520%2528Fa2N-4%2520cells%2529%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D897%26epage%3D905%26doi%3D10.1124%2Fdmd.112.050054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lien, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solheim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueland, P. M.</span></span> <span> </span><span class="NLM_article-title">Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4837</span>â <span class="NLM_lpage">4844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=4837-4844&author=E.+A.+Lienauthor=E.+Solheimauthor=P.+M.+Ueland&title=Distribution+of+tamoxifen+and+its+metabolites+in+rat+and+human+tissues+during+steady-state+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLien%26aufirst%3DE.%2BA.%26aulast%3DSolheim%26aufirst%3DE.%26aulast%3DUeland%26aufirst%3DP.%2BM.%26atitle%3DDistribution%2520of%2520tamoxifen%2520and%2520its%2520metabolites%2520in%2520rat%2520and%2520human%2520tissues%2520during%2520steady-state%2520treatment%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D4837%26epage%3D4844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reasor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, R. G.</span></span> <span> </span><span class="NLM_article-title">Drug-induced phospholipidosis: issues and future directions</span>. <i>Expert Opin. Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">567</span>â <span class="NLM_lpage">583</span>, <span class="refDoi">Â DOI: 10.1517/14740338.5.4.567</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1517%2F14740338.5.4.567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=16774494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSksL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=567-583&author=M.+J.+Reasorauthor=K.+L.+Hastingsauthor=R.+G.+Ulrich&title=Drug-induced+phospholipidosis%3A+issues+and+future+directions&doi=10.1517%2F14740338.5.4.567"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced phospholipidosis: issues and future directions</span></div><div class="casAuthors">Reasor, Mark J.; Hastings, Kenneth L.; Ulrich, Roger G.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">567-583</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Numerous drugs contg. a cationic amphiphilic structure are capable of inducing phospholipidosis in cells under conditions of in vivo administration or ex vivo incubation.  The principal characteristics of this condition include the reversible accumulation of polar phospholipids in assocn. with the development of unicentric or multicentric lamellated bodies within cells.  There is an abundance of data providing an understanding of potential mechanisms for the induction of phospholipidosis; however, the process is likely to be complex and may differ from one drug to another.  The functional consequences of the presence of this condition on cellular or tissue function are not well understood.  The general consensus is that the condition is an adaptive response rather than a toxicol. manifestation; however, addnl. studies to examine this question are needed.  Until this issue is resolved, concerns about phospholipidosis will continue to exist at regulatory agencies.  Procedures for the screening of potential phospholipogenic candidate compds. are available.  In contrast, a clear need exists for the identification of valid biomarkers to assess the development of phospholipidosis in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwYtmd7pqUebVg90H21EOLACvtfcHk0lhzVClwqUfwIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSksL8%253D&md5=a2801d85bc4f1730f69272eaea3ce17b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1517%2F14740338.5.4.567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.5.4.567%26sid%3Dliteratum%253Aachs%26aulast%3DReasor%26aufirst%3DM.%2BJ.%26aulast%3DHastings%26aufirst%3DK.%2BL.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26atitle%3DDrug-induced%2520phospholipidosis%253A%2520issues%2520and%2520future%2520directions%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2006%26volume%3D5%26spage%3D567%26epage%3D583%26doi%3D10.1517%2F14740338.5.4.567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNaney, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drexler, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hnatyshyn, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvyaga, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belcastro, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M.</span></span> <span> </span><span class="NLM_article-title">An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">121</span>â <span class="NLM_lpage">129</span>, <span class="refDoi">Â DOI: 10.1089/adt.2007.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1089%2Fadt.2007.103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=18336089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=121-129&author=C.+A.+McNaneyauthor=D.+M.+Drexlerauthor=S.+Y.+Hnatyshynauthor=T.+A.+Zvyagaauthor=J.+O.+Knipeauthor=J.+V.+Belcastroauthor=M.+Sanders&title=An+automated+liquid+chromatography-mass+spectrometry+process+to+determine+metabolic+stability+half-life+and+intrinsic+clearance+of+drug+candidates+by+substrate+depletion&doi=10.1089%2Fadt.2007.103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion</span></div><div class="casAuthors">McNaney, Colleen A.; Drexler, Dieter M.; Hnatyshyn, Serhiy Y.; Zvyaga, Tatyana A.; Knipe, Jay O.; Belcastro, James V.; Sanders, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">121-129</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">An automated process is described for the detailed assessment of the in vitro metabolic stability properties of drug candidates in support of pharmaceutical property profiling.  Compds. are incubated with liver microsomes using a robotic liq. handler.  Aliquots are taken at various time points, and the resulting samples are quant. analyzed by liq. chromatog.-mass spectrometry utilizing ion trap mass spectrometers to det. the amt. of compd. remaining.  From these data metab. rates can be calcd.  A high degree of automation is achieved through custom software, which is employed for instrument setup, data processing, and results reporting.  The assay setup is highly configurable, allowing for any combination of up to six user-selected time points, variable substrate concn., and microsomes or other biol. active media.  The data, based on relative substrate depletion, affords an est. of metabolic stability through the calcn. of half-life (t1/2) and intrinsic clearance, which are used to differentiate and rank order drug leads.  In general, t1/2 is the time necessary for the metab., following first-order kinetics, of 50 of the initial compd.  Intrinsic clearance is the proportionality const. between rate of metab. of a compd. and its concn. at the enzyme site.  Described here is the setup of the assay, and data from assay test compds. are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEaz4jJWXzM7Vg90H21EOLACvtfcHk0lhzVClwqUfwIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtbs%253D&md5=3833f7d7c4be366bc2d4b3e656ef4ae2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.103%26sid%3Dliteratum%253Aachs%26aulast%3DMcNaney%26aufirst%3DC.%2BA.%26aulast%3DDrexler%26aufirst%3DD.%2BM.%26aulast%3DHnatyshyn%26aufirst%3DS.%2BY.%26aulast%3DZvyaga%26aufirst%3DT.%2BA.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DBelcastro%26aufirst%3DJ.%2BV.%26aulast%3DSanders%26aufirst%3DM.%26atitle%3DAn%2520automated%2520liquid%2520chromatography-mass%2520spectrometry%2520process%2520to%2520determine%2520metabolic%2520stability%2520half-life%2520and%2520intrinsic%2520clearance%2520of%2520drug%2520candidates%2520by%2520substrate%2520depletion%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D121%26epage%3D129%26doi%3D10.1089%2Fadt.2007.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span> <span> </span><span class="NLM_article-title">A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">112</span>â <span class="NLM_lpage">117</span>, <span class="refDoi">Â DOI: 10.1016/j.jpba.2012.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1016%2Fj.jpba.2012.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=23312388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1WnsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=112-117&author=C.+Wangauthor=N.+S.+Williams&title=A+mass+balance+approach+for+calculation+of+recovery+and+binding+enables+the+use+of+ultrafiltration+as+a+rapid+method+for+measurement+of+plasma+protein+binding+for+even+highly+lipophilic+compounds&doi=10.1016%2Fj.jpba.2012.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds</span></div><div class="casAuthors">Wang, Changguang; Williams, Noelle S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112-117</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The aim of this study is to further validate the use of ultrafiltration (UF) as a method for detg. plasma protein binding (PPB) by demonstrating that non-specific binding (NSB) is not a limitation, even for highly lipophilic compds., because NSB sites on the app. are passivated in the presence of plasma.  Mass balance theory was used to calc. recovery of 20 com. and seven investigational compds. during ultrafiltration in the presence and absence of plasma.  PPB was also measured using this mass balance approach for comparison to PPB detd. by rapid equil. dialysis (RED) and as found in the literature.  Compd. recovery during UF was dramatically different in the presence and absence of plasma for compds. with high NSB in PBS only.  A comparison of PPB calcd. by ultrafiltration with literature values or calcd. by RED gave concordant results.  Discrepancies could be explained by changes in pH, insufficient time to equil., or compd. instability during RED, problems which were circumvented by ultrafiltration.  Therefore, NSB, as measured by the traditional incubation of compd. in PBS, need not be an issue when choosing UF as a PPB assay method.  It is more appropriate to calc. compd. recovery from the device in plasma as measured by mass balance to det. the suitability of the method for an individual compd.  The speed with which UF can be conducted addnl. avoids changes in pH or compd. loss that can occur with other methods.  The mass balance approach to UF is thus a preferred method for rapid detn. of PPB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_4BPF0CHgYbVg90H21EOLACvtfcHk0ljmwlfzzpJnMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1WnsQ%253D%253D&md5=c5d42f85a2cd8edafae32d9662faabed</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2012.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2012.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26atitle%3DA%2520mass%2520balance%2520approach%2520for%2520calculation%2520of%2520recovery%2520and%2520binding%2520enables%2520the%2520use%2520of%2520ultrafiltration%2520as%2520a%2520rapid%2520method%2520for%2520measurement%2520of%2520plasma%2520protein%2520binding%2520for%2520even%2520highly%2520lipophilic%2520compounds%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2013%26volume%3D75%26spage%3D112%26epage%3D117%26doi%3D10.1016%2Fj.jpba.2012.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span> <span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: Implications for rational drug discovery</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">327</span>â <span class="NLM_lpage">338</span>, <span class="refDoi">Â DOI: 10.1002/bdd.325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+Implications+for+rational+drug+discovery&doi=10.1002%2Fbdd.325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0ljmwlfzzpJnMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520Implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338%26doi%3D10.1002%2Fbdd.325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, Y.</span></span> <i>The Handbook of Essential Pharmacokinetics, Pharmacodynamics, and Drug Metabolism for Industrial Scientists</i>; <span class="NLM_publisher-name">Kluwer Academic/Plenum Publishers</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2001</span>; pp  <span class="NLM_fpage">231</span>â <span class="NLM_lpage">232</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=231-232&author=Y.+Kwon&title=The+Handbook+of+Essential+Pharmacokinetics%2C+Pharmacodynamics%2C+and+Drug+Metabolism+for+Industrial+Scientists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DY.%26btitle%3DThe%2520Handbook%2520of%2520Essential%2520Pharmacokinetics%252C%2520Pharmacodynamics%252C%2520and%2520Drug%2520Metabolism%2520for%2520Industrial%2520Scientists%26pub%3DKluwer%2520Academic%252FPlenum%2520Publishers%26date%3D2001%26spage%3D231%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amewu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabbani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocks, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charnaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bongard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozanom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JesÃºs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gargallo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeill, P. M.</span></span> <span> </span><span class="NLM_article-title">Two-step synthesis of achiral dispiro-1,2,4,5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profiles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2170</span>â <span class="NLM_lpage">2177</span>, <span class="refDoi">Â DOI: 10.1021/jm701435h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701435h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlOjsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2170-2177&author=G.+L.+Ellisauthor=R.+Amewuauthor=S.+Sabbaniauthor=P.+A.+Stocksauthor=A.+Shoneauthor=D.+Stanfordauthor=P.+Gibbonsauthor=J.+Daviesauthor=L.+Vivasauthor=S.+Charnaudauthor=E.+Bongardauthor=C.+Hallauthor=K.+Rimmerauthor=S.+Lozanomauthor=M.+Jes%C3%BAsauthor=D.+Gargalloauthor=S.+A.+Wardauthor=P.+M.+O%E2%80%99Neill&title=Two-step+synthesis+of+achiral+dispiro-1%2C2%2C4%2C5-tetraoxanes+with+outstanding+antimalarial+activity%2C+low+toxicity%2C+and+high-stability+profiles&doi=10.1021%2Fjm701435h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Two-Step Synthesis of Achiral Dispiro-1,2,4,5-tetraoxanes with Outstanding Antimalarial Activity, Low Toxicity, and High-Stability Profiles</span></div><div class="casAuthors">Ellis, Gemma L.; Amewu, Richard; Sabbani, Sunil; Stocks, Paul A.; Shone, Alison; Stanford, Deborah; Gibbons, Peter; Davies, Jill; Vivas, Livia; Charnaud, Sarah; Bongard, Emily; Hall, Charlotte; Rimmer, Karen; Lozanom, Sonia; Jesus, Maria; Gargallo, Domingo; Ward, Stephen A.; O'Neill, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2170-2177</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Piperidinedispirotetraoxanes such as I (R = Et, cyclopropyl) are prepd. by a rapid, two-step method; the products have potent antimalarial activity both in vitro and in vivo.  Sulfonylpiperidinones are prepd. by sulfonylation of 4-piperidinone hydrochloride with sulfonyl chlorides; oxidn. of the sulfonylpiperidinones with hydrogen peroxide in the presence of methyltrioxorhenium followed by cyclocondensation with either 2-adamantanone or cyclododecanone in the presence of fluoroboric acid in ether yields the title piperidinedispirotetraoxanes.  The 1,2,4,5-tetraoxanes prepd. are more stable than similar 1,2,4-trioxolanes and are both more stable and more active as antimalarial agents than the corresponding 1,2,4-trioxanes.  I (R = Et, cyclopropyl) showed no mutagenicity or cytotoxicity at the doses tested in a variety of cell lines.  A fluorescent nitrobenzaoxadiazole-tagged tetraoxane is prepd. as a probe; laser scanning confocal microscopy of red blood cells dosed with the probe indicates that tagged mols. accumulate selectively only in parasite infected erythrocytes and that intraparasitic formation of adducts could be inhibited by co-incubation with the iron chelator desferrioxamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgtxzi2qAKTLVg90H21EOLACvtfcHk0ljmwlfzzpJnMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlOjsL4%253D&md5=3c4b69f56bbf84ca035f4fe62716073e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm701435h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701435h%26sid%3Dliteratum%253Aachs%26aulast%3DEllis%26aufirst%3DG.%2BL.%26aulast%3DAmewu%26aufirst%3DR.%26aulast%3DSabbani%26aufirst%3DS.%26aulast%3DStocks%26aufirst%3DP.%2BA.%26aulast%3DShone%26aufirst%3DA.%26aulast%3DStanford%26aufirst%3DD.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DVivas%26aufirst%3DL.%26aulast%3DCharnaud%26aufirst%3DS.%26aulast%3DBongard%26aufirst%3DE.%26aulast%3DHall%26aufirst%3DC.%26aulast%3DRimmer%26aufirst%3DK.%26aulast%3DLozanom%26aufirst%3DS.%26aulast%3DJes%25C3%25BAs%26aufirst%3DM.%26aulast%3DGargallo%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DTwo-step%2520synthesis%2520of%2520achiral%2520dispiro-1%252C2%252C4%252C5-tetraoxanes%2520with%2520outstanding%2520antimalarial%2520activity%252C%2520low%2520toxicity%252C%2520and%2520high-stability%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2170%26epage%3D2177%26doi%3D10.1021%2Fjm701435h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsalkova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepurny, O. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holz, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of small molecules as potent and specific EPAC2 antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">952</span>â <span class="NLM_lpage">962</span>, <span class="refDoi">Â DOI: 10.1021/jm3014162</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3014162" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVartA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=952-962&author=H.+Chenauthor=T.+Tsalkovaauthor=O.+G.+Chepurnyauthor=F.+C.+Meiauthor=G.+G.+Holzauthor=X.+Chengauthor=J.+Zhou&title=Identification+and+characterization+of+small+molecules+as+potent+and+specific+EPAC2+antagonists&doi=10.1021%2Fjm3014162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of Small Molecules as Potent and Specific EPAC2 Antagonists</span></div><div class="casAuthors">Chen, Haijun; Tsalkova, Tamara; Chepurny, Oleg G.; Mei, Fang C.; Holz, George G.; Cheng, Xiaodong; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">952-962</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">EPAC1 and EPAC2, two isoforms of exchange proteins directly activated by cAMP (EPAC), respond to the second messenger cAMP and regulate a wide variety of intracellular processes under physiol. and pathophysiol. circumstances.  Herein, we report the chem. design, synthesis, and pharmacol. characterization of three different scaffolds (diarylsulfones, N,N-diarylamines, and arylsulfonamides) as highly potent and selective antagonists of EPAC2.  Several selective EPAC2 antagonists have been identified including 20i (HJC0350, I), which has an apparent IC50 of 0.3 Î¼M for competing with 8-NBD-cAMP binding of EPAC2 and is about 133-fold more potent than cAMP.  Compds. 1 (ESI-05), 14c (HJC0338), and 20i, selected from each series, have exhibited no inhibition of EPAC1-mediated Rap1-GDP exchange activity at 25 Î¼M, indicating that they are EPAC2-specific antagonists.  Moreover, live-cell imaging studies using EPAC1, EPAC2, or PKA FRET sensor also demonstrate that 20i functions as an EPAC2 specific antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrumM4DblVhxLVg90H21EOLACvtfcHk0lipuPyA8QOS_A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVartA%253D%253D&md5=5f100066fb30778ba2793a8543d4b89a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm3014162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3014162%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTsalkova%26aufirst%3DT.%26aulast%3DChepurny%26aufirst%3DO.%2BG.%26aulast%3DMei%26aufirst%3DF.%2BC.%26aulast%3DHolz%26aufirst%3DG.%2BG.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520small%2520molecules%2520as%2520potent%2520and%2520specific%2520EPAC2%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D952%26epage%3D962%26doi%3D10.1021%2Fjm3014162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i165"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00532">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_03361"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00532">10.1021/acs.jmedchem.9b00532</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Biological assay data and SMILES structures for all tested compounds (Table S1); procedures and characterization of synthetic intermediates; and copies of <sup>1</sup>H and <sup>13</sup>C spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_001.pdf">jm9b00532_si_001.pdf (17.71 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00532/suppl_file/jm9b00532_si_002.csv">jm9b00532_si_002.csv (12.87 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00532&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00532%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-10%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00532" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a97692f133d36","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
